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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
76 
 
major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
78 
 
 
 
Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
82 
 
Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
 
 
83 
 
In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
104 
 
 
Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
137 
 
original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
 
151 
 
Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
162 
 
which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
254 
 
vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
 
284 
 
As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
 
 
  
359 
 
 
 
During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
19 
 
administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
28 
 
11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
70 
 
infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
119 
 
 
There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
 
 
 
 
 
120 
 
Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
 
123 
 
 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
 
 
 
 
 
 
 
 
 
 
 
 
145 
 
Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
154 
 
d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
172 
 
regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
176 
 
a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
202 
 
corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
219 
 
infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
224 
 
C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
240 
 
severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
 
 
 
 
255 
 
Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
  
262 
 
 
Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
 
 
280 
 
Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
  
301 
 
studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
 
  
304 
 
Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
19 
 
administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
 
 
 
53 
 
12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
61 
 
were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
 
 
 
 
 
 
64 
 
12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
79 
 
Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
107 
 
ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
 
143 
 
The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
181 
 
scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
 
 
 
190 
 
 
 
 
14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
 
 
205 
 
Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
 
214 
 
A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
 
 
 
 
255 
 
Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
260 
 
        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
315 
 
18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
 
 
 
 
 
  
357 
 
 
 
…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
21 
 
al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
31 
 
 
The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
36 
 
participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
37 
 
The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
55 
 
independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
 
 
 
 
 
 
73 
 
 
 
 
Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
 
96 
 
The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
97 
 
Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
102 
 
 
There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
110 
 
Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
114 
 
compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
117 
 
maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
119 
 
 
There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
136 
 
contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
150 
 
13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
 
 
205 
 
Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
 
214 
 
A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
 
 
 
 
218 
 
14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
221 
 
response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
 
235 
 
16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
273 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
275 
 
 
 
Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
 
 
 
 
  
364 
 
 
 
 
 
 
 
 
 
 
 
 
CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
18 
 
10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
21 
 
al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
84 
 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
162 
 
which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
238 
 
"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
 
 
 
245 
 
17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
 
283 
 
The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
  
286 
 
Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
 
 
 
 
 
  
360 
 
 
 
…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
 
  
366 
 
 
 
Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
 
34 
 
This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
136 
 
contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
 
143 
 
The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
 
 
 
178 
 
Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
 
206 
 
The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
 
 
 
 
 
 
 
 
 
 
216 
 
 
Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
 
233 
 
subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
246 
 
Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
 
 
 
 
 
 
 
279 
 
Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
 
283 
 
The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
 
  
300 
 
The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
 
  
304 
 
Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
 
 
 
 
  
365 
 
 
 
 
 
MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
42 
 
completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
58 
 
 
The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
90 
 
  
 
Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
127 
 
 
13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
 
139 
 
Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
 
164 
 
Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
168 
 
association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
 
 
 
178 
 
Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
194 
 
analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
 
 
 
 
 
 
 
 
201 
 
Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
 
 
205 
 
Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
225 
 
2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
230 
 
 
It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
236 
 
• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
 
 
244 
 
16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
266 
 
Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
276 
 
Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
285 
 
Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
 
  
293 
 
All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
  
310 
 
having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
321 
 
 
 
19 REFERENCES 
 
• Ahern, D. K., Gorin L, Anderson GL, Tierney C, Hallstrom A, Ewart C, 
Copne RJ, Schrom E, et al. (1990-A) Cardiac Arrhythmia Pilot Study 
(CAPS) Investigators: Bio-behavioural variables and mortality or cardiac 
arrest in the Cardiac Arrhythmia Pilot Study (CAPS) Am J Cardiol; 66:59-
62 
• Akhter SM, Malik BS, Khan AM (2008). Psychosocial factors associated 
with symptoms of depression and anxiety following AMI. Pak J Med Scie. 
24(2) 192-197 
• American Psychiatric Association Committee on Nomenclature and 
Statistics. Diagnostic and Statistical Manual of Mental Disorders, 
Revised. 4th ed. Washington, DC: APA (1994) 
• Balarajan, R.(1996).Ethnicity and variations in morality from coronary 
heart disease. Hlth Trends; 28:45-51 
• Barefoot JC, Schroll M. Symptoms of depression, acute myocardial 
infarction and total mortality in a community sample. Circulation 1996; 
93:1976–80. 
• Barefoot, J. C., Helms, M. J., Mark, D. B., Blumenthal, J. A., Califf, R. M., 
Haney, T. L., et al. (1996). Depression and long-term mortality risk in 
patients with coronary artery disease. American Journal of Cardiology, 
78(6), 613-617. 
• Bayard-Burfeld L, Sundquist J, Johansson SE, (2001) Ethnicity, self 
reported psychiatric illness and intake of psychotropic drugs in five ethnic 
groups in Sweden. J Epidemiology Community Health. 55:657-664 
• Beck A. T., Ward CH, Mendelson M, et al. (1961). An inventory for 
measuring depression. Arch General Psychiatry ;4 : 561-571 
• Beck A. T., Steer RA., (1987). Beck depression inventory manual. San 
Antonio: Harcourt Brace Jovanovich. 
  
322 
 
• Beck, A. T., Steer RA, Garbin M (1981). Psychometric properties of the 
depression inventory. Twenty-five years of evaluation. Clinical 
Psychology Review; 8:1003-1009.  
• Beck, C. A., Joseph, L., Belisle, P., & Pilote, L. (2001). Predictors of 
quality of life 6 months and 1 year after acute myocardial infarction. 
American Heart Journal, 142(2), 271-279. 
• Berkman, L. F., Leo-Summers, L., & Horwitz, R. I. (1992). Emotional 
support and survival after myocardial infarction. A prospective, 
population-based study of the elderly. Annals of Internal Medicine, 
117(12), 1003-1009. 
• Bhui, K et al. (2004). Assessing the prevalence of depression in Punjabi 
and English primary care attenders: the role of culture, physical illness 
and somatic symptoms, Transcult Psychiatry, 41(3): 307-22.  
• Bhui, K., Bhugra, D., & Goldberg, D. (2000). Cross-cultural validity of the 
Amritsar Depression Inventory and the General Health Questionnaire 
amongst English and Punjabi primary care attenders. Social Psychiatry 
and 
• Bokhari SS, Samad AH, Hanif S et al (2002)., Prevalence of depression 
in patients with coronary heart disease in a tertiary care hospital in 
Pakistan. J Pak Med Assoc ; 52(9)  436-439) 
• Brink, E et al (2002). Health Experience of first time myocardial 
infarction: factors influencing women’s and men’s health related quality of 
life (QOL) after five months. Psychology, Health and Medicine, 7, 1:5 -16. 
• Brown, G.W. & Harris, T.(1978) Social Origins of Depression. London:  
• Brown, N., Melville, M., Gray, D., et al. (1999). Quality of life four years 
after acute myocardial infarction: Short form 36 scores compared with a 
normal population. Heart; 81:351-358 
• Bush, D.E., Zeigelstein, R.C., Tayback, M., et al. (2001). The American 
Journal of Cardiology; 88(15):337-341 
• Carney R, Blumenthal J, Cattelier,D et al (2003). Depression s a risk 
factor for mortality after AMI; Am J Cardiology 92: 1277-1281 
  
323 
 
• Carney, R. M., Rich, M. W., Freedland, K. E., et al. (1988). Major 
depressive disorder predicts cardiac events in patients with coronary 
artery disease. Psychosomatic Medicine, 50(6), 627-633. 
• Carney, R. M., Rich, M. W., Freedland, K. E., Saini, J., teVelde, A., 
Simeone, C., et al. (1988).  Major depressive disorder predicts cardiac 
events in patients with coronary artery disease. Psychosomatic Medicine, 
50(6), 627-633. 
• Christenfeld, N., J, S, Sloan, R., P, Carroll, D., & Greenland, S. (2004). 
Risk factors, confounding and the illusion of statistical control. 
Psychosomatic Medicine, 66, 868-875. 
• Cohen, J. (1988). Statistical power analysis for the behavioural sciences. 
Hillsdale, NJ, Erlbaum. 
• Commander, J.M., Odell, S.M., Surtees, P.G., Sashidharan, S.P. (2004). 
Care pathways for South Asian and white people with depressive and 
anxiety disorders in the community. Soc Psychiatry Psychiatr Epidemiol, 
39:259-264. 
• de Jonge, P., Spijkerman, T. A., Van den Brink, R. H., & Ormel, J. 
(2006a). Depression after myocardial infarction is a risk factor for 
declining health related quality of life and increased disability and cardiac 
complaints at 12 months. Heart, 92, 32-39. 
• Dean, C., Surtees, P.G. & Sashidharan, S.P. (1983). Comparison of 
research diagnostic systems in an Edinburgh community sample, British 
Journal of Psychiatry. 142:247-256. 
• Dias CC, Mateus P, Santos L et al (2005)  Acute coronary syndrome and 
predictors of quality of life. Rev Port Cardiol;24:819– 31. 
• Dickens, C. M., McGowan, L., Percival, C., Tomenson, B., Cotter, L., 
Heagarty, A., et al. (2006). Contribution of depression and anxiety to 
impaired health-related quality of life following first myocardial infarction. 
British Journal of Psychiatry, 189(4), 367-372. 
• Dickens, C. M., McGowan, L., Percival, C., Tomenson, B., Cotter, L., 
Heagarty, A., et al. (2007). Depression is a risk factor for mortality after 
myocardial infarction. Journal of the American College of Cardiology, 
49(18), 1834-1840. 
  
324 
 
• Dickens, C. M., McGowen, L., Percival, C., Douglas, J., Tomenson, B., 
Cotter, L., et al. (2004). Lack of a close confidant, but not depression, 
predicts further cardiac events after myocardial infarction. Heart, 90(5), 
518-522. 
• Dogar AI, Khawaja SI , Azeen WM et al ( 2008). Prevalence and risk 
factors for depression and anxiety in hospitalised cardiac patients in 
Pakistan. Psychiatry ( Edgmont) .5( 2) 38-41. 
• Failde, I. & Ramos, I. (2000) Validity and reliability of the SF^36 Health 
Survey Questionnaire in patients with coronary artery disease. Journal of 
Clinical Epidemiology, 53, 359-365. 
• Fauerbach, J. A., Bush, D. E., Thombs, B. D., McCann, U. D., Fogel, J., 
& Ziegelstein, R. C. (2005). Depression Following Acute Myocardial 
Infarction: A Prospective Relationship with Ongoing Health and Function. 
Psychosomatics, 46(4), 355-361  
• Field, A. (2000) Discovering statistics using SPSS for Windows. London: 
Sage Publications. 
• Frasure-Smith, N., Lesperance, F., & Talajic, M. (1995 a1). The impact of 
negative emotions on prognosis following myocardial infarction: is it more 
than depression? Health Psychology, 14(5), 388-398. 
• Frasure-Smith, N., Lesperance, F., & Talajic, M. (1995 a2). The impact of 
negative emotions on prognosis following myocardial infarction: is it more 
than depression? Health Psychology, 14(5), 388-398. 
• Frasure-Smith, N., Lesperance, F., & Talajic, M. (1993 b1). Depression 
following myocardial infarction: impact on 6 month survival. JAMA, 
270(15), 1819-1825. 
• Frasure-Smith, Lesperance, & Talajic. (1995 b2). Coronary Heart 
Disease / Myocardial Infarction: Depression and 18-month prognosis 
after myocardial infarction. Circulation, 91(4), 999-1005. 
• Frasure-Smith, Lesperance, & Talajic. (1995 b4). Coronary Heart 
Disease / Myocardial Infarction: Depression and 18-month prognosis 
after myocardial infarction. Circulation, 91(4), 999-1005. 
 
  
325 
 
• Frasure-Smith, N., Lesperance, F., Juneau, M., Talajic, M., & Bourassa, 
M. G. (1999). Gender, depression and one year prognosis after 
myocardial infarction. Psychosomatic Medicine, 61(1), 26-37. 
• Gater, R, Tomenson B, Percival C, et al., (2009) Persistent depressive 
disorder and social stress in people of Pakistani origin and white 
Europeans in the UK. Soc Psychiatry Psychiatrica Epidemiol. 44:198-207 
• Glassman, A., Shapiro, P., Ford, D., Culpepper, L., Finkel, M., Swenson, 
R., et al. (2003). Cardiovascular Health and Depression. Journal of 
Psychiatric Practice, 9(6), 409-421. 
• Goldberg, D. & Huxley, P. (1992). Common Mental Disorders: Bio-Social 
Model. Routledge: London. 
• Goldberg, D. P., Gater, R., Sartorius, N., Ustun, T. B., Piccinelli, M., 
Gureje, O., & Rutter, C.(1997). The validity of two versions of the GHQ in 
the WHO study of mental illness in general health care. Psychological 
Medicine, 27(1),191–197. 
• Gorkin, L., Schron EB, Brooks MM, et al. (1993). Psychosocial predictors 
of mortality in the Cardiac Arrhythmias Suppression Trial-1(CAST-1). 
.Am J Cardiol ;71: 263-267 
• Grace, S. L., Abbey, S. E., Kapral, M. K., Fang, J., Nolan, R. P., Stewart, 
D. E., et al. (2005). Effect of depression on five-year mortality after an 
acute coronary syndrome. American Journal of Cardiology, 96(9), 1179-
1185. 
• Hemingway, H., Whitty, C. J., Shipley, M, et al( 2001). Psychosocial risk 
factors for coronary disease in White, South Asian and Afro-Caribbean 
civil servants: the Whitehall II study. Ethn Dis;11:391-400 
• Husain, N; Gater,R, Tomeson B et al ( 2004). Social factors associated 
with chronic depression among a population based sample of women in 
rural Pakistan. Soc Psychiatr Epidemiol39: 618-624 
• Husain, N., Creed, F., & Tomenson, B. (1997). Adverse social 
circumstances and depression in people of Pakistani origin in the UK. 
British Journal of Psychiatry 
• Husain, N., Creed, F., Tomenson, B., (2000) Depression and social 
stress in Pakistan. Pschol Med 30:395-402. 
  
326 
 
• Jacobs, K. S., Bhugra D, Mann AH. (1991). Validation of the 12-item 
General Health Questionnaire among ethnic Indian women living in the 
United Kingdom. Psycol Med; 10:18-24  
• Jenkinson, C. M., Coulter, A., & Wright, L. (1993). Short form 36 (SF 36) 
health survey questionnaires: normative data for adults of working age. 
British Medical Journal, 306, 1437-1440. 
• Jenkinson, C. M., Madeley, R. J., Mitchell, J. R., & Turner, I. D. (1993). 
The influence of psychosocial factors on survival after myocardial 
infarction. Public Health, 107(5), 305-317. 
• Kaplan, R.M., (2003). The significance of quality of life in health care. 
Qual Life Res; 12(suppl 1):3-16 
• Kaufmann, W. M., Fitzgibbons JP, Sussman EJ, Reed JF III et al. (1999). 
Relation between MI, depression, hostility, and death.  American Heart 
Journal; 138 (3) :550-553 
• Ladwig KH, Kieser M, Konig J, Breithardt G, Borggefe M. (1991). 
Affective disorders and survival after acute myocardial infarction: results 
from the post-infarction late potential study. Eur Heart J; 12:959-964 
• Ladwig, K. H., Roll, G., Breithardt, G., Budde, T., Borggrefe, M., Ladwig, 
K. H., et al. (1994). Post-infarction depression and incomplete recovery 6 
months after acute myocardial infarction.[see comment]. Lancet, 343(88), 
20-23. 
• Lam CLK, Pan PC, Chan AWT et al (1995). Can the HADS be used on 
Chinese elderly in general practice? Family Practice  12 (2) 149-154 
• Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. (2000). Do 
depression and anxiety predict recurrent coronary events 12 months 
after myocardial infarction? Quarterly Journal of Medicine, 93, 739-744. 
• Lane, D., Carroll, D., Ring, C., Beevers, D. G., Lip, G. Y., Lane, D., et al. 
(2000). Effects of depression and anxiety on mortality and quality-of-life 4 
months after myocardial infarction. Journal of Psychosomatic Research, 
49(4), 229-238. 
• Lane, D., Carroll, D., Ring, C., Beevers, D. G., Lip, G. Y., Lane, D., et al. 
(2001). Mortality and quality of life 12 months after myocardial infarction: 
  
327 
 
effects of depression and anxiety. Psychosomatic Medicine, 63(2), 221-
230. 
• Langford, C. P, Bowsher J, Maloney JP et al (1997).Social Support: a 
conceptual analysis. J Adv Nurs; 25: 95-100 
• Lauzon, C., Beck, C. A., Huynh, T., Dion, D., Racine, N., Carignan, S., et 
al. (2003). Depression and prognosis following hospital admission 
because of acute myocardial infarction. Canadian Medical Association 
Journal, 168(5), 547-552. 
• Lesperance, F., Frasure-Smith, N., & Talajic, M. (1996 b3). Major 
Depression Before and After Myocardial Infarction: Its Nature and 
Consequences. Psychosomatic Medicine, 58(2), 99-110. 
• Lesperance, F., Frasure-Smith, N., Talajic, M., & Bourassa, M. G. (2002). 
Five-year risk of cardiac mortality in relation to initial severity and one-
year changes in depression symptoms after myocardial infarction. 
Circulation, 105(9), 1049-1053. 
• Lloyd GG, Cawley RH. (1983) Distress or illness? A study of the 
psychological 
• Mayou, R. A., Gill, D., Thompson, D. R., Day, A., Hicks, N., Volmink, J., 
et al. (2000). Depression and anxiety as predictors of outcome after 
myocardial infarction. Psychosomatic Medicine, 62(2), 212-219. 
• Mc Dowell, I , Newall C (1996) Measuring Health; In a guide to rating of 
the Scale  and Questionnaires, Second Edition ,New York,  Oxford  
University Press ; 380-492 
• McHorney, C., Ware, J., Rogers, W., Raczek, A., & Lu, R. (1992). The 
Validity and Relative Precision of MOS Short and Long Form Health 
Status Scales and Dartmouth COOP Charts: Results from the Medical 
Outcomes Study. Medical Care, 30(5 (Suppl.)), 253-265. 
• McKeigue, PM, Miller GJ, Marmot MG. (1989) Coronary heart disease in 
South Asians overseas, a review. J Clin Epimediol; 42: 597-609 
• Meltzer H, Gill B, Petticrew M, et al.(1995) The OPCS survey of 
Psychiatric Morbidity in Great Britain.  Report Number One.  The 
prevalence of psychiatric morbidity among adults aged 16-64 living in 
private households in Great Britain. HMSO: London 
  
328 
 
• Mendes de Leon, C. F. (1999). Depression and social support in 
recovery from myocardial infarction: Confounding and confusion. 
Psychosomatic Medicine, 61(6), 738-739. 
• Morrin,L, Black,S, & Reid R (2000). Impact of duration in a cardiac 
rehabilitation program on coronary risk profile ad health related quality of 
life outcomes. J Cardio-pulmonary Rehabilitation.;20: 115-121  
• Murray, C., & Lopez, A. (1997a). Alternative projections of mortality and 
disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 
349, 1498-1504. 
• Murray, C., & Lopez, A. (1997b). Global mortality, disability and the 
contribution of risk factors: Global Burden of Disease Study. Lancet, 349, 
1436-1442. 
• Musselman, D., L, Evans, D., L, & Nemeroff. (1998). the relationship of 
depression to cardiovascular disease. Archives of General Psychiatry, 
55, 580-592. 
• Nazroo, J, Fenton S, Karlsen S , et al (2002).Context, cause and 
meanings: qualitative insights. In : Sproston K , Nazroo J (eds) Ethnic 
minority psychiatric illness rates in the community ( EMPIRIC). National 
Centre for Social Research, London, pp 137-158 
• Odell , S , Surtees PG, Wainwright NW J et al (1997). Determinants of 
general practioner recognition of pschological problems in a multiethnic 
inner city health district. Br J Psych; 171: 537-541 
• OPCS (1992). 1991 Census Definitions Great Britain. HMSO: London 
• Parashar, S., Rumsfeld, J. S., Spertus, J. A., Reid, K. J., Wenger, N. K., 
Krumholz, H. M., et al. (2006). Time course of depression and outcome 
of myocardial infarction. Archives of Internal Medicine, 166(18), 2035-
2043. 
• Pilote, L., LauzonC, Huynh T et al. (2002). Quality life after AMI among 
patients treated at sites with and without on site availability of 
angiography. Arch Intern Med; 162:553-559 
• Pratt, et al; (1996).Depression, psychotic medication and the risk of MI: 
Prospective data from the Baltimore ECA follow up. Circulation 94:3123-
31 
  
329 
 
• Rahman, A., Iqbal, Z., Waheed, W., Hussain, N., (2003). Translation and 
cultural adaptation of health questionnaires. J Pak Med Assoc (JMPA) 
53:142-147. 
• Rehman UR, Ansari AM , Siddiqui A A et al ( 2009). Correlation of Urdu 
version of HADS and Hamilton Depression Rating Scale in quantifying 
depression  among post-MI patients 8( 02) 131-135  
• Ronalds, C., Creed FH., Webb S,. et al (1997). The outcome of anxiety 
and depressive disorder in primary care. BJ Psychiatry; 171:427-433 
• Rufaie OEF, Absood GH (1995). Retesting the validity of the Arabic 
version of the HADS in primary health centre. Soc Psychiatry Psychiatr 
Epidemiol; 30 ; 26-31 
• Rumsfeld, J. S et al (2003). History of depression, angina, and quality of 
life after acute coronary syndrome. Am Heart J March 2003; 493-499. 
• Rumsfeld, J.S., Magid DJ, Plomondon ME, O’Brien MM, Spertus JA, 
Every NR, Sales AE. (2001). Predictors of quality of life following acute 
coronary syndromes. Am J Cardiol. 88:781-4 
• Ruo, B., Rumsfeld JS, Hlatky MA, et al. (2003). Depressive symptoms 
and health related quality of life. The Heart and Soul Study. JAMA;290: 
215-221.  
• Sarason, I., Levine H, Basham R et al. (1983).Assessing social support. 
The Social support Questionnaire. J of Personality and Social 
Psychology.;44: 127-139.  
• Schipper, H., Clinch JJ, Olweny CLM (1996): Quality of life studies: 
definitions and conceptual issues. In Quality of Life and Pharmaco-
economics in Clinical Trials, Second Edition. Edited by Spilker B, 
Philadelphia: Lippincott-Raven; 11-23. 
• Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin 
R, Zucker HD.  (1989). Nature and course of depression following 
myocardial infarction. Arch Intern Med. 149:1785-1789. 
• Shiotani, I., Sato, H., Kinjo, K., Nakatani, D., Mizuno, H., Ohnishi, Y., et 
al. (2002). Depressive symptoms predict 12-month prognosis in elderly 
patients with acute myocardial infarction. Journal of Cardiovascular Risk, 
9(3), 153-160. 
  
330 
 
• Singleton, N., Bumpstead, R., O’Brien et al. (2001). Psychiatric morbidity 
among adults living in private households. The Stationary Office: London 
• Smith, P. & Prior, G. (1997). The fourth National Survey of Ethnic 
Minorities: Technical Report. Social and Community Planning Research: 
London. 
• Stewart, R. A., North, F. M., West, T. M., Sharples, K. J., Simes, R. J., 
Colquhoun, D. M., et al. (2003). Depression and cardiovascular morbidity 
and mortality: cause or consequence? European Heart Journal, 24(22), 
2027-2037. 
• Strik, J. J., Denollet, J., Lousberg, R., & Honig, A. (2003). Comparing 
symptoms of depression and anxiety as predictors of cardiac events and 
increased health care consumption after myocardial infarction. Journal of 
the American College of Cardiology, 42(10), 1801-1807. 
• Strik, J. J., Honig, A., & Maes, M. (2001). Depression and Myocardial 
Infarction: Relationship between Heart and Mind. Neuro-
psychopharmacol & Biological Psychiatry, 25, 879-892. 
• Strik, J. J., Lousberg, R., Cheriex, E. C., & Honig, A. (2004). One year 
cumulative incidence of depression following myocardial infarction and 
impact on cardiac outcome. Journal of Psychosomatic Research, 56, 59-
66.  
• Sullivan, M, D et al. (1997).  Functional Status in Coronary Artery 
Disease (CAD): A one-year prospective study of the role of Anxiety & 
Depression. The Am J of Medicine. 103: 348-56. 
• Thombs, B. D., Ziegelstein, R., Stewart, D. E., Abbey, S. E., Parakh, K., 
& Grace, S. L. (2008). Usefulness of Persistent Symptoms of Depression 
to Predict Physical Health Status 12 Months after an Acute Coronary 
Syndrome. American Journal of Cardiology, 101, 15-19. 
• Valiogo, J., Conrad, M; Poston SW et al(2004).Testing the performance 
of the ENRICHD Social Support Instrument in cardiac Patients. Health 
Qual Life Outcome; 2:24.  
• van der Wurrf FB, Beekman AT, Dijkshoorn et al (2004) Prevalence and 
risk factors for depression in elderly Turkish and Moroccan migrants in 
the Netherlands. J Affect Disord 83: 33-41 
  
331 
 
• van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G., Ormel, 
J., van Veldhuisen, D. J., et al. (2004). Prognostic association of 
depression following myocardial infarction with mortality and 
cardiovascular events: a meta-analysis. Psychosomatic Medicine, 66(6), 
814-822. 
• Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey 
(SF-36). I. Conceptual framework and item selection. Med Care (1992); 
30:473– 83. 
• Ware, J E , Kosinski M., Keller, S.(1994) SF-36 Physical and Mental 
Health Summary Scales: a user’s manual  (2nd edition) Boston ,MA: The 
Health Institute. 
• Weich S, Karlsen S, King M, Lloyd K, Stansfeld S, Tyrer P, (2004). 
Common mental disorders and ethnicity in England: the EPMIRIC study. 
Psychol Med 34:1543-1551 
• Welin, C., Lappas, G., & Wilhelmsen, L. (2000). Independent importance 
of psychosocial factors for prognosis after myocardial infarction. Journal 
of Internal Medicine, 247, 629-639. 
• Wenger NK (1999): Improvement of quality of quality of life in the 
framework of cardiac rehabilitation. In Clinical Cardiac Rehabilitation: A 
Cardiologist’s Guide, Second Edition. Edited by Pashkow FJ, Dafoe WA. 
Baltimore: Williams & Wilkins; 1999:43-51. 
• Wilkinson, P., Sayre J, Lajik, et al. (1996). Comparison of case fertility in 
South Asians and White patients after acute MI: Observational study. 
BMJ; 312: 1330-1333 
• Williams, R. B. , Barefoot JC , Califf RM (1992). Prognostic importance of 
social and economic resources among medically treated patients with 
angiographically documented CAD. JAMA;m267: 520-524 
• Wilson IB, Cleary PD (1995). Linking clinical variables with health-related 
quality of life: a conceptual model of patient outcomes. JAMA; 273:59– 
65. 
• Wilson, S., Delaney, B., Roalfe, A., Roberts, L., Redmain, V., Wearn, A., 
et al. (2000). Randomised controlled trials in primary care: case study. 
British Medical Journal, 321, 24-27. 
  
332 
 
• World Health Organisation (1947). Constitution of the World Health 
Organisation: Chronicle of the world health organisation, Geneva 
• Ziegelstein, R., Fauerbach, J., Stevens, S., Romanelli, J., Richter, D., & 
Bush, D. (2000). Patients with depression are less likely to follow 
recommendations to reduce cardiac risk during recovery from myocardial 
infarction. Archives of Internal Medicine, 160, 1818-1823. 
• Ziegelstein,R,C. (2001).Depression in patients recovering from a 
myocardial infarction. JAMA 286:1621-7 
• Zigmond, A., & Snaith, R.P (1983). The Hospital Anxiety and Depression 
Scale. Acta Psychiatr Scand, 61, 361 - 370. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
333 
 
 
 
 
 
  
 
 
 
 
 
20 APPENDICS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
334 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
335 
 
 
 
 
  
336 
 
 
  
337 
 
 
  
338 
 
 
  
339 
 
Demographic Data Sheet  
 
 
  
340 
 
 
 
 
 
  
341 
 
 
 
  
342 
 
 
 
  
343 
 
 
 
  
344 
 
 
 
  
345 
 
 
  
346 
 
 
  
347 
 
 
  
348 
 
 
 
  
349 
 
 
  
350 
 
 
  
351 
 
 
  
352 
 
 
 
 
  
353 
 
SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
 
 
  
359 
 
 
 
During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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• SF -36  Short Form 36  
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
 
34 
 
This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
 
 
 
 
 
 
 
 
 
 
40 
 
Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
68 
 
medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
70 
 
infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
 
 
 
72 
 
 
 
Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
 
103 
 
Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
112 
 
Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
124 
 
al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
180 
 
other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
 
233 
 
subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
  
 
237 
 
16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
 
  
306 
 
Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
315 
 
18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
  
355 
 
 
 
FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
24 
 
unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
32 
 
and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
55 
 
independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
 
 
 
 
 
 
64 
 
12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
 
 
 
 
113 
 
Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
128 
 
mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
136 
 
contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
141 
 
 
 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
149 
 
association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
  
169 
 
14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
  
 
237 
 
16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
 
270 
 
 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
  
289 
 
community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
  
303 
 
had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
24 
 
unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
 
25 
 
10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
39 
 
focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
 
 
 
 
 
 
 
 
 
 
40 
 
Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
42 
 
completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
49 
 
 
11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
55 
 
independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
 
 
 
 
 
 
64 
 
12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
94 
 
standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
110 
 
Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
230 
 
 
It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
  
 
237 
 
16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
 
 
 
 
 
250 
 
 
Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
285 
 
Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
 
  
  
291 
 
18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
20 
 
 
10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
 
 
 
 
 
62 
 
Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
 
63 
 
 
The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
86 
 
 
The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
90 
 
  
 
Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
94 
 
standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
 
103 
 
Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
 
151 
 
Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
153 
 
severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
 
182 
 
Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
199 
 
The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
208 
 
14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
212 
 
significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
248 
 
(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
  
308 
 
(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
315 
 
18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
 
 
 
 
  
361 
 
 
 
…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
 
25 
 
10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
38 
 
 
On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
 
51 
 
The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
92 
 
Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
100 
 
of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
 
139 
 
Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
 
143 
 
The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
 
 
 
 
 
 
 
 
 
 
 
 
145 
 
Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
149 
 
association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
 
155 
 
There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
179 
 
excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
202 
 
corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
226 
 
allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
 
233 
 
subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
  
305 
 
 
 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
21 
 
al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
 
34 
 
This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
70 
 
infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
 
 
 
72 
 
 
 
Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
74 
 
database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
77 
 
patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
 
 
 
 
 
120 
 
Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
121 
 
refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
160 
 
whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
162 
 
which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
 
182 
 
Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
187 
 
 
14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
200 
 
researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
 
257 
 
Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
 
 
 
267 
 
 
 
17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
  
290 
 
Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
  
314 
 
used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
37 
 
The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
 
 
 
 
 
 
 
 
 
 
40 
 
Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
 
 
 
 
 
 
64 
 
12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
89 
 
12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
97 
 
Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
114 
 
compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
 
 
 
 
 
 
 
 
 
 
 
130 
 
13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
183 
 
 
The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
208 
 
14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
236 
 
• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
247 
 
Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
  
292 
 
 
All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
 
  
293 
 
All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
 
  
300 
 
The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
  
320 
 
including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
321 
 
 
 
19 REFERENCES 
 
• Ahern, D. K., Gorin L, Anderson GL, Tierney C, Hallstrom A, Ewart C, 
Copne RJ, Schrom E, et al. (1990-A) Cardiac Arrhythmia Pilot Study 
(CAPS) Investigators: Bio-behavioural variables and mortality or cardiac 
arrest in the Cardiac Arrhythmia Pilot Study (CAPS) Am J Cardiol; 66:59-
62 
• Akhter SM, Malik BS, Khan AM (2008). Psychosocial factors associated 
with symptoms of depression and anxiety following AMI. Pak J Med Scie. 
24(2) 192-197 
• American Psychiatric Association Committee on Nomenclature and 
Statistics. Diagnostic and Statistical Manual of Mental Disorders, 
Revised. 4th ed. Washington, DC: APA (1994) 
• Balarajan, R.(1996).Ethnicity and variations in morality from coronary 
heart disease. Hlth Trends; 28:45-51 
• Barefoot JC, Schroll M. Symptoms of depression, acute myocardial 
infarction and total mortality in a community sample. Circulation 1996; 
93:1976–80. 
• Barefoot, J. C., Helms, M. J., Mark, D. B., Blumenthal, J. A., Califf, R. M., 
Haney, T. L., et al. (1996). Depression and long-term mortality risk in 
patients with coronary artery disease. American Journal of Cardiology, 
78(6), 613-617. 
• Bayard-Burfeld L, Sundquist J, Johansson SE, (2001) Ethnicity, self 
reported psychiatric illness and intake of psychotropic drugs in five ethnic 
groups in Sweden. J Epidemiology Community Health. 55:657-664 
• Beck A. T., Ward CH, Mendelson M, et al. (1961). An inventory for 
measuring depression. Arch General Psychiatry ;4 : 561-571 
• Beck A. T., Steer RA., (1987). Beck depression inventory manual. San 
Antonio: Harcourt Brace Jovanovich. 
  
322 
 
• Beck, A. T., Steer RA, Garbin M (1981). Psychometric properties of the 
depression inventory. Twenty-five years of evaluation. Clinical 
Psychology Review; 8:1003-1009.  
• Beck, C. A., Joseph, L., Belisle, P., & Pilote, L. (2001). Predictors of 
quality of life 6 months and 1 year after acute myocardial infarction. 
American Heart Journal, 142(2), 271-279. 
• Berkman, L. F., Leo-Summers, L., & Horwitz, R. I. (1992). Emotional 
support and survival after myocardial infarction. A prospective, 
population-based study of the elderly. Annals of Internal Medicine, 
117(12), 1003-1009. 
• Bhui, K et al. (2004). Assessing the prevalence of depression in Punjabi 
and English primary care attenders: the role of culture, physical illness 
and somatic symptoms, Transcult Psychiatry, 41(3): 307-22.  
• Bhui, K., Bhugra, D., & Goldberg, D. (2000). Cross-cultural validity of the 
Amritsar Depression Inventory and the General Health Questionnaire 
amongst English and Punjabi primary care attenders. Social Psychiatry 
and 
• Bokhari SS, Samad AH, Hanif S et al (2002)., Prevalence of depression 
in patients with coronary heart disease in a tertiary care hospital in 
Pakistan. J Pak Med Assoc ; 52(9)  436-439) 
• Brink, E et al (2002). Health Experience of first time myocardial 
infarction: factors influencing women’s and men’s health related quality of 
life (QOL) after five months. Psychology, Health and Medicine, 7, 1:5 -16. 
• Brown, G.W. & Harris, T.(1978) Social Origins of Depression. London:  
• Brown, N., Melville, M., Gray, D., et al. (1999). Quality of life four years 
after acute myocardial infarction: Short form 36 scores compared with a 
normal population. Heart; 81:351-358 
• Bush, D.E., Zeigelstein, R.C., Tayback, M., et al. (2001). The American 
Journal of Cardiology; 88(15):337-341 
• Carney R, Blumenthal J, Cattelier,D et al (2003). Depression s a risk 
factor for mortality after AMI; Am J Cardiology 92: 1277-1281 
  
323 
 
• Carney, R. M., Rich, M. W., Freedland, K. E., et al. (1988). Major 
depressive disorder predicts cardiac events in patients with coronary 
artery disease. Psychosomatic Medicine, 50(6), 627-633. 
• Carney, R. M., Rich, M. W., Freedland, K. E., Saini, J., teVelde, A., 
Simeone, C., et al. (1988).  Major depressive disorder predicts cardiac 
events in patients with coronary artery disease. Psychosomatic Medicine, 
50(6), 627-633. 
• Christenfeld, N., J, S, Sloan, R., P, Carroll, D., & Greenland, S. (2004). 
Risk factors, confounding and the illusion of statistical control. 
Psychosomatic Medicine, 66, 868-875. 
• Cohen, J. (1988). Statistical power analysis for the behavioural sciences. 
Hillsdale, NJ, Erlbaum. 
• Commander, J.M., Odell, S.M., Surtees, P.G., Sashidharan, S.P. (2004). 
Care pathways for South Asian and white people with depressive and 
anxiety disorders in the community. Soc Psychiatry Psychiatr Epidemiol, 
39:259-264. 
• de Jonge, P., Spijkerman, T. A., Van den Brink, R. H., & Ormel, J. 
(2006a). Depression after myocardial infarction is a risk factor for 
declining health related quality of life and increased disability and cardiac 
complaints at 12 months. Heart, 92, 32-39. 
• Dean, C., Surtees, P.G. & Sashidharan, S.P. (1983). Comparison of 
research diagnostic systems in an Edinburgh community sample, British 
Journal of Psychiatry. 142:247-256. 
• Dias CC, Mateus P, Santos L et al (2005)  Acute coronary syndrome and 
predictors of quality of life. Rev Port Cardiol;24:819– 31. 
• Dickens, C. M., McGowan, L., Percival, C., Tomenson, B., Cotter, L., 
Heagarty, A., et al. (2006). Contribution of depression and anxiety to 
impaired health-related quality of life following first myocardial infarction. 
British Journal of Psychiatry, 189(4), 367-372. 
• Dickens, C. M., McGowan, L., Percival, C., Tomenson, B., Cotter, L., 
Heagarty, A., et al. (2007). Depression is a risk factor for mortality after 
myocardial infarction. Journal of the American College of Cardiology, 
49(18), 1834-1840. 
  
324 
 
• Dickens, C. M., McGowen, L., Percival, C., Douglas, J., Tomenson, B., 
Cotter, L., et al. (2004). Lack of a close confidant, but not depression, 
predicts further cardiac events after myocardial infarction. Heart, 90(5), 
518-522. 
• Dogar AI, Khawaja SI , Azeen WM et al ( 2008). Prevalence and risk 
factors for depression and anxiety in hospitalised cardiac patients in 
Pakistan. Psychiatry ( Edgmont) .5( 2) 38-41. 
• Failde, I. & Ramos, I. (2000) Validity and reliability of the SF^36 Health 
Survey Questionnaire in patients with coronary artery disease. Journal of 
Clinical Epidemiology, 53, 359-365. 
• Fauerbach, J. A., Bush, D. E., Thombs, B. D., McCann, U. D., Fogel, J., 
& Ziegelstein, R. C. (2005). Depression Following Acute Myocardial 
Infarction: A Prospective Relationship with Ongoing Health and Function. 
Psychosomatics, 46(4), 355-361  
• Field, A. (2000) Discovering statistics using SPSS for Windows. London: 
Sage Publications. 
• Frasure-Smith, N., Lesperance, F., & Talajic, M. (1995 a1). The impact of 
negative emotions on prognosis following myocardial infarction: is it more 
than depression? Health Psychology, 14(5), 388-398. 
• Frasure-Smith, N., Lesperance, F., & Talajic, M. (1995 a2). The impact of 
negative emotions on prognosis following myocardial infarction: is it more 
than depression? Health Psychology, 14(5), 388-398. 
• Frasure-Smith, N., Lesperance, F., & Talajic, M. (1993 b1). Depression 
following myocardial infarction: impact on 6 month survival. JAMA, 
270(15), 1819-1825. 
• Frasure-Smith, Lesperance, & Talajic. (1995 b2). Coronary Heart 
Disease / Myocardial Infarction: Depression and 18-month prognosis 
after myocardial infarction. Circulation, 91(4), 999-1005. 
• Frasure-Smith, Lesperance, & Talajic. (1995 b4). Coronary Heart 
Disease / Myocardial Infarction: Depression and 18-month prognosis 
after myocardial infarction. Circulation, 91(4), 999-1005. 
 
  
325 
 
• Frasure-Smith, N., Lesperance, F., Juneau, M., Talajic, M., & Bourassa, 
M. G. (1999). Gender, depression and one year prognosis after 
myocardial infarction. Psychosomatic Medicine, 61(1), 26-37. 
• Gater, R, Tomenson B, Percival C, et al., (2009) Persistent depressive 
disorder and social stress in people of Pakistani origin and white 
Europeans in the UK. Soc Psychiatry Psychiatrica Epidemiol. 44:198-207 
• Glassman, A., Shapiro, P., Ford, D., Culpepper, L., Finkel, M., Swenson, 
R., et al. (2003). Cardiovascular Health and Depression. Journal of 
Psychiatric Practice, 9(6), 409-421. 
• Goldberg, D. & Huxley, P. (1992). Common Mental Disorders: Bio-Social 
Model. Routledge: London. 
• Goldberg, D. P., Gater, R., Sartorius, N., Ustun, T. B., Piccinelli, M., 
Gureje, O., & Rutter, C.(1997). The validity of two versions of the GHQ in 
the WHO study of mental illness in general health care. Psychological 
Medicine, 27(1),191–197. 
• Gorkin, L., Schron EB, Brooks MM, et al. (1993). Psychosocial predictors 
of mortality in the Cardiac Arrhythmias Suppression Trial-1(CAST-1). 
.Am J Cardiol ;71: 263-267 
• Grace, S. L., Abbey, S. E., Kapral, M. K., Fang, J., Nolan, R. P., Stewart, 
D. E., et al. (2005). Effect of depression on five-year mortality after an 
acute coronary syndrome. American Journal of Cardiology, 96(9), 1179-
1185. 
• Hemingway, H., Whitty, C. J., Shipley, M, et al( 2001). Psychosocial risk 
factors for coronary disease in White, South Asian and Afro-Caribbean 
civil servants: the Whitehall II study. Ethn Dis;11:391-400 
• Husain, N; Gater,R, Tomeson B et al ( 2004). Social factors associated 
with chronic depression among a population based sample of women in 
rural Pakistan. Soc Psychiatr Epidemiol39: 618-624 
• Husain, N., Creed, F., & Tomenson, B. (1997). Adverse social 
circumstances and depression in people of Pakistani origin in the UK. 
British Journal of Psychiatry 
• Husain, N., Creed, F., Tomenson, B., (2000) Depression and social 
stress in Pakistan. Pschol Med 30:395-402. 
  
326 
 
• Jacobs, K. S., Bhugra D, Mann AH. (1991). Validation of the 12-item 
General Health Questionnaire among ethnic Indian women living in the 
United Kingdom. Psycol Med; 10:18-24  
• Jenkinson, C. M., Coulter, A., & Wright, L. (1993). Short form 36 (SF 36) 
health survey questionnaires: normative data for adults of working age. 
British Medical Journal, 306, 1437-1440. 
• Jenkinson, C. M., Madeley, R. J., Mitchell, J. R., & Turner, I. D. (1993). 
The influence of psychosocial factors on survival after myocardial 
infarction. Public Health, 107(5), 305-317. 
• Kaplan, R.M., (2003). The significance of quality of life in health care. 
Qual Life Res; 12(suppl 1):3-16 
• Kaufmann, W. M., Fitzgibbons JP, Sussman EJ, Reed JF III et al. (1999). 
Relation between MI, depression, hostility, and death.  American Heart 
Journal; 138 (3) :550-553 
• Ladwig KH, Kieser M, Konig J, Breithardt G, Borggefe M. (1991). 
Affective disorders and survival after acute myocardial infarction: results 
from the post-infarction late potential study. Eur Heart J; 12:959-964 
• Ladwig, K. H., Roll, G., Breithardt, G., Budde, T., Borggrefe, M., Ladwig, 
K. H., et al. (1994). Post-infarction depression and incomplete recovery 6 
months after acute myocardial infarction.[see comment]. Lancet, 343(88), 
20-23. 
• Lam CLK, Pan PC, Chan AWT et al (1995). Can the HADS be used on 
Chinese elderly in general practice? Family Practice  12 (2) 149-154 
• Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. (2000). Do 
depression and anxiety predict recurrent coronary events 12 months 
after myocardial infarction? Quarterly Journal of Medicine, 93, 739-744. 
• Lane, D., Carroll, D., Ring, C., Beevers, D. G., Lip, G. Y., Lane, D., et al. 
(2000). Effects of depression and anxiety on mortality and quality-of-life 4 
months after myocardial infarction. Journal of Psychosomatic Research, 
49(4), 229-238. 
• Lane, D., Carroll, D., Ring, C., Beevers, D. G., Lip, G. Y., Lane, D., et al. 
(2001). Mortality and quality of life 12 months after myocardial infarction: 
  
327 
 
effects of depression and anxiety. Psychosomatic Medicine, 63(2), 221-
230. 
• Langford, C. P, Bowsher J, Maloney JP et al (1997).Social Support: a 
conceptual analysis. J Adv Nurs; 25: 95-100 
• Lauzon, C., Beck, C. A., Huynh, T., Dion, D., Racine, N., Carignan, S., et 
al. (2003). Depression and prognosis following hospital admission 
because of acute myocardial infarction. Canadian Medical Association 
Journal, 168(5), 547-552. 
• Lesperance, F., Frasure-Smith, N., & Talajic, M. (1996 b3). Major 
Depression Before and After Myocardial Infarction: Its Nature and 
Consequences. Psychosomatic Medicine, 58(2), 99-110. 
• Lesperance, F., Frasure-Smith, N., Talajic, M., & Bourassa, M. G. (2002). 
Five-year risk of cardiac mortality in relation to initial severity and one-
year changes in depression symptoms after myocardial infarction. 
Circulation, 105(9), 1049-1053. 
• Lloyd GG, Cawley RH. (1983) Distress or illness? A study of the 
psychological 
• Mayou, R. A., Gill, D., Thompson, D. R., Day, A., Hicks, N., Volmink, J., 
et al. (2000). Depression and anxiety as predictors of outcome after 
myocardial infarction. Psychosomatic Medicine, 62(2), 212-219. 
• Mc Dowell, I , Newall C (1996) Measuring Health; In a guide to rating of 
the Scale  and Questionnaires, Second Edition ,New York,  Oxford  
University Press ; 380-492 
• McHorney, C., Ware, J., Rogers, W., Raczek, A., & Lu, R. (1992). The 
Validity and Relative Precision of MOS Short and Long Form Health 
Status Scales and Dartmouth COOP Charts: Results from the Medical 
Outcomes Study. Medical Care, 30(5 (Suppl.)), 253-265. 
• McKeigue, PM, Miller GJ, Marmot MG. (1989) Coronary heart disease in 
South Asians overseas, a review. J Clin Epimediol; 42: 597-609 
• Meltzer H, Gill B, Petticrew M, et al.(1995) The OPCS survey of 
Psychiatric Morbidity in Great Britain.  Report Number One.  The 
prevalence of psychiatric morbidity among adults aged 16-64 living in 
private households in Great Britain. HMSO: London 
  
328 
 
• Mendes de Leon, C. F. (1999). Depression and social support in 
recovery from myocardial infarction: Confounding and confusion. 
Psychosomatic Medicine, 61(6), 738-739. 
• Morrin,L, Black,S, & Reid R (2000). Impact of duration in a cardiac 
rehabilitation program on coronary risk profile ad health related quality of 
life outcomes. J Cardio-pulmonary Rehabilitation.;20: 115-121  
• Murray, C., & Lopez, A. (1997a). Alternative projections of mortality and 
disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 
349, 1498-1504. 
• Murray, C., & Lopez, A. (1997b). Global mortality, disability and the 
contribution of risk factors: Global Burden of Disease Study. Lancet, 349, 
1436-1442. 
• Musselman, D., L, Evans, D., L, & Nemeroff. (1998). the relationship of 
depression to cardiovascular disease. Archives of General Psychiatry, 
55, 580-592. 
• Nazroo, J, Fenton S, Karlsen S , et al (2002).Context, cause and 
meanings: qualitative insights. In : Sproston K , Nazroo J (eds) Ethnic 
minority psychiatric illness rates in the community ( EMPIRIC). National 
Centre for Social Research, London, pp 137-158 
• Odell , S , Surtees PG, Wainwright NW J et al (1997). Determinants of 
general practioner recognition of pschological problems in a multiethnic 
inner city health district. Br J Psych; 171: 537-541 
• OPCS (1992). 1991 Census Definitions Great Britain. HMSO: London 
• Parashar, S., Rumsfeld, J. S., Spertus, J. A., Reid, K. J., Wenger, N. K., 
Krumholz, H. M., et al. (2006). Time course of depression and outcome 
of myocardial infarction. Archives of Internal Medicine, 166(18), 2035-
2043. 
• Pilote, L., LauzonC, Huynh T et al. (2002). Quality life after AMI among 
patients treated at sites with and without on site availability of 
angiography. Arch Intern Med; 162:553-559 
• Pratt, et al; (1996).Depression, psychotic medication and the risk of MI: 
Prospective data from the Baltimore ECA follow up. Circulation 94:3123-
31 
  
329 
 
• Rahman, A., Iqbal, Z., Waheed, W., Hussain, N., (2003). Translation and 
cultural adaptation of health questionnaires. J Pak Med Assoc (JMPA) 
53:142-147. 
• Rehman UR, Ansari AM , Siddiqui A A et al ( 2009). Correlation of Urdu 
version of HADS and Hamilton Depression Rating Scale in quantifying 
depression  among post-MI patients 8( 02) 131-135  
• Ronalds, C., Creed FH., Webb S,. et al (1997). The outcome of anxiety 
and depressive disorder in primary care. BJ Psychiatry; 171:427-433 
• Rufaie OEF, Absood GH (1995). Retesting the validity of the Arabic 
version of the HADS in primary health centre. Soc Psychiatry Psychiatr 
Epidemiol; 30 ; 26-31 
• Rumsfeld, J. S et al (2003). History of depression, angina, and quality of 
life after acute coronary syndrome. Am Heart J March 2003; 493-499. 
• Rumsfeld, J.S., Magid DJ, Plomondon ME, O’Brien MM, Spertus JA, 
Every NR, Sales AE. (2001). Predictors of quality of life following acute 
coronary syndromes. Am J Cardiol. 88:781-4 
• Ruo, B., Rumsfeld JS, Hlatky MA, et al. (2003). Depressive symptoms 
and health related quality of life. The Heart and Soul Study. JAMA;290: 
215-221.  
• Sarason, I., Levine H, Basham R et al. (1983).Assessing social support. 
The Social support Questionnaire. J of Personality and Social 
Psychology.;44: 127-139.  
• Schipper, H., Clinch JJ, Olweny CLM (1996): Quality of life studies: 
definitions and conceptual issues. In Quality of Life and Pharmaco-
economics in Clinical Trials, Second Edition. Edited by Spilker B, 
Philadelphia: Lippincott-Raven; 11-23. 
• Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin 
R, Zucker HD.  (1989). Nature and course of depression following 
myocardial infarction. Arch Intern Med. 149:1785-1789. 
• Shiotani, I., Sato, H., Kinjo, K., Nakatani, D., Mizuno, H., Ohnishi, Y., et 
al. (2002). Depressive symptoms predict 12-month prognosis in elderly 
patients with acute myocardial infarction. Journal of Cardiovascular Risk, 
9(3), 153-160. 
  
330 
 
• Singleton, N., Bumpstead, R., O’Brien et al. (2001). Psychiatric morbidity 
among adults living in private households. The Stationary Office: London 
• Smith, P. & Prior, G. (1997). The fourth National Survey of Ethnic 
Minorities: Technical Report. Social and Community Planning Research: 
London. 
• Stewart, R. A., North, F. M., West, T. M., Sharples, K. J., Simes, R. J., 
Colquhoun, D. M., et al. (2003). Depression and cardiovascular morbidity 
and mortality: cause or consequence? European Heart Journal, 24(22), 
2027-2037. 
• Strik, J. J., Denollet, J., Lousberg, R., & Honig, A. (2003). Comparing 
symptoms of depression and anxiety as predictors of cardiac events and 
increased health care consumption after myocardial infarction. Journal of 
the American College of Cardiology, 42(10), 1801-1807. 
• Strik, J. J., Honig, A., & Maes, M. (2001). Depression and Myocardial 
Infarction: Relationship between Heart and Mind. Neuro-
psychopharmacol & Biological Psychiatry, 25, 879-892. 
• Strik, J. J., Lousberg, R., Cheriex, E. C., & Honig, A. (2004). One year 
cumulative incidence of depression following myocardial infarction and 
impact on cardiac outcome. Journal of Psychosomatic Research, 56, 59-
66.  
• Sullivan, M, D et al. (1997).  Functional Status in Coronary Artery 
Disease (CAD): A one-year prospective study of the role of Anxiety & 
Depression. The Am J of Medicine. 103: 348-56. 
• Thombs, B. D., Ziegelstein, R., Stewart, D. E., Abbey, S. E., Parakh, K., 
& Grace, S. L. (2008). Usefulness of Persistent Symptoms of Depression 
to Predict Physical Health Status 12 Months after an Acute Coronary 
Syndrome. American Journal of Cardiology, 101, 15-19. 
• Valiogo, J., Conrad, M; Poston SW et al(2004).Testing the performance 
of the ENRICHD Social Support Instrument in cardiac Patients. Health 
Qual Life Outcome; 2:24.  
• van der Wurrf FB, Beekman AT, Dijkshoorn et al (2004) Prevalence and 
risk factors for depression in elderly Turkish and Moroccan migrants in 
the Netherlands. J Affect Disord 83: 33-41 
  
331 
 
• van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G., Ormel, 
J., van Veldhuisen, D. J., et al. (2004). Prognostic association of 
depression following myocardial infarction with mortality and 
cardiovascular events: a meta-analysis. Psychosomatic Medicine, 66(6), 
814-822. 
• Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey 
(SF-36). I. Conceptual framework and item selection. Med Care (1992); 
30:473– 83. 
• Ware, J E , Kosinski M., Keller, S.(1994) SF-36 Physical and Mental 
Health Summary Scales: a user’s manual  (2nd edition) Boston ,MA: The 
Health Institute. 
• Weich S, Karlsen S, King M, Lloyd K, Stansfeld S, Tyrer P, (2004). 
Common mental disorders and ethnicity in England: the EPMIRIC study. 
Psychol Med 34:1543-1551 
• Welin, C., Lappas, G., & Wilhelmsen, L. (2000). Independent importance 
of psychosocial factors for prognosis after myocardial infarction. Journal 
of Internal Medicine, 247, 629-639. 
• Wenger NK (1999): Improvement of quality of quality of life in the 
framework of cardiac rehabilitation. In Clinical Cardiac Rehabilitation: A 
Cardiologist’s Guide, Second Edition. Edited by Pashkow FJ, Dafoe WA. 
Baltimore: Williams & Wilkins; 1999:43-51. 
• Wilkinson, P., Sayre J, Lajik, et al. (1996). Comparison of case fertility in 
South Asians and White patients after acute MI: Observational study. 
BMJ; 312: 1330-1333 
• Williams, R. B. , Barefoot JC , Califf RM (1992). Prognostic importance of 
social and economic resources among medically treated patients with 
angiographically documented CAD. JAMA;m267: 520-524 
• Wilson IB, Cleary PD (1995). Linking clinical variables with health-related 
quality of life: a conceptual model of patient outcomes. JAMA; 273:59– 
65. 
• Wilson, S., Delaney, B., Roalfe, A., Roberts, L., Redmain, V., Wearn, A., 
et al. (2000). Randomised controlled trials in primary care: case study. 
British Medical Journal, 321, 24-27. 
  
332 
 
• World Health Organisation (1947). Constitution of the World Health 
Organisation: Chronicle of the world health organisation, Geneva 
• Ziegelstein, R., Fauerbach, J., Stevens, S., Romanelli, J., Richter, D., & 
Bush, D. (2000). Patients with depression are less likely to follow 
recommendations to reduce cardiac risk during recovery from myocardial 
infarction. Archives of Internal Medicine, 160, 1818-1823. 
• Ziegelstein,R,C. (2001).Depression in patients recovering from a 
myocardial infarction. JAMA 286:1621-7 
• Zigmond, A., & Snaith, R.P (1983). The Hospital Anxiety and Depression 
Scale. Acta Psychiatr Scand, 61, 361 - 370. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
333 
 
 
 
 
 
  
 
 
 
 
 
20 APPENDICS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
334 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
335 
 
 
 
 
  
336 
 
 
  
337 
 
 
  
338 
 
 
  
339 
 
Demographic Data Sheet  
 
 
  
340 
 
 
 
 
 
  
341 
 
 
 
  
342 
 
 
 
  
343 
 
 
 
  
344 
 
 
 
  
345 
 
 
  
346 
 
 
  
347 
 
 
  
348 
 
 
 
  
349 
 
 
  
350 
 
 
  
351 
 
 
  
352 
 
 
 
 
  
353 
 
SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
 
 
 
 
 
  
354 
 
 
 
…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
 
  
366 
 
 
 
Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
22 
 
The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
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11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
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Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
46 
 
CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
 
 
71 
 
This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
 
 
 
 
 
 
 
 
 
 
 
95 
 
12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
97 
 
Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
102 
 
 
There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
 
103 
 
Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
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13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
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Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
136 
 
contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
141 
 
 
 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
149 
 
association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
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Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
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13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
166 
 
higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
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14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
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Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
 
184 
 
A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
185 
 
 
There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
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Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
210 
 
14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
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The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
 
 
 
245 
 
17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
265 
 
 
17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
281 
 
Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
  
289 
 
community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
  
299 
 
reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
 
  
302 
 
Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
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used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
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SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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9 ABSTRACT 
PSYCHOSOCIAL PREDICTORS OF HEALTH RELATED QUALITY OF LIFE OF SOUTH- 
ASIANS WITH ACUTE CORONARY SYNDROME 
Introduction: South-Asians are the largest ethnic minority group in the UK. 
Depression and coronary heart disease (CHD) are common in this group.  The 
importance of depression in South Asians has not attracted significant research 
interest, to date; yet there is evidence that it is associated with the development 
of CHD, and when it develops after CHD leads to poor prognosis.  
Objective: This study aims to investigate the effects of depression on quality of 
life of the South Asians under secondary care, by reviewing previous literature 
and performing a prospective research. The hypothesis was that, after 
controlling for demographic, psychological and medical variables depression 
would be associated with impaired HRQoL in South Asians 6 months after 
acute coronary syndrome (ACS).  
Methods: Demographic, psychological and medical data were collected. 
Participants completed the Hospital Anxiety and Depression Scale (HADS), 
Short-Form 36 (SF-36) and ENRICHD Social Support Instrument (ESSI) in the 
first phase. In the 2nd phase the Structured Clinical Interview for DSM-IV (SCID) 
was performed to validate the HADS. The PCS (SF-36) and HADS were 
completed at follow up.  
Results: Of the 250 enrolled patients 202 completed follow up. A HADS score of 
≥ 17 was identified as the best cut off point. The prevalence of depression was 
30%. Baseline depression, lack of education and retirement were predictors of 
poor QoL (p<0.05). Moreover, diabetes mellitus, respiratory and haematological 
disorders were associated (p< 0.05) with QoL; however after adjustment 
depression was the only significant predictor of poor HRQoL.   
Conclusions: This study suggests that depression is common in South Asians 
following ACS and it is associated with poor HRQoL. Further developments in 
the liaison psychiatry and increasing mental health knowledge of the 
cardiologists may help the earlier identification and subsequent treatment of 
depression to improve the prognosis of CHD patients. 
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10 INTRODUCTION  
Depression is a common psychiatric disorder across the world.  It is predicted 
that by 2020 coronary heart disease will be first and depression will be 2nd 
leading cause of worldwide disability (Murray & Lopez 1997). Moreover, 
cardiovascular disease is a major global health problem reaching epidemic 
proportions (WHO 1999). Coronary heart disease is the leading cause of 
disability and mortality in the industrialised world.  According to the British Heart 
Foundation (2008) 1.5 million people with myocardial infarction and 2.1 million 
with angina are living in the UK. Moreover, around 124,000 people suffer from 
heart attack each year in the UK. 
 
10.1  WHAT IS DEPRESSION?  
Depression has been defined by two well known diagnostic criteria; 
International Classification of Diseases-10 (ICD-10) and Diagnostic Statistical 
Manual-1V (DSM 1V). Depression is a syndrome which has a number of 
biological, psychological and social dimensions. Based on ICD-10 it is 
characterised by low mood, loss of interest and enjoyment, and reduced energy 
leading to excessive tiredness. It is divided into mild, moderate and severe 
forms based on the number of somatic symptoms and requires two weeks 
symptoms duration.  
10.1.1 ASSESSMENT OF DEPRESSION 
Generally, two types of tool are used for the assessment of depression; semi-
structured interviews; such as Structured Clinical Interview for Diagnostic 
Statistical Manual-1V (SCID), a gold standard for the assessment of depression 
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administered by the researcher, and self reporting standardised questionnaires 
such as Hospital Anxiety and Depression Scale (Zigmond AS & Snaith RP1983) 
which can be used with a cut off point. The Hospital Anxiety and Depression 
Scale (HADS) have been commonly used as a screening tool for depression in 
the community and in coronary heart disease patients (Dickens C et al., 2004). 
 
SCID is a commonly used tool in research across the world. It determines 
Diagnostic Statistical Manual-1V (DSM 1V) criteria for depression (APA 1994). 
DSM 1V classifies depression into two categories; major depressive disorder 
and minor depressive disorder, based on the number of core features. The 
criteria for major depression are as follows:  
A. Five or more of the following symptoms are required; at least one of the 
symptoms should be either (1) or (2): 
 (1) depressed mood most of the day, as indicated by either subjective report or 
observation made by others (2) markedly diminished interest in all, or almost all, 
activities (3) significant weight loss or weight gain (> 5% of body weight in a 
month)  (4) insomnia or hypersomnia  (5) psychomotor agitation or retardation 
(6) loss of energy nearly every day (7) feelings of worthlessness or excessive or 
inappropriate guilt (8) diminished ability to think or concentrate, or 
indecisiveness, (9) recurrent thoughts of death /suicidal ideation. 
B. Symptoms cause significant distress or impairment in social functioning 
C. The symptoms are not due to substance abuse or medical conditions  
D. The symptoms do not fulfil criteria for bereavement 
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10.1.2  PREVALENCE OF DEPRESSION  
 At any one time around one adult in six is suffering from symptoms of mental 
illness and it is anticipated that one in four will experience mental illness in their 
lifetime . A number of European studies (William R & Hunt, K 1997; Beayard-
Burfeld, L et al., 2001; Van der Wurrf FB et al., 2004) indicated a higher 
prevalence of depression in ethnic minority groups compared to the Whites. 
 
United Kingdom is a multiethnic society hosting around 4.6 million Black Ethnic 
migrants from various parts of the world. South Asians constituting people from 
India, Pakistan and Bangladesh, is the biggest ethnic minority group which 
accounts for 4% of the total UK population (Census 2001). In certain parts of 
the country such as the North West (Manchester & Lancashire), this proportion 
has reached up to 12% - 22% ) of the local population.  
 
Most of these people were economic migrants when they entered in the UK in 
early seventies. Due to low literacy level, language and cultural barriers, they 
developed their own communities in the thickly populated area of the cities with 
all culturally appropriate amenities. These people have maintained an active 
contact with their families in South Asia, which is an important part of their 
acculturation process.  The number of people per household in the South Asian 
communities is high. Having an unskilled or a low grade job (Hemingway H et 
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al., 2001) along with social isolation from rest of the community puts them in a 
vulnerable position.    
 
10.1.3 DEPRESSION AND SOUTH ASIANS 
Depression is said to be quite high in people living in Pakistan. Husain, N et al., 
(2000) found a prevalence of depression of 44% in males and 57% in females, 
in their study conducted in a village near Islamabad.  
 
Depression is common in the South Asians living in the United Kingdom as well 
(Husain, N et al., 1997; Bhui, K et al., 2004; Gater, R et al 2009). There is not 
much research in this ethnic group; however migration, acculturation, socio-
economic imbalances and low literacy level are amongst the well reported risk 
factors for depression. Similarly, cultural beliefs and stigmatisation are other 
dimensions of their psychosocial risk for depression. 
 
10.2  SOUTH ASIANS AND ISCHAEMIC HEART DISEASE 
Coronary heart disease is a global problem. South Asians have higher rates of 
coronary heart disease than their Caucasian compatriots (McKeigue, P M et al., 
1989). The incidence of heart attacks among the Scots of Pakistani and Indian 
origin is 60% higher compared to the non South Asians (Scotland Report 2005). 
Admittance to hospitals of South Asians with myocardial infarction is twice as 
compared to their White counterpart (Wilkinson, P et al., 1996). 
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The explanation for the higher prevalence of coronary heart disease among 
South Asians in the United Kingdom remains unclear, though a number of risk 
factors have been implicated. A high prevalence of diabetes-mellitus, smoking, 
hypertension and sedentary life style are amongst the well reported physical 
risk factors. Similarly excessive consumption of diet rich in saturated fats 
enhances atherosclerosis process; increasing their vulnerability for IHD. 
 
10.3  DEPRESSION, CORONARY HEART DISEASE AND SOUTH ASIANS 
The excess of depression among the United Kingdom South Asians may be, at 
least in part, responsible for the higher rates of coronary heart disease. The 
importance of depression in South Asians has not attracted much research 
interest, to date. Yet there is evidence that history of major depression (Cohen, 
et al., 2001), current depressive symptoms (Barefoot JC et al., 1996) and a 
diagnosis of clinical depression (Ford DE et al., 1998) can predict the 
development of CHD in otherwise healthy individuals. 
 
Depression also predicts poor outcome when it develops in people with 
established CHD. It is associated with a two to seven fold increased risk of 
morbidity and mortality (Carney RM et al., 1998 & 2003; Ladwig KH et al., 1991; 
Frasure-Smith N et al., 1993 & 1995; Lesperance, F et al., 1996; Grace LS et 
al., 2005). The reviewed literature gives mixed findings; some studies have 
strongly supported the adverse impact of depression on cardiac morbidity and 
mortality, while others found such associations to be weak. However the 
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researchers seem to be in agreement that it is the depression following 
ischaemic heart disease (IHD) rather than the depression developing in the 
days or weeks prior to IHD event which is associated with poor prognosis. 
Moreover, researchers have claimed that it is the ‘persistent’ rather than 
‘transient’ depression having association with poor prognosis. This 
heterogeneity in the findings can be due to a number of variables including 
setting, sampling, cardiac diagnosis, timing of the assessment of depression, 
persistence of depression, tools used to assess depression, collection of follow-
up data, duration of follow up, lack of standardisation of the outcome measure 
and statistical analysis. Even those studies that found an association between 
depression and poor prognosis came up with  higher odds with univariate than 
the multivariate analysis; suggesting the contribution of confounding effects. 
Severity of cardiac disease is an important confounding factor which has been 
either partially or not at all controlled in most of the studies. It may be because 
of its multiple parameters which are difficult to take into account at baseline 
assessment. Similarly, co-morbid medical conditions have not been adjusted in 
multivariate analysis in a number of studies despite their significant confounding 
effect.    
 
There are inherent challenges while diagnosing depression in patients admitted 
with IHD. First of all it can be an acute stress reaction to a life threatening 
illness. Moreover, these patients are more likely to have physical complaints 
which  are not typical depressive symptoms, such as lack of energy and 
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unusual tiredness, but can be easily attributed to their cardiac condition, rather 
than to their emotions (Musselman, Evans & Nemeroff, 1998 ) 
 
However, there are reports of improvements in cardiac morbidity and survival 
rates in the Caucasian population (Rumsfeld & Ho, 2005), which could have 
been due to the recent advances in the treatments of coronary heart disease 
(NSF99, BHF 2008) and increasing public health education. Such findings have 
contributed towards shifting the focus of main treatment from traditional medical 
outcomes to the quality of life.  
  
10.4  WHAT IS QUALITY OF LIFE? 
 Quality of life (QoL) is a soft outcome measure. It is a concept, which 
encompasses the ways in which a patient is affected by the illness and various 
components of its treatments (Wegner NK 1996). She claims that the QoL 
focuses on the attributes of life, which are valuable to the patient such as sense 
of well-being, comfort, ability to maintain reasonable level of physical, emotional 
and intellectual functions, and the ability to take part in various activities. Most 
concepts of HRQoL include social functioning, physical functioning, role 
functioning, mental health and general health perception (Wilson IB et al., 
1995). As both depression and QoL are multi-dimensional measures which tend 
to overlap with each other making the precise assessment of QoL somewhat 
challenging.  
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10.4.1 ASSESMENT OF QUALITY OF LIFE 
There are two main types of tools which have been commonly used in cardiac 
patients; generic such as Short Form-36 Health Survey (SF36) and disease 
specific such as Seattle Angina Questionnaires (SAQ). Both have a score range 
of 0-100, where a higher score denotes a good quality of life and lower scores 
reflects a poor quality of life. Both are self reporting and can be easily 
completed in 20-25 minutes. Reporting bias is the more likely problem with 
these tools and it becomes even more important when these tools are 
completed by patients admitted to the hospital with a life threatening condition. 
 
10.5  DEPRESSION, CORONARY HEART DISEASE AND QUALITY OF LIFE 
The Global Burden of Disease Study organised by the World Health 
Organisation found that depression is the fourth major cause of health 
impairment in the world and is likely to become the second leading cause by 
2020 (Murray & Lopez, 1997). Moreover, depression following IHD is a 
recognised risk factor for impaired health related quality of life (Ladwig KH et al., 
1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 2001; Mayou R A et al., 
2000; Dickens C et al., 2006; Thombs D et al., 2008). Variation in the findings of 
some studies is possibly due to different methodologies adopted by different 
researchers. 
 
The evaluation of health related QoL becomes even more important when both  
depression and ischaemic heart disease  are known for their adverse impact  on 
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the QoL and this impact becomes  additive when they occur concurrently 
(Glassman et al., 2003). As ischaemic heart disease tends to follow a chronic 
course requiring lifelong prophylactic medications, improvements in quality of 
life seems to be natural desire of the patients. 
 
10.6 DEPRESSION, CORONARY HEART DISEASE, QUALITY OF LIFE AND 
SOUTH ASIANS  
To date there is no significant research evidence available that might have 
explored the prevalence of depression in South Asians with coronary heart 
disease, and its prognostic impact on their health related QoL. The experience 
of South Asians needs to be considered, as their interaction with, and access to 
health care provisions, experience of social adversity and opportunities for 
social support and network may differ from other sections of the population 
living in the UK.  
 
The aim of this prospective study is to find the prevalence of depression in 
South Asians living in the UK with acute coronary syndrome, and then to 
examine its impact on their health related quality of life. 
 
10.7  VALIDATION OF HADS 
 Validation of a screening tool can provide best sensitivity and specificity. HADS 
Urdu version has been used as a screening tool in a number of studies 
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conducted in South Asians but not in those living in the UK with acute coronary 
syndrome (ACS); hence its validation against SCID has been examined as well.  
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11 SOUTH ASIANS AND DEPRESSION  
 
In this chapter will review the existing literature about the prevalence of 
depression in South Asian communities.  
 
In the subsequent chapters the review will focus on the studies exploring the 
impact of depression on cardiac morbidity, mortality, and quality of life following 
coronary heart disease.  
11.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In EMBASE firstly articles relevant to the study population were identified using 
key words “South Asians, Pakistani, Indians”. This was supplemented by a 
research of articles that included depression, depressive disorder and low 
mood. Both the searches were then combined to find the relevant articles. 
Additionally bibliographies of the identified papers were hand searched. 
Relevant articles which were known to the author and supervisors were, also 
included.  
Six studies were identified for this review; most of them seem to be supporting 
the view that depression is more prevalent among South Asians than 
Caucasians. These studies have been grouped on the basis of the tool used for 
the assessment of depression. 
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11.2  STUDIES USING SEMI-STRUCTURED INTERVIEW AND 
STANDARDISED QUESTIONNAIRES FOR DEPRESSION  
Three studies were identified which looked at the prevalence of depression 
among South Asians living in the UK while using semi-structured interviews and 
standardised questionnaires. All of them have suggested that the prevalence of 
depression is higher in this ethnic group. Table 1 summarises these studies.  
 
Study No; 1 
Husain, N et al., (1997) conducted a study to look at the prevalence of 
depression and its correlation in people of Pakistani origin in the North 
Manchester. The study population comprised of all those who attended GP 
surgery and were aged 16-64. The ethnicity was determined from their name, 
language or direct questioning. The researcher attended the surgery once 
weekly and approached all eligible patients, who were invited to complete the 
Patient Health Questionnaire (PHQ) in English or Urdu, while waiting for the 
doctor. All high scorers and a random selection of low scorers were interviewed 
using the Psychiatric Assessment Schedule (PAS); either at the person's home 
or at the surgery, within four weeks of completing the Patient Health 
Questionnaire. The PAS was analysed using the CATEGO diagnostic system 
which produces the index of definition. Cases were identified if they had an 
index of definition level of 5 or over. Statistical analysis involved the χ2 test or 
the Mann Whitney U test as appropriate.  
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Of the 221 potential participants, 218 completed the Personal Health 
Questionnaire; 129 in Urdu and 89 in English. Of them 78 (35.7%) scored 7 or 
above while 140 (64.3%) scored 6 or below. Of the high scorers 50 were 
approached for the interview, 38 (82.6%) qualified for being a case. Of the low 
scorers (< 7) 32 were invited but only 31 completed interviews. Of them 6 (19.3 
%) reached the threshold to become a case. On the basis that 82.6% (n=64) of 
the high scorers in the whole sample would have been cases and that 19.3% 
(n=27) of the low scorers would be cases, the estimated prevalence of 
depression in the whole sample would have been 42%. 
 
It seems to be one of the few studies conducted on the South Asian population. 
The study was conducted in North Manchester; an area with a high proportion 
of Pakistani Immigrants, making it fairly representative of the study population. 
Interviews were conducted in their native language and by a researcher who 
belonged to the same ethnic group, which made the participants more relaxed. 
The Urdu version of the Personal Health Questionnaire was used to prevent 
exclusion because of language. The PHQ has been validated and used in 
several studies in Pakistan.  
 
 A 2nd stage interview was conducted using the Psychiatric Assessment 
Schedule (Dean et al., 1983). PAS provides data on symptoms over the last 
month. Participants were interviewed within 4 weeks at home, in a relaxed 
environment. The depression rate was quite high in people of Pakistani origin. 
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The study has a number of weak areas. Its sample size is small. A number of 
eligible subjects were possibly lost as the researcher visited the GP surgery 
once a week. Patients completed baseline questionnaires while waiting for their 
turn, not an ideal time for conducting research. The study was conducted at 
only one GP surgery. Researchers have not given the details of the other study 
(Ronald C et al., 1997) with whom they compared their findings. PAS was used 
in a small number of participants. The study only recruited Pakistanis; hence its 
findings cannot be generalised in the whole South Asian population. 
 
The study highlights a high prevalence of depression in the Pakistani 
community residing in the UK. 
 
Study No; 2 
Bhui, K et al., (2004) in their survey compared   the prevalence of depression in 
Punjabi Asians and English primary care attendees, in United Kingdom. 
 
Five general practices from a single electoral ward, in South-East of London 
were selected. Consecutive patients of ‘White European’ or ‘Asian’ appearance 
attending these surgeries over a 1-year period were approached and asked 
about their cultural origins. Those identifying themselves to be of Punjabi culture 
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and having a family originating from the Punjab, Indian subcontinent were 
enrolled for the study. The other group consisted of the White, English-speaking 
or those self-identifying as being English. People identifying themselves to be of 
Irish, Scottish or Welsh origin, and those with learning difficulties, severe 
hearing impairment or psychosis were excluded. 
 
It was a two-phase design. Two screening questionnaires; the General Health 
Questionnaire (GHQ-12) (Goldberg et al., 1997) and the Amritsar Depression 
Inventory (ADI) developed in India; were used (Bhui, Bhugra, & Goldberg, 
2000). The ADI includes lay and psychiatric clinic populations’ expressions of 
distress. It includes items on burning sensations in the hands and feet, 
heaviness in the head, lack of energy and more typical depressive items. 
Demographic details, the screening procedure, translation methods and the 
validity of the instruments are reported in a separate methodology article (Bhui 
et al., 2000).  
 
Two bilingual assistants administered screening questionnaires. All those 
scoring 2 or more on the ADI, or 5 or more on the GHQ-12 were considered to 
be screen positive. All screen positive and a third of screen-negative subjects 
proceeded to the second phase. Depressed participants were grouped on the 
basis of gender. Second-phase interviews were administered by one bilingual 
researcher when the Clinical Interview Schedules-Revised (CIS-R) was used.  
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The CIS-R explores the presence and severity of 14 non-psychotic symptoms 
during the week prior to interview. These are: somatic complaints associated 
with low mood or anxiety, fatigue, problems with memory and/ or concentration, 
sleep disturbance, irritability, worry about physical health, depressed mood, 
depressive thoughts, non-health-related worry, generalized anxiety, phobic 
anxiety, panic attacks, compulsive behaviours, and obsessional thoughts. The 
specific diagnosis was grouped into broad categories of depression (ICD-10, 
F32-39). 
 
In total 503 subjects were screened; 252 Punjabi and 251 English. Of them 180 
English and 209 Punjabis subjects completed the second phase interview. 
Depression was more common (28.8% vs. 18%; OR = 1.73. 95% CI: 1.08-2.8, p 
=0.02) among Punjabis than the English. By gender, Punjabi women were more 
likely to be depressed than English women in the unadjusted analysis; (39.1% 
vs. 19.5%; OR= 2.65, 95% CI ; 1.41- 4.99, p= 0.02). Even after adjustment for 
age this difference remained significant (OR=2.57, 95% CI ; 1.37- 4.83, p= 
0.003). When compared in two age bands (< and > 40), only Punjabi women 
over 40 were having more depression than their English counterparts (44% vs. 
13%; OR= 5.30, 95% CI ; 1.98-14.07, p= 0.001). Depression was higher in 
Punjabi women than Punjabi men (OR 2.72, 95% CI; 1.45-5.10, p=0.002), with 
no differences between English men and women (OR 1.01, 95% CI ; 0.48-2.12, 
p=0.98). 
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This study has a number of strengths. Both the groups were demographically 
similar, ruling out the possibility of confounding risk factors. They used a 
screening instrument (ADI) which was developed in the Punjab (Indian 
Subcontinent) along with General Health Questionnaire. Although the GHQ-12 
is a well-established screening instrument, it may be insensitive among South 
Asians (Rait, 1999; Williams & Hunt, 1997). The ADI helped the Punjabis where 
their expressions of distress did not conform to the English-speaking population. 
Subjects were given the option of the language of interview. The analyses were 
adjusted for potential confounders. Therefore, differences in demographic and 
social status between Punjabi and English subjects cannot account for the 
differences in prevalence. GP practices from the same geographical area were 
selected to rule out the contextual effects on the results. ICD-10 diagnosis was 
used.  
 
Not all the screen negative patients were included in the second phase 
interview. Punjabis born outside the Indian Sub-continent were also included 
which may suggest that people having recurrent migration are at higher risk of 
developing depression. The study does not represent the all South Asians as a 
number of groups speaking other languages (Urdu, Gujarati or Bengali), were 
not included. 
 
The researchers have concluded that depression is more prevalent among 
Punjabis (South Asians) living in the UK. 
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Study No; 3 
Gater R et al., (2009) conducted a study to compare the depressive disorder 
between people of Pakistani origin and White Europeans. The study was well 
publicised at GP surgeries, shops, community centres, mosques and local 
Pakistani Radio in Manchester, UK. 
 
Four local GP surgeries from the inner city area were selected. The practice 
registers were used to identify Pakistani and White Europeans aged 18-65. At 
random one person from each household address was selected between 
August 2001 and September 2003. Explanatory letters and screening 
questionnaires (English & Urdu) were sent to potential participants. Those who 
did not respond within 3 weeks were visited at home. People with learning 
disability, psychotic illness, and dementia or alcohol dependence were 
excluded. 
 
Ethnicity was established based on three of the grand-parent’s birth place. All 
tools were translated into Urdu which were reviewed by a bilingual focus group 
of mental health specialists and lay people according to a standard procedure 
(Rahman, A et al., 2003). Socio-demographic data were collected. Twenty items 
Self-Reporting Questionnaire (SRQ) was used for screening process. Pakistani 
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participants were interviewed by a researcher of the same ethnic origin in 
English or Urdu. Power calculation was performed. 
 
All participants who scored ≥ 7 on SRQ and one-in-four randomly selected from 
the low scorer (< 7) were invited for 2nd stage interview when they underwent 
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN). SCAN is a 
semi-structured research interview which provides International Classification of 
Diseases (ICD-10)- diagnosis based on symptoms over the last four weeks.   
 
 A total 3011 potential participants were identified, whilst 1856 (66%) completed 
the SRQ; 932 white Europeans, and 924 of Pakistani origin. There were 625 (34 
%) participants who scored ≥ 7 on SRQ while 1231 (66%) scored < 7 on SRQ. 
Based on the gender SRQ completion rates were 66% in white European men, 
74% in white European women, whilst 59% in Pakistani men and 66% in 
Pakistani women. 
 
 In total 943 were invited for 2nd stage interview when SCAN was administered. 
Of them 651(69%) completed a SCAN interview; 210 from low scorers and 441 
from high scorers. Eighty-seven percent of the participants having depressive 
disorder (SRQ ≥ 7) met the ICD-10 criteria for depressive episode whilst the 
remaining 13% met DSM-IV criteria for major depressive disorder. Only 3% 
(6/210) of the participants with low scores (SRQ < 7) had depressive disorder.  
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The unadjusted prevalence of depression was not significantly different 
between white European and Pakistani men (12.3% vs. 9%; 95% CI 7.2-17.3; 
95% CI 5.0-13.00; p= 0.31) respectively, however this difference was significant 
in Pakistani and European women ;( 31.1%; 95% CI 24.1- 38.0 vs. 19.3%; 95 % 
CI 14.1-24.5 p= 0.007) respectively. The difference was highest in women of 
Pakistani origin who were aged over fifty years than the respective white 
Europeans (65.4%; 95% CI 41.1-89.4 vs. 21%;95% CI 12.7-30.2). After 
adjustment for age, marital and socioeconomic status the odds ratio for 
depression for Pakistani women remained significant (OR= 2.1, 95% CI 1.2-3.7, 
p=0.008). Since the two ethnic groups differed in terms of average household 
size, the researchers controlled for this variable as well but the difference 
between Pakistani and white European women still remained significant (OR= 
1.97, 95% CI 1.09 -3.54, p=0.024).  
 
The study has a number of strengths. A large number of potential participants 
were invited, after random selection. Repeated attempts were made to contact 
those who failed to response to the initial contact.  A number of correlations for 
depression were addressed in the study. All tools were translated in Urdu and 
were reviewed by a bilingual focus group of mental health specialists and lay 
people (Rahman, A et al., 2003). Pakistani participants were interviewed by a 
researcher of the same ethnic origin in English or Urdu. Power calculation was 
done before the start of study. Depression was higher among Pakistani women, 
which is in line with previous studies (Bhui, K et al., 2004). Multivariate analysis 
was conducted. 
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On the other hand, the study has some weaknesses. It was limited to Pakistanis 
only and hence cannot be generalised to South Asians. A huge number of 
exclusions may suggest selection bias. The SRQ was completed only by half of 
eligible men which may suggest that depressed individuals did not bother to 
complete the questionnaires. SCAN was not administered to all participants. 
The researchers failed to give prevalence of depression in both ethnic groups. 
 
The study suggests that depression is only more prevalent in Pakistani women 
when compared to the white women.  
 
11.2.1 SUMMARY OF THE SECTION  
Two out of three studies have reached the conclusion that depression is 
commoner among South Asians compared to the Caucasian population. 
Husain, N et al., (1997) just conducted a survey without any comparison with 
the Caucasian population. All the three studies used diagnostic interview in 
addition to screening tool. Both studies (Bhui, K et al., 2004; Gator, R et al., 
2009) stratified the sample based on gender and age. Similarly both of them 
used 4 or more number of surgeries for recruitment and conducted multivariate 
analysis. To prevent exclusion based on the language, all the studies used Urdu 
or Punjabi version of the questionnaires. Husain, N et al., (1997) and Gator, R 
et al., (2009) studied people of Pakistani origin while Bhui, K et al., (2004) 
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focussed on Punjabi speaking South Asians; hence the findings of these studies 
may not be applicable to all sections of South-Asians. 
 
Despite using different screening tools and population sub-groups all the 
researchers found a high prevalence of depression in the South-Asian 
population. 
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Table 1; Studies using semi-structured interview and standardised questionnaire for depression 
Study Age Ethnic Group Tools Sample  Depression COMMENTS 
Commander JM et al 
(2004) 
16-64 South Asian & 
White  
SCID 1 GP Surgery South Asians =22% 
Whites = 14% 
No Stratification age & 
Gender 
Weick S, et al  (2004) 16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  CMD 
41 
 
11.3 STUDIES USING SEMI-STRUCTURED INTERVIEWS ONLY WHEN 
LOOKING FOR DEPRESSION IN SOUTH ASIANS 
Two studies were identified that explored depression among South Asian 
people using a semi-structured interview. Table 2 gives a summary of these 
studies. 
 
Study No; 1 
Commander JM et al., (2004) made an attempt to compare the prevalence of 
depression between South Asians and the White people living in the UK. This is 
a subsidiary study of a wider project replicating Goldberg and Huxley’s 
pathways to care model (Goldberg and Huxley 1992). It was conducted in a 
deprived inner-city catchment area (the old West Birmingham Health District) 
having a high (23%) proportion of South Asian people (Census 1991) between 
December 1994 and May 1995.  
 
A sample was obtained randomly from the West Birmingham residents who 
were registered with a GP. All aged 16-64 were included. This population had 
an equal access to specialist psychiatric services provided by one local mental 
health unit. GPs were involved in regard to the access to the patient’s record 
and their involvement in this study. All identified people were contacted first by 
letter and subsequently were approached for interview. A trained researcher 
interviewed the enrolled subjects in three languages (English, Punjabi and 
Urdu) at their home address. A member of the research team reviewed the 
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completed interviews. A payment of ten pounds (￡10) was made to each 
participant. Ethnic group codes were based on the OPCS 1991 Census 
classifications (OPCS 1992).The term ‘South Asian’ was referred to people 
identified by self-report as Pakistani, Indian or Bangladeshi. The Structured 
Clinical Interview for DSM-IIIR (SCID) was used to determine the depression.  
Data were analysed using SPSS (1993).  
 
In all 1500 people were eligible; 227 South Asians and 424 Whites were 
enrolled. Of the South Asians 149 (66%) whilst of the White people 310 (73%) 
were interviewed (χ2=4.0, p=0.05).  Depressive disorder was higher in South-
Asians than the Whites (22% vs. 14%; χ2=4.6, p=0.03). All White people 
preferred to be interviewed in English whereas 8 South Asians were interviewed 
in Punjabi and 1 in Urdu. 
 
SCID was used for the assessment of depression. A large sample was 
collected. The interview was conducted in English, Punjabi and Urdu to prevent 
exclusion because of language. The study was conducted in a catchment area 
(the old West Birmingham Health District) having a high (23%) proportion of 
South Asian people (Census 1991). 
 
The study has a few weak points. It was conducted in an extremely deprived 
area. Participants were rewarded with money, which might have contributed in 
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the present findings. Relying on a GP list for the sample is not very accurate as 
many people live out of the catchment area. A high refusal rate or exclusion 
may suggest recruitment bias. Those South Asians who were not English 
speaking might have been excluded; as in the first place only English speaking 
researchers approached the participants that might have put South Asians off; 
one of the explanations for high refusal. Participants were rewarded with 
money. The study has not performed multivariate analysis. 
 
The study has established that depression is more prevalent among the South 
Asians than the White population. 
 
Study No; 2 
Weick S  et al., (2004) conducted a cross sectional survey (EMPIRIC) to look at 
the prevalence of common mental disorders (CMD). Six of the largest ethnic 
groups (White, Irish, Black Caribbean, Bangladeshi, Indian and Pakistani) living 
in England were included. Revised Clinical Interview Schedule (CIS-R) was 
used to assess depression.  
 
Ethnic minority samples were drawn from the Health Survey 1999 for England 
(HSE 99). Over 31 000 addresses were selected in 340 postal sectors using a 
two stage design based on the small user Postcode Address File (PAF). 
Sectors were stratified on the basis of ethnic composition. Focused 
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enumeration (Smith & Prior, 1997) was employed in 1 of 3 strata, consisting of 
178 sectors having 1%-10% population of Black Caribbean, Indian, 
Bangladeshi, or Pakistani. The White sample was drawn from the HSE 1998, 
because a full interview was not conducted in the White informants in 1999 
HSE.  
 
Over 64 000 addresses were sampled in total, and up to 4 persons aged 16-74 
were selected randomly within each household.  Ethnicity was defined by self-
assessment using the same categories as the 1991 Census (OPCS, 1992).  
 
Survey materials were translated into five languages by an experienced 
independent professional translation service: Hindi, Gujarati, Punjabi, Urdu and 
Bengali. Proof reading was done by an independent translator rather than back 
translation. Informants who were unable to understand English were provided 
with an interviewer who was able to understand their language.  
 
In total 4281 participants were interviewed; a response rate of 68.2%. The 
response rate was higher in the Whites than the Indians (71% vs. 62%).  
Overall, 83% of interviews were conducted in English, with Bengali (10.3% of 
interviews) being the second most commonly used language. The proportion of 
interviews in English was 87% among Indian, 69% among Pakistani and 37% 
among Bangladeshi participants. 
45 
 
 
Compared to White counterparts, the prevalence of CMD was higher among 
Pakistani men aged 35-54 years compared to the Whites of the similar age 
(adjusted RR 2.38, 95% CI 1.25-3.53, p=0.02). Similarly higher prevalence of 
CMD was also observed among Pakistani (unadjusted RR 2.80, 95% CI 1.29- 
3.83, p < 0.05) and Indian women (unadjusted RR 3.15, 95 % CI 1.65-3.93, p < 
0.01) aged 55-74 compared to White women. The prevalence of CMD among 
Bangladeshi women was lower than the White women, but it was not significant. 
 
The study has a number of strengths. The CMD were assessed using the 
Revised Clinical Interview Schedule (CIS-R), which was also used in both UK 
national surveys of psychiatric morbidity (Meltzer et al., 1995; Singleton et al., 
2001). Differences in the prevalence of CMD between ethnic groups were 
assessed based on gender. Response rates varied between ethnic groups, 
being highest among the White (71%) and lowest among the Indian group 
(62%). Individuals in other ethnic groups were younger (especially the South 
Asian groups), more likely to live in urban areas, less likely to be employed, to 
have educational qualifications, or to live in households headed by an individual 
in a non-manual social class. 
 
This was the largest and most comprehensive study of non-psychotic 
psychiatric morbidity among ethnic groups in England. The questionnaires were 
translated into 5 languages. Based on the stratification of age a difference of 
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CMD has been found between South Asians and the Whites. Similarly Asian 
women were older than the White women. Symptoms of anxiety and depression 
can occur in the same individual both consecutively and concurrently, 
particularly in community settings (Goldberg & Huxley, 1992). 
 
Multivariate analysis was conducted. Proof reading was done by an 
independent translator rather than back translation, for a number of reasons; it 
is an accepted practice that a translator should only use their mother tongue as 
their target language. However, there are few if any suitably qualified, registered 
translators in the UK who can translate the Asian languages and have English 
as their mother tongue. 
 
The data was derived from a national survey; prone to documentary error. The 
researchers have not given the prevalence of depression as such. Common 
mental disorder includes other disorders like anxiety as well. 
 
 The researchers found modest but important differences in the prevalence of 
the common mental disorders between the Whites and South Asians.   
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11.3.1 SUMMARY OF THE SECTION  
 
Both studies have found high prevalence of depression in the South Asians 
compared to Caucasian population. Commander JM et al., (2004) included all 
sections of South Asians and maintained inter-rater reliability in their study. 
They found that depression was more prevalent among South Asians than the 
White people. This study was conducted in a very deprived district which may 
not reflect the living conditions of the South Asians in other parts of the UK. 
Social deprivation is associated with higher depression (Brown & Harris 1987). 
Weick S  et al., (2004) stratified his sample on the basis of age and gender and 
found out that depression was higher among South Asians but only in certain 
age groups; South Asian men had higher depression in the age band of 34-54 
while  South Asian women had higher depression  in the age band of 55-74.  
Depression is common among women but its peak being in the late middle life 
perhaps gives flavour of ‘empty nest syndrome’. Moreover hormonal changes 
(menopause) can be another factor among women for high depression. It is well 
known that the education level among South Asian women is much lower than 
men; which makes them vulnerable for social isolation as the children grown up 
in the western society prefer to live independently; perhaps away from parents. 
Moreover, the employment rate among South Asian women is minimal, leaving 
fewer opportunities for social interaction and subsequent high self esteem and 
confidence. These are speculations at this stage but would require further 
exploration through quantitative research designs.
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Table 2 Studies using Semi-structured interview for determining depression 
Study 
 
Age Ethnic Group Tools Sample  Depression COMMENTS 
 
Commander JM et al 
(2004) 
 
 
16-64 
 
South Asian & 
White  
 
SCID 
 
1 GP Surgery 
 
South Asians =22% 
Whites = 14% 
No  age or 
gender 
stratification 
 
Weick S, et al  (2004) 
16-74 6-ethnic groups 
(self assessed) 
CIS-R 
 
HSE99 & HSE98  Pakistani men aged  
(35-54) had higher dep 
; Pakistani women (55-
74)  had > dep than 
White 
Looked  for  
CMD 
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11.4  STUDIES USING STANDARDISED QUESTIONNAIRES FOR 
DEPRESSION  
One study was identified that tried to look at the prevalence of depression 
among the South Asians using standardised questionnaires.   
 
Study No; 1 
Hemingway, H et al., (2001) conducted a survey to compare the depressive 
disorder between the White and South Asians. It is a subsidiary study of The 
Whitehall 11-Cohort looking at the psychosocial risk factors for coronary heart 
disease among the Whites and South Asians. 
 
This study examined the employees of twenty civil service departments in 
London. Minor psychiatric morbidity was assessed using the 30-items General 
Health Questionnaire. A 4-item depression and 5 item anxiety subscale were 
identified on the basis of factor analysis. At baseline screening, a researcher 
classified the ethnicity of the participants. At phase five, participants self 
assigned their ethnicity based on 1991 Census. 
 
In total 8973 whites and 577 Asians aged 35-55 years, were enrolled. 
Response rate was 73%. Of the South Asians 61.6% were Indians. Mean age 
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of the White participants was 44.2 years and of the South Asians was 45.7 
years. Compared to the Whites, South Asians were more likely to be in the top 
tertile of the depression sub-scale (OR=1.42; 95% CI 1.2-1.7, p< 0.05) after 
adjustment for age and sex. Similarly when employment grade was adjusted 
for, South Asians still appeared to be at high risk of depression (RR 1.38, 95 
%CI 1.1-1.7, p=0.001).  
 
It was one of the pioneer studies looking at the psychosocial risk factors for the 
CHD. It was conducted in London; one of the biggest cosmopolitan city of the 
UK. The GHQ has been widely used in different ethnic groups and validated in 
the UK South Asian population (Jacob, K S et al., 1997). There was a good 
agreement between observer rated and self rated ethnicity (Kappa of 0.85; 95% 
CI 0.83-0.87). 
 
The study has some weak points. Only a selected class (civil servants) were 
studied; hence its findings cannot be generalised. The inclusion of participants 
aged 35-55 years made it more age specific. It is also a cross sectional survey, 
having little weight in the hierarchy of research. Although the target was the 
South Asian population, the sample was predominantly of people having Indian 
origin. Full details of Whitehall study are not available in this article. 
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The researchers have supported that South Asians working in civil services are 
at high risk of depression compared to the Whites. 
 
11.5 OVERALL SUMMARY OF THE SUB-CHAPTER  
Except Husain, N et al., (1997) all the other studies compared the   prevalence 
of depression in South Asians and the Whites when they found inconsistent 
difference. Husain, N et al., (1997) assessed depression in Pakistani and found 
a strikingly high prevalence (36%). It was a two phased design covering a full 
range of adult population. 
 
Hemingway H et al., (2001) and Commander JM et al., (2004) compared the 
prevalence of depression in the South Asians and the Whites. Weick S  et al., 
(2004) compared 6 ethnic groups. Gater, R et al., (2009) compared Pakistanis 
and the Whites while Bhui, K et al., (2004) compared the Punjabis and the 
Whites while investigating the prevalence of depression. Despite such 
heterogeneity in the samples the prevalence of depression was higher in 
females and certain age groups the South Asians compared to the Whites. 
 
Husain, N et al., (1997), Weick S  et al., (2004) and Commander JM et al., 
(2004) sampled people with an age range of 16-74 while Hemingway H et al., 
(2001) included Civil servants in the age range of 35-55. Bhui, K et al., (2004) 
did not mention the age limit of their sample.  
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Bhui, K et al., (2004), Weick S  et al., (2004) and Gator R et al., (2009) stratified 
their sample on the basis of gender and found  high prevalence of depression in 
South Asian women in their middle age.  
 
Three studies Hemingway H et al., (2001), Weick S et al., (2004) and Bhui, K et 
al., (2004) even conducted multivariate analysis but their findings remained 
unchanged. 
 
In summary, depression tends to be somewhat higher in South-Asians; 
particularly in females when they are in their middle age. One of the possible 
explanation is that women are generally less educated and dependant on their 
spouse in this culture. There are also some views about the association of 
depression and menopausal hormonal changes. It is unclear that to what extent 
‘empty nest syndrome’ plays its role in the development of depression in middle 
age. The inconsistency in the findings would have been due to other factors 
including different settings, age, sample size, language and ethnic sub-groups. 
A careful interpretation would be required to apply these results on all South 
Asians as there are many sub-groups who remain unexplored in this review. 
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12  DEPRESSION FOLLOWING CORONARY HEART DISEASE AND 
MORBIDITY 
Depression following coronary heart disease is common. It can be due to direct 
or indirect effects of the ischaemic heart disease. This depression plays an 
important role in the cardiac prognosis. It is reported to have adverse impact on 
cardiac morbidity; cardiac or non cardiac mortality and health related quality of 
life. Cardiac prognosis will be discussed under following headings. 
 
a. Depression following coronary heart disease and cardiac morbidity 
b. Depression following coronary heart disease and mortality 
c. Depression following coronary heart disease and health related quality of 
life 
 
12.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review were selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
morbidity as an outcome measure without any restriction of date or language to 
ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease by using the key words   “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease”.  To 
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search for the outcome ‘cardiac morbidity’ was used as a key word. Each 
search was then combined to identify relevant articles. Additionally the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched.  Moreover relevant studies known to the supervisors and 
author were also included. Details of the search performed and the output is in 
the appendices. 
 
LITERATURE REVIEW 
Most of the literature that examined the association of depression and 
prognosis in coronary heart disease patients has used multiple end points in 
regard to morbidity. A number of studies included death as a part of the 
outcome measure as well. The biological, social and psychological mechanisms 
involved in the association of depression and an increased risk of cardiac 
morbid events are likely to differ from the mechanisms involved in the 
association of depression and deaths. It is therefore difficult to make 
comparisons between the findings of studies that included deaths in the 
outcome measure and those that only looked at morbid events. This issue 
becomes further complex when we see that generally cardiac events precede 
the cardiac mortality with varying time intervals. Despite this, researchers have 
tried to review the association of depression in coronary heart disease patients 
and cardiac events; as an outcome measure. 
 
The following sections will review evidence for an association between 
depressive symptoms/depressive disorder and cardiac morbidity in coronary 
heart disease patients. Depression has been reported in some studies to be an 
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independent predictor of cardiac morbidity but not in others. Studies that 
considered the association between depression and cardiac morbidity, have 
mainly examined patients following myocardial infarction whether it is the first or 
subsequent episode. Others have investigated patients following catheterisation 
for a suspected coronary artery disease (CAD).  
 
A number of studies used rigorous semi-structured interviews to identify 
patients with depressive disorder using diagnostic criteria (ICD-10/DSM 111) 
while others relied on the cut off scores of the self-reported standardised 
questionnaires. Some researchers relied on both measures at the same time. 
Generally standardised tools are easy and cost effective to measure the 
disease severity while semi-structured diagnostic tools are time consuming but 
a gold standard for the diagnosis of depression. Studies assessing depression 
by different tools will be reviewed separately. 
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12.2  STUDIES USING SEMI-STRUCTURED INTERVIEWS FOR 
DEPRESSION 
Three studies were identified that used semi-structured interviews while 
investigating the association of depression and cardiac morbidity. Two of them 
supported this association whilst one failed to find such an association. Table 3 
summarises these studies. 
 
Study No; 1 
Carney RM et al., (1988) conducted a study to determine the relationship 
between major depressive disorder and the cardiac endpoints following 
diagnostic coronary angiography. The endpoints included coronary artery 
bypass graft surgery (CABG), percutaneous transluminal angioplasty (PCTA), 
myocardial infarction (MI), hospitalisation resulting from cardiac disease and 
death due to cardiac disease. Coronary artery disease (CAD) was defined as 50 
% or more narrowing of one or more major coronary arteries. 
 
Patients undergoing elective cardiac catheterization for a suspected coronary 
artery disease were screened for this study. Those aged > 70 years, having a 
recent myocardial infarction (within the past 4 weeks), previous bypass surgery 
or coronary angioplasty, valvular heart disease other than known or suspected 
cardiomyopathy, were excluded. A modified version of the Diagnostic Interview 
Schedule (DIS) was used for depression prior to catheterisation. There was 
addition of question in regard to the duration of each symptom.  
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At 12 months follow up, the participants were contacted by a researcher (who 
was blinded to the baseline data) to determine the outcome measure.  
 
Of the 82 eligible patients, 77 (94%) were enrolled for the study. Of them 52 
(67.5%) participants had coronary artery disease and 9 (17%) of them met 
criteria for depression. At follow up, 1 depressed and 1 non-depressed patient 
reported having had a myocardial infarction, while 5 (56%) depressed and 12 
(28%) non-depressed patients underwent either coronary angioplasty or bypass 
surgery. A significantly higher proportion of the depressed than the non-
depressed (77.8% vs. 34.9%) participants experienced at least one major 
cardiac event (χ2=5.6, p< 0.02). 
 
The study has a number of strengths. The screening of all patients ruled out the 
possibility of selection bias. Coronary artery disease was well defined and clear 
exclusion criteria were applied. The researchers administered DIS, which ruled 
out possibility of reporting bias. DIS is a clinical depression rather than symptom 
scale leading to DSM 111 diagnosis of depression. It is a highly structured 
diagnostic interview and has been shown to have high reliability and concurrent 
validity. Prevalence of depression (17%) is in line with other studies (Frasure-
Smith, N et al., 1993). The outcome measure was clearly defined. At follow up, 
the participants were contacted by a researcher who was blinded to their 
baseline status which prevented researcher bias. Although the small number of 
participants studied precluded analysis of specific endpoints, combining 
endpoints gave a high incidence of cardiac events in the depressed than the 
non-depressed group. 
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The study has some weak areas. It has a small sample size and the participants 
underwent elective angiography rather than having ischaemic heart disease like 
myocardial infarction. A modified version of DIS was used for the diagnosis of 
depression. The outcome measure also included mortality (death) in addition to 
morbid events. The researchers did not perform multivariate analysis. 
 
The researchers have shown that major depression is a predictor of the cardiac 
morbidity in patients having coronary artery disease but without any history of   
ischaemic heart disease.  
 
 
Study No; 2 
Carney RM et al., (2003A) conducted a study to determine whether depression 
is associated with an increased risk of morbidity.  All patients admitted to the 4 
Coronary Care Units (out of 8), from October 1997 to January 2000 for 
myocardial infarction, were screened within 4 weeks of admission.  This is a 
subsidiary study of the “Enhancing Recovery In Coronary Heart Disease” 
(ENRICHD) clinical trial that examined whether treating depression and social 
isolation improves survival after acute myocardial infarction. Myocardial 
infarction was documented by cardiac enzymes combined with chest pain 
compatible with acute myocardial infarction and characteristic ST segment 
changes, or new Q waves. Those who had other life-threatening medical 
illnesses, cognitive impairment, other major psychiatric disorders, were too ill or 
logistically unable to participate or were on anti-depressant medications, were 
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excluded. The depressed and non-depressed groups were taken from the 
ENRICHD trial. Those who met the Diagnostic and Statistical Manual-IV (DSM-
IV) criteria for depression were eligible for this study. The criteria were modified 
for participants with a history of major depression; requiring symptoms for 7 
rather than 14 days for a major or minor depressive episode. Moreover 
depressed participants scored 10 or above on Becks Depression Scale (BDI).  
 
The BDI is a 21-item self-report questionnaire, which assesses the current 
depressive symptoms. These items include mood, sense of failure, pessimism, 
lack of satisfaction, sense of punishment, guilt feelings, self dislike, self 
accusation, suicidal wishes, irritability, crying, social withdrawal, indecisiveness, 
body image distortion, work inhibition, sleep disturbance, fatigue, loss of 
appetite and weight, somatic preoccupation and loss of libido. Each item scores 
0-3, where a high score reflects high intensity of depressive symptoms. For 
scoring, the ranks for each item are added up leading to a continuous score 
ranging from 0-63, where a higher score suggests severe depression and a vice 
versa. The BDI is a reliable tool having split-half reliability coefficient of 0.86 
(Beck, AT.et al., 1961).  Moreover, BDI has high sensitivity of 83.8% and a 
specificity of 71.7%. 
 
 
Dysthymia was also included in the depressed group. Those who did not meet 
the ENRICHD criteria for major depression, had no history of depression, and 
scored less than 10 on BDI were taken as non-depressed controls. The 
ENRICHD end point classification committee looked at the major end points 
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including nonfatal myocardial infarction. Participants were followed up at 6 
months and annually thereafter for up to 30 months. Outcome measure was 
determined from follow-up visits, telephone calls, routine hospital surveillance, 
and contacts with the patients' physician.  
 
Of the enrolled 408 were non-depressed while 358 were depressed 
participants. Of the depressed 163 (45%) participants met the criteria for major 
while 195 (55%) met the criteria for minor depression or dysthymia. Of the 
participants 57 (7.4%) experienced myocardial infarction while 709 (92.6%) 
remained event free at follow-up. In the unadjusted models, depressed 
participants were 1.5 times (95% CI 0.91-2.6, p=0.11) more likely to have a 
nonfatal recurrent myocardial infarction than the non-depressed participants. 
After adjustment, this association still remained (HR 1.2, 95% CI 0.69-2.0, p= 
0.54) but was insignificant.  
  
 
There are number strengths of the study. Screening 4 weeks after admission 
was a positive point of the study as it gave sufficient time for the depression to 
evolve to meet the DSM-IV criteria. This approach excluded those who were too 
ill to survive. The study has a large sample size and a long follow up.  The 
sample seems to be a representative of the population as it spans over 4 
Coronary Care Units located in different states of USA. The researchers used 
clear exclusion criteria. The definition of myocardial infarction was standardized. 
The outcome measure was determined by experienced cardiologists who 
remained masked to the participants’ depressive status. Multiple approaches 
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were used to collect follow up data to ensure its accuracy. Appropriate statistical 
tests were used for analysis. 
 
 
This study has some weaknesses. It relies entirely on the ENRICHD trial for its 
methodology, which was designed to determine whether treating depression 
and social isolation improve survival after acute myocardial infarction. The 
researchers have not mentioned the criteria for selection of 4 out of 8 CCUs and 
have not given the full details of the ENRICHD trial. The participants with history 
of depression were also included but with a different criteria for depression. 
Patients with dysthymia were also included in the depressed group which 
makes its comparison difficult with other studies (Ziegelstein, R C 2001, Mayou 
A R et al., 2000). It is not clear from the study that how many participants 
underwent modified criteria for depression. It is unclear why the 6 monthly 
follow up was then extended to 12 monthly later on. The morbidity rate could 
have been higher if the recruitment was started earlier (< 4 weeks).  
 
 
The researchers have underscored the important association of depression 
following myocardial infarction and subsequent cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a1) conducted this study to look at the impact of 
major depression on the prognosis of myocardial infarction at 18 months follow 
up. In brief, baseline social and demographic data were collected and a 
modified version of DIS was used to determine the depressive status. Moreover 
Becks Depression Inventory (BDI), a self-report questionnaire was also 
completed by the participants. However depression based on DIS will be 
discussed here. Where a physician had concerns about the psychological 
status of the participant, a psychiatrist was asked to do assessment. The 
outcome measure was cardiac events, which included both recurrences of 
acute coronary syndromes (unstable angina admissions and survived and non-
survived myocardial infarction) and probable arrhythmic events. The criteria for 
recurrence myocardial infarction were the same as that of the index myocardial 
infarction. All participants were contacted 12 months after the hospital 
admission. Multiple logistic regression analysis was conducted.  
 
 
 Out of 332 eligible patients, 227 (68%) completed baseline data. A total 34 (16 
%) met criteria for major depression. As 5 participants died in the hospital, 222 
were discharged home. At follow up 48 participants experienced cardiac events; 
36 (16%) experienced acute coronary syndrome while 12 (5%) had arrhythmic 
events. A higher proportion of the depressed (38.2 % vs. 18.8 %) than the non-
depressed participants experienced any cardiac event (OR 2.67, 95 % CI 1.22-
5.85, p=0.017).  
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The study has some weak areas. A huge number of exclusion may suggest 
recruitment bias; or the other possibility is that those who were severely 
depressed did not bother to participate in the study.  As the outcome measure 
also includes deaths, it will make its comparison difficult with other studies 
looking at the association of depression and prospective morbidity in ischaemic 
heart disease patients.   
 
 
There are a number of strengths of the study. It is a prospective study. DIS 
leads to DSM-111 diagnostic criteria for depression. Myocardial infarction and 
outcome measure were clearly defined. Outcome measure included acute 
coronary syndrome which covers a broad range of ischaemic heart disease 
including unstable angina, STEMI and non-STEMI. Appropriate statistical tests 
were used. Cardiac events occurred more frequently among those who fulfilled 
the DSM 111 R criteria for depression.  
 
The researchers have established that depression following myocardial 
infarction is associated with increased risk of cardiac morbidity. 
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12.2.1 SUMMARY OF SECTION  
 
All the three studies have used DIS for the DSM V1/ 111 diagnostic criteria. The 
prevalence of depression was similar in two studies (Carney RM et al., 1988 & 
Frasure-Smith, N et al., 1995a1) despite the different target populations. Both 
the studies followed up their cohort for 12 months. Carney RM et al., (1988) 
recruited stable patients having coronary artery disease, had a small sample 
size but supported the association of depression and cardiac events without 
recourse to multivariate analysis. Similarly, Frasure-Smith N et al., (1995a1) 
supported this association in patients having myocardial infarction. On the other 
hand, Carney RM et al., (2003) used modified and standard DSM 1V criteria for 
their sample but failed to find any association of post-myocardial infarction 
depression and cardiac events, which may be partly due to the fact that 
dysthymic patients were included in the depressed group. Dysthymia is a 
chronic, mild variant of depression which may not have the same impact on the 
cardiac prognosis as the depression based on DSM 111 or 1V criteria. 
Moreover Carney RM et al., (2003) carried out an ancillary study of the 
ENRICHD clinical trial which may not have recruited severely depressed 
patients anyway, thus having an impact on the cardiac prognosis.  
 
 
This review highlights that the depression developing among those at high risk 
of developing ischaemic heart disease (Caney RM et al., 1988) and those who 
have developed such disease, is associated with poor cardiac prognosis. 
Despite different target populations and methods of statistical analysis, both the 
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studies (Carney RM et al., 1988 & Frasure-Smith, N et al., 1995a1) used 
diagnostic interviews and reached the same conclusion. 
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Table 3 Studies exploring association of depression (Semi structured interview) and morbidity 
 
Study CD Enrolled OC & FU Tools Results Comments 
 
Carney et al 
(1988) 
 
 
CAD  
 suspected CAD 
pat, 
 mixed gender, 
Enrolled 77 
 
 Cardiac  events & 
mortality 
F/U 12 months 
 
Modified 
DIS (DSM 
111R) 
Dep associated 
with morbidity  
Dep17%  
Sample size too small to have a 
robust statistical analysis. a 
weak association 
 
 
Carney  et al  
(2003- A) 
 
 
AMI 
ENRICHD  trial, 
Screening;  4 
weeks  
Enrolled 776 
Mixed gender 
    
 
OC; Non-fatal MI 
F/U 30 months 
DSM 1V 
criteria 
 
weak association 
with morbidity. 
Dep= 45 % 
major 
Dep=55% minor 
 
 
Full details of ENRICHD trial 
are not available. NO criteria for 
selecting 4 out of 8 trial site 
Patient with history of 
depression and dysthymia were 
included.  
 
Frasure -Smith 
N et al 
1995(a1) 
MI 
 
Enrolled 227 
mixed gender 
OC; Recurrent 
ACS & arrhythmias  
F/U 12 months 
 
modified 
DIS 
Dep= 16 % 
 
MI associated with cardiac 
morbidity 
Key 
CAD: coronary artery disease OC: outcome  Dep: depression
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12.3 STUDIES ASSESING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES 
In addition to diagnostic interviews which are gold standard for making the 
diagnosis of depression, the researchers also used self-reported standardised 
questionnaires.  
  
Nine studies were identified that explored the association of depression 
diagnosed using cut off scores on standardised questionnaires, and cardiac 
prognosis. Five of them reported an association between depression and 
subsequent cardiac morbidity whilst the remaining three could not find any 
significant association.  Table 4 summarises these studies. 
 
 
Study No; 1  
 Lane D et al., (2000A) conducted a study to look at whether depression 
predicts recurrent coronary events after myocardial infarction. Myocardial 
infarction required two of the three features: 
a. typical ischemic chest pains lasting for at least 20 minutes,  
b. new pathological Q wave on ECG,  
c.  A peak creatine phosphokinase level (CPK) > 1.5 into normal limit.  
 
The physician must have informed patients of their diagnosis. MI as a result of 
cardiac surgery or angiography was excluded. Similarly those co-morbid 
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medical conditions likely to lead death within the next 12 months, inability to 
speak English, cognitive impairment or those who were too unstable to 
complete baseline assessment, were excluded. All consecutive admissions 
(January 1997- August 1998) to the Coronary Care Units (CCU) at two general 
hospitals in the West Midlands (UK) were screened within two weeks of 
admission. Participants completed the Beck Depression Inventory  and 
demographic, socio-economic and clinical data were collected at baseline. A  
BDI score of ≥10 was used as a cut-off point in this study. ‘Patient Information 
System’ (held at each hospital) and medical records were used to determine the 
main outcome measure at 12 months; fatal & non-fatal events requiring 
admission. Non-fatal events included recurrent myocardial infarction, unstable 
angina, coronary artery bypass graft (CABG) surgery, heart failure and 
arrhythmic events.   
 
Of the 437 eligible patients, 288 (66%) were enrolled. Of them 81 (30%) scored 
BDI ≥ 10.  At follow-up 272 participants could be traced; 190 (70%) were event 
free while 82 (30%) participants experienced at least one recurrent cardiac 
event which required hospitalisation. Of the 82 who experienced cardiac events, 
24 were depressed (BDI ≥ 10) while 57 were non-depressed (BDI < 10). This 
difference was not statistically significant (OR 0.97, 95% CI 0.55-1.70, p= 0.90).   
 
 
There are a number of weak areas of the study. The high refusal rate could 
have resulted in selection bias with subsequent impact on outcome measures. 
Similarly, those who refused were either not depressed or were too depressed 
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to bother about the study. BDI is a self-report measure prone to reporting bias. 
As it determines the severity of depression, it would be difficult to comment on 
whether the onset of depression was pre or post-myocardial infarction. The 
outcome measure was entirely based on the hospital record, and as such was 
prone to error. 
 
On a positive note, it is a prospective study. Participants were given up to two 
weeks to be fit for baseline interview facilitating a large sample size. Prevalence 
of depression (30%) is in line with other studies (Mayou RA et al., 2000; 
Ziegelstein, R C 2001). A standardised definition of myocardial infarction is 
another strong point of the study. Exclusion of myocardial infarction as a result 
of cardiac surgery or angiography would help to apply the results of this study to 
ischaemic heart disease patients. The participants with any medical condition 
(other than cardiac) likely to lead to death within the next 12 months were 
excluded as it could have acted as a confounding factor. High response rate at 
12 months and use of appropriate statistical tests seem to be among the 
strengths of the study.  
 
The researchers have not supported the association of depression following 
myocardial infarction and subsequent increased risk of cardiac morbidity. 
 
 
Study No; 2 
Lauzon C, et al., (2003A) conducted a prospective study looking at the 
association of depression and cardiac morbidity after acute myocardial 
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infarction. This is an ancillary study to a prospective study of quality of life after 
acute myocardial infarction (Pilote, L et al., 2002). The study was conducted in 
Quebec, Canada from December 1996 to November 1998. Patients admitted 
with myocardial infarction to the 5 tertiary care and 5 community hospitals were 
screened within 2-3 days of admission. Inclusion criteria included sustained or 
non-sustained Q wave for myocardial infarction, survival up to 24 hours after 
admission, admission through emergency department and literacy in English or 
French. At baseline, the researcher recorded demographic and clinical data, 
and the participants completed BDI. A BDI score ≥ 10 was used as a cut-off 
point. Follow up lasted for 12 months when participants were asked to give 
details of all hospital admissions since last contact.  
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) scored ≥ 10 while 359 scored < 10 on BDI. Those who were depressed 
at baseline underwent more cardiac catheterisation (57% vs. 47%, 95% CI 0.1 
% - 19.6%) and percutaneous  transluminal coronary angioplasty (PTCA; 32% - 
24%, 95% CI 0.1% - 16.2%) within 30 days of admission. Moreover they had a 
higher rate of readmission because of angina (22% vs. 13%, 95% CI, 2% - 
17%) and a higher composite index of readmission because of cardiac 
complications (31% vs. 18%, 95% CI 5% - 22%). After adjustment, depression 
remained associated with a higher risk of cardiac complications over the 12-
month follow up (HR 1.4, 95% CI 1.05-1.86). 
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This study has some weaknesses. It is an ancillary study to a prospective 
cohort study of quality of life after myocardial infarction (Pilonte, L et al., 2002). 
The researchers approached the client within 2-3 days, which could be too early 
for the depression to develop after myocardial infarction.  Of the participants, 
191 (35%) had BDI ≥10 which indicates at least mild depression. The 
researchers have not given the detailed criteria for myocardial infarction.  It is 
also possible that community hospitals were having less severe cardiac 
pathologies, thus having an impact on the outcome measure. Exclusion of the 
severe myocardial infarction patients, who could have led to higher morbidity, 
would have an impact on the outcome measure. The adjusted results are well 
supported by the confidence interval but it would have been a better practice to 
give the p value to highlight statistical significance. Outcome measure was 
entirely based on the patients account recorded on the postal questionnaires 
without any verification. 
 
On a positive note, it is a prospective study. The prevalence of depression (35 
%) is comparable with the previous study (Lane, D et al., 2000). Patients from 
both tertiary care and community hospitals seem to be reflective of the target 
population.  
 
The researchers have supported a weak association of depression following 
myocardial infarction and cardiac morbidity. 
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Study No; 3 
Frasure-Smith, N et al., (1995a2) tried to look at the association of depression 
and the prognosis of the myocardial infarction patients while using self-
administered Becks Depression Inventory. A cut off score of ≥ 10 was used for 
depression. The methodology and duration of follow up remained the same as 
described in section 12.2(Study No; 3). The outcome measure included both 
recurrences of ACS and probable arrhythmic events. Multiple logistic regression 
analysis was performed.   
 
Of the 332 eligible patients, 216 (65%) completed BDI at the baseline. A higher 
proportion (36.4%) of the depressed (BDI ≥10) than the non-depressed (14.7%) 
participants experienced cardiac events including acute coronary syndrome and  
arrhythmic events, and this difference was statistically significant (OR 3.32, 95% 
CI 1.69-6.43, p=0.005). 
 
The researchers once again supported the association of post-myocardial 
infarction depression and cardiac morbidity at 12 months follow up. 
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Study No; 4 
Shiotani I et al., (2002) explored the impact of depression on the prognosis of 
acute myocardial infarction. The samples were taken from a district-based 
survey; Osaka Acute Coronary Insufficiency Study (OACIS) in Osaka. OACIS 
included 1828 consecutive patients with myocardial infarction who were directly 
admitted or transferred to 25 collaborating hospitals within 1 week of the 
myocardial infarction between April 1998 and April 2000. Myocardial infarction 
required two of the following three criteria:  
a. a clinical history of central chest pressure, pain or tightness lasting for 30 
minutes 
b. a rise in serum CPK concentration to more than twice the normal 
laboratory value   
c. ST segment elevation on ECG  
 
 Those who died in the hospital, were unable to communicate or had a major 
psychological disease were excluded. Depression was assessed with Zung 
Self-rating Depression Scale (SDS). The SDS assesses the biological, 
emotional and physiological symptoms using 20 items. Its score ranges 20-80 
and a cut off score ≥ 40 was used in conformity with original recommendations 
(Zung 1965). The SDS was mailed out 3 months after the index myocardial 
infarction for baseline data. Participants were followed up for 12 months after 
hospital discharge. Follow-up data were obtained from the OACIS follow-up 
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database, hospital records, interviews with patients or family members by 
telephone. The outcome measure included; non-fatal recurrent myocardial 
infarction, coronary angioplasty or bypass, cardiac deaths, unstable angina, or 
uncontrolled arrhythmia.  
 
Of 1828 eligible patients, 1418 consented to participate before their discharge 
from the hospital. Of them 1042 completed baseline self-rating depression 
scale; 438 (42%) scored ≥ 40 while 604 (58%) scored < 40. At follow-up 283 
patients had cardiac events; 31.2% (138) in the depressed and 23.9% (145) in 
the non-depressed group. After controlling for age, gender, severity of 
myocardial infarction and other cardiac risk factors, post-myocardial infarction 
depression (post-MI depression) was associated with  the outcome measure 
(OR 1.41, 95% CI 1.03 - 1.92, p = 0.03).  
 
 
The study has a number of strengths; it has a large sample size and its baseline 
data were collected 3 months after hospital discharge which allowed the 
patients to stabilise to some extent. The diagnosis of MI was made by the 
cardiologist. Those who died before discharge and having severe depressive 
illness were excluded. Multivariate analysis included cardiac disease severity as 
well. The SDS has been used in other studies (Welin C et al., 2000) as well. As 
depressive status can change after discharge from the hospital, the researchers 
completed SDS on 111 patients 10-21 days after the myocardial infarction. The 
SDS scores of these participants were comparable with those completing it after 
discharge from the hospital.  
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Among the limitations of the study is the possibility of selection bias as there are 
a huge number of exclusions, which may have affected the outcome measure. 
The study has a high prevalence (42%) of depression compared to other 
studies (Dickens, C et al., 2004). SDS is a self-rating scale prone to reporting 
bias. The study relied on another study (OACIS) whose details are not 
available. The baseline data were collected 3 months after the index myocardial 
infarction which prevented inclusion of cardiac events happening from the 
discharge date to the commencement of the study. Follow up data (cardiac 
events) were obtained from hospital records, which is prone to documentary 
error. No selection criteria have been mentioned for those 111 participants who 
had had the SDS test performed during hospital admission.  
 
In summary, the researchers have supported the association of depression 
following myocardial infarction and poor cardiac prognosis. 
 
 
Study No; 5 
Strik JJMH et al., (2003) tried to look at the effects of depression following first 
myocardial infarction on cardiac events in a male cohort. Consecutive 
admissions between May 1994 and September 1999, to the First Heart Aid of 
the Academic Hospital of Maastricht, were screened. A typical clinical picture 
and ECG changes, and a maximum value of the aspartate aminotransferase 
(ASAT) were required for the diagnosis of myocardial infarction. Those with a 
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major psychiatric disorder other than affective disorder, an inability to 
communicate reliably (because of cognitive dysfunction or non-Dutch speaking) 
or a co-morbid life threatening condition were excluded. Participants completed 
the Symptom Check List-90 (SCL-90), one month after myocardial infarction at 
home or during the first visit at the outpatient clinic.  
 
 
Each of the items of the SCL-90 ranges from 0-4, where 0 indicates no 
complaint and 4 reflects maximal complaint. A 16-item sub-scale for depression 
(from the SCL-90) was used for the purpose of this study with a cut-off point of 
23.The outcome measure included cardiac death or recurrent myocardial 
infarction as diagnosed by the cardiologist. Participants were followed up for 3 
years.  
 
 
Of 407 eligible patients, 318 (78.1%) were enrolled for the study. Of them 47% 
scored above the cut-off point. At follow up 144 (45.2%) participants remained 
event-free, whereas 25 (7.9%) had experienced a major cardiac event.  After 
controlling for age, left ventricular ejection fraction ( LVEF ) and the use of anti-
depressants, the depression was significantly associated with outcome 
measure (HR 2.32, 95% CI 1.04-5.18; p=0.039).  
 
The limitations of this study include a relatively small number of cardiac events, 
the exclusion of female patients, and the lack of information on treatment for 
depression during the course of follow-up. Exclusion of a large number of 
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patients may suggest the possibility of recruitment bias. Starting the follow up 
one month after the index myocardial infarction allowed potentially eligible 
patients to be excluded, having an impact on the outcome measure. A high 
proportion (47%) of participants scoring above the cut-off point makes its 
comparison with other studies relatively difficult. SCL-90 is a self-report 
instrument prone to reporting bias. The researchers have not clearly divided the 
participants on the basis of outcome; recurrent myocardial infarction or cardiac 
death. There is a discrepancy in the numbers used in the analysis, which may 
suggest analysis bias; 318 participants were enrolled in the study but at follow 
up 25 had major cardiac events while 144 were event free (total 169). Major 
cardiac events also included cardiac deaths.  
 
 
Among the merits, it is a prospective study with long-term follow up. Patients 
with first myocardial infarction were enrolled. A refusal rate of 21.9% is 
comparable to other studies in which myocardial infarction patients were 
screened for depression. As ischaemic heart disease is more common among 
the males, perhaps that is the reason that the researchers included them only. 
Robust statistical tools (multivariate analysis) were used in the study. The 
researchers used SCL-90, a valid instrument having a sensitivity of 81.1% and 
a specificity of 83.5%, which is comparable with BDI having a sensitivity of 
83.8% and a specificity of 71.7%. 
 
The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity over a long term follow up. 
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Study No; 6 
Dickens C et al., (2004) conducted a study to investigate the long-term impact 
of depression on cardiac morbidity. Consecutive admissions with suspected 
myocardial infarction (MI) to 4 inner-city hospitals, at central Manchester 
between October 1997 and November 1999 were screened 3-4 days after 
hospitalisation. The World Health Organisation (WHO) criteria for the diagnosis 
of myocardial infarction were used. Two of the followings were required:  
a. History of typical chest pain  
b. Characteristic ECG changes 
c. A serial increase in creatine phosphokinase (CPK) to more than 
twice normal limits  
 
Patients were excluded; if they were too ill to complete the assessment even 
with assistance from the researcher, suffered from a serious co-morbid medical 
condition, were insufficiently fluent in English, were > 80 years old, or lived 
outside the catchment areas of the hospitals. Baseline depression was 
assessed using the Hospital Anxiety and Depression Scale (HADS) when 
subjects were instructed to reflect their feeling in the week preceding the MI. A 
HADS score of ≥ 17 was used as the cut-off.  
 
For the validation of the HADS, they administered the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN), to a sub-group of patients. SCAN is a 
semi-structured research interview which provides International Classification of 
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Diseases (ICD-10) diagnoses based on symptoms over the last four weeks. 
Severity of the index MI was assessed using 4 measures: Killip class, CPK 
values, medication on discharge and ECG. The follow up lasted for 12 months. 
The outcome measure included angiography, CABG, hospital admission or 
visits to the Accident & Emergency for cardiac problems. 
 
 
Of the 654 eligible subjects, 589 (90%) completed baseline assessments. Of 
them 140 (23.8%) had a depressive disorder (HADS ≥17). Follow-up 
information was completed on 583 participants. Of them, 118 experienced 
cardiac events while 456 remained event free. The proportion of the depressed 
participants were the same in both the groups; those who experienced cardiac 
events and those who did not (23.7% vs. 23.5%, p=1.0). Cox regression 
analysis revealed that the risk of cardiac events almost became double when 
history of angina, female sex and prescription of calcium channel blockers were 
added individually. However, depression failed to significantly improve the 
model.   
 
 
The study has a number of strong points. Clear inclusion and exclusion criteria 
were used. Myocardial infarction was based on WHO diagnosis. A high number 
of the participants were located at follow up. As the sample consisted of 
significant number of participants having first myocardial infarction, perhaps that 
is the reason for the low number of cardiac events in the depressed group. 
SCAN was used to validate HADS in their study. 
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The researchers used multiple outcomes which can lead to false positive 
results. The researchers seem to be eliciting pre rather than post-MI depression 
which may have different impact profile in cardiac patients. Of the cohort only a 
subgroup had had SCAN. 
 
The researchers have highlighted that there is no association of depression 
(preceding myocardial infarction) and cardiac morbidity at 12 months follow up. 
 
 
Study No; 7 
Ladwig, KH, et al., (1991A) explored the impact of depression following 
myocardial infarction on cardiac morbidity in a male cohort.  The study 
population is a sub-set of (779) patient who participated in the Post-infarction 
Late Potential Study (PILP).  
 
 
All the consecutive patients (aged 29-65) brought to hospital with myocardial 
infarction were screened if they survived up to 3 weeks. The diagnosis of 
myocardial infarction required a typical chest pain, ECG changes with loss of R 
wave and/ or presence of new Q wave and elevation of infarct related enzymes 
more than twice the upper normal value. Depression was assessed with a 12-
item depression scale consisting of 3 sub-scales (emotional isolation, psychotic 
tendency and vulnerability) with a rating of 1-3. Depression was divided into 
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mild, moderate or severe grades. Follow-up information was obtained at 6 
months after hospital discharge. Study end-points were spontaneous 
occurrences of a symptomatic sustained ventricular tachycardia leading to 
emergency admission to hospital. 
 
 
Of the 770 participants of the PILP study, 560 were enrolled in this study. 
During the 6 months follow-up, 17 participants suffered from arrhythmic events. 
The frequency of arrhythmic events was significantly higher in the severely 
depressed group than in the mildly depressed group (6.3% vs. 2%, p=0.035). 
However, multiple regression analysis failed to support the association of 
depression and subsequent arrhythmic events. 
 
 
Among the limits of the study are that it is centred on male patients only, hence 
its results cannot be generalised. It is a subsidiary study. The study does not 
mention the tool used for depression or its cut off point.  A huge drop out in the 
study may reflect selection bias. The researchers only relied on univariate 
association of depression and cardiac events because their multivariate 
analysis did not support such an association which suggests that confounding 
effect. 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. Outcome was well defined. 
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Non-fatal events were confirmed from the hospital record. Six months is a very 
vulnerable period in the course of a chronic illness (Moss AJ et al., 1990). They 
graded depression into mild, moderate or severe degree a step forward in the 
existing literature. 
 
The researchers have found insignificant relationship between depression and 
cardiac morbidity in patients having myocardial infarction.  
 
 
Study No; 8 
Ladwig, KH et al., (1994) Following on from the above study (Study No; 7) the 
same researchers explored the impact of depression following myocardial 
infarction on angina in the same cohort.  The study population is a sub-set of 
(779) patient who participated in the Post-infarction Late Potential Study (PILP). 
The methodology remained the same. 
 
 
All the consecutive admissions (aged 29-65) with myocardial infarction were 
screened if they survived up to 3 weeks. Depression was assessed with a 12-
item depression scale and was divided into mild, moderate or severe based on 
the score. The outcome measure was angina which was determined from the 
participant’s interview and hospital record. Participants were followed up for 6 
months. The researchers conducted multivariate analysis.  
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In total 552 participants were enrolled. Of them 80 (14.5%) had severe, 123 
(22.3%) had moderate and 349 (63.2%) had low degree of depression at 
baseline. Of the enrolled only 377 (68%) participants could be traced at follow 
up. Of them 50 (13.3%) participants had severe, 85 (22.5%) had moderate and 
242 (64.2 %) had low degree of depression. The risk for angina was higher 
among the severely than mildly depressed participants; (unadjusted RR 3.12, 
95% CI 1.58-6.16) and (adjusted RR 2.31, 95% CI; 1.11- 4.80). 
 
 
This study has some weak areas. Post-infarct angina pectoris was determined 
from participant’s interview and hospital record, which are prone to recall bias 
and documentary error respectively. A patient’s account of angina pectoris may 
not necessarily be a true reflection of angina; as psychosomatic complaints can 
easily give a false picture. Researchers have not given the incidence of angina 
pectoris. The whole sample suffered from depression, which may suggest 
selection bias. The researchers failed to give level of significance (p value) in 
their findings. 
 
 
On the positive note, it is a prospective study with a standard definition of 
myocardial infarction.  Six months post-myocardial infarction is a very vulnerable 
period in the course of a chronic illness (Moss AJ et al., (1990). Non-fatal events 
were clearly defined. Recruitment 3 weeks after myocardial infarction allowed 
sufficient time for the mood symptoms to develop. The researchers used 
multivariate analysis to rule out any potential confounders.  
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The researchers have supported the association of depression following 
myocardial infarction and cardiac morbidity; a dose-response effect. 
 
 
Study No; 9 
Parashar S  et al., (2006a) investigated the impact of depressive symptoms 
developing over 30 days following  myocardial infarction  on the morbidity. 
Patients were screened between January 2003 and June 2004 as part of the 
Prospective Registry Evaluating outcomes after Myocardial Infarction: Events 
and Recovery (PREMIER) study.  
 
Briefly, consecutive patients admitted with MI were eligible to participate in the 
PREMIER study if they were 18 years or older; had increased level of troponin 
or creatine phosphokinase within 24 hours of hospital admission; and 
demonstrated evidence for myocardial infarction (prolonged ischemic 
signs/symptoms or ECG changes). Patients were excluded if they had been 
transferred to the research centres from another facility 24 hours after their first 
presentation, could not speak English or were incarcerated. 
 
The 9-question Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ) was used for depression twice; at baseline (during 
admission) and at one month. For each of the 9 depressive symptoms, 
participants had to report whether symptoms had bothered them; “not at all,” 
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“several days,” “more than half of the days” or “nearly every day” in the past two 
weeks, yielding a score from 0 to 3. The PHQ score ranges from 0 to 27, with a 
standard cut-off score of 10 or above. Participants were grouped into 4 
categories based on depressive symptoms; 
a. no depression (PHQ score < 10 at baseline and at 1 month)  
b. new depression (PHQ score < 10 at baseline and ≥ 10 at 1month)  
c. transient depression (PHQ score ≥ 10 at baseline and < 10 at 1 month)  
d. persistent depression (PHQ score ≥10 both at baseline and at 1 month) 
 
History of depression was defined as receiving medications or counselling for 
depression. Outcome measure was the attacks of angina pectoris at 6 months 
follow up. 
 
Of the 3953 eligible patients, 2498 (63%) were enrolled in the PREMIER study. 
Of them 2096 (84%) were eligible for this study because their data for 
depression both at baseline and at 1 month were available. Follow-up data were 
available for 1873 (89%) participants. 
 
Of the cohort, 6% experienced new depression (PHQ < 10 at baseline but > 10 
at 1 month), 7.1% experienced persistent depression (PHQ >10 at both 
baseline and 1 month) and 13.5% experienced transient depression (PHQ >10 
at baseline but <10 at 1 month). Corresponding odds for angina were 2.73, 2.64 
and 1.62 (P< 0.01) when compared to the non depressed participants. 
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The researchers have demonstrated that it is the persistent and newly 
developed depression in 30 days that is associated with cardiac morbidity , not 
the transient depression. 
The researchers gave elaborate criteria for MI. The study has given a clear 
inclusion and exclusion criteria. The PHQ is a well known tool for screening of 
depression. A large number (89%) of participants were followed up. Depression 
was assessed twice, which highlighted the limited role of transient depression 
when compared to newly developed or persistent depression. It possibly 
answered the question as to why depression in some studies is associated with 
morbidity  but not in others. 
 
 
In regard to its weaknesses it is a subsidiary study. Follow up is limited. Angina 
pectoris is generally based on the clinical account as there is no corresponding 
ECG or cardiac enzymes changes. Depressed patients may present with 
excessive somatisation. There are no details given concerning how the follow up 
data were collected. 
 
The researchers have found that newly developed or persistent depression has 
a more marked impact on the cardiac morbidity compared to transient 
depression.
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Table 4 Studies exploring association of depression (Standardised Questionnaire-cut off score) and morbidity 
 
Study CD  Enrolled OC & F/U Tools Results Comments 
Lane, D et 
al (2000-A) 
UK 
MI Screening; 2 weeks 
gender, mixed  
Enrolled 228 
F/U 12 months 
OC; fatal & non 
fatal events 
BDI  ≥ 10 dep=30% 
Multivariate  
analysis was 
conducted 
Multiple outcome 
Weak association 
Lauzon C, 
et al 
(2003A)  
 
(Ancillary 
study) 
MI Screening; mixed 
gender,  2-3 days after 
admission,  
Enrolled 550 
Community & tertiary 
hospitals  
OC; angina and 
readmissions 
F/U 12 months 
BDI  ≥ 10 Dep=35% 
 Positive 
Association of 
dep & cardiac 
morbidity 
Multivariate 
analysis 
High refusal rate; researcher 
bias, outcome measure-not 
defined. An ancillary.. 
 
Sample from community & 
tertiary service; F/U data 
collected by postal 
questionnaires only 
Frasure- 
Smith, N at 
al (1995 a2) 
 
MI Enrolled 216 
 gender; mixed 
OC;ACS & 
arrhythmias 
F/U 12 months 
BDI  ≥ 10 
 
 
 
Positive 
association of 
dep & morbidity 
Multivariate analysis done 
 
Shiotani  I et 
al (2002) 
 
AMI Enrolled 1042 
Screening: mixed 
gender, 3 months    
 non-fatal 
events &cardiac 
deaths 
F/U 12 months 
SDS, cut off 
point=40 
 Dep=42% 
Multivariate done 
SDS –self rating scale 
A subsidiary study of OACIS  
Strik JJMH 
et al (2003)   
First 
MI 
 
 
Enrolled 318 
Screening; male only, 
baseline data 1 month 
after MI  
OC; cardiac 
death and 
recurrent MI 
F/U 3 yrs 
SCL-90  
Cut off =  23 
 
Dep=47% 
 
Multivariate 
analysis + 
Gender restriction, baseline data 
from home, death included in 
outcome measure, high 
prevalence of dep 
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Dickens C 
et al (2004) 
 
UK 
MI 
(WHO) 
Enrolled 589 
Screening :mixed 
gender, 3-4 days  
OC; cardiac 
deaths, further 
cardiac events 
F/U 12 months 
HADS Dep= 24% 
 
No association of 
dep& morbidity 
Pre MI depression 
HADS validated 
Multiple outcomes 
Multivariate analysis done 
Ladwig KH 
(1991 A) 
(ancillary 
study) 
 
MI 
 
Enrolled 560 
Screening: 3 weeks, 
male only, age 29-65 
OC; sustained 
ventricular 
tachycardia 
F/U 6 months 
 
12 item dep 
scale 
Mild 
Moderate 
Severe dep 
Univariate = positive 
Multivariate =  negative 
Part of PILP study 
Dose-response effect 
Ladwig, KH, 
et al (1994) 
 
(ancillary 
study) 
AMI 
 
 
Enrolled 552 
Screening; 3 weeks, 
male only, age 29-65 
 
OC; non fatal 
events, angina 
F/U 6 months 
 
 
12 item dep 
scale 
 
 
Severe 
depression   
>association with 
cardiac morbidity 
than mild dep. 
No name or cut of point of dep 
scale 
Sample: only male , age 
restriction, 
multi variate analysis conducted 
dose response effect 
Parashar S 
et al (2006) 
MI Enrolled 2498 
Screening: twice within 
30 days of MI, mixed 
gender 
OC; angina 
attacks 
F/U 6 months 
9 question 
PHQ 
The odds ratio 
was highest for 
new & lowest with 
transient dep 
Persistent dep= associated  
Morbidity 
Part of PREMIER study 
 
Key; ACS: acute coronary syndrome; AMI: acute myocardial infarction; CAD: coronary artery disease; F/U: follow up; OC: outcome, 
CD: cardiac disease; Dep: depression, MI: myocardial infarction 
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12.3.1 SUMMARY OF SECTION 
All the reviewed studies are prospective in design that examined patients 
following myocardial infarction except Parashar,S et al., (2006a) who recruited 
patient with a diagnosis of acute coronary syndrome. Overall, these studies 
have found a high prevalence of depression compared to those using semi 
structured diagnostic interviews (DIS, SCAN) as expected. This was particularly 
high (47%) among patients at high risk of  recurrent myocardial infarction (Strik 
JJHM et al., 2003 ) and lowest (23.8%) among those having depression prior to 
the index myocardial infarction (Dickens, C et al., 2004).   
 
 
A big majority of the studies found an adverse impact of depression on the 
cardiac prognosis despite variation in their methodology. Three studies 
recruited males only (Ladwig KH et al., 1991 &1994; Strik JJHM et al., 2003) but 
interestingly came up with a positive association of depression and cardiac 
morbidity. It might raise the question as to whether it is the female gender which 
is relatively immune to further cardiac events or some other factors interplay 
between the genders of participants. 
 
Most of the studies assessed depression after the cardiac event. Researchers 
also supported a dose-response effect between depression and cardiac 
morbidity (Ladwig KH et al., 1991 &1994). Moreover, it has been supported that 
a persistent rather than transient depression can have more adverse impact on 
the cardiac morbidity (Parashar S et al., 2006a).  
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Dickens, C et al., (2004) failed to find association of depression and morbidity 
but it could be due to the fact that the researchers were trying to elicit the 
depression preceding rather than following the myocardial infarction. Moreover 
a significant proportion of their participants were having first experience of 
myocardial infarction.    
 
 
Furthermore, variation in the outcome measure could be the result of different 
demographic, settings, cardiac risk factors and disease severity (myocardial 
infarction) variables leading to heterogeneous findings.  
 
The researchers used various measures to assess the depression (BDI, HADS, 
SCL-90, and SDS) but there does not seem to be any clear pattern suggesting 
that some measures are more likely to support the association of depression 
and subsequent cardiac morbidity than others. In fact the studies using the 
same measures like Becks Depression Inventory have come up with mixed 
findings;   Frasure-Smith N et al., (1995a2) and Lauzon C et al., (2003a) found 
an association between depression and cardiac morbidity while Lane, D et al., 
(2000a) could not establish any association between depression and cardiac 
morbidity.  
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There are no consistent differences in outcome measures attributable to the 
timing of the depression assessment.  The studies that assessed depression 
within a week (Lauzon, C et al., 2003) or within a few months (Carney RM et al., 
2003; Shiotanti I et al., 2002) of the myocardial infarction were able to highlight 
its association with cardiac morbidity.  On the other hand others researchers 
such as Strik JJMH et al., (2003) assessed depression one  month after the 
myocardial infarction, but failed to find its association with poor cardiac 
prognosis. Dickens, C et al., (2004) identified pre-myocardial infarction 
depression by advising the participants to reflect on their mood preceding the 
myocardial infarction when completing HADS but could not find its association 
with adverse cardiac prognosis.  
 
 
There were no consistent differences in the outcome measure attributable to the 
number of ischaemic episodes. Perhaps somewhat unexpectedly,  studies 
having recruited participants with first episode of myocardial infarction (Strik 
JJMH  et al., 2003) supported the association of depression and cardiac 
morbidity. On the other hand, Dickens C et al., (2004) failed to show this 
association when a significant part of their sample was having first myocardial 
infarction (>65%). Similarly  Frasure-Smith N et al.,  (1995a1) possibly  recruited  
patients having   myocardial infarction ( first or subsequent episode) but still 
appear to support the association of depression and cardiac morbidity while 
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Lane, D et al., (2000) failed to show such an  association despite having 
matching  sample. 
 
 
The duration of follow up period has varied, ranging from 6 months following 
myocardial infarction to an average of 3 years.  Once again, there is no clear 
pattern in the association of depression and subsequent cardiac events based 
on the follow up period. Lane, D et al., (2000) followed up their cohort for 12 
months but failed to find association between depression and subsequent 
cardiac events whilst Frasure-Smith N et al., (1995a2) supported such an 
association despite having a similar follow up period. 
 
 
Studies have used different and multiple outcomes measures when looking at 
the cardiac morbidity (unstable angina, recurrent myocardial infarction and 
rehospitalisation, arrhythmias) making their comparisons with each other 
somewhat difficult.  Some studies relied upon patient self-reports of cardiac 
events during the follow up period (Lauzon C et al., 2003), while others used 
multiple sources when collecting follow up data (Shiotanti I et al., 2002) to 
increase their validity. Others collected data from the participants but then used 
medical records to confirm whether the event had occurred and whether it was 
cardiac or non-cardiac. Other studies used surgical procedures such as 
coronary artery bypass graft (CABG) or angioplasty to indicate morbidity (Lane, 
D et al., 2000; Dickens, C et al., 2004), although it was not always specified 
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whether this was an elective or an emergency  intervention. Also seemingly 
objective measures such as revascularisation procedures can depend on 
patient and physician’s preferences for treatment as well.  
  
Statistical analysis is another important part of methodology, which determines 
the strength of the results.  Some studies have only given Chi-square values; 
some were contended to univariate analysis only, while others failed to give p 
values while reporting their results. The multivariate statistical analysis is a gold 
standard to determine the association of whether one variable is independently 
associated with another variable, but depends on the accuracy of the 
measurement of potential confounding variables. In prospective research, it is 
not always possible to control for all potential confounders, so studies that 
accurately measured and controlled for a range of variables are likely to be 
more reliable than those that only controlled for a limited number of variables. 
Most of the studies tried to control for cardiac risk factors and ischaemic 
disease severity variables but not the co-morbid conditions that were controlled 
by few researchers (Dickens, C et al., 2004) in their final analysis.   
 
 
Of the studies reviewed in this section Frasure-Smith N et al., (1995 a1) seems 
to provide the best evidence of an association between depression following 
myocardial infarction and subsequent morbidity. Consecutive admissions with 
myocardial infarction were screened within 5-15 days. Myocardial infarction was 
well defined as was the outcome measure. The Beck Depression Inventory, a 
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standardised self-report questionnaire was used to determine depressive 
symptoms and its association with cardiac events at 6 months follow up.  The 
study also controlled for a range of potential variables for poor prognosis in its 
multivariate analysis. 
 
 
Most of the studies seem to be supporting the association of depression 
following myocardial infarction and cardiac morbidity, irrespective of its 
complexity. This review suggests that it is post-myocardial infarction rather pre-
myocardial infarction depression which has an association with subsequent 
poor cardiac prognosis. Variations in the findings of the reviewed studies are 
more likely due to differences in sample, settings, depressive measures, timings 
of depression assessment, cardiac disease severity, follow up measures, 
sources of follow up data and statistical analysis.  
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12.4 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES  
The association of depression and subsequent morbidity have been explored 
from different dimensions. This section will examine three studies that explored 
the association of depression and cardiac prognosis using continuous scores on 
standardised questionnaires. Table 5 gives summary of the studies. 
 
Study No; 1 
Lane D et al., (2000B) Following on from the section 12.3( Study No; 1) the 
same researchers  also tried to look at the association of depression and 
recurrent coronary events at 12 months follow up using continuous scores on 
Becks Depression Inventory. Methodology remained the same (Lane, D et al., 
2000 A) except that the participants completed the BDI at baseline. Outcome 
measure remained the non-fatal events, which included recurrent myocardial 
infarction, unstable angina, CABG surgery, heart failure, angioplasty, and 
cardiac arrhythmias.  The results were analysed using the Beck Depression 
Inventory as a total score. 
 
Of the 437 eligible patients, 288 (66%) were enrolled. The non-fatal events were 
as follows: recurrent myocardial infarction 14(5.1%), unstable angina 24 (8.8%), 
CABG 13 (4.8%), PCTA 13 (4.8%),  heart failure 8 (2.9%) and arrhythmias 8 
(2.9%). Mean BDI scores of those who were event free (7.4) was the same as 
that of those who experienced any coronary heart disease (7.5) events (OR 
1.00, 95% CI 0.96-1.05, p=0.92).  
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The researchers have maintained their position (Lane, D et al., 2000A) that 
depression following MI is not associated with cardiac morbidity. 
 
Study No; 2 
Carney RM et al., (2003B) Following on from the section 12.2 (Study No; 2) the 
same researchers tried to explore the association of depression and cardiac 
morbidity from a different perspective; using a self reporting depression tool. 
The methodology remained the same (Carney RM et al., 2003 A) except that 
the participants completed the BDI at baseline. Those who experienced cardiac 
events and those who remained event free, were compared. Participants were 
followed up for 30 months. 
 
 
All 766 participants were followed up. Of them 57 (7.4%) had a non-fatal 
recurrent infarction while 709 (91%) remained event free. The mean BDI score 
was significantly higher for those who experienced non-fatal infarction than 
those who remained event free (13.07 vs. 10.15, p= 0.01).  
 
The researchers supported the association of depression following myocardial 
infarction and cardiac morbidity without recourse to complex statistical analysis.
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Table 5 Studies exploring association of depression (continuous score) and morbidity 
 
Study CD 
 
Enrolled &Gender OC & F/U Tools Results Comments 
 
Lane, D et 
al ( 2000B)   
 
 
MI  
 
 
Enrolled 228 
Screen; 2 weeks, 
mixed gender 
 
 
 fatal& non-fatal 
events;  cardiac 
death ,MI,ABS, 
F/U 12 months 
Continuous 
BDI score 
Mean BDI 
score equal for 
dep and non 
dep 
Negative 
No comparison of the 
depressed and non-dep 
group, self rating scale, 
 
 
Carney  et 
al (2003B) 
 
AMI 
Enrolled 776 
Screen 4 weeks, 
mixed gender 
 
recurrent MI 
F/U 30 months 
BDI score Higher BDI 
score was 
associated 
with morbidity  
 
Key; AMI: acute myocardial infarction; F/U: follow up. OC: outcome, CD: cardiac disease; Dep: depression                                                                 
MI: myocardial infarction 
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12.4.1 SUMMARY OF THE SECTION   
Both studies have explored the association of depression and cardiac morbidity 
but have reached different conclusions. Lane D et al., (2000B) failed to find any 
significant association of depression and morbidity while Carney RM et al., 
(2003B) seem to be supporting the association of post-myocardial infarction 
depression and adverse cardiac prognosis. Carney RM et al., (2003B) found a 
significant association between higher BDI total score and cardiac morbidity in a 
long-term follow up. Their outcome measure was non-fatal MI. Lane D et al., 
(2000B) failed to show the association of depression following myocardial 
infarction and cardiac morbidity despite giving elaborate criteria for myocardial 
infarction. However they explored multiple outcomes which can be vulnerable to 
errors.  
 
 In summary, both studies have come up with different results. The researchers 
have relied on the mean score of BDI which to some extent helps to resolve the 
issues revolving around the thresholds of cut off points in the research.  
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12.5 OVERALL SUMMARY 
 
The literature reviewed in this chapter has revealed: 
a. Depression is common among patients having ischaemic or coronary 
heart disease. 
b. Depression following myocardial infarction or coronary artery disease is 
associated with cardiac morbidity in some studies but not in others.  
c. The association of depression and cardiac morbidity is intricated in a 
complex relationship. 
d. Methodological differences in the settings of the study, sample size, 
cardiac diagnosis, first or subsequent episode of myocardial infarction, 
timing and measures of depression, outcome measures, follow up data 
collection, and duration of follow up; are some of the known variables 
responsible for heterogeneity in the reviewed literature. 
e. Variations in the statistical analysis to control for disease severity also 
played a part in the inconsistent findings. 
 
Methodological differences in the studies, which have been reviewed, could 
potentially explain variation in the results to some extent. 
 
Settings 
Studies which have been conducted geographically in different parts of the 
world or have been a part of another study, could lead to different findings. Two 
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of the studies that reported significant findings for an association between 
depressive symptoms and post myocardial infarction morbidity recruited 
patients from other larger studies. Shiotani I et al., (2002) recruited patients 
from a district based survey in Japan that examined the prognosis of myocardial 
infarction. The sample of Ladwig, KH et al., (1994) belonged to the PILP study 
taking place in Germany. The studies that reported non-significant findings 
recruited patients from one hospital in the Netherlands (Strik JJMH et al., 2003) 
or from hospitals within the UK ( Lane, D  et al.,  2000; Dickens  C et al., 2004;). 
The reviewed studies do not seem to be following any consistent pattern based 
on the geographical location.  
 
Timing of Baseline Assessment 
The timing of the baseline assessment and differences in the measures used to 
assess depression could explain variations in the results.  Except Dickens C et 
al., (2004) the studies that recruited myocardial infarction patients generally 
assessed depression shortly after the myocardial infarction. Both Lane, D et al., 
(2000) and Lauzon C et al., (2003)  assessed depression between 2 to 5 days 
of the myocardial infarction. Strik JJMH et al., (2003) assessed his patients 1 
month and Shiotani I et al., (2002) assessed his cohort 3 months after the index 
myocardial infarction for depression.  In contrast, Dickens, C et al., (2004) 
asked the patients to report depressive symptoms experienced in the days prior 
to hospital admission for myocardial infarction in an attempt to elicit pre-
myocardial infarction depression. There is no consistent pattern of findings in 
the studies irrespective of whether they assessed the depression earlier or later 
on following myocardial infarction. However, one consistent finding is that it is 
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the depression following myocardial infarction which is associated with cardiac 
morbidity, not the depression developing in the days preceding myocardial 
infarction. 
 
Depression Tools 
Studies assessing depressive disorder using semi structured interviews have 
reported mixed findings; Frasure-Smith, N et al., (1995 a1) supported the 
association of depression and cardiac morbidity in patients having myocardial 
infarction. Similarly, Carney RM et al., (1988) supported this association in his 
patients who underwent coronary angiography for a suspected coronary artery 
disease. On the other hand, Carney RM et al., (2003c) failed to support the 
association of post-myocardial infarction depression and cardiac morbidity. 
Similarly, heterogeneous findings have been reported by the studies that used 
cut off scores on standardised symptoms scales such as BDI. Nine studies 
assessed depressive symptoms in patients following myocardial infarction but  
six  reported a significant association between depression and subsequent 
morbidity while 3 reported a non-significant association.   
 
There have been inconsistent findings from the studies that used continuous 
scoring on standardised symptoms scales.  Carney RM et al., (2003B)  
supported the association of depression and cardiac prognosis in their patients 
following myocardial infarction. On the other hand, Lane, D et al., (2000B) failed 
to reflect such an association in his cohort 12 months following myocardial 
infarction.  
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There is no difference however, between the findings of studies that assessed 
depression using semi-structured interviews compared to those that assessed 
depression using cut off scores on standardised questionnaires. This finding is 
in line with Van Melle et al., (2004) who found no difference between diagnostic 
interview and standardised  questionnaire assessments or in the strength of the 
association between depression and poor prognosis. 
 
Sample  
There are likely to be differences between studies based on the target 
population; those that recruited participants after first myocardial infarction 
should be less likely to have severe depression leading to poor cardiac 
morbidity. However Strik JJMH et al., (2003), despite having recruited patients 
with first myocardial infarction supported the association of depression and high 
cardiac morbidity. Other studies that recruited patients with arrhythmias were 
more likely to have increased risk of morbidity.   
 
In the studies reviewed, gender might have contributed to the variability of the 
outcome measure. All the three studies that recruited male patients only appear 
to be supporting the association of depression following myocardial infarction 
rather than those having gender mixed samples, as might be expected. IHD is 
predominantly found among the males, and perhaps based on the life style and 
other co-morbid conditions they are at high risk of recurrent cardiac events. 
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Outcome Measure 
Lack of standardisation of the outcome measure, is one of the factors leading to 
diverse findings. Some researchers included deaths (cardiac or non-cardiac) in 
their outcome measure, which might have inflated the morbidity rate compared 
to those who did not include `death` as an outcome measure. Others put 
multiple outcome measures such as CABG, angioplasty, angina, MI and 
arrhythmias. 
 
Follow-up Data Collection 
Collection of follow up data might have led to inconsistent findings. For 
example, some studies (Lauzon, C et al., 2003) relied entirely on self-reported 
questionnaires whereas other studies assessed cardiac events such as 
recurrent myocardial infarction, unstable angina pectoris, uncontrollable 
arrhythmia, and coronary angioplasty or CABG surgery with enhanced 
objectivity. These studies used multiple sources to get full and accurate picture 
of the follow up data. Some studies also used repeat outpatient hospital visits 
and emergency admissions as a measure of morbidity.  As the studies vary in 
the criteria for outcome measure, discrepancies in the results are likely to reflect 
this. The measures of cardiac event that depend upon patient’s account, which 
cannot be verified with medical records, may not be fully reliable.  This is due to 
reason that those patients who are depressed are more likely to report somatic 
symptoms and to consult with their GP more often (Lesperance,F et al.,2000  & 
Frasure-Smith, N et al.,  2000) which could artificially inflate the morbidity rate 
compared to the non-depressed patients. 
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Relationship between Depression and Cardiac Disease Severity  
Mendes de Leon (1999) raised a number of concerns about the relationship 
between depression and severity of disease.  One issue relates to the nature of 
depression in post myocardial infarction patients.  Mendes de Leon (1999) 
questioned whether the depressive symptoms assessed in post myocardial 
infarction period are true depressive symptoms or whether some somatic 
symptoms being perceived as depressive, are actually cardiac symptoms; 
suggesting that it could be possibly cardiac rather than depressive symptoms 
that are associated with poor prognosis.  Studies that found an association 
between depression and cardiac morbidity (Frasure-Smith N et al., 1995a2 & 
Lauzon C et al., 2003) assessed depression with the Beck Depression 
Inventory, which has items to assess somatic symptoms of depression which 
may mimic cardiac symptoms.  Studies that were unable to find an association 
between depression and subsequent morbidity (Dickens C et al., 2004), 
however, assessed depression, using self-reported questionnaires that do not 
contain items to assess somatic symptoms of depression, such as the Hospital 
Anxiety and Depression Scale. 
 
A second issue raised by Mendes de Leon (1999) is that whether it is 
depression following myocardial infarction or cardiac disease severity, which 
acts as a risk factor for a poorer cardiac prognosis.  The answer to this question 
is that all the necessary markers for the disease severity should be recorded in 
the data, and then these markers should be controlled for when looking for the 
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independent impact of depression on cardiac morbidity. Hierarchical multiple 
regression analysis is one of the best examples for this. The real issue is that 
whether those studies that reported a significant association between post 
myocardial infarction depression and morbidity, were able to adequately control 
for disease severity in their analysis.   
 
The studies reviewed in this chapter that reported a significant association 
between depression and poor prognosis, tried to control for various variables 
such as, previous angina pectoris, history of myocardial infarction, Killip class 
and left ventricular ejection fraction. Variables such as left ventricular ejection 
fraction and Killip class are often used to control for disease severity.  Although 
(Lane, D et al., 2003) has argued that these variables may not be sufficient to 
adequately control for disease severity and that additional variables such as 
medication at discharge and duration of hospital stay should also be controlled 
for, before reaching a final conclusion of the association of depression and poor 
prognosis.  
 
Inconsistency in the variables used to measure and control for disease severity 
suggest that even studies that attempted to have controlled for disease severity 
in their analysis might not have done so adequately. Statistically controlling for 
potential confounding variables (in multivariate analysis) depends upon the 
variables selected for inclusion and how well they have been measured.  If 
covariates have not been measured accurately then there is a risk of residual 
confounding (Christenfeld et al., 2004). Moreover those studies who did 
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adjusted analysis, found that the odd ratios was lower than in the non-adjusted 
results; reflecting the contribution of confounding effects in the association of 
depression and poor prognosis.   
 
When looking at the association of depression following myocardial infarction 
and cardiac prognosis, another issue that needs addressing is whether studies 
have controlled for co-morbid medical conditions such as rheumatological, 
chronic respiratory and neurological disorders that could have an adverse 
impact on the patient’s prognosis. Of the studies reviewed only one study 
(Dickens C et al., 2004) controlled for non-cardiac co-morbid disorders. Studies 
that did not take into account co-morbid conditions in their analysis cannot claim 
with certainty that depression is independently associated cardiac morbidity.    
 
It is not only the `mere depression` following myocardial infarction that is 
associated with morbidity but the degree of depression is also important. In the 
reviewed studies, it has been highlighted that the severe depression following 
myocardial infarction is a stronger predictor of cardiac morbidity than the mild or 
moderate depression; supporting a dose-response relationship. Moreover the 
research has highlighted that it is the persistence of depression after ischaemic 
heart disease which matters rather than just presence of depression.  
 
In summary, the there is a variable association between depression following 
coronary heart disease and morbidity but due to its complexity it remains 
debatable. Possibly it could be due to lack of any standardised criteria for 
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ischaemic heart disease, severity, depression and the outcome measure. 
Moreover adjustment for co-morbidity and cardiac disease severity are amongst 
the big challenges for the heterogeneous findings.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
108 
 
 
13 DEPRESSION AND MORTALITY      
This chapter will make an attempt to investigate the association of depression 
following myocardial infarction and mortality. Mortality is another hard outcome 
measure but it is much more precise than the cardiac morbidity. However it has 
a problem of whether it is cardiac or non-cardiac mortality or a combination of 
all called ‘all cause’ mortality. As expected the prevalence of all cause mortality 
will be higher than mere cardiac or non cardiac mortality.  As there is no study 
available on the South Asian population yet, the discussion will be centred on 
the Caucasian population. 
 
13.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
In Medline, firstly articles relevant to the patient population were identified using 
key words “depression, depressive disorder, mood disorder”. This was 
supplemented by a search of articles that included coronary heart disease. For 
this key words “myocardial infarction, acute coronary syndrome/ or angina, 
unstable and ischaemic heart disease” were used.  To search for the outcome 
key words such as ‘cardiac mortality’ and ‘all cause mortality’ were used. Each 
search was then combined to identify relevant articles. In addition the 
bibliography of identified papers, systematic reviews and editorials in this area 
were hand searched. Relevant articles which were known by the supervisor and 
writer were also included. 
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13.2  IMPACT OF DEPRESSION ON MORTALITY 
The majority of studies investigated the impact of depression in patients having 
myocardial infarction. There were only a few studies that recruited patients with 
first myocardial infarction or acute coronary syndrome.  Depression following MI 
has been reported by some researchers to be an independent predictor of 
‘cardiac or all cause mortality’ but not by others. Among the reviewed studies, 
some researchers assessed depression by semi-structured interviews for 
diagnostic criteria such as DSM VI while others relied on cut off or continuous 
scores on the self-rated standardized questionnaires such as BDI. Studies 
assessing depression with different measures will be reviewed separately along 
with a comparison of their findings. 
 
13.3 STUDIES ASSESSING DEPRESSION USING SEMI-STRUCTURED 
INTERVIEWS  
Seven studies were identified that used semi-structured interviews while looking 
at the association of depression following myocardial infarction and mortality. 
Three of them supported this association at significant level whilst the other four 
could not find this association. Table 6 summarises these studies. 
 
Study No; 1 
Frasure-Smith, N et al., (1993b1) conducted a study to determine the 
independent impact of depressive disorder on the cardiac mortality. 
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Consecutive admissions with myocardial infarction to the Montreal Heart 
Institute were screened. The diagnosis of myocardial infarction required two of 
the following;  
a. typical ischaemic chest pain lasting ≥ 20 minutes 
b. new pathological Q waves on the electrocardiogram  
c. a CPK level greater than 1.5 times normal or a CPK-MB value > 5 % of a 
simultaneous CPK value 
 
 The inclusion criteria included literacy in English or French, intact cognition, 
absence of serious co-morbid condition and clinical stability 5-15 days after MI.  
   
Baseline demographic data were collected and a modified version of the 
National Institute of Mental Health Diagnostic Interview Schedule (DIS) was 
applied for DSM-111-R criteria to determine the diagnosis of depression. 
Modifications were made to DIS to include depressive symptoms experienced 
since hospitalisation (an average of 7 days) rather than the standard two-week 
criteria. The participants were simply asked whether each symptom occurred 
daily since admission. Moreover, questions not relevant to the hospital setting 
were removed, e.g. “whether treatment had been sought for depressive 
symptoms and whether any impairment in daily activities had been 
experienced”. The BDI was also used to determine the depression but only the 
DIS will be considered here. Where physician had concerns about the 
psychological condition of the participant, a psychiatrist who was (blinded) to 
the depression status was asked for an assessment. Participants were 
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contacted at 6 months. Follow up data were obtained from ambulance and 
hospital records, interviews with the family or witnesses of death, and death 
certificates. Deaths were recorded as cardiac or non-cardiac by the 
independent cardiologists. Cox proportional hazards regression analysis was 
conducted. 
 
Out of 332 eligible patients,105(33%) refused; hence 227 completed baseline 
interviews. Of the participants 35 (16%) met criteria for major depression while 
187 (84%) did not. Of the non-depressed participants, 5 died in the hospital and 
222 were discharged from the hospital. At follow up 12 participants had cardiac 
deaths; 6 (17%) from the depressed group and 6 (3%) from the non-depressed 
group (OR 5.74, 95%CI 4.61-6.87,p< 0.05). The impact of depression remained 
significant on the mortality even when Killip Class and the previous MI were 
controlled for (OR 4.29, 95% CI, 3.14-5.44, p=0.013), but lesser in magnitude.  
 
This study has a number of strengths. It has a prospective design with a precise 
definition of myocardial infarction. The depressed and non-depressed groups 
did not differ in regard to the severity of the cardiac disease, an important 
confounding factor. The participant’s were interviewed within 5 to 15 days 
(average 7 days) of the admission to get a large sample size. The DIS is a 
semi-structured Interview leading to the DSM 111 R criteria for depressive 
disorder.  Due to potential recall bias, a modified DIS was used, which would 
not require two weeks duration of symptoms. As patients were hospitalised, the 
DIS criteria for impairment were also excluded. Modified DIS criteria have been 
used by other researchers (Reiger D A et al., 1984; Carney R A et al., 1988; 
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Schleifer et al., 1989) to control reporting bias. The prevalence of depression 
(16%) is in line with other studies (Mayou RM et al., 2000; Bush ED et al., 
2001). Classification of deaths (cardiac or non-cardiac) by independent 
cardiologists is another major strength of the study. Logistic regression analysis 
was conducted. 
 
In terms of limitations, a high refusal rate (33%) is the weakness of the study 
particularly involving women and elderly patients, which may suggest selection 
bias. Although the researchers observed a relationship between depression and 
mortality, there were only a few deaths. The researchers have not mentioned 
the demographic features of the non-participants; for instance whether they 
were too depressed to participate. Modification of the DIS (duration and 
impairment), is another weak point of the study. Multivariate analysis showed a 
reduced odds ratio suggesting confounding effects of other variables in the 
association of depression and cardiac mortality. 
 
The study concludes that those having major depression are at a greater risk of 
cardiac mortality than the non-depressed participants at 6 months follow up.  
This finding also suggests that the first 6 months following MI are a more 
vulnerable period. 
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Study No; 2 
Frasure-Smith, N et al., (1995 b2) Following on from the study just mentioned 
above (Study No;1) the same researchers while exploring the impact of 
depressive disorder on the prognosis of MI extended the follow up of the same 
cohort to 18 months. The rest of the methodology remained the same. In brief, 
all of the participants and their family members were contacted at follow-up to 
determine their survival status. 
 
Of the discharged 222 participants, 21 died (9.5%) at 6 months follow up. A 
further 9 deaths occurred between 6 and 18 months, and 2 of these were 
among the depressed participants (OR 1.04, 95% CI 0.12-8.98, p= 0.97). 
 
The researchers have highlighted that baseline depression is not having any 
significant impact on the risk of mortality from 6 to 18 months following 
myocardial infarction. The number of deaths has been too small. Possibly it is 
due to a small sample size. A larger sample would have been helpful to 
overcome this problem. It is also possible that some protective factors might 
have crept in due to long-term follow up. 
 
Study No; 3 
 Lesperance F et al.,(1996B3) looked at the further findings of those 222 
patients who were discharged from the hospital as mentioned in this section 
(Study No;1). A different team of researchers assessed the surviving 
participants at 6 months again for depression applying DIS. The aim was to 
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compare the impact of baseline depression and the depression at 6 months 
following MI on the mortality at 18 months follow up.    
 
Of the admitted participants, 222 survived to be discharged from the hospital. 
Based on the baseline depression 12 participants died at 6 months; 6 (17%) 
from the depressed and 6 (3%) from the non-depressed group (OR 6.24; 95% 
CI 1.88-20.67; p=0.004). All deaths were cardiac-related and the difference was 
statistically significant.  
 
At 12 months, 7 participants died from the depressed group and 10 from the 
non-depressed group (OR; 4.43, 95% CI 1.56-12.58; p=0.008).  
 
Survival status was obtained on 220 participants at 18 months. Between 12 and 
18 months another 4 patients died; one from the depressed group. The 
researchers concluded that although the impact of baseline depression 
remained significant over 18 months (OR 3.96, 95% CI 1.50-10.5, p=0.008) it 
was more marked in the first 6 months of follow up period. On the other hand 
the depression assessed at 6 months did not predict cardiac mortality 18 
months after MI. 
 
The researchers have concluded that the baseline depression is associated 
with high risk of mortality; highest in the first 6 months and then gradual tapering 
down of such risk over the next 12 months. Depression assessed 6 months 
after the myocardial infarction could not predict the high risk of mortality. It looks 
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like that depression developing soon after the myocardial infarction has special 
features leading to adverse impact on ‘all cause mortality’. It is also possible 
that cardiac disease itself takes times to make full recovery from the ischaemic 
damage and perhaps the risk of arrhythmias remains highest in the first 6 
months. Moreover it is possible that depression evolving soon after MI is more 
severe and persistent leading to adverse impact while the depression identified 
at 6 months may be transient, mild or a recurrent episode having a different 
impact profile. 
 
Study No; 4 
Bush DE et al., (2001a) conducted a study to look at whether major depression 
increases the risk of mortality after acute myocardial infarction (AMI). They 
screened patients within 2-5 days of admission to a teaching hospital, from 
July1995- December 1996, in Baltimore, Maryland. Those who were likely to die 
within 6 months of the non-cardiac illnesses, undergoing coronary angioplasty 
or coronary bypass, having other medical conditions precluding reliable verbal 
communication, not admitted to the cardiology service and those who died or 
were transferred to other facilities within the first 2 days of hospitalization were 
excluded. AMI was defined as having at least 2 of the following: 
a. presence of  ECG changes typical of ischemia/infarction, 
b. typical ischemic chest pain lasting ≥ 20 minutes,  
c.  Peak creatine phosphokinase (CPK) 1.5 times normal or a CPK-MB 
value 0.10 ng /ml, with a simultaneous CPK exceeding the normal limits.  
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The Structured Clinical Interview for DSM-III-R (SCID-NP) and BDI were used 
to determine the mood disorder. Demographic data were gathered via chart 
review after discharge. AMI severity and other cardiac risk factors were 
evaluated by a cardiologist blinded to the psychiatric status of the participants. 
The primary outcome measure, all-cause mortality, was determined from the 
phone call to a surviving contact at 4 months follow up. Logistic regression was 
conducted. 
 
Of the 696 identified patients, 285 (41%) were enrolled for the study. Of them 
14 were lost at follow up and hence 271 were followed up. Of them 46 (17%) 
had a mood disorder (including dysthymia) while 221 (83%) did not.  BDI scores 
of ≥10 were achieved by 19.9% of the participants.  Mood disorder and or BDI ≥ 
10 were present in 27.3% of the participants. Most of deaths (17 out of 18) 
occurred in those ≥ 65, hence the researchers focused their analysis only on 
this group. Mortality was significantly higher among those having mood disorder 
and or BDI ≥ 10 than those neither having mood disorder nor BDI ≥ 10 (14% vs. 
4 %, RR 3.8; p < 0.05). 
 
The study has a number of strengths. It is a prospective study. SCID, a gold 
standard method was used to determine mood disorder. The prevalence of 
mood disorder (17.2%) is comparable with other studies (Ziegelstein, R C 2001, 
Mayou RA et al., 2000). Exclusion criteria were clear and those who were likely 
to die within 6 months of the index MI due to the non-cardiac illnesses were 
excluded. Starting recruitment 48 hours after admission helped to recruit the 
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maximum number of subjects. Those who were excluded from the study did not 
differ from those who were included.  
 
The study has a number of limitations. A huge number of exclusions may 
indicate selection bias. The primary outcome measure (all-cause mortality) was 
determined by a follow-up phone call to the surviving contact. It can be a major 
methodological flaw of the study as non-responders may have been on 
holidays, have moved away, be too depressed to respond or have changed 
their phone number. Mood disorder included dysthymia which might be the 
reason for lower mortality in the depressed group. Inclusion of dysthymia in the 
mood disorder may make comparison difficult with other contemporary studies. 
Dysthymia is a sub-syndromal mood disorder relatively refractory to treatment. 
The number of deaths is small and the follow up period is limited. 
 
In summary, the researchers have established an association of depression 
with all cause mortality after myocardial infarction. 
 
Study No; 5 
Carney RM et al., (2003c) Following on from the section 12.2 (Study No; 2) the 
same researchers explored the impact of depression on ‘all-cause mortality’ 
after MI. The methodology remained the same. This is a subsidiary study of the 
“Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial that 
examined whether treating depression and social isolation improves survival 
after AMI. 
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In brief, participants completed the BDI and were administered the Depression 
Interview and Structured Hamilton (DISH). Those meeting Diagnostic and 
Statistical Manual-IV (DSM-IV) criteria for depression and had a BDI ≥ 10 were 
eligible for this study. The criteria were modified to 7 days (usual 14 days) for 
the participants having a history of major depression. Patients meeting the 
modified criteria for either minor or major depression or dysthymia were 
classified as "depressed." The findings based on the DSM IV criteria for 
depression are reported here. Those not meeting the ENRICHD criteria for 
depression, having no history of depression and were not socially isolated, were 
grouped as non-depressed. The major end point was monitored by the 
ENRICHD end point classification committee which consisted of cardiologists. 
Participants were followed up at 6 months and annually thereafter for up to 30 
months. The outcome measure was determined from follow-up visits, telephone 
calls, routine hospital surveillance, and contacts with the patients' physicians.  
Death certificates were obtained for all reported deaths.  
 
Of the participants, 408 were not depressed while 358 were depressed; 163 
(45.5%) met the criteria for major depression while 195 (54.5 %) met the criteria 
for minor depression or dysthymia. Of the cohort, 719 survived while 47 (6.1%) 
deaths occurred in the follow-up period. In the unadjusted analyses, depressed 
participants were 2.8 times (95 % Cl 1.5 - 5.3, P < 0.001) more likely to die than 
the non-depressed participants. After adjusting for other risk factors, depressed 
participants were still at higher risk of all-cause mortality (hazard ratio 2.4, 95% 
CI 1.2-4.7, p=0.009).  
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There are number strengths of the study. The study has a large sample size 
and a long-term follow up.  The sample seems to be a representative of the 
population as it spans over 4 CCUs located in different states of USA. 
Screening 4 weeks after admission was another strong point of the study as it 
gave sufficient time for the depression to evolve to meet the DSM-IV criteria. 
This approach also excluded those who were too ill to survive.   
 
The mortality rate could have been higher if recruitment had been started earlier 
(<4 weeks). The researchers used clear exclusion criteria and a standard 
definition of MI. The outcome measure was determined by experienced 
cardiologists who remained masked to depressive status of the participants. 
Appropriate statistical tests were used for analysis. Multiple approaches were 
used to collect follow up data which minimised the risk of missing the eligible 
participants. 
 
The researchers have established that major depression following myocardial 
infarction is associated with a high risk of ‘all cause mortality’. 
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Study No; 6 
Strik JJMH et al., (2004) conducted a prospective study to look at the predictive 
role of depression on cardiac outcome following first myocardial infarction.  All 
the consecutive admissions to Emergency Aid of the Department of Cardiology 
of the University Hospital of Maastricht, the Netherlands were approached. MI 
was diagnosed by the physician on the basis of following criteria: 
a. ECG changes typical of ischaemic heart disease  
b. Clinical picture  
c. Maximum value of asparate aminotransferase (ASAT) of at least 80 Units 
/ L (twice above the upper limit).    
 
Those with major psychiatric disorders (excluding affective disorder), 
communication difficulties, co-morbid life threatening medical conditions and 
living >50km from the study centre, were excluded. A trained physician 
administered Structural Clinical Interview for DSM-V1 (SCID-I-R) one month 
after MI. Outcome measure included major cardiac events; death or recurrent 
MI. Follow up data were collected from patient’s record and/or a systematic 
hospital assessment computer programme of the University Hospital. Survival 
data were evaluated over 36 months. Independent t test for continuous and Chi 
square test for dichotomous variables were used. 
 
A total 422 consecutive admissions were screened. Of them 206 (49%) were 
enrolled; 96 were excluded (including 28 deaths in the first month) while 99 
eligible patients refused. An additional 21 only completed questionnaires but 
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refused to attend the interview. After the first month, the incidence of both major 
and minor depression was highest (14.4%). At 6 months follow up, 5 
participants died and between 6 months and 3 years 2 more died; hence the 
total number of deaths was 7 (3%). Univariate Cox regression model did not 
find any significant association of depression and cardiac events (HR 1.10, 95% 
CI 0.36-3.42, P=0.867). Similarly on multivariate analysis, depression failed to 
have any significant impact on cardiac outcome (exp b 0.88, 95 % CI 0.26-2.93, 
p= 0.832). 
 
There are a number of strengths of the study. It is a prospective design. 
Participants with first MI were included as they were functioning well prior to the 
index attack. Baseline assessment was carried 4 weeks after the index MI 
which excluded those who were seriously ill. Similarly, it gave sufficient time for 
the depression to develop. A clear exclusion criterion was used. SCID was used 
to diagnose depression, which is administered by the researcher ruling out the 
possibility of reporting bias. Prevalence of depression (14.4%) is in line with 
other studies (Mayou, R A et al., 2000). A cardiologist diagnosed MI and cardiac 
outcome was well defined. Multivariate Cox regression model was used to 
determine the independent impact of depression on mortality. 
 
Regarding weaknesses of the study, a high refusal rate may suggest 
recruitment bias. The mortality rate was very low; partly it could be due to the 
exclusion of those 28 deaths, which occurred before the commencement of 
study and were not included in the analysis. The other possibility is that 
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prognosis of MI has improved in the last decade. As three years is a long-term 
follow up, it is possible that some of the protective factors may have been in 
place.  Death was noted from patient’s record and/or from computer programme 
of University Hospital, and as such is prone to documentary error. Similarly, 
they have not specified the association of depression and mortality, but rather 
have used the term cardiac events. Although 2 weeks duration of symptoms is 
required for the DSM-IV diagnosis, participants were enrolled 4 weeks after the 
myocardial infarction. 
 
The authors seem to underscore the important association of post-MI 
depression and mortality in this study. 
 
Study No; 7 
Kaufmann W M et al., (1999) conducted a study to examine the impact of 
depression on mortality at 6 and 12 months following myocardial infarction. The 
study was conducted at a University-affiliated tertiary academic medical centre, 
in Pennsylvania. Consecutive admissions between January 1995 and 
December 1995 were screened. Diagnosis of an MI required two out of three 
criteria:  
a. typical chest pain  
b. presence of new pathological Q waves on the ECG  
c.  Peak creatine phosphokinase level > 1. 
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 Those having other medical conditions likely to influence one year survival, 
cognitive impairment, lack of proficiency in English, and inability to participate in 
the study within 2 weeks of the MI were excluded. Social and demographic data 
were collected, and a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS) was used by a trained researcher to 
identify current depression. A cut-off score of ≥ 5 was used on DIS. The 
outcome measure was death. Participants were re-contacted at home 6 and 12 
months after index MI to determine their survival status. Variables were 
dichotomized for Chi-square test. A stepwise logistic regression model was 
used to examine independent impact of depression on mortality. 
 
Of the 358 eligible patients, 331 were enrolled for the study. Of them 90 (27.2%) 
met the criteria for clinical depression while 241 (77.8%) did not. At 6 months 
follow up 15 died; 7 (7.8%) from the depressed and 8 (3.3%) from the non-
depressed group (p= 0.08). Similarly at 12 months follow up, 14 (16.1%) and 19 
(8.2%) died from the depressed and non-depressed groups respectively (p= 
0.04). Univariate analysis revealed that post-MI depression was a significant 
predictor of deaths (OR 2.33,95%CI 1.16-4.65;p=0.015). However on 
multivariate analysis, depression could not survive as an independent predictor 
of death at 12 months.  
 
This study has a number of strong points; it is a prospective study. The criteria 
for myocardial infarction are clearly described. The prevalence of depression 
(27.2%) is higher than other studies (Frasure-Smith, N et al., 1993; Bush DE et 
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al., 2001;.Grace, SL et al., 2005) using diagnostic criteria. Both univariate and 
multivariate analysis were conducted.  
 
This study has some weak areas. The researchers do not clearly mention how 
many patients refused to participate. They also did not precisely define the 
outcome measure; whether they were looking for ‘cardiac or all cause morality’. 
The recruitment period is relatively short. The researchers have not highlighted 
any refusal, which may suggest researcher bias. The participants were 
interviewed a week after admission which did not allow the DSM-111 criteria for 
duration of depressive symptoms to be fulfilled. Multivariate analysis did not 
support the association of depression and subsequent mortality, which may 
suggest the presence of a confounding effect.   
 
The study has shown that there is a weak association between depression 
following myocardial infarction and mortality. 
125 
 
 
Table 6; Studies exploring association of depression (semi-structured interview) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-
Smith, N., et 
al. (1993b1) 
  
MI 
 
Screening; at 5-15 
days post-MI 
Enrolled 222 
OC; cardiac 
mortality 
F/U 6 months 
DIS 
(DSM 
111R) 
Post-MI depression 
associated with 
mortality; Dep= 
16%  
Precise definition of MI 
Cardiologist was involved in the assessment and was 
blind 
 
Frasure-
Smith, N., et 
al. (1995b2) 
MI 
 
Screening: at 5-15 
days 
Enrolled 222 
OC; cardiac 
mortality 
F/U 18 
months 
DIS 
modified 
Dep not correlated 
with mortality 
 
High refusal rate 
Few deaths only 
Two weeks criteria was not used 
Lesperance, 
F., et al. 
(1996b3) 
 
 
MI 
 
Screening; at 1 week 
Enrolled 222 
 
 
OC; all cause 
mortality 
F/U 18 
months 
Modified 
DIS 
Baseline dep is 
associated with 
cardiac mortality 
while dep assessed 
at 6 months is not 
associated with 
mortality at 18 
months 
Dep immediate after MI is important 
Bush, D. E., 
et al. 
(2001a) 
 
USA 
Acute MI 
 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
SCID-
NP 
BDI 
Mood disorder; 
17.2% 
Mortality with BDI 
score ≥ 10 was 
13.2%  & BDI < 10 
was 5.1%  (P= 
0.06). 
High number of exclusion of subjects-researcher bias. 
Major depression and dysthymia were both included. 
There was overlap between them 
A phone call was used to determine OC 
Carney, R. 
M., et al. 
AMI 
 
Screening: at 4 
weeks after 
OC; all cause 
mortality 
DSM 1V 
criteria 
Post-MI depression 
was associated 
Full details of ENRICHED trial are not available. NO 
criteria for selecting 4 out of 8 trial site 
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(2003-C) admission 
Enrolled 766 
F/U 30 
months 
BDI 
 
with higher risk of  
all cause mortality 
Patient with history of depression and dysthymia were 
included. Participants on anti-depressant medications. 
Mortality was delayed( 8months) 
Only unadjusted analysis supported the association 
Strick, 
JJMH.,  et 
al. (2004) 
 
MI(First) Screening: at  4 
weeks 
Enrolled 206 
 
OC; mortality 
F/U 3 years 
SCID Major dep; 14.6% 
Minor dep; 30% 
Mortality was 3 % 
 
Dep not associated 
with mortality 
High refusal rate 
Low mortality 
Those who died in the hospital were not included in the 
study 
Recruitment 4 weeks after MI was too late- having 
impact on sample size 
28 patient died prior to discharge 
Kauffman, 
W. K. (1999) 
 
 
USA 
MI 
  
Screening: at 3-5 
days 
Enrolled 331 
OC; only 
mortality 
F/U 12 
months 
 
DIS 6 months- positive 
(insignificant) 
12 moths-positive 
(significant) 
Only mortality 
Association was positive only on univariate not on 
multivariate analysis 
 
Key 
ACS: acute coronary syndrome AMI: acute myocardial infarction       CAD: coronary artery disease  F/U: follow up 
OC: outcome    CD: cardiac disease   Dep: depression    MI: myocardial infarction 
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13.3.1 SUMMARY OF SECTION 
 
All the reviewed studies are prospective; they recruited patients following 
myocardial infarction and used semi-structured interviews (SCID & DIS) for 
DSM 111 / 1V diagnosis of depression. Some researchers clearly defined minor 
and major depression (Bush DE et al., 2001a; Strik JJMH et al., 2004) while 
others considered them together. The prevalence of depression has varied from 
16% to 27% in these studies.   
 
Two of the seven studies (Frasure-Smith, N et al.,1993 b1; Lesperance, F et 
al.,1996b3 ) that used the modified DIS, found a significant association between 
depression and mortality, whilst the other two (Carney RM et al., 2003C; 
Kaufmann WM et al.,1999) found a partial association between depression and 
mortality not supported on multivariate analysis. Modifications in the DIS were 
made in regard to the duration of symptoms and impairments, particularly in 
relation to the hospital stay. Seven days duration helped the participants to 
overcome recall problems.  
 
The studies reviewed used different outcome measures; two used cardiac 
mortality, three used ‘all cause mortality’ whilst the remaining two used major 
cardiac events including death; possibly leading to variations in the results. ‘All 
cause mortality’ does include cardiac mortality but not the vice versa; hence it is 
expected to be high. The mechanics of association of depression and cardiac 
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mortality are different from the mechanics of association of depression and ‘all 
cause mortality’. 
 
Similarly, different approaches to collect the outcome data were used, leading 
to heterogeneous findings. Bush ED et al., (2000a) relied on a phone call while 
Carney RM et al., (2003) used multiple sources to collect full and accurate 
follow up data. 
 
Some of the researchers presented both adjusted and non-adjusted analysis 
while looking at the independent impact of depression on mortality whilst others 
failed to do a multivariate analysis. Multivariate analysis generally found a lower 
odds ratio than the univariate analysis; suggesting the presence of a 
confounding effect. 
 
Two studies included dysthymia in their depressed group as well; one 
supported the association of depression and ‘all cause mortality’ (Carney RM et 
al., 2003a) while the other failed to reflect such findings (Bush ED et al., 2001a). 
Dysthymia is a sub-syndromal chronic mood disorder, generally refractory to 
traditional treatment of depression.  
 
 Frasure-Smith, N et al.,  (1995 b2) supported the significant predictive role of 
baseline depression in the first 6 months but failed to show such  impact on 
mortality  in the long-term, which could be due to the time dependant 
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covariates. The review also suggests that depression assessed 6 months after 
myocardial infarction was not associated with a high risk of mortality. 
 
In summary, all the reviewed studies used semi-structured interviews (DSM 111 
criteria) for the assessment of depression, which are the most specific measure 
of depression, and are free from the reporting bias which happens in the self 
reported  questionnaires (BDI, HADS). The heterogeneous findings in the 
reviewed studies are more likely to be due to methodological variation 
particularly in regard to study settings, sample size, duration of follow-up, follow-
up measures, the way follow up data was collected, and the control of disease 
severity marker in the final analysis. 
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13.4 STUDIES ASSESSING DEPRESSION USING CUT OFF SCORES ON 
STANDARDISED QUESTIONNAIRES AND MORTALITY 
 
Ten studies were identified that have investigated the association of depression 
following myocardial infarction and mortality using cut off scores on 
standardised questionnaires. Most of them used Becks Depression Inventory 
(BDI) and Hospital Anxiety & Depression scales (HADS); both are well known 
for their use in the patients having cardiac disease. All the reviewed studies are 
prospective in their design.  Table 7 summarises these studies. 
 
Study No; 1 
Frasure-Smith N et al., (1995b4) Following on from section 13.3 (Study No;2) 
the same researchers made an attempt to examine the effects of depression on 
cardiac mortality by using cut off score(≥ 10) on the BDI as a measure for 
depression. Follow up lasted for 18 months. Univariate and multiple logistic 
regression analyses were performed. 
 
Of the participants 218 completed BDI at baseline; 68 (31%) had depression 
(BDI ≥ 10) while 150 (69%) had no depression (BDI < 10).  At follow up 21 
deaths (9.5%) occurred; 19 of these were cardiac. Of the cardiac deaths, 12 
occurred among the depressed participants (BDI ≥ 10). On logistic regression 
depression was a predictor of cardiac mortality (OR 7.82, 95% CI 2.42-25.26, 
p< 0.05). This association still persisted even when other significant predictors 
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(Killip Class, previous MI and PVCs) were controlled for (OR 6.64, 95%CI 1.76-
25.09, p=0.0026) but with a lesser magnitude. 
 
The study has suggested that depression following myocardial infarction is 
associated with cardiac mortality at 18 months follow up. 
 
Study No; 2 
 Lane, D et al., (2000C) examined the relationship between depression and 
cardiac mortality after myocardial infarction while using BDI a measure for 
depression. The researchers used the same methodology as discussed in 
section 12.3 (Study No;1). A cut off score of 10 or above (BDI ≥10) was used. 
Follow up lasted for 4 months. The participant’s survival status was determined 
from the ‘Patient Information System’ held at each hospital. The depressed and 
non-depressed groups were compared using correlation and stepwise multiple 
linear regression model.  
 
Of the 437 eligible patients, 149 (34%) refused. Of the enrolled (288) 
participants, 89 (30%) were depressed (BDI ≥ 10) while 199 (70%) were non-
depressed (BDI < 10). At four months follow up 25 (8.7%) participants had died; 
3 with non-cardiac causes and 22 (7.6%) with cardiac causes while 263 
survived. Of the 22 cardiac deaths, 8 were from the depressed group while 14 
were from the non-depressed group. The cardiac mortality was not significantly 
different between the depressed (9%) and non-depressed (7%)   groups (OR 
1.31; 95 % CI 0.53 - 3.24, p= 0.56).  
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The researchers found a weak association of depression and risk of cardiac 
mortality four months after myocardial infarction.  
 
Study No; 3 
Lane, D et al., (2001a) Following on from section 12.3 ( Study No; 1) the same 
researchers  extended the follow-up period to 12 months while looking at the 
impact of depression on the mortality in the same cohort. The methodology 
remained much the same except BDI was used to assess depression. The data 
were analyzed using correlation and multiple linear regression models. 
 
Out of 437 eligible patients, 149 (34%) refused. Of the enrolled 288 (65.9 %), 89 
(30%) were depressed (BDI ≥10) while 199 (70%) were non-depressed. At the 
12-month follow up, 31 (10.8%) had died; 27 of cardiac and 4 of non-cardiac 
causes. Final analysis excluded those having non-cardiac deaths.  Of the 
depressed group, 9 died and 78 survived; while in the non-depressed group 18 
died and 179 survived (OR 1.15; 95% CI 0.49-2.67. p=0.75). The cardiac 
mortality was not significantly different between the depressed and non-
depressed groups.  
 
The researchers could not support a strong association of depression and 
mortality at 12 months follow up while using BDI as a depression tool.  
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Study No; 4 
Lauzon C, et al., (2003b) Following on from the section 12.3 (Study No; 2) the 
same researchers used BDI as a measure for depression while exploring the 
association of depression and cardiac mortality 12 months after AMI. The rest of 
the study details remained the same. A BDI score of 10 or above (BDI ≥ 10) 
was used as a cut-off point. Vital status was determined from Central Death 
Registry for all those who were lost to follow-up.  Cox proportional hazards 
model was applied. 
 
Out of 587 eligible subjects, 550 (94%) completed baseline data. Of them 191 
(35%) had BDI ≥ 10 while 359 had BDI <10. Overall baseline clinical and 
demographic characteristics were similar in the depressed and non-depressed 
participants. The unadjusted incidence of mortality was slightly high in the 
depressed group at 6 months (6% vs. 3%, 95% CI 0.4% - 7%) and at 1 year (7 
% vs. 4%, 95% CI 0.2% - 7%) but these differences were not significant. 
Similarly adjusted analysis did not predict depression to be a risk factor for 
mortality (hazard ratio 1.3, 95% CI; 0.59-3.05). 
 
The researchers have under estimated the important association between post 
MI depression and mortality which is in line with previous studies (Lane, D et al., 
2000 & 2001). 
 
 
Study No; 5 
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 Grace LS et al., (2005) conducted a study to determine the effects of 
depression on mortality 5 years after an acute coronary syndrome (ACS). The 
study was conducted in South-central Ontario, Canada between 1997 and 
1999. Consecutive admissions to 12 Coronary Care Units (CCU) were 
approached 2-5 days after an ACS. Self-reported data were linked with 
participant’s clinical data on the CCU administrative database compiled by the 
nursing staff. BDI was completed by the participants. Follow up information was 
obtained from the Registered Person Database. Cox proportional hazard model   
was used.  
 
Out of 1800 eligible patients 910 (50%) were enrolled. Of them 482 (53%) had a 
confirmed diagnosis of MI and 424 (47%) were having unstable angina. Due to 
further losses and mismatches in the electronic records, the final sample 
became 750.  Of them 235 (31.3%) had BDI ≥10.  At 5 years follow up 115 (15 
%) died and 635 (84.7%) survived.  After adjusting for prognostic factors 
depression remained  a significant predictor of mortality at 2 years (HR 1.90, 
95% CI 1.12-3.24) while at 5 years the risk of mortality reduced further (HR 
1.53, 95% CI 1.04 -2.24, p=0.03).  
 
There are a number of limitations of the study. Exclusion of nearly 50% of the 
eligible patient indicates recruitment bias. Similarly, a 9.5% drop out of the 
enrolled subjects in the initial stages of the study suggests selection bias. 
Participant’s clinical data on the CCU administrative database were compiled by 
the nursing staffs which is prone to error. The researchers have not given the 
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definition of acute coronary syndrome. Approaching the participants 2-5 days 
after an ACS may have excluded those developing depression afterwards. BDI 
is a self-report measure which can lead to reporting bias and assesses the 
severity of illness rather than the diagnosis. The researchers have not broken 
down the mortality into cardiac or non-cardiac. Five years follow up is a long-
time which might have allowed other confounding factors to creep in, thus 
having an impact on the outcome measure. Follow-up information was obtained 
from the Ontario Registered Person Database, which is prone to documentary 
error. Similarly there is no mention of clear inclusive or exclusive criteria. 
Outcome measure was not defined. Comparison with other studies (Welin C et 
al., 2000; Carney RM .et al., 2003) would be relatively difficult as it sampled 
patients with acute coronary syndrome which encompasses unstable angina, 
ST segment elevation myocardial infarction (STEMI) and non ST segment 
elevation myocardial infarction (non-STEMI). 
 
On the other hand there are a number of strengths of the study. It is a 
prospective study with long-term follow up. Like many other studies BDI ≥ 10 
was used as a cut off point. The prevalence of depression is comparable with 
other studies (Mayou RA et al., 2000; Ziegelstein, R C 2001). Early approach to 
the participants helped to recruit a large sample size as patient turnover is rapid 
in the current practice. Recruiting from a diverse area (12 CCUs) may represent 
the target population; hence the results of the study can be generalized. This 
study looked at a wider picture of ischaemic heart disease by including unstable 
angina, STEMI and non-STEMI compared to many other studies that remained 
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contended to myocardial infarction (Ahern DK et al.,1990; Welin C et al., 2000; 
Mayou RA et al., 2000; Dickens, C et al., 2007). 
In summary, researchers have established the association of post-ACS 
depression and higher risk of mortality. 
 
Study No; 6 
Welin, C et al., (2000) conducted a study to look at the role of depression in the 
prognosis of myocardial infarction. Consecutively registered patients during 
October 1985-October 1987 were screened. There was 8 weeks interruption 
resulting from the leave of principal investigator. Acute myocardial infarction 
required two or more of the following criteria were fulfilled;  
a. a central chest pain of least 15 minutes duration, 
b. transient elevation of trans-aminases in serum to levels greater than the 
upper limit of laboratory,  
c. ECG with addition of pathological Q wave and / or disappearance of 
localised ST elevation in combination with development of T wave 
inversion in at least two of the eleven ECG leads. 
 
 MI was diagnosed by a physician from the MI Clinic. Participants completed 
self-administered questionnaires 3-6 days after the myocardial infarction and 
then 3 months after index MI the data were collected again. Depression was 
determined using the Zung Self-Rating Depression Scale (SDS). Its score 
ranges 20-80 and a cut-off score of 40 or above was used in conformity with 
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original recommendations. For fatal events the death certificate diagnosis was 
used. Follow up started 3 months after myocardial infarction lasting for 10 
years. Both univariate and multivariate analyses were conducted.  
 
 A total of 343 patients were enrolled. Of them 275 were left 3 months later. Of 
them 98 (35.6%) scored SDS ≥ 40.  A higher number of the depressed than the 
non-depressed participants experienced cardiac mortality (26.5% vs. 8.3%, HR 
3.54; 95% CI 1.85-6.79, p< 0.05) and all cause mortality (36.7% vs. 17.2%; HR 
2.45, 95% CI 1.49-4.02; p< 0.02). In multivariate analysis, higher SDS score 
was an independent predictor of increased risk of all-cause mortality (HR 1.75; 
95% CI 1.02-2.99, p< 0.05) and of cardiac mortality (HR 3.16; 95% CI 1.38 - 
7.25, p <0.05).  
 
Among the merits of the study are the prospective design, precise criteria for 
myocardial infarction and longer duration of follow up.  The diagnosis of 
myocardial infarction was made by a physician from the ‘MI Clinic’. Zung Self-
Rating Depression Scale was used to determine depression which assesses 
the biological, emotional and physiological symptoms. The cut off point used by 
the researchers conformed to that originally suggested by Zung as indicative of 
clinically significant depression.  Having baseline assessments 3 months after 
myocardial infarction, ruled out those with serious medical condition. Robust 
statistical analysis was carried out.   
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A high number of exclusions may suggest recruitment bias. It is possible that 
those patients who were lost to follow up were too depressed to bother about 
the study. The prevalence of depression is quite high. Death Certificate 
diagnosis is prone to documentary error. An interruption of 8 weeks in the 
recruitment may have led to recruitment bias having an impact on the outcome 
measure. Ten years is a long term follow up in which certain confounding 
factors may have developed.  
 
In summary, researchers have supported the association of depression 
following myocardial infarction and cardiac / all cause mortality over a period of 
10 years.  
 
Study No; 7 
Mayou R A et al., (2000) examined the predictive role of depression in the risk 
of all cause mortality at 18 months follow up.  All the consecutive admissions to 
two general hospitals (Oxfordshire) with myocardial infarction, between 
November 1994 and November 1995 were screened. Monica Trends and 
Determinants in Cardiovascular Disease (MONICA), which is primarily based on 
the ECG, cardiac symptoms and enzymes was used for diagnosis of myocardial 
infarction. Participants completed Hospital Anxiety and Depression Scale 
(HADS), within three days of admission. A score of ≥ 19 on the HADS was used 
as a cut off point. Cox multiple regression analysis was conducted.  
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Of the 546 potential participants 344 (63%) were enrolled. Of them   51 (14.8 %) 
patients were distressed and 293 (85%) were non-distressed at baseline.  
 
At 6 months follow up 14 participants died; 3 from the distressed and 11 from 
the non-distressed group. Moreover an additional 14 participants (3 from 
distressed and 11 from non-distressed) died at 18 months follow up. On Cox 
multiple regression analysis, baseline distress did not predict all cause mortality 
at 6 or 18 months follow up.  
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally it would have been affected by the high cut off point. 
Similarly this approach could have led to selection bias as those who were 
seriously ill and unfit on the 3rd day, had to be left out. Perhaps they were more 
likely to be become cases (distressed) at a later stage, thus having an impact 
on the outcome measure. On the other hand, those who presented with distress 
by the 3rd day could have presented a better picture if they had been given 
sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias. . A 
follow up reminder to the participants could have increased the response rate. 
The authors have not given the full details of the MONICA and it has not been 
used in other studies (Lane, D et al., 2000a & 2001b; Brink, E et al., 2002; 
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Beck, C A et al., 2001; Fauerbach, J A et al., 2005 ; de Jonge P et al., 2006)  
hence its comparison with other studies would be rather difficult.   
 
On the positive note it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool determining the severity of depressive symptoms in cardiac 
patients.  
 
The study has established that distress following myocardial infarction is a weak 
predictor of mortality at 18 months follow up. 
 
Study No; 8 
Parashar S et al., (2006b) Following on from the section 12.3 ( Study No;9) the 
same researchers also explored the impact of depression  developing over 30 
days after  myocardial infarction  on the mortality. The methodology remained 
the same. Briefly, consecutive patients admitted with MI who qualified inclusion 
criteria were enrolled. The 9-question PHQ was used twice for depression; 
during admission and then at one month. Participants were grouped into 4 
categories based on the course of depressive symptoms; no depression, new 
depression, transient depression, and persistent depression. Outcome 
measures were a combined end point of all cause re-hospitalisation or mortality 
at 6 months. Vital status was determined from the family members and the 
Social Security Death record.  
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 In all 2096 subjects were enrolled because their data for depression both at 
baseline and at 1 month were available. Of the cohort 6 % experienced new 
depression (PHQ<10 at baseline but >10 at 1 month), 7.1% experienced 
persistent depression (PHQ >10 at both baseline and 1 month) and 13.5% 
experienced transient depression (PHQ >10 at baseline but <10 at 1 month). 
Follow-up was completed on 1873 (89%) participants. The adjusted hazard 
ratios for re-hospitalization or mortality were 1.34, 1.71, and 1.42 for transient, 
new, and persistent depression respectively (all P< 0.05).  
 
Significant associations with mortality were reported for new, persistent and 
transient depressive symptoms compared to those not having depressive 
symptoms.  
 
Study No; 9 
Dickens C et al., (2007) Further to the section 12.3 (Study No; 6) the same 
researchers tried to explore the long-term impact of depression on cardiac 
mortality. The methodology remained the same. In brief consecutive admissions 
with suspected MI were screened 3-4 days after admission. The WHO criteria 
for the diagnosis of myocardial infarction were used. Baseline depression was 
assessed using the HADS when subjects were instructed to reflect their feelings 
in the week preceding the MI. A HADS score of ≥ 17 was used as the cut-off. 
Severity of the index MI was assessed as well. The main outcome of the study 
was cardiac mortality as determined from death certificate diagnoses obtained 
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from the Office of National Statistics. Cox regression analysis was performed to 
examine the association of depression and cardiac mortality. 
 
Of the 654 eligible subjects, 588 (90%) completed baseline assessments. Of 
them 140 (23.8%) had depressive disorder (HADS ≥ 17). Mean duration of 
follow-up was 6.75 years. Follow-up information was obtained on 587 subjects. 
Of them 78 (13.3%) had cardiac deaths while 60 (10.2%) had non-cardiac 
deaths. There was no significant difference in survival between the depressed 
group (mean survival 89.2 months, 95% CI; 84.7-93.8) and non-depressed 
group (mean survival 89.9 months, 95% CI 87.4- 92.4). The 313 subjects who 
underwent the SCAN and were depressed showed similar survival to those who 
were not depressed (mean survivals 95.4 months; 95% CI; 91.2 - 99.6 and 92.0 
months; 95% CI 89.1- 95.0 respectively). 
 
There are a number of strengths of the study. It is a prospective study with a 
long follow up. Sample size is fairly large.  WHO criteria for MI and a detailed 
inclusion and exclusion criteria were used. The prevalence of depression 
(23.8%) is in line with other studies. For the validation of HADS they 
administered SCAN (ICD-10) to a sub-group of the study sample. A HADS 
score of ≥ 17 was used as the cut-off, which provided the best sensitivity 
(87.7%) and specificity (84.7%) to diagnose depression (Dickens CM et al., 
2004). The participants were fully compliant with the modified version of HADS.  
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The study has a number of weaknesses. The HADS was used but in a slightly 
differently way from the conventional use when the subjects were instructed to 
report their feelings in the 7 days preceding the index MI. According to 
researchers, their patients were only in the hospital for a few days which may 
raise questions about the severity of cardiac disease.  
 
Their finding that there is lack of association of the depression preceding 
myocardial infarction with subsequent risk of mortality, cannot be compared with 
other studies as most of them examined depression following myocardial 
infarction.  
 
Study No; 10 
Ladwig, KH, et al., (1991B) Following on from the section 12.3 (Study No; 7), 
the same researchers explored the impact of depression following MI on cardiac 
mortality in the same cohort. In brief it was a subsidiary study of PILP. All the 
consecutive admissions (aged 29-65) to hospital with myocardial infarction were 
screened within 3 weeks. Depression was assessed with a 12-item depression 
scale and was divided into mild, moderate or severe grades. Follow-up 
information was obtained from hospital physicians, family physicians, relatives 
or bystanders. Follow up lasted for 6 months. The study end-point was cardiac 
death.   
 
In total 560 participants were enrolled. During follow-up 12 participants died. 
The frequency of cardiac deaths was significantly higher in the depressed 
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(p<0.001) than the non-depressed group. Moreover, the death rate was 0.9%, 
2.4% and 7.5% in the mildly, moderately and severely depressed participants 
respectively (p< 0.001); supporting the notion of a dose-response effect.  
 
The study has a number of strengths. It is a prospective study with a standard 
definition of myocardial infarction. Recruitment 3 weeks after myocardial 
infarction allowed sufficient time for the mood symptoms to develop. Outcome 
was well defined. The depression was divided into mild, moderate or severe 
degree to explore the dose-response relationship. 
 
The researchers have found significant support for a dose-response relationship 
between depression and cardiac mortality.  
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Table 7 Studies exploring association of depression (Standardised Questionnaire-cut off score) and mortality 
Study CD Enrolled OC & F/U Tools Results Comments 
Frasure-Smith, 
N.,  et al. 
(1995b4) 
 
 
MI 
Screening: at 5-15 days 
Enrolled 218 
 
OC; cardiac mortality 
F/U 18 months 
 
BDI 
High BDI score 
associated with mortality 
Adjusted analysis revealed 
effects but lesser in 
magnitude 
Lane, D et al 
(2000C)   
MI Screening:  2 weeks of 
admission, Enrolled 277 
cardiac mortality 
F/U 4 months 
 
BDI;  ≥ 10 Dep ;30 % ,mortality; 
7.6% ; No significant 
association; between  
dep and mortality 
High refusal rate; 
researcher bias, Less 
number of deaths in the 
depressed group 
Lane, D., et al. 
(2001a) 
MI Screening:  2 weeks 
Enrolled 277 
cardiac mortality 
F/U 12 months 
 
BDI Weak  association; post-
MI depression and 
mortality 
Less number of deaths in 
the depressed group 
No significant impact of 
dep on cardiac mortality 
  
Lauzon, C., et al. 
(2003b) 
 
First 
AMI 
Screening: 2-3 days 
Enrolled 550 
OC; mortality 
F/U 12 months 
 
BDI; a cut off 
score ≥ 10 
Depression rate;35% 
Weak association of 
post-MI depression and 
mortality 
An ancillary study, no 
criteria for MI given  
Adjusted and non adjusted 
results were given 
 
Grace, L. S., et 
al. (2005)   
 
ACS 
Screening: 2-5 days after 
ACS 
Enrolled 910 
OC; mortality 
F/U 5 years 
 
BDI  ≥ 10  dep;31.3 % 
 dep associated with high 
risk of mortality 
High refusal rate- 
researcher bias; long 
follow up-creeping  up of  
confounders 
 
Wellin, C., et al. 
(2000) 
 
First MI 
 
 
Screening: 3 months after 
hospital discharge 
Enrolled 343 
fatal events 
F/U 10 years  
SDS Dep 36% 
Depression associated 
with high risk of cardiac 
mortality and all cause 
mortality 
Baseline assessment was 
done at 3 months after MI 
8 weeks interruption 
Univariate and multivariate  
+ 
Mayou, R. A., et 
al. (2000A) 
MI 
 
Screening: within 3 days of 
admission; Enrolled 344 
OC: all cause 
mortality 
F/U 18 months 
HADS ≥ 19 Dep;15% 
 
 MONICA for MI; Only 63% 
people were enrolled 
Parashar S et al 
(2006) 
MI Screening: twice within 30 
days  
Enrolled 2096 
OC; mortality 
F/U 6 months 
PHQ New dep 6% 
Persistent dep 7% 
Transient dep 13.5% 
Does response effect 
positive 
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Dickens, C., et al. 
(2007) 
 
MI  Screening: 3-4 days 
Enrolled 588 
OC; cardiac mortality 
F/U 8 years 
HADS ≥ 17 Dep 24% 
Dep not associated with 
mortality 
SCAN was performed on a 
sub group 
Ladwig, K. H., et 
al. (1991B) 
Germany 
MI Enrolled 560 
Screening: 3 weeks, male 
only, age 29-65 
OC; cardiac mortality 
F/U 6 months 
12 item dep 
scale 
Mild dep 0.9% 
Moderate dep 2.4% 
Severe dep 7.5% 
Dose-response effect 
positive 
 
Key 
ACS: acute coronary syndrome  AMI: acute myocardial infarction F/U: follow up   OC: out come 
CD: cardiac disease;    Dep: depression   MI: myocardial infarction 
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13.4.1   SUMMARY OF SECTION 
Nine of ten studies explored the association of depression following myocardial 
infarction and subsequent mortality, whereas one (Dickens, C et al., 2007) 
study measured depression preceding the myocardial infarction. Of the 5 
studies that used a similar cut off score on BDI, two (Frasure-Smith N et al., 
1995, Grace SL et al., 2005) have strongly supported the association of 
depression and mortality. Their follow up period ranged from 4 - 60 months and 
the prevalence of depression ranged from 19% to 30%. Their outcome measure 
varied from “all cause” to cardiac mortality as well.  Grace SL et al., (2005) 
recruited patients having acute coronary syndrome covering a full spectrum of 
IHD along with a long term follow up.  
 
Both studies by Lane, D et al., (2000 & 2001) found a weak association of 
depression and cardiac mortality. Follow up data were collected from the 
hospital records. Lauzon C et al., (2003) found that depression was a risk factor 
for mortality but this association could not survive in the adjusted analysis; 
suggesting the contribution of the confounding factors. Moreover they recruited 
patients from community hospitals as well who were perhaps less severely ill; 
having impact on the outcome measure. Interestingly the prevalence of 
depression has remained 30 or above in all studies. 
 
On the other hand, two reviewed studies used HADS as measure for 
depression but failed to support any significant association of depression and 
mortality.  Both Mayou R A et al., (2000) and Dickens, C et al., (2007) who 
assessed depression within a week of index MI, used different thresholds for 
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depression (HADS cut off points; 19 vs. 17) leading to different prevalence of 
depression;15% and 24% respectively. Mayou R A et al., (2000) excluded a 
huge proportion of the participants suggesting selection bias and they did not 
define the outcome measure. Primarily this study was not for this purpose. 
Dickens, C et al., (2007) validated HADS against SCAN but explored the impact 
of pre-MI depression rather than depression developing following MI and their 
outcome was mainly determined from death certificate diagnosis. One possible 
explanation for their results could be that with recent advances in the treatment 
of IHD, and growing trends for healthy diet and more health education might 
have improved the mortality in cardiac patients.  
 
Welin C et al., (2003) on the other hand used SDS and found a high prevalence 
of depression (35%) compared to the studies using HADS. They found that 
depression was associated with high risk of mortality despite interruption in the 
study for 8 weeks.  
 
The prevalence of depression is much higher in the studies that used BDI / SDS 
than the studies using HADS. It is of interest that the prevalence of the latter 
studies is fully comparable with the studies using semi-structured interviews.  
 
In summary researchers have found mixed results; a reflection of complex 
association of depression and mortality affected by various overt and covert 
variables. Depression is a syndrome having biological, psychological and social 
dimensions, which can be picked up differently depending upon the timing and 
the tool used for its assessment. It is not clear how many studies looked at the 
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association of depression and the severity of disease at baseline and how many 
controlled for other co-morbid medical conditions. Baseline cardiac diagnosis, 
depressive measures, and outcome measure have not been standardized; 
leading to heterogeneous findings in the reviewed studies. ‘Cardiac mortality’ 
and ‘all cause mortality’ are more likely to have different perspectives 
particularly in reference to co-morbid conditions that need to be taken into 
account before reaching to any final conclusion.  
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13.5 STUDIES ASSESSING DEPRESSION USING CONTINUOUS SCORES 
ON STANDARDISED QUESTIONNAIRES AND MORTALITY  
Five studies used continuous scores on BDI to assess depressive symptoms. 
Three of them seem to be supporting the association of depression and 
mortality whilst the other two reflect a weak association. Table 8 gives summary 
of these studies. 
 
 
 
Study No; 1 
Ahern, D K et al., (1990) investigated the predictive role of depression on the 
prognosis of myocardial infarction. This evaluation occurred in the context of a 
prospective clinical trial, the Cardiac Arrhythmias Pilot Study (CAPS). In all 502 
patients were enrolled in CAPS. Major criteria for inclusion were that; 
a.  myocardial infarction must have occurred 6-60 days before enrolment  
b. participants should be < 75 years old  
c. participants should be  literate in English   
d. left ventricular ejection fraction > 20%  
 
At baseline BDI was completed by the participants and their follow up lasted for 
12 months. The outcome measures included both the death and cardiac arrest.  
Based on the mean BDI score, the participants having cardiac arrest or death 
were compared with those who survived. Data from 10 centers were pooled for 
the analysis purpose. 
 
151 
 
Of the 353 eligible participants, 351 completed baseline BDI. At follow up 324 
participants survived and 27 experienced cardiac events. The baseline BDI 
score of the survivors was lower than those who experienced cardiac events 
(8.13 ± 6.18 vs. 12.5 ± 8.70).  
 
The study has a number of strengths. A clear inclusion criterion was given. It 
had a large ample size which was followed up for 12 months. Up to 60 days 
were given for the depression to develop and it gave sufficient time to those 
who were acutely ill to get some stability.  The BDI, a commonly used tool for 
depression was used in this study. The researchers used mean scores of BDI 
which overcomes the issues of threshold revolving around the cut off points. 
The parameters that the researchers used for the severity of cardiac disease 
were noted. 
 
The study has a number of limitations. It is a subsidiary of CAPS. For the 
myocardial infarction to have occurred 6-60 days prior to enrolment might have 
allowed a number of mortality events to go unnoticed. The researchers have not 
given the criteria for myocardial infarction. A significant part of methodology is 
missing; for example we do not know that how the follow up data was collected. 
A huge exclusion (from the initial study) may suggest recruitment bias. The 
study used 10 centers but no details have been given in the paper. 
 
The researchers have supported the association of depression following 
myocardial infarction and mortality. 
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Study No; 2 
Bush ED et al., (2001b) Following on from their previous work discussed in the 
section 13.3(Study No;4) the same researchers tried to explore whether minimal 
depressive symptoms increased the risk of ‘all cause mortality’ after acute 
myocardial infarction. Participants completed BDI at baseline and were divided 
into three groups based on the score. 
a. BDI score 0-3 
b. BDI score 4-9  
c. BDI score >10  
 
AMI severity and other cardiac risk factors were evaluated by a cardiologist 
blinded to the psychiatric status of the participants. The primary outcome 
measure, all-cause mortality, was determined from the phone call to a surviving 
contact at 4 months follow up. Logistic regression was conducted. In multiple 
logistic model depression was entered as a 3-category variable (BDI; 0-3, 4-9, ≥ 
10). 
 
Of the 696 identified patients, 285(41%) were enrolled for the study. Of them 
267 were followed up. Those with a BDI scores of 0-3, 4-9 and ≥10 had a 
mortality of 2.6% (2 of 76), 17.1% (8 of 48) and 23.3% (7 of 30) (p < 0.002) 
respectively. The RR ratios were 6.5 for those having a BDI score of 4-9 and 
8.9 for those having a >10 BDI (p < 0.001).  
 
The researchers have supported that even a lower level of depression is 
associated with a higher risk of mortality. They have supported that the more 
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severe the depression then the higher is the mortality risk; which is in line with 
dose-response effect. 
 
The study has a number of strengths. It is a prospective study. Previous 
investigators have dichotomized BDI; those scoring ≥10 had a significantly 
greater mortality than those scoring < 10. This cut-off point was based on the 
view that BDI< 10 does not represent clinically significant depressive symptoms. 
However in this study, BDI scores as low as 4- 5 have been associated with a 
higher risk of mortality than BDI scores of 0-3. Mortality risk was increased in 
line with BDI score, showing a dose-response effect.  
  
In summary, the researchers have established a dose-response relationship 
between depression and the subsequent risk of ‘all cause mortality’. 
 
 
Study No; 3 
Lesperance, F et al., (2002) Further to the previous work discussed in the 
section 13.3 (Study No; 3), the same team made an attempt to examine 
whether there is a dose-response effect between depression and cardiac 
mortality. Detailed methodology remained the same. BDI, socio-demographics, 
medical history, and cardiac risk factors were gathered at baseline. BDI scores 
were divided into 4 categories as suggested by Beck et al., (1987). 
a. BDI scores < 5  
b. BDI scores 5-9  
c. BDI scores 10-18  
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d. BDI scores ≥19  
 
Participants were classified alive at follow up if they made any contact with a 
physician after 1825 days (5 years). Additional information was obtained from 
hospital charts and death certificates. Deaths were classified as cardiac or non-
cardiac by a cardiologist.  
 
In total 896 participants completed baseline BDI; 335 (47.4%) had a score (< 5) 
in the low normal range, (271) 30.2% had high normal level (5-9), 211(23.5%) 
had scores (10-18) indicative of mild depression, and only 79 (8.8%) scored (≥ 
19) suggestive of moderate to severe depression. Of them 26 (2.9%) 
participants were lost; hence 870 were followed up. Of them 155 died; 121 from 
cardiac while 34 from non-cardiac causes.  
  
Baseline depression remained significantly associated with 5 years cardiac 
mortality after covariate control (BDI score 5-9 vs. < 5; HR 1.76, 95% CI  0.98-
3.17; p= 0.059; BDI 10-18 vs. < 5; HR 3.17; 95% CI 1.79 - 5.60; p< 0.001; BDI 
score ≥19 vs. <5;HR 3.13; 95% CI 1.56-6.27 p=0.001). The independent impact 
of depression continued when the analysis was restricted to one year (70 
deaths; p= 0.009) and two years survivors (49 deaths, p= 0.015). 
 
The researchers observed a significant long-term dose-response relationship 
between depressive symptoms during admission and cardiac mortality.  
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There are a number of strengths of the study; it is a prospective study having a 
large sample. Participants were followed up for a long period. Deaths were 
divided into cardiac and non-cardiac by a cardiologist who was blinded to the 
BDI score. Instead of dichotomization BDI score was divided into 4 categories in 
an attempt to establish the impact of low grade depression on mortality.  
 
The researchers have supported the association of depression and cardiac 
morbidity and this association is in agreement with a dose-response effect. 
 
 
Study No; 4 
Lane, D et al., (2000d) examined the relationship between depression and 
anxiety in hospital, and mortality following myocardial infarction while using 
continuous scores on BDI. Full details of the study have been highlighted in 
section 12.3 (Study No; 1).   
 
Of the 437 eligible patients, 149(34%) refused while 288 participated. At four 
months follow up 25 (8.7%) participants had died; 3 with non-cardiac causes 
while 22 (7.6%) with cardiac causes. Of the participants 263 survived.  The 
mean BDI scores of survivors (7.7 ± 6.3) and non-survivors (7.5 ± 4.9) was 
different but not statistically significant (OR 0.99, 95 % CI 0.92-1.07, p=0.85). 
 
The researchers have not supported the association of depression following 
myocardial infarction and cardiac mortality. 
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Study No; 5 
Carney RM et al., (2003d) Following on from the previous work  discussed in 
the section 13.3 (Study No;5) the same group explored the impact of 
depression on the risk of ‘all cause mortality’ following acute myocardial 
infarction while using continuous scores on the Beck Depression Inventory. 
 
The mean BDI score of the non-depressed group was lower than the depressed 
group (3.89 ± 2.90 vs. 17.52 ± 6.74, p < 0.05) at baseline and it was statistically 
significant. Of the cohort 719 (94%) survived while 47 (6.1%) died. The mean 
BDI scores of the survivors was lower than those who died (10.05 ± 8.70 vs. 
15.21 ± 9.86, p= 0.0001) a.   
 
The researchers have established that depression is associated with increased 
risk of ‘all cause mortality’ in patients having myocardial infarction at long term 
follow up. 
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Table 8 Studies exploring association of depression (standardised questionnaires-continuous score) and mortality 
 
Study CD Enrolled OC & F/U Tools Results Comments 
Ahern, D. K., 
(1990b) 
 
MI 
 
Screening: from 6-
60 days after MI 
Enrolled 351 
OC: cardiac arrest/ 
death 
F/U 1 year 
 
BDI 
 
No association 
of dep with OC 
No criteria for MI 
A subsidiary study of CAPS 
Bush., et al. 
(2001B) 
 
AMI 
 
Screening at:  2-5 
days 
Enrolled 285 
OC: all cause 
mortality 
F/U 4 months 
BDI High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose- response effect was supported 
 
Lesperance,F et 
al (2002) 
 
 
 
MI Screening: 1 week 
Enrolled 896 
OC; cardiac and non 
cardiac mortality 
F/U 5 years 
 
 
BDI 
4 sub 
categories 
High BDI score 
was higher risk 
for all cause 
mortality and 
lower BDI score 
was lesser risk 
Dose-response effect was positive 
Lane, D., et 
al.(2000-d)  
MI Screening: 2 weeks 
Enrolled 288 
OC; mortality 
F/U 4 months 
BDI No impact of 
dep on mortality 
 
Carney RM et al 
(2003-d) 
AMI 
 
Screening: at 4 
weeks after 
admission 
Enrolled 766 
OC; all cause 
mortality 
F/U 30 months 
BDI 
 
Post-MI 
depression was 
associated with 
higher risk of  all 
cause mortality 
Full details of ENRICHED trial are not available. 
NO criteria for selecting 4 out of 8 trial sites 
Patient with history of depression and dysthymia 
were included. Mortality was delayed (8months) 
Only unadjusted analysis supported the 
association 
Key  
AMI: acute myocardial infarction F/U: follow up  OC: outcome  CD: cardiac disease  Dep: depression  
MI: myocardial infarction
158 
 
 
13.5.1  SUMMARY OF SECTION  
 
Three of the five studies (Bush ED et al., 2001c;;Lesperance F et al., 2002; 
Carney RM et al., 2003d ) supported the association of depression and higher 
risk of mortality. Moreover Lesperance F et al., (2002) also supported the “dose-
response relationship” between depression and the mortality risk. In this study, 
the maximum number of deaths occurred in the first year. It recruited a large 
sample size and conducted multivariate analysis. The remaining two studies 
(Ahern D K et al., 1990, Lane D et al., 2000) recommended a weak association 
of depression and mortality. Bush E D et al., (2001c) relied on phone calls only 
for the outcome measure, their follow up was relatively short and a huge 
number of patients were excluded; suggesting selection bias. Ahern D K et al., 
(1990) have not given criteria for myocardial infarction or any details of 
collection of follow up data.  
 
In summary the researchers have reached different conclusions possibly due to 
different outcome measures, different sources of data collection, different follow 
ups and different criteria for myocardial infarction. 
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13.6 OVERALL SUMMARY 
 
The important findings of the literature review in the above chapter are as 
followings. 
a. Depression has been assessed with semi-structured interviews and self 
reporting tools. 
b. Depression is common in patients having myocardial infarction and acute 
coronary syndrome. 
c. Depression is associated with high risk of mortality in some but not in 
other studies 
 
Of the seven studies that used semi structured interviews to assess depressive 
disorder in patients following myocardial infarction, three reported a significant 
association between depression and cardiac / all cause mortality, and four 
found a non-significant association. Further heterogeneous results were 
reported by the studies that measured depression using cut off or continuous 
scores on standardised questionnaires (BDI, HADS).  Of the 16 studies that 
assessed depression with symptoms scales in cardiac patients, 7 found a 
significant association between depressive symptoms and subsequent mortality 
whilst 9 failed to find such an association. Most of the studies used either 
cardiac or ‘all cause mortality’ as an outcome measure. 
 
Methodological variability in the sampling of participants, onset of depression, 
severity of depression, measure of depression, data collection process, and 
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whether the severity of MI was adequately controlled for in the statistical 
analysis, are likely factors leading to different findings. 
 
Sampling; 
Variability in the studies in the sampling of participants is likely to be one 
explanation for different results. For example Bush ED et al., (2001a) only 
included those aged ≥ 65 in their analysis while Welin C et al., (2000) included 
only < 65. Similarly Ladwig KH et al., (1991) included only male patients in his 
study and found an association between depression and mortality. On the other 
hand some researchers who recruited gender mixed patients found a significant 
association between depression and mortality (Frasure-Smith N et al., 1993; 
Lesperance, F et al., 1996 & Carney RM et al., 2003) while others (Lane, D et 
al., 2000 & 2001) failed to find this association. Kaufman WM et al., (1999) 
included patients from a tertiary unit when he found association between 
depression and mortality while Lauzon C et al.,  (2003b) recruited patients both 
from community  and tertiary level hospitals, but could not find any  association 
of  depression and mortality.  
 
Furthermore studies have been conducted in different perspectives of different 
countries; for instance Kaufmann, W M (1993) and Carney RM et al., (2003 a) 
conducted their studies in USA, Strik JJMH et al., (2004) carried out his study in 
Netherland while Frasure-Smith, N et al., (1993) did their work in Canada. The 
state provisions for heath care vary across the countries as are the cultural 
demands; having an impact on the association of depression and mortality. 
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Carney RM et al., (2003) examined cohorts of patients who were originally 
recruited for a clinical trial; the level of motivation of such patients and their 
ability to participate in randomised controlled trial are less likely to be 
representative of patients with coronary heart disease.  It is due to the fact that 
clinical trials tend to have a strict inclusion and exclusion criteria which could 
mean that participants in clinical trials are less likely to have severe depression 
or poor general health.   
 
 Assessment of Depression; 
The timing of the depression and the tools used for its assessments could also 
explain variations in the results. Most of the studies assessed depression in 
patients following MI after variable periods of time. In some studies (Bush ED et 
al., 2001a; Lesperance, F et al., 1996) patients were assessed between 2 to 7 
days; in others within two weeks (Frasure-Smith, N et al., 1993 &1995; 
Kaufman W K 1999) while Carney R M et al., (2003) and Strik JJHM et al., 
(2004) screened their patients within 4 weeks of index MI. As all of these 
studies examined depression following coronary heart disease, it looks like that 
it is depression developing in the days or weeks after myocardial infarction 
which is more important. Possibly heterogeneity in the findings of these studies 
could be due to methodological variations. 
 
In addition to the assessment of depression at baseline, researchers 
(Lesperance, F et al., 1996) also assessed depression 6 months after 
myocardial infarction to examine its prospective impact on the cardiac mortality 
but failed to find such an association. It could be due to several factors; one of 
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which could be that perhaps the depression developing soon after myocardial 
infarction is specifically cardiotoxic or it could be the damaged myocardium is 
more vulnerable to certain types of arrhythmias; leading to excessive cardiac 
mortality. This explanation is further supported by one study (Dickens C et al., 
2007) that advised their patients to report depressive symptoms experienced in 
the week prior to hospital admission for myocardial infarction. They failed to find 
any association of depression and mortality; possibly due to the depression 
which was pre rather than post myocardial infarction. 
 
There does not seem to be any consistent difference in the findings between 
studies that investigated depression in the days or weeks following myocardial 
infarction compared to those that assessed depression in the days preceding 
myocardial infarction. 
 
Depressive Measure 
Another possible explanation for the diversity of the results in the reviewed 
studies could be the type of depressive measure used by the researchers.  
Seven studies used semi structured interview for the DSM 111 / IV diagnosis of 
depression. Some of these used modified criteria for depression particularly 
relating to the duration of symptoms; when it was reduced from 14 to 7 days to 
comply with post-MI depression. Equally it helped participants to overcome 
recall problems, particularly when they were suffering from depression which 
can adversely affect the memory. Three of the seven studies supported the 
association of depression and mortality while 4 failed to reflect such an 
association.  
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Furthermore (15) studies relied on the self report standardised questionnaires 
for the assessment of depression. Of them 11 used BDI, 2 used HADS, and 1 
used SDS while the remaining one used an unknown tool. Of those studies that 
used BDI, 6 of them appeared to support the association of depression and 
mortality, while 4 failed to do so. In contrast all (two) studies that used HADS as 
a depressive measure failed to support the association between depression and 
mortality; one of them was Dickens C et al., (2007) who examined pre-MI 
depression. One explanation for this difference could be that the Hospital 
Anxiety and Depression Scale differs from the Beck Depression Inventory as it 
does not have items to assess somatic symptoms including insomnia, fatigue 
and pains that might arise as the result of the physical illness; thus falsely 
inflating depression scores.   
 
Mendes de Leon (1999) has  questioned whether it is actually cardiac rather 
than depressive symptoms that are associated with poor prognosis of ischaemic 
heart disease.  As it seems, only studies that assessed depression with the 
Beck Depression Inventory, that contains somatic items, found a strong 
association between depression and cardiac mortality. Moreover the prevalence 
rate of depression was the highest in these studies (around 30%). Interestingly 
the reviewed studies have highlighted that the prevalence of depression is alike 
whether it is assessed with HADS or semi-structured interview (16 % vs. 17%). 
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Furthermore symptoms scales were associated with high prevalence of 
depression (except HADS) compared to semi structured interviews; which is 
perhaps an expected finding.  
 
Despite the use of different depressive measures by the reviewed studies, it has 
not followed any consistent pattern in regard to the association of depression 
and mortality in IHD patients. This finding is in line with the meta analysis of Von 
Melle (2004). He found a consistent association between post-MI depression 
and adverse cardiovascular prognosis; cardiac or all cause mortality and the 
magnitude of the risk was 2 to 2.5 times. The significance of association 
between post-MI depressions and all cause mortality or cardiac mortality, was 
not affected by the way depression was assessed. 
 
Severity of Depression (Dose-Response effect) 
Variations in the current review might have arisen due to variation in the 
severity of depression. Carney RM et al., (2003) found an association between 
depressive disorder and mortality when the diagnosis of depression was based 
on DSM 111 R criteria. They found higher odds for mortality risk with major 
depression than with minor depression. Major depression is based on higher 
number of items from the core criteria than the minor depression. Moreover 
Lesperance, F et al., (2002) while looking at the impact of depression on 
mortality divided participants into four groups based on the BDI score. The odds 
for mortality were lower in those having low scores on BDI and vice versa; 
supporting the notion of dose-response effect. Similarly Bush ED et al., (2001) 
divided his participants into three groups. He also found that a higher score on 
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BDI was associated with high risk of mortality and vice versa. This finding is 
further explained by Judd et al., (2000) who states that sub-syndromal 
depression is a risk factor for the major depression. Even a marginally raised 
BDI score can lead to the development of major depression in the months to 
follow. About 50% of cardiac patients having a diagnosis of minor depression 
are likely to develop major depression within a 12 months period (Hance et al., 
1995). 
 
Although a dose-response relationship between depression and mortality is 
supported by some of the reviewed studies, this aspect has not been explored 
at length by most of the researchers. Perhaps further evidence would be 
required to establish such an association between depression and subsequent 
risk of mortality.  
 
Follow up Periods 
Another explanation for the heterogeneous findings of the reviewed studies 
could be due to the variable periods of follow-up. Frasure-Smith,N et al.,  (1993) 
found an association of depression (assessed within few days of admission) 
and cardiac mortality at 6 months follow up but failed see the impact of post-MI 
depression on mortality between 6 to 18 months in his cohort. Similarly 
Lesperance, F et al., (1996) looked at the association of depression and all 
cause mortality 18 months after myocardial infarction. They found a gradual 
reduction of mortality risk over 18 month’s period; odds were highest at 6 
months while lowest at 18 months.  Moreover Grace SL et al., (2005) found a 
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higher risk of mortality in the first 2 years followed by a gradual reduction of risk 
over the next three years follow up.  
 
Outcome Measure 
Whether variation in the reviewed studies has resulted from the outcome 
measures or the way they are determined, further explorations are needed. 
Most of the studies have investigated the association of depression and cardiac 
or ‘all cause mortality’. The studies that looked into the association of 
depression and ‘cardiac mortality’ or depression and ‘all cause mortality’ have 
come up with mixed findings. Frasure-Smith N et al., (1993) found that 
depression was a risk factor for cardiac mortality whilst Lane, D et al., (2000) 
failed to find such association. Similarly while looking at the  ‘all cause mortality’ 
as an outcome measure Lesperance F et al., (1996) found significant 
association between depression and subsequent risk of mortality while Bush ED 
et al., ( 2001a) failed to find such an association. 
 
 
Both clinically and theoretically ‘cardiac mortality’ differs from ‘all cause 
mortality’ and the mechanism of association with depression may be different. 
Medical co-morbidity becomes an important variable when examining the ‘all 
cause mortality’. Chronic medical conditions such as respiratory disorders, 
rheumatoid arthritis and diabetes-mellitus etc can influence the cardiac 
prognosis by direct or indirect ways. For example, chronic rheumatoid disorders 
can impair the mobility including exercise, leading to obesity; having adverse 
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impact on cardiac mortality. On the other hand diabetes-mellitus can directly 
affect the micro vasculature and myocardium leading to cardiomyopathy.  
 
Follow up Data Collection 
Moreover the reviewed studies have highlighted that follow up data were 
collected by different resources; some collected data over the phone (Bush ED 
et al., 2001a) while others used multiple resources. Some studies involved 
cardiologists for differentiating cardiac or non-cardiac deaths (Frasure -Smith N 
et al., 1993) whilst others tended to rely on the death certificates.  The source of 
information on which outcome measure is based is very important. It is 
problematic to adjudicate the cause of death on the basis of death certificate 
(Lloyd-Jones DM et al., 1998).  The heterogeneity of findings in the reviewed 
studies cannot be fully explained on the basis of different outcome measure; 
whether cardiac or all cause mortality. 
 
In short, depression is a syndrome which can have a chronic or recurrent 
course, variable intensity in different settings, at different times leading to 
differential impact on the patients having coronary heart disease. As it is 
multidimensional and not each dimension is equally marked in each and every 
patient; this can have a different impact in different individuals. There is another 
opinion which is not yet well established that there is dose-response 
relationship between depression and mortality. Due to a number of cardiac 
disease severity markers it still remains a challenge to adjust for them all in 
statistical analysis to establish the independent impact of depression. 
Depression is associated with mortality (cardiac & non-cardiac) but this 
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association is complicated by a number of medical and psychological factors; 
hence the heterogeneity in such association is inevitable.  
 
It is also possible that gradually improving public health education and 
preventative management approaches towards coronary heart disease may 
have contributed towards reducing mortality. 
  
169 
 
14 DEPRESSION AND HEALTH- RELATED QUALITY OF LIFE  
 
 The biomedical model of health care gives more importance to the clinical 
markers such as cardiac morbidity and mortality whilst the outcome model of 
health care gives priority to the health related quality of life (Kaplan, RM 2003). 
Unfortunately, there is no consensus on the definition of QoL and its 
measurement, particularly when it is very subjective. Health status, functional 
status and QoL, are still being used interchangeably (McDowell I 1996; Kaplan, 
RM 2003). Functional status generally refers to the ability to participate in day-
to-day activities, in distinction to psychological aspects of QoL such as 
perception of health. 
 
In current practice, there is increasing recognition of the patient’s own views 
about the impact of depression on their QoL. As there are no significant 
published studies on the South Asians living in the UK so far, this chapter will 
be reviewing studies exploring the association of depression and health related 
quality of life in the White population with coronary heart disease.  
 
14.1 DESCRIPTION OF SEARCHES AND KEY WORDS USED 
Papers in this non-systematic review are selected from studies identified using 
the following research strategies: 
 
Medline electronic database was searched for the studies that looked at the 
QoL as an outcome measure without any restriction of date or language to 
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ensure optimum coverage of literature. Firstly articles relevant to the patient 
population were identified using key words “depression, depressive disorder, 
mood disorder”. This was supplemented by a search of articles that included 
coronary heart disease. For this key words “myocardial infarction, acute 
coronary syndrome/ or angina, unstable and ischaemic heart disease” were 
used.  To search for the outcome key words such as ‘quality of life’ and ‘health 
related quality of life’ were used. Each search was then combined to identify 
relevant articles. In addition the bibliography of identified papers, systematic 
reviews and editorials in this area were hand searched. Relevant articles which 
were known by the supervisor and author were also included. Details of the 
search performed and the output is in the appendices. 
 
14.2 LITERATURE REVIEW 
Depression following coronary heart disease is reported by some studies to be 
having an independent adverse impact on the HRQoL, while others have shown 
such an association to be weak. There is a lot of variation in the methodology of 
the studies, which is likely to be the explanation for heterogeneity in the 
findings. For the purpose of discussion previous research has been divided into 
four main groups; 
 
a. Studies having patients with myocardial infarction (First & repeat MI) 
b. Studies having patients with first myocardial infarction 
c. Studies having patients with acute coronary syndrome  
d. Studies having patients having coronary artery disease  
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14.3 STUDIES HAVING PATIENTS WITH MYOCARDIAL INFARCTION 
 Seven studies were identified that looked at the association of depression 
following myocardial infarction and health related quality of life. Most of them 
appear to be supporting the association of depression and poor quality of life in 
the months following myocardial infarction despite methodological variations. 
Table 9 summarises these studies. 
 
Study No; 1 
 
Lane, D et al., (2000e) Following on from the section 12.3 (Study No; 1) the 
same researchers also explored the impact of depression following myocardial 
infarction on the quality of life. Participants completed Beck’s Depression 
Inventory at baseline. A BDI score ≥ 10 was used as a cut-off point. Dartmouth 
Primary Care Cooperative Information Project (COOP) charts were mailed out 
at 4 months follow up, as a measure of QoL. Dartmouth COOP charts are a 
self-report questionnaire, which measures physical, social, and role functioning, 
emotional status,  overall health, change in health, social support, perceived 
pain, and perceived QoL. 
 
Each chart consists of a title, a question and five response choices. A total 
score ranges from 9-45, where a high score denotes good QoL and a lower 
score reflects poor QoL.  The data collected also included previous history of an 
MI. The participant’s survival status was determined from the ‘Patient 
Information System’ held at each hospital. The depressed and non-depressed 
groups were compared using correlation tests and a stepwise multiple linear 
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regression model. 
 
Of the 437 eligible patients, 149 refused. Of the enrolled 288, 89 (30.9%) were 
depressed while 199 (69%) were not depressed. At entry there were significant 
differences between the depressed and non-depressed groups (Mean BDI p= 
0.001). The history of previous myocardial infarction in the depressed group 
was higher (25%) compared to the non-depressed group (20%).  At follow up, 
263 participants completed the Dartmouth COOP charts when depression was 
significantly correlated (r=0.26,p<0.05) with HRQoL. Multivariate analysis 
showed that baseline BDI score was an independent predictor of quality of life 
(β 0.21, 95% CI 0.05-0.37, p=0.0001). 
 
The study has supported the association of depression following myocardial 
infarction and HRQoL. 
 
Study No; 2 
Lane, D et al., (2001) Following on from the previous section 12.3(Study N0;1)  
the researchers extended the follow-up of the same cohort to 12 months while 
looking at the impact of depression on the quality of life. The methodology 
remained much the same as in Lane, D et al., (2000 a). The participants were 
sent out the Dartmouth COOP Charts at 12 months. The data were analysed 
using correlation tests and multiple linear regression models.  
 
Of the 288 patients enrolled in the study, 31 died and 257 survived; 78 from the 
depressed group and 179 from the non-depressed group. Baseline depression 
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was significantly correlated with quality of life at 12 months (r=0.32, p=0.001). 
The multiple regression model analyses showed that baseline BDI was an 
independent risk factor for poor quality of life (β 0.21,95% CI 0.05-0.37). 
p=0.001). 
 
There are a number of weak areas of the study. The high refusal rate could 
have been due to selection bias with subsequent impact on outcome measures. 
Those who refused could have been either not depressed and having a better 
QoL, or too depressed to bother about the participation in the study. The 
depressed group is relatively small and may not be representative of the target 
population. As QoL was not measured at baseline, it was not adjusted for in the 
multivariate analysis.  
 
Although the study provides clear evidence of the impact of depression on QoL, 
it is unclear what degree of depression affects the QoL. In their analysis, 
researchers have shown a correlation between the baseline depression and 
QoL at 12 months among survivors without differentiating them into depressed 
and non-depressed groups. As BDI determines the severity of depression, it 
would be difficult to comment on the onset of depression (pre or post MI). The 
authors have not mentioned the response rate to the mailed questionnaires at 
follow up. Similarly, a high level of co-morbidity in the depressed group may 
have led to the confounding effect on the outcome measure. As Dartmouth 
COOP charts are a self-report questionnaire, reporting bias might have affected 
the outcome measure.  
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The study has some advantages. Participants were given up to 2 weeks to be fit 
for interview, facilitating a large sample size. The BDI was used to measure 
emotional status instead of Dartmouth COOP charts. The BDI is a reliable tool 
having a split-half reliability coefficient of 0.86 (Beck et al., 1961). The baseline 
prevalence of depression (30%) is in line with other studies (Mayou, R A et al., 
2000; Ziegelstein, 2001). Using a standardised definition of MI is another strong 
point of the study. Exclusion of myocardial infarction as the result of cardiac 
surgery or angiography would help to apply the results of this study to the MI 
patients. The criteria that a patient must have been informed of his diagnosis by 
the physician minimised the risk of documentary errors. A high response to the 
mailed questionnaires and use of appropriate statistical tests are further 
strengths of the study. Apparently, all the survivors (100%) responded to the 
mailed questionnaires. 
 
The researchers have established the association of depression following MI 
and health related quality of life.  
 
Study No; 3 
Beck C A et al., (2001) conducted a study looking at the predictors of health 
related quality of life after an acute myocardial infarction. Participants with 
confirmed diagnosis of MI (Q or non-Q wave) and receiving treatment in the 
acute coronary care units at 10 hospitals, in Quebec, Canada from December 
1996 to November 1998, were screened.  
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The participants completed BDI, SF-36 and Euro QoL at baseline. A BDI score 
of ≥10 was used as a cut-off point.  Case notes were consulted. Both SF-36 and 
Euro QoL were mailed out at 6 and 12 months after MI. Euro QoL is a visual 
analogue scale used to measure subjective perception of overall QoL. The 
participants rate their health status on a continuous scale of 0-100 where zero 
denotes death and 100 represents excellent health. Multivariate linear 
regression models were used to analyse the data. Secondary analyses 
excluded those having depression at the time of follow-up assessments. 
 
The study population comprised of 587 enrolled patients. Of these, 480 
participants (82%) at 6 and 491 (84%) at 12 months completed both SF-36 and 
Euro QoL. The baseline BDI score predicted impaired physical (coefficient: -1.6, 
95% CI -2.9 to - 0.4), mental (coefficient: - 3.7, 95% CI -5.3 to -2.2) and overall 
QoL (coefficient -5.4, 95%CI; -7.7 to - 3.2) at 6 months. However, BDI remained 
an independent predictor of impaired mental component scores at 12 months 
(coefficient -3, 95%CI -4.5 to -1.5) with no effect on pphysical component 
scores (PCS) and overall QoL. 
 
This study is important in having a large sample size, long-term follow up, using 
two QoL measuring tools and having a high response rate to postal 
questionnaires. The researchers looked at the overall QoL instead of the 
specific components. The BDI determines the severity of depressive symptoms. 
The researchers have demonstrated that depression does affect the both major 
components of QoL; physical and mental functioning at 6 months but this 
impact becomes differential on these domains 12 months after MI. It might have 
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a number of explanations but one might be that it is first 6 months which are 
more crucial for the effects of depression. Moreover the MCS (SF-36) overlaps 
with depression so it is possible that apparently perceived low QoL at follow up 
was in fact a reflection of depression. Another explanation could be that QoL 
might have started improving after 6 months, which was reflected in partial 
impairment at 12 months. The researchers relied on generic rather than disease 
specific tools for measuring QoL: the SF-36 and Euro QoL. The criteria for 
myocardial infarction were not very clear, as mere presence of Q wave would 
not be indicative of a recent myocardial infarction. Similarly, treatment in an 
acute coronary care unit (CCU) does not necessarily mean ischaemic heart 
disease (IHD) as a number of cardiac pathologies, including arrhythmias are 
managed in the same units. The authors have not mentioned the prevalence of 
depression at baseline and neither have they divided the participants into 
depressive and non-depressive groups. The number of participants who 
completed BDI at entry is also unclear. 
 
In summary the researchers have supported the differential impact of 
depression on the health related quality of life over 12 months follow up. 
  
Study No; 4 
Parashar S et al., (2006b) Following on from the previous study discussed in 
the section 12.3 (Study No;9) the same researchers tried to see the impact of 
persistent depressive symptoms (over 30 days) following myocardial infarction  
on the HR QoL. Briefly, it is a subsidiary study of the PREMIER study. PHQ was 
used for depression twice; at baseline (during admission) and at one month. 
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Participants were grouped into 4 categories. The Seattle Angina Questionnaire 
was completed twice by the participants; at baseline and at 6 month follows up. 
Multivariate analysis was conducted. 
 
 In total 2096 (84%) participants were eligible for this study. Of the cohort 6% 
experienced new,7.1% experienced persistent and 13.5% experienced transient 
depression. Follow up was completed by 1703 (81%) participants. Those having 
persistent, new, transient, or no depressive symptoms scored 65.7 (± 27), 72.1 
(± 25), 76.6 (± 21.6) and 86.9 (±15.4) on SAQ respectively. Multivariate analysis 
revealed that the impact of persistent depression was highest (β -15.80), 
followed by newly depressed (β -12.56) and the least with transient depression 
(β - 6.85).  
 
It is a subsidiary study. This study has ruled out the impact of acute stress 
reaction or any short lived depression. It has supported the finding that 
depression which persists for 30 days or a sub-syndromal depression which 
reaches a certain threshold over 30 days can predict the quality of life at 6 
months follow up.  
 
There was significant association of health related quality of life with persistent 
depression followed by new and transient depression compared to non-
depressed participants. 
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Study No; 5 
De Jonge P et al., (2006) conducted a study to look at whether post-MI 
depression is a risk factor for impaired health related quality of life. Patients 
admitted with an MI between September 1997 and September 2000 to four 
hospitals in the North of the Netherlands, were screened. For a diagnosis of an 
MI, patients had to have two of the following three criteria:  
 
a. Chest pain for at least 20 minutes, 
b. Creatine phosphokinase concentration 100% greater than normal or CK- 
MB fraction >10%  
c. Presence of new pathological Q wave on the ECG in at least two leads. 
 
Patients were excluded if their life expectancy was less than one year due to 
non-cardiovascular disease, had cognitive dysfunction, were unable to speak or 
read Dutch, had very poor physical condition according to hospital staff, or 
admission was not for an MI or angina pectoris.  
 
Participants were interviewed at home 3 (baseline) and 12 months after the 
myocardial infarction for depression and health status. The depression was 
assessed with the Composite International Diagnostic Interview (CIDI-Auto), in 
line with International Classification of Diseases, 10th revision criteria. Health 
status (QoL) was assessed by the RAND, a 36-item health survey. A Dutch 
version was used which groups the 36-items into eight sub-scales. The 
researchers used only six sub-scales; physical functioning, social functioning, 
role limitations-physical, role limitations-emotional, pain and general health, and 
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excluded mental health and vitality scales. For continuous variables with normal 
distributions, t tests were used. Logistic regression analysis was performed.  
 
In total, 1166 patients were screened and of them 284 were excluded. Of the 
882 eligible patients, 528 (60%) were enrolled for the study. At 3 months 421 
(90.0%) responded; 106 (25.2%) had depressive disorder while 315(74.8%) 
respondents did not. At 3 months, the RAND score was higher in the non-
depressed compared to depressed participants. Similarly HRQoL of the non-
depressed (315) group was better than the depressed (106) group at 12 months 
follow up.  
 
For the sensitivity analyses, 36 of the 106 (depressed at baseline) who were still 
depressed at 12 months after index MI were excluded. Multivariate analyses 
found the following estimates of the effects of depression on the health related 
quality of life: physical functioning, -12.6  (95% CI  -18.6 to -6.6 ); social 
functioning, -19.8 (95% CI -24.9 to -14.7 ) role limitations-physical, -32.1 (95% 
CI -41.8 to -22.5); role limitations-emotional, -34.0 ( 95% CI -43.0 to -25.1) and  
general health, -15.4  (95% CI  -20.3 to -10.4). 
 
The study has a number of merits such as its prospective design and large 
sample size. As the initial assessment was conducted at 3 months, the 2-weeks 
ICD-10 criteria were met and those having late onset depression were included 
in the study. Those having acute psychological problems including stress 
reaction or an adjustment disorder got sufficient time to make a full recovery by 
the time study commenced. The prevalence of depression (25.2%) is in line with 
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other studies (Rumsfeld, J. S et al., 2001; Ruo, B. et al., 2003).  The RAND 36-
item health survey (Dutch version) was used, which has been developed and 
validated in the International Quality of Life Assessment (IQoLA) project. They 
used 6 out of 8 sub-scales and excluded mental health and vitality because of 
their operational overlap with depression. Their findings are in line with previous 
reports (Lane, D et al., 2000 & 2001; Mayou R A et al., 2000) establishing the 
association of post-MI depression and poor health status and that this 
association was independent of cardiac condition. They performed secondary 
analyses (after excluding those having depression at 12 months) when they 
found that depression was still associated with poor health status but with a 
lesser magnitude of the effects. 
 
There are a number of limitations of the study. The exclusion of a considerable 
proportion of the patients may suggest recruitment bias. Only Dutch speakers 
were included. Those who were excluded (non-consenting, had incomplete 
assessments, or were lost to follow-up) may have resulted in an under 
representation of the outcome measure. The baseline assessment was 
conducted 3 months after the index MI which might have allowed a number of 
depressed cases to make full recovery; hence having an impact on the outcome 
measure. On the other hand, depression assessed 3 months after index MI 
would have been due to other factors (confounding) rather than due to IHD. In 
fact, researchers overlooked the baseline HR QoL (soon after MI) which might 
have positively changed 3 months after MI, having an impact on the outcome 
measure. The RAND 36 is a generic self-report tool, which has the same 
contents as the SF-36. However, it uses a different scoring for two of the eight 
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scales and is therefore not directly comparable.  It is also less widely used than 
the SF-36.  As a self-report tool, it is prone to reporting bias.  
 
 The researchers have supported the impact of depression on health related 
QoL 12 months after myocardial infarction. 
 
Study No; 6 
Fauerbach JA et al., (2005) examined the relationship between depression and 
quality of life 4 months after an acute myocardial infarction. The study consisted 
of admitted patients in a teaching hospital. Diagnosis of myocardial infarction 
required at least two of the following; 
 
a. Typical ischemic chest pain lasting ≥ 20 minutes, 
b. ECG changes typical of ischaemia / infarction, 
c. Peak CPK > 1.5 times normal.  
 
The Structured Clinical Interview for DSM-111 R (SCID) criteria was conducted 
within 2-5 days of admission. The participants also completed the BDI. A BDI 
score ≥10 was used as a cut-off point. Data collected also included a history of 
previous MI. The SF-36 was completed at baseline and at 4-month follow up. 
Significance of differences between the depressed and non-depressed groups 
was evaluated using χ2 and t tests. Analysis of variance (ANOVA) was 
conducted to look at the association of post-MI depression and QoL.  
 
182 
 
Out of 696 eligible patients, 285 (41%) were recruited. Eighty-nine patients were 
lost to follow up. Of the 196 participants, 44 (22.4%) were depressed while 152 
(77.5%) were not depressed. All 196 patients were included in the final analysis. 
At 4 months after removing the effects of covariates, a significant multivariate 
effect of depression still persisted on QoL in the aggregate mental domains (F= 
8.06,df =5,195, p< 0.01); however, the adjusted effect on aggregate physical 
domains was not significant (F=0.11,df=5,195,p=0.57). The history of 
myocardial infarction was higher in the depressed than the non-depressed 
group (32% vs. 22%). 
  
This study has some weak areas. It does not highlight the baseline 
characteristics of those who were lost to follow-up. Those who dropped-out 
might be having poor QoL or not bothering to participate in the study. Obviously, 
their inclusion in the study might have a different impact on the outcome 
measure. Severely ill patients, who were left out as they were unfit for the 
interview within the first five days might have had a greater risk of impaired QoL 
if they had been included. The outcome measure might have been affected by 
differential recruitment (recruitment bias) since the consenting subjects had a 
higher rate of previous MI than the total admission with MI. SF-36 being a self-
report tool is vulnerable to reporting bias. It is quite possible that the current 
association would have been different if the participants were experiencing their 
first MI. The sizeable dropout of the consenting participants led to a smaller 
sample, making it less representative.SF-36 mental component domain 
overlaps with clinical depression; hence the outcome measure might not 
necessarily reflect the true picture of QoL.     
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The study has a number of strengths. It has a prospective design and the 
researchers used clear criteria for MI. Screening was done within a week of 
admission, which allowed a good sample size. SCID was applied in the study, 
which is a gold standard for the diagnosis of depression. The trained 
researchers administered SCID ruling-out the possibility of reporting bias. The 
study also used two tools for depression. Prevalence of depression was 15% in 
the study which is in line with previous studies (Ziegelstein, R C 2001). The 
findings of this study are in line with Beck, C A et al., (2001) and Brink, E et al., 
(2002). QoL was assessed at baseline.  
 
This study partially underscores the important association of post-MI depression 
and health related QoL. 
 
Study No; 7 
Mayou RA et al., (2000b) Following on from the section 13.4 (Study No; 7) the 
same researchers investigated the impact of depressive symptoms on the risk 
of poor quality of life following myocardial infarction. All participants completed 
the Hospital Anxiety and Depression Scale and SF-36 Health Survey within 
three days of admission and then at 3 and 12 months follow up. A HADS score 
of ≥19 was taken as a cut off point for distress (cases). Differences in the 
means of SF-36 scores at baseline, 3 and 12 months after MI were compared 
between the distressed and non-distressed participants.  
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A total 546 patients were screened, of whom 344 (63%) were enrolled. Fifty-one 
(14.8%) patients were distressed and 293 (85%) were non-distressed at 
baseline. At 3 months, 243 (71%) patients responded while at 12 months 224 
(65%) responded. Twenty-nine patients were lost in the intervening period due 
to communication problems. Baseline distress was associated with low SF-36 
score at 3 months. Similarly at 12 months follow up, distressed participants 
scored lower than the non-distressed on all the dimensions SF-36; general 
health perception (47.2 vs. 64.0, p < 0.05), physical functions (59.1 vs. 71.4, p < 
0.05), role limitation (35.8 vs. 58.8,p< 0.05), emotional role limitation (33.3 
vs75.7, p< 0.05), social functions (64.5 vs. 85.5,p< 0.05), mental health (56.7 
vs. 79.1, p < 0.05), energy and vitality (41.0 vs. 59.7, p < 0.05),  and pain (66.7 
vs. 76.3,p < 0.05). 
 
The study has a number of limitations. A high number of exclusions (202) 
suggest the possibility of recruitment bias. The researchers approached the 
patients too early as those who could have become cases after the 3rd day, 
were left out; perhaps this is one of the reasons for the low prevalence (14%) of 
emotional disorder. Equally, it would have been affected by a high HADS cut off 
point. Similarly this approach could have led to selection bias as those who 
were seriously ill and unfit on 3rd day, had to be left out. Perhaps they were 
more likely to be become cases (distressed) at a later stage, thus having an 
impact on the outcome measure. On the other hand, those who presented with 
distress by the 3rd day could have presented a better picture if they had been 
given sufficient time to readjust. HADS is a symptom scale rather than a clinical 
diagnosis scale and being a self-reporting tool can lead to reporting bias.  
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There is a high dropout as 65% of the participants responded at 12 months. A 
significant number of non-responders might have a better QoL; hence the 
outcome measure would have been different. A follow-up reminder to the 
participants could have increased the response rate. MI was diagnosed on the 
basis of MONICA, an uncommonly used tool. The authors have not given the 
full details of the MONICA assessment and it has not been used in other studies 
(Lane, D et al., 2000a & 2001b;Brink, E et al., 2002;Fauerbach, J A et al., 
2005 ;Beck, C A et al., 2001;De Jonge P et al., 2006). This makes its 
comparison with other studies rather difficult.   
 
On the positive note, it is a prospective study. All the consecutive patients were 
screened. One of the main advantages of approaching potential participants on 
the 3rd day was aiding recruitment, thus giving a large sample size. HADS is an 
established tool for determining the severity of depressive symptoms. SF-36 
Health Survey is a well-established tool measuring the quality of life in patients 
with IHD (Beck, C A et al., 2001; Fauerbach, J A et al., 2005) and it was used 
both at baseline and follow up. The researchers have highlighted that baseline 
depression can predict the QoL 12 months after myocardial infarction. 
 
Despite some methodological flaws, the study has established that baseline 
distress is a strong predictor of poor quality of life at 12 months follow up. 
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Table 9 Studies exploring impact of depression on QOL following MI  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Lane D et al 
(2000e) 
MI  
Enrolled 288 
 
OC: QoL 
F/U 4 months 
BDI 
COOP 
 
Dep 31% 
Dep associated with 
impaired Q0L 
Linear regression 
analysis was done 
Lane et al (2001) 
 
MI 
 
Enrolled 288 
 
 
 
OC; QoL 
F/U  12 months 
 
BDI 
COOP 
Dep was a risk factor for 
QoL  
Beck et al (2001) 
 
 
AMI 
 
Enrolled 587 
 
 
OC: QoL 
F/U 12 months 
 
 
SF – 36 
Euro QoL 
BDI BDI weakly associated with QoL 
Multiple tools used for 
QoL 
Parashar S et al 
(2006) 
 
MI Enrolled 2096 
OC: QoL 
F/U 6 months 
SAQ 
BDI 
 
Persistent and new dep had 
worse impact on QoL then 
transient dep 
Dose- response effect 
supported 
de Jonge P et al 
(2006a) 
 
MI 
 
Enrolled 528 
 
OC: QoL 
F/U 12 months 
CIDI – Auto 
BDI 
RAND 
Dep was associated with 
poor QoL  
Fauerbach et al 
(2005) 
 
MI 
 
 
Enrolled 285 
OC; QoL 
F/U 4 months 
SCID 
BDI 
SF- 36 
 Dep affected mental 
domains but not the 
physical domains QoL  
QoL and depressive 
feature overlap 
Mayou 
 RA et al (2000b) 
 
MI Enrolled 344 
OC; QoL 
F/U 12 months 
HADS 
SF- 36 
 
 dep strongly associated 
with QoL 
 
65% responded at 12  
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14.3.1  SUMMARY OF SECTION 
In the above review five of the seven studies; Lane; D et al., (2000 &2001);  
Mayou, RA (2000b); Parashar S et al., (2006b) and De Jonge P et al., (2006) 
have strongly supported the association of depression and HRQoL between 4 
to 12 months follow ups despite using different tools for QoL; Dartmouth COOP 
charts, RAND 36 and SF-36.  However, the remaining two studies (Beck, C A et 
al., 2001; Fauerbach, J A et al., 2005) found such an association to be very 
weak.  
 
Two studies failed to assess QoL at baseline (Lane, D et al., 2000; Lane, D et 
al., 2001; Beck, C A et al., 2001) while the remaining five assessed QoL both at 
baseline and at follow up (Mayou, R A et al., 2000c; Beck, C A et al., 2001; 
Parashar S et al., 2006; De Jonge P et al., 2006); hence, could control the 
quality of life in their analysis.  
 
De Jonge P et al., (2006) conducted a sensitivity analysis to rule out the impact 
of depression at the time of outcome assessment. Their criteria for MI were very 
clear. Six out of 8 scales of RAND 36 were used to assess QoL excluding 
mental health and vitality scales. Post-MI depression was assessed 3 months 
after index IHD that may not necessarily reflect post-MI depression and may 
make its comparison relatively difficult with other studies. It was limited to the 
Dutch population only. 
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Both Beck C A et al., (2001) and Fauerbach, J A et al., (2005) have supported 
the partial association of depression and quality of life. Fauerbach, J A et al., 
(2005) only found evidence of an association between depression and MCS 
while Beck, C A et al., (2001) found evidence of association of depression and 
MCS, PCS and overall QoL at 6 months but no association with PCS at 12 
months follow up. De Jonge P et al., (2006) assessed depressive disorder using 
ICD-10 criteria, a gold standard for the diagnosis of depression.  
 
The criteria used for myocardial infarction by Beck CA et al., (2001) are not 
precise as mere presence of Q wave would not mean recent MI. Similarly, 
treatment in an acute coronary care unit (CCU) does not necessarily mean IHD 
as a number of cardiac pathologies including cardiac arrhythmias, can be 
managed on the same units. On the positive note, those having depression at 
the time of follow-up were excluded from the analysis. Fauerbach, J A et al., 
(2005) did not control for disease severity and excluded a lot of potential 
participants. Moreover the history of MI was high (32%) in the depressed group.  
 
Both Fauerbach, A et al., (2005) and De Jonge P et al., (2006) looked at the 
impact of depressive disorder rather than depressive symptoms, but their  
results were different. Possible reasons for this could be the different timings of 
baseline assessments (2-5 days by  Fauerbach, A et al., (2005) and 3 months 
after hospital discharge  by de Jonge P et al., (2006); different tools used to 
assess QoL (RAND 36 and SF 36) and different  durations of follow up (4  and 
12 months).  In addition, de Jonge P et al., (2006) conducted a sensitivity 
analysis, controlled for cardiac condition and their sample met ICD-10 criteria 
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for depression. The methodology of the both studies was significantly different 
from each other.  
 
Assessment of depression has been done at different timings. It  was assessed 
in the first week by Fauerbach, A et al., (2005); within two weeks by Lane, D et 
al., (2000 & 2001) and 3 months after hospital discharge by de Jonge P et al., 
(2006).  
 
Parashar S et al., (2006) examined a different profile of depression. He found 
that it is the depression which persists (for 30 days) after acute cardiac event 
which has an adverse impact on the quality of life. Moreover, newly developed 
depression which might have been at a sub-syndromal level at the time of an 
ischaemic cardiac event, does have more impact on the quality of life than 
transient depression. 
 
In summary, there is strong evidence for the impact of depression on the health 
related quality of life. As mental component scale overlaps with depression, 
some researchers even went on to do sensitivity analysis  by excluding those 
participants who were depressed at the time of assessment of main outcome 
measure; quality of life. Although some studies seem to be lacking such an 
association, this is more likely to be due to the methodological variation and 
subjective nature of the quality of life.  
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14.4 STUDIES INVESTIGATING PATIENTS WITH FIRST MYOCARDIAL 
INFARCTION AND QUALITY OF LIFE 
 
History of myocardial infarction can have an adverse impact on the quality of life 
(Stewart LE et al., 1989; Brown N et al., 1998). To overcome this confounding 
factor, the researchers tried to recruit patients with first myocardial infarction. 
Two studies were identified that recruited patients after first myocardial 
infarction while exploring the impact of depression on the health related QoL. 
Table 10 gives a summary of these studies. 
 
Study No; 1 
In their study, Brink E et al., (2002) examined the factors influencing women 
and men’s health related QoL 5 months after first myocardial infarction. 
Consecutive admissions from October 1998 - September 1999 to the CCU of a 
Swedish rural hospital were screened. Those having severe disease, limited life 
expectancy, dementia and inability to speak Swedish fluently were excluded.  
The HADS was completed one or two days before discharge. Two cut-off 
scores; ≥8 for possible, and ≥11 for probable anxiety and depression were 
used. Medical data were obtained from the hospital records. HADS and SF-36 
questionnaire were sent out 5 months after hospital discharge. Hierarchical 
regression analysis was performed. 
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Of the 144 eligible patients 134 (93%) were enrolled. At baseline, 13(10%) 
participants scored HADS ≥8 points, and 9(70%) of them had ≥11 points 
showing probable morbidity. Surviving individuals (n=114) were sent follow up 
questionnaires. On univariate analysis, depression was associated with a worse 
QoL at follow up. However, on multivariate analysis the baseline HADS could 
not predict PCS but had a low predictive power for MCS (R2 = 0.16).   
 
There are some weak points of the study. The researchers have not mentioned 
any criteria for myocardial infarction making its comparison rather difficult with 
other studies (Lane, D et al., 2000a ; Beck, C A et al., 2001 ).  Prevalence of the 
probable anxiety or depression (7%) is very low, which could be due to various 
reasons; less severe cases of MI are more likely to attend a rural hospital or 
that participants did not had enough time to re-adjust to their cardiac status 
before their completion of baseline assessments. The depressed group was too 
small to be representative of the target population, therefore its findings cannot 
be generalised. Using two cut off points on the HADS, is another weakness of 
the study. Although baseline data were collected on 134 patients, only 114 were 
analysed suggesting analysis bias. The SF-36 Health Survey is a generic rather 
than disease specific QoL tool and being a self-report is prone to reporting bias. 
As PCS (SF-36) was not completed at baseline, the researchers were not able 
to control for it in the multivariate analysis. Association on univariate analysis 
but no such association on multivariate analysis strongly suggests the 
contribution of confounding effects. As certain features of MCS are quite similar 
to those of HADS, it is quite possible that those who were labeled as having 
poor QoL were in fact suffering from depressive disorder. This study is 
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suggesting a weak association of HADS and QoL 5 months after first MI. This 
finding is almost in line with Beck, C A et al., (2001) and Mayou, R A et al., 
(2000).  
 
On a positive note, it is a prospective study that enrolled patients with a first MI. 
This is important as a history of MI can cause an enduring impact on the QoL 
making it difficult to differentiate whether it is post MI-depression or the poor 
QoL at entry leading to worse QoL at follow up. Clear exclusion criteria were 
used. The response rate to the mailed SF-36 was good. Participants were given 
sufficient time to settle before their baseline assessment. 
 
The study concludes that depression following first MI has a weak association 
with the QoL. 
 
 Study No; 2 
Dickens C et al., (2006) conducted a study to look at the adverse effects of 
depression and anxiety, on the physical aspect of HRQoL following first 
myocardial infarction. The details of methodology have been discussed in the 
section 12.3 (Study No; 6). In brief, depression was assessed using HADS at 
baseline, 6 months after index admission out and at 12 months follow up.  The 
HADS total score of 17 or above was used for depression. Participants also 
completed the SF-36 at baseline and at 12 months follow up. They used 
hierarchical multiple regression techniques to identify  variables having an 
impact on PCS (SF-36) at follow up after controlling for co-morbid non-cardiac 
illnesses and any further cardiac events. 
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At 6 months assessment after index MI admission, 268 participants responded 
when the mean HADS and SF-36 PCS scores were 5.6, and 39.0 respectively. 
At 12-month follow-up, data were collected on 260 (83% of original sample) 
participants. The participants who did not complete 12 months follow up were 
significantly younger than those who participated. Depression assessed 6 
months following myocardial infarction was significantly associated with low 
PCS scores at 12 months (p< 0.05).  
 
The study has a number of strengths; the researchers screened consecutive 
patients, and managed to follow up a high proportion of eligible individuals. 
They excluded those having any history of previous myocardial infarction to 
avoid any confounding effect on the association of depression and HRQoL. The 
cut off score (HAD ≥ 17) used in this study has already been validated against a 
standardised research interview by the same researchers (Dickens et al., 
2004b). The researchers completed HADS 6 months after myocardial infarction. 
They were able to highlight that HADS completed within days of a MI in fact 
reflects depression preceding MI; hence not having any prospective impact on 
the QoL. On the other hand, depression assessed at 6 months was significantly 
associated with a worse QoL at 12 months follow up. Moreover, the assessment 
of depression fulfilled the requirement of two weeks symptoms duration. 
 
 To look at the impact of post MI depression on the QoL, they used only PCS 
(SF-36) scores and were able to do a sensitivity analysis at the follow up as 
they completed HADS at follow up as well. They used hierarchical multivariate 
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analyses so that they were able to control for potential confounders, in particular 
cardiac events, cardiac and non-cardiac illnesses, severity of MI and baseline 
(SF-36) PCS. Those who were depressed at 12 months were found to have 
worse QoL than those who were not depressed. 
 
Their study has some weaknesses.  The HADS assessments at 6 months follow 
up might have detected depression due to other factors which might have crept 
in over the period of time rather than due to MI. 
 
The researchers have shown that depression recorded 6 months after first 
myocardial infarction is a risk factor for the health related quality of life. 
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Table 10 Studies investigating patients with first MI and QOL  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Brink et al 
(2005) 
 
 
MI 
 
 
Enrolled 134 
 
OC:  QOL 
F/U 5 months 
after 
 
 
HADS 
SF- 36 
 
 
 
 
HADS was 
completed 2 days 
before discharge and 
there were 2 cut of 
score for HADS ≥8 & 
≥11 
Dickens C 
et al 
(2006) 
 
 
 
MI 
 
 
 
Enrolled 268 OC: QOL (PCS) 
F/U 12 months 
 
 
 
HADS 
SF-36 
 
 
Dep was associated 
with PCS 
 
 
Baseline depression 
was assessed at 6 
months 
PCS was selected for 
QOL not many 
studies assessed 
dep 6 months after 
MI 
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14.4.1  SUMMARY OF SECTION  
 
In the above review, both the studies are prospective and used HADS as a 
measure for depression but reached different conclusions. Dickens, C et al., 
(2006) have supported the association of depression and low QoL, whilst Brink, 
E et al., (2002) failed to support any significant association between depression 
and health related quality of life. 
 
Dickens, C et al., (2006) assessed depression 6 months after first myocardial 
infarction using a well validated cut off point (≥17 HADS) in a similar population. 
They used HADS that does not contain items related to bodily symptoms; hence 
tends to delineate more effectively between depression and disease symptoms. 
Their focus was on the PCS rather than the MCS, which has similarities with 
depressive features. In their multivariate analysis, they were able to control for 
baseline QoL, severity of cardiac disease, co-morbid conditions and any 
prospective cardiac events to rule out the confounding effect. They performed 
secondary analyses as well. Assessing depression at 6 months ruled out the 
possibility of acute stress reaction, which has been one of the explanations for 
post MI depression. On the other hand, it might reflect that the depression is still 
persisting since the index admission, and it is the ‘persistent’ rather than 
‘transient ‘depression which is associated with poor prognosis in cardiac 
patients (Thombs D et al., 2008b).  
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Brink, E et al., (2002) enrolled participants with first myocardial infarction and 
despite using HADS for the assessment of depression and SF-36 as a measure 
for QoL,  came up with differential impact of  depression on the  QoL of males 
and females. It could be possibly due to their small sample size and 
assessment of depression 1 or 2 days prior to hospital discharge; suggesting 
perhaps their patients stayed longer in the hospital at that time than the 
contemporary practice. Moreover, they used two cut off points on HADS, 
without any explanation whether these cut off points were ever validated in such 
a population. Their sample was collected from a rural hospital, possibly having 
less severe morbidity, which also might have affected the outcome measure.  
 
 In summary, depression following myocardial infarction is associated with a 
worse health related quality of life.  
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14.5 STUDIES LOOKING AT PATIENTS HAVING ACUTE CORONARY 
SYNDROME AND HEALTH RELATED QUALITY OF LIFE. 
 
The researchers have explored the full range of ischemic heart disease while 
looking at the impact of depression on the health related quality of life. Acute 
coronary syndrome includes three components; ST elevation myocardial 
infarction (STEMI), non-ST elevation myocardial infarction (non-STEMI) and 
unstable angina. Four studies were identified that examined the association of 
depression following acute coronary syndrome and the health related quality of 
life. Table 11 highlights salient features of these studies. 
 
 
Study No; 1 
Rumsfeld, J S et al., (2003) conducted a retrospective study to explore the 
association of history of depression and quality of life after acute coronary 
syndrome. The data used in this survey belonged to the Veterans Health 
Administration Access to Cardiology study. The researchers identified patients 
with a discharge diagnosis of acute coronary syndrome (ICD-9 criteria), which 
was confirmed from the medical notes. Patients were eligible for this study if 
they were alive 7 months after discharge. The survival status was obtained from 
the original study. The history of depression was determined from the medical 
notes or from the patient’s account of having depression requiring medical 
treatment, not merely from having depressive symptoms. The Seattle Angina 
Questionnaire was mailed out to the participants. Moreover, the participants 
were asked to rate their overall health (excellent, very good, good, fair or poor). 
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The non-responders were sent a reminder. The respondents were divided into 
two groups; those with and without history of depression. Univariate and 
multivariate regression analyses were performed. 
 
A total of 2733 patients consented to participate in the original study. Of these, 
2427 (88.8%) were alive at 7 months but 1957 (80%) consented and completed 
the SAQ. Of them 526 (26.7%) participants had a history of depression, while 
1431 (73.7 %) had no history of depression. Multivariate analysis revealed that 
the history of depression was associated with greater physical limitations (OR 
2.89, 95% CI 2.17-3.86, p<0.001), and worse QoL (OR 2.84, 95% CI 2.16 - 
3.72, p<0.001). Arthritis was more prevalent in the group with history of 
depression than those not having history of depression (65% vs. 51%, 
p=0.001). 
 
The study has certain weaknesses. It is a retrospective study  with all the 
inherent weaknesses of this design of study. The researchers have not given 
the definition of ACS and have relied on the data of another study whose 
methodology is not accessible.  For the history of depression, the researchers 
relied on the case notes, which are prone to documentary error or a patient’s 
personal account, which is prone to recall bias, particularly after 7 months. As 
the researchers used a disease specific measure for the QoL, their results 
cannot be compared with other studies (Beck CA et al., 2001; De Jonge P et al., 
2006) that used a generic tool (SF-36) for QoL. Arthritis was significantly higher 
in the group having history of depression, which might have acted as a 
confounding factor in the association of history of depression and QoL. The 
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researchers did not assess depression at the time of study  which leaves the 
possibility that some participants were still depressed; which might have 
reflected additive effects on the QoL.  
  
Among the merits of the study are that its prevalence of history of depression 
(26.9%) is comparable with previous studies (Ziegelstein, R, C 2001) reporting 
a prevalence of 17% - 65% of depressive symptoms and 15%-22% active major 
depression following myocardial infarction. The study also had a large sample 
size. In addition, history of depression was verified from the case notes. 
Reminders were sent to the non-responders to achieve maximum response 
rate. Using ICD-9 criteria for MI is another strong point of the study. They used 
a disease specific tool (SAQ) for the outcome measure rather than a generic 
tool. 
 
Despite a number of limitations, the researchers have demonstrated that the 
history of depression is associated with a poor quality of life in patients having 
acute coronary syndrome. 
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Study No; 2 
Dias CC et al., (2004) conducted a study exploring the impact of depression on 
the quality of life of patients with a discharge diagnosis of acute coronary 
syndrome. Consecutively admitted patients to the cardiology department 
between July 2001 and December 2002, were screened. 
 
Eligibility criteria required for the patients to be clinically stable, willing to 
respond to questionnaires and have been educated for more than 12 years. 
Clinical interviews were conducted for demographic, social and medical data. 
Quality of life was measured using a Portuguese SF-36 (v2) while depression 
was assessed with BDI. Participants completed follow up questionnaires 
between 12 and 18 months. 
 
Based on median score of PCS  and MCS,  the participants were divided into 
four groups; those  scoring less than 56 and those scoring 56  or more on  
MCS; those scoring less than 55 and those  scoring 55 or above on PCS. 
Multivariate analysis was conducted to determine the independent impact of 
depression. Two logistic models were used; one for MCS and other for PCS 
 
Of the screened patients, 278 were enrolled in the study. Of them 222 
completed SF-36 and BDI at baseline. Follow up data were available on 181 
(65%) participants. Of those who completed the follow up, 66 participants 
scored below the median (<56) on MCS and 115 scored ≥ 56. BDI score was 
higher in those scoring low on the MCS than in the high MCS scorers (12.9 ± 9 
vs.  7 ± 7, p=0.05). Similarly  73 scored < 55 while 103 scored ≥ 55 on PCS with 
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corresponding BDI scores of  11± 8 and 7 ± 6 (p=0.007). Female gender was an 
independent predictor of poor QoL (MCS & PCS), while baseline depression 
was a predictor of lower MCS scores only (OR 3.4, p=0.001) but not of the PCS 
scores. 
 
The study has a number of strengths. The researchers determined severity of 
the disease. Moreover baseline MCS and PCS were controlled in the 
multivariate analysis. BDI contains a number of somatic items which may at 
times reflect cardiac disease symptoms rather than depressive features. 
Moreover MCS overlaps with depression; hence it is somewhat difficult to 
delineate depression and quality of life at follow up.  
 
On the other hand the researchers used standardised questionnaires for 
depression rather than semi-structured interviews. As the items of MCS and 
depression overlap, it is possible that what is apparently perceived as QoL at 
follow up may in fact have been the reflection of persistent depression.   
 
The researchers have partially supported the association of depression 
following acute coronary syndrome and low quality of life (MCS) in their 
prospective cohort. 
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Study No; 3 
Thombs D et al., (2008a) conducted a study to investigate the impact of 
depressive symptoms on physical health status 12 months after hospital 
admission. The adult patients from 12 Coronary Care Units of the urban 
teaching and community hospitals in South-central Ontario, Canada, who were 
diagnosed with an acute coronary syndrome, were screened within 2 to 5 days 
of the admission. Enrolled patients completed BDI and Physical Component 
Summary (PCS) of the Short Form 12 (SF-12). Both cut off and continuous 
scores on BDI were determined, although only cut off scores will be used here. 
A BDI score of ≥10 was used as a cut off point for at least mild symptoms of 
depression. The SF-12 is a 12-item version of the SF-36, which provides 
empirically derived mental and physical health composite summary 
measurements, which reproduce the composite scores of the SF-36. Its raw 
scores are standardized, ranging from 0-100, where 0 denotes to the poorest 
health status and 100 to an excellent QoL.  Patients rated their health status 
during the 4 weeks before the admission. Data on socio-demographic features, 
history of previous myocardial infarction, co-morbid condition and Killip class, 
were collected. Participants were mailed out the BDI and PCS of the SF-12 at 
follow up.   
 
A total 913 patients consented but 812 (89%) completed baseline assessments. 
The prevalence of depression (10 ≥ BDI) was 28.9%. Of the 812 participants, 
45 died, 11 were lost to follow up while 331(41%) did not provide complete data 
at 12 months; hence 425 (52%) participants completed both baseline and 
follow-up data. Patients having a baseline BDI score ≥10  had significantly 
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poorer physical health status (p<0.001) at 12 months compared to those having 
BDI score <10 even after  controlling for baseline physical health status, age, 
gender, history of acute myocardial infarction and Killip class.  
 
The study has a number of strengths; it is a prospective study with a large 
sample size. The sample was well representative of the target population as the 
participants were both from the teaching and community hospitals.  Potential 
participants were contacted within 5 days of admission. Both depression and 
physical health status were assessed at baseline and at follow up. The 
researchers defined the acute coronary syndrome. The prevalence of 
depression after 12 months was (24%) which suggests that it is important not to 
overlook it while exploring the association of baseline depression and 
prospective quality of life.  
 
There are a few weaknesses of the study including a large drop out (55%). 
Patients who could not complete the study had more depressive symptoms and 
worse physical health at baseline than those who completed the study, which 
may suggest selection bias. The SF-12 instead of SF-36 was used for the QoL, 
which may be a less reliable measure. 
 
Despite using a different measure of QoL (SF-12), the researchers have proved 
that baseline depression can adversely affect the physical health status 
following acute coronary syndrome.  
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Study No; 4 
Thombs D et al., (2008b) Following on from the study discussed above,  the 
same researchers tried to assess whether a different pattern of depressive 
symptoms is related differently to health status. They classified depressive 
symptoms as following; otherwise the methodology remained almost the same. 
 
a. Depressive symptoms were classed as “not present” if participants 
scored less than 10 on BDI at admission and at 12 months follow up.  
b. Patients who had an initial BDI score <10 (during admission) but had an 
increased score (BDI ≥10) 12 months later, were classed as having “new 
symptoms”.  
c. Patients having BDI scores of ≥10 during admission but less than 10 at 
follow up were classed as having “transient symptoms”.  
d. Depressive symptoms were labeled as “persistent” if the BDI score 
remained ≥10 on both occasions.  
 
Categorical variables were analysed using Chi-square test and continuous 
variables with independent t tests. 
 
At follow up those having ‘persistent’ symptoms were at a significantly higher 
risk of poor quality of life (β = - 0.22, p< 0.001); those having ‘new’ symptoms 
were also at a higher, but not significant risk (β - 0.073, p= 0.060). However 
those having ‘transient’ symptoms of depression were not at risk of poor 
physical health. 
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The researchers have highlighted the importance of serial assessment of 
depression following acute coronary syndrome. Moreover they seem to have 
provided one of the explanations as to why some studies failed to show the 
association of the depression and quality of life; perhaps because the 
depression they identified was transient in nature. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
207 
 
Table 11 Studies exploring impact of depression on QoL following ACS  
 
Study CD Enrolled OC & F/U Tools Results Comments 
Rumsfeld, J. S et al 
(2001) 
 
 
ACS 
 
 
Enrolled 
1957 
 
Retrospective 
study 7 months 
 
 
H/O dep 
SAQ 
27% had history 
of depression 
Retrospective study, 
disease specific tool 
was used for QOL 
Dias CC et al 
(2004) 
 
 
ACS 
 
 
Enrolled 
278 
OC; QOL 
F/U 12/18 months 
 
 
BDI 
SF- 36 (V2) 
 
 Dep associated 
with lower MCS 
but not with PCS 
Depression and QoL 
overlap 
Thombs D et al 
(2008a) 
 
ACS 
 
Enrolled 
812 
OC: QoL 
F/U 12 months 
 
BDI 
SF- 12 
(PCS) 
Dep  associated 
with poor PCS 
52% completed both 
baseline and F/U 
Thombs D et al 
(2008b) 
ACS Enrolled 
812 OC: QOL F/U 12 months 
 
 
BDI 
SF- 12 
(PCS) 
Persistent dep 
was strongly 
associated with 
poor QOL. 
Dose- response 
effect supported 
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14.5.1 SUMMARY OF SECTION 
 
 In the above section all the four studies recruited patients having a diagnosis of 
acute coronary syndrome, which encompasses a broad range of ischaemic 
heart disease rather than the myocardial infarction alone. Three of them were 
prospective while one was a retrospective study. All seem to be supporting the 
complete or partial adverse impact of depression on health related quality of life. 
  
Thombs D et al., (2008) assessed depression at baseline as well as at follow 
up. SF-12 is more sensitive to the effects of co-morbid medical conditions, 
which occur commonly in such populations. Moreover, the outcome measure 
was PCS rather than MCS; a more precise indicator of health related quality of 
life. Additionally the researchers found out that it is ‘persistent or newly 
developed depression’ which is associated with poor quality of life, not the 
transient depression following acute coronary syndrome. This finding possibly 
answered the question that why in some studies depression following 
myocardial infarction is associated with health related quality of life but not in 
others. Dias CC et al., (2004) studied stable patients with acute coronary 
syndrome, used SF-12 (Portuguese version) for QoL while assessing 
depression with BDI. They used different median values as a cut off point for 
the mental component scale and physical component scale. They found that 
depression was a predictor for impaired mental functioning as assessed by the 
MCS scores, but not for physical functioning, as assessed by the PCS. 
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Rumsfeld J S et al., (2001) conducted a retrospective study, using the Seattle 
Angina Questionnaire; a disease specific tool for quality of life. They relied on 
history of depression rather than its actual assessment. Being a subsidiary and 
retrospective study, it carries much less weight in the hierarchy of research.  
The history of depression (27%) in their cohort is comparable with other studies 
(Lane, D et al., 2000; Grace LS et al., 2005). 
 
In summary depression after ischaemic heart disease is associated with poor 
quality of life. The observed variation in the reviewed studies could be partly 
due to fact that the depression in their cohort was transient rather than 
persistent (Thombs D et al., 2008a).  
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14.6  IMPACT OF DEPRESSION ON QUALITY OF LIFE IN PATIENTS HAVING 
CORONARY ARTERY DISEASE  
 
In addition to acutely ill patients such as with myocardial infarction or acute 
coronary syndrome, the researchers have also tried to examine the impact of 
depression on health related quality of life of those having coronary artery 
disease on investigation but who have not experienced any ischaemic cardiac 
episode yet. Only two studies were identified for this review.  Table 12 
summarises them. 
 
 
 
Study No; 1 
Sullivan MD et al., (1997) looked at the association of depression with physical 
functioning and activity interference. Members of a Washington Health 
Maintenance Organisation (HMO), who were 45-85 years old and were waiting 
for an elective cardiac catheterisation for a suspected coronary artery disease, 
were contacted by telephone. The inclusion criteria included ≥ 50% occlusion of 
one major coronary artery, a treadmill stress test within the last year, coronary 
artery disease which must be the most disabling disease as assessed by the 
physician, and being ambulatory. Following catheterisation, a research nurse 
interviewed the potential participants in the hospital when they completed 
Physical Functioning and Activity Interference scales. Physical functioning is a 
9-item scale, which assesses difficulty with the basic and intermediate activities 
of daily living, derived from the University of California at Los Angeles (UCLA) 
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Functional Status Questionnaire (FSQ). Its scoring was amended to match with 
SF-36 Health Survey. Activity interference is an 11-item scored on a six-point 
Likert Scale ranging from none to severe, from an adapted version of the 
Multidimensional Pain Inventory (MPI). Where possible, a participant’s spouse 
also completed the adapted version of the MPI (spouse form) at baseline. The 
researchers administered the Hamilton Rating Scale for depression (HAM-D) to 
determine depression. It is 24-item scale used to determine the severity of 
depressive symptoms. Based on the HAM-D score, participants were divided 
into quartiles to see the dose-response effect;  
a. HAM-D  0- 4 
b. HAM-D  5-7  
c. HAM-D  8-12 
d. HAM-D ≥ 13.  
 
Physical functioning and Activity interference assessments were repeated at 12 
months by mailed questionnaires. Pearson Correlation Coefficient and one-way 
ANOVA were used for statistical analysis.   
 
A total of 409 subjects were screened; 232(56%) completed baseline 
assessments. Of these, 198(85%) completed both baseline and 12 months 
assessments. At baseline, both subjects and spouses (N=165) completed the 
activity interference scale of the MPI. High baseline depressive scores were 
significantly associated with lower physical functions scores (r=0.2-0.4) at 12 
months follow up. One-way ANOVA revealed physical function scores to differ 
by baseline depression groups at 12 months (p=0.01). There was also a 
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significant correlation between baseline depression and 12 months activity 
interference (r =0.3-0.4). The impact was higher on the 4th quartile than the 1st 
or 2nd quartile. The responses of the participants and their spouses were closely 
matched, limiting any reporting bias. 
 
There are a few weaknesses in the study. The sample size is relatively small 
and predominantly male (81%), possibly suggesting recruitment bias. The 
researchers preferred quartile grouping to diagnostic threshold as only a small 
number of participants qualified for depression. The severity of depressive 
symptoms was assessed by HAM-D rather than by clinical diagnosis. Physical 
Functioning and Activity Interference scales were self reporting tools, prone to 
reporting bias. The inclusion criteria were non-specific and focused on patients 
having CAD, without any mention of whether the participants ever suffered from 
ischaemic heart disease. Moreover, elective cardiac catheterisation suggests 
that the cardiac problems perhaps were not so acute. 
 
 
The study has a number of merits. It is prospective in design and measured the 
outcome measure (QoL) at the baseline and at 12 months follow-up. Although 
researchers have relied on an uncommonly used tool for quality of life, physical 
functions and activity interference are good markers of the health related quality 
of life. The interviewer administered HAM-D to minimise the reporting bias. 
There was no significant difference between participants’ and spouses’ scoring, 
ruling out any reporting bias. Being a prospective study, it allows the causal 
inference to be drawn and stands high up in the hierarchy of research evidence.  
213 
 
 
The study has provided prospective evidence of a significant impact of 
depression on the functional status and activity interference of CAD patients. 
 
 
Study No; 2 
In their cross-sectional survey, Ruo, B et al., (2003) looked at the impact of 
depressive symptoms on the health status of patients with coronary artery 
disease. The researchers used the data of the ‘Heart and Soul Study’. Patients 
were identified from administrative databases from the  9 public health clinics in 
the Community Health Network, 1 university medical centre (University of 
California) and 2 Department of Veterans Affairs Medical Centers in San 
Francisco. The eligibility criteria included at least one of the following;  
a. history of MI  
b. angiographic evidence of at least 50% narrowing  in one or more of the 
coronary arteries  
c. exercise-induced ischaemia  
d. a diagnosis of coronary artery disease by the cardiologist  
 
Eligible patients were invited to attend a baseline study day to complete medical 
history and a 9-item Patient Health Questionnaire. A score of 10 or above on 
PHQ was used as a cut-off point. The researchers used the Seattle Angina 
Questionnaire to assess physical limitations and disease specific quality of life.  
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A total of 2495 (16%) of the 5438 eligible patients responded to an invitation 
letter.  Of these, 505 (20%) could not be approached, 596 (24%) declined and 
370 (15%) were excluded due to an MI in the last 6 months. Hence, 1024 
patients were enrolled; 201 (20%) scored ≥10 on PHQ while 823 (80%) scored 
below the cut-off point. A significantly higher proportion of the depressed 
participants reported physical limitations (73% vs. 40%; p< 0.001), diminished 
QoL (67% vs. 31%; p < 0.001) and poor overall health (66% vs. 30%; p< 0.001) 
compared to those who were not depressed.  In the  multivariate analysis after 
adjusting for other independent variables, depressive symptoms were strongly 
associated with severe physical limitation (OR 3.1; 95% CI, 2.1- 4.6; p< 0.001), 
worse QoL (OR 3.1;95% CI , 2.2- 4.6; p< 0.01)  and worse overall health ( OR 
2.0; 95% CI, 1.3-2.9; p< 0.001). 
 
The study has a few shortcomings. The researchers used the data of the Heart 
and Soul study whose methodology is not accessible. There seems to be an 
element of selection bias as only 41% of the eligible patients were enrolled.  As 
PHQ is a self administered questionnaire, the risk of reporting bias is there. As 
the participants were generally stable cardiac patients, the results of the study 
may not be applicable to the patients having acute ischaemic heart disease. 
Being a cross-sectional study; it carries much less weight in the hierarchy of 
research, as it cannot determine the direction of causality between depression 
and quality of life.  
   
On a positive note, the study has a large study sample. Prevalence of 
depression (20%) is in line with the other studies (Ziegelstein, R C 2001& 
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Rumsfeld, J. S et al., 2001). One of the interpretations for this prevalence is that 
stabilised cardiac patients continue to suffer from the depressive disorder for a 
long period as the researchers excluded those having an MI in the last 6 
months. Another advantage of the study was that participants attended a 
baseline study day. 
 
The researchers have provided further evidence that depression following 
coronary artery disease is a risk factor for poor quality of life. 
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Table12; Studies exploring impact of depression on QoL following CAD 
Study CD Enrolled OC & F/U Tools Results Comments 
Sullivan, M 
D.et al 
(1997) 
CAD Enrolled 232 
OC:QOL 
F/U 12 
months 
FSQ 
HAM-D 
 
Baseline dep was 
significantly associated 
with lower physical 
functioning 
Sample is relatively 
small 
Ruo, B. et 
al (2003) 
CAD Enrolled 1024 OC:QOL 
F/U cross 
sectional 
survey 
 
PHQ 
SAQ 
Dep was associated 
with poor QOL 
Only 41% of eligible 
patients were enrolled, 
and they were generally 
stable 
The data was used of  
the Heart and Soul study 
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14.6.1 SUMMARY OF SECTION  
 
The above review highlights that both Sullivan MD et al., (1997) and Ruo, B. et 
al., (2003) despite different methodology supported the association of 
depression and the subsequent quality of life. Sullivan MD et al., (1997) 
assessed depression with HAM-D which was administered by the researchers 
ruling out possibility of reporting bias. Health related quality of life was 
measured with Activity interference and physical functioning. Depressed 
participants were divided into quartiles; possibly due to the low number of 
depressed patients. Reporting bias was ruled out by involving a number of 
spouses.  
 
Ruo, B et al., (2003) used PHQ as a measure for depression and SAQ as a 
measure for QoL. SAQ is a disease specific QoL measure. Moreover it is a 
subsidiary study and being a cross-sectional survey, it carries much less weight 
in the hierarchy of research and does preclude the determination of the 
direction of causality between depression and quality of life. 
 
Despite major methodological variation, the researchers have supported the 
association of depression and poor health related QoL in patients having 
coronary artery disease. 
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14.7  OVERALL CHAPTER SUMMARY   
 
The literature review in the above chapter has highlighted a number of 
important findings. 
 
a. Depression is prevalent in patients having acute or stable coronary heart 
disease. 
b. Depression is a syndrome having a biological, psychological and social 
profile in varying proportions in different individuals.  
c. Depressive cognition can be an important profile when it comes to 
measuring the quality of life. 
d. Quality of life is multi-dimensional and some of its dimensions can easily 
overlap the clinical picture of depression.  
e. Depression in coronary heart disease patients is associated 
independently with poor health related QoL in most of the studies but not 
in others. 
 
This heterogeneity in the findings can be due to variations in the settings, 
samplings, depressive measure, cardiac diagnosis and health related quality of 
life measures. 
 
Geographical Location 
The studies reviewed have been conducted in a number of countries including 
Canada, USA, Sweden and UK. Of the 15 studies that investigated the 
relationship of depression and QoL, 9 recruited patients with myocardial 
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infarction; two of them sampled patients with first myocardial infarction. Two  
studies explored this association among patients having CAD while four studies 
recruited patients having a diagnosis of acute coronary syndrome. In terms of 
depressive measures, seven  studies used BDI, three used HADS, one used 
PHQ, and one used HAM-D, while two (de Jonge P et al., 2006a; Fauerbach JA 
et al., 2005a) used semi-structured interviews for DSM 111 / ICD-10 diagnostic 
criteria. 
 
Settings 
One of the explanations for different findings could be different settings of the 
studies; Brink E et al., (2002) conducted their study in a rural hospital while 
Fauerbach, J A et al., (2005) collected their sample from a teaching hospital. 
Rumsfeld J et al., (2005)   explored stable cardiac patients in the community 
while Thombs D et al., (2008) recruited participants from rural teaching and 
community hospitals. There is no consistent pattern in the findings of the 
studies based on different settings. 
 
Depressive Measures  
Another explanation of variation in the findings could be the use of different 
depressive measures. The depression assessment has been mainly conducted 
with self-report standardised questionnaires which generally assess the severity 
of symptoms rather than the onset of clinical depression; six studies including 
Lane, D et al., (2000 & 2001); Beck, C A et al., (2001), Fauerbach, J A et al., 
(2005) and Thombs, D et al., (2008a&b) used BDI but they came up with mixed 
findings. Similarly, Brink, E et al., (2002) used HADS for depression but failed to 
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find the association of depression and QoL; on the other hand both (Mayou, R. 
A. et al., 2000c &Dickens, C et al., 2006) applied HADS in their cohort but  
showed a positive  association between depression and  QoL.  
 
Furthermore Fauerbach, J A et al., (2005) and de Jonge P et al., (2006) used 
semi-structured interviews for the ICD-10 and DSM IV diagnostic criteria, but 
came up with differing results. Fauerbach, J A et al., (2005) found evidence of 
an association of depression and MCS (SF-36) whilst de Jonge P et al., (2006) 
used PCS (RAND-36) as an outcome measure but still were able to support   
the association of depression following MI and subsequent health related QoL. 
 
 
Timing of Depression Assessment  
There is a lot of variation in the timings of assessment of depression; Mayou, R 
A et al., (2000) assessed depression 3 days after admission and Lane, D et al., 
(2000&2001) assessed it within 2 weeks of admission but both found an 
association of depression and QoL. On the other hand Fauerbach, J A et al., 
(2005) assessed depression within 2-5 days of admission but succeeded in 
finding a partial association between depression and QoL. Similarly, Brink, E et 
al., (2002) assessed depression 2 days prior to discharge but could not find any 
association between depression and QoL. In contrast, de Jonge P et al., (2006) 
collected baseline data 3 months after myocardial infarction and found an 
association between depression and QoL. The response of patients who were 
approached within 2-5 days after MI may well have been coloured by their 
emotions preceding the MI or may be reflecting an acute stress reaction in 
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response to a life threatening disease. This issue has been highlighted by 
Dickens, C et al., (2006) and Thombs D et al., (2008) in their studies.  
 
In summary, even the variations in the timings of baseline depression 
assessment have not highlighted any particular trend in the association of 
depression and QoL. 
 
 
Secondary Analysis 
As a number of depressive features (HADS) and the quality of life measure (SF-
36 MCS) overlap with each other, it becomes necessary to ensure that the 
outcome measure is valid rather than the disguised manifestation of depression. 
It is an important issue that has been taken into account by few researchers. 
Most of studies assessed depression at baseline only (Sullivan, M D et al., 
1997 ; Lane, D et al., 2000 & 2001; Mayou, R A et al., 2000 ; Ruo, B et al., 
2003; Brink, E et al., 2002 and Fauerbach, J A et al., 2005) ; except for Beck, C 
A et al., (2001), Dickens, C et al., (2006) and de Jonge P et al., (2006) who  
assessed depression twice; at baseline and at follow up as well. To get a clear 
picture of the outcome measure de Jonge P et al., (2006) conducted their final 
analysis by excluding those who were depressed at follow-up. They were able 
to find the association of depression following myocardial infarction and the 
physical health related quality of life but with a lesser magnitude. Similarly 
Dickens C et al., (2006) tried to overcome the overlapping picture of depression 
(HADS) and QoL (SF-36) by excluding MCS from the main outcome measure. 
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The heterogeneity in findings of the reviewed studies could be partly due to lack 
of a sensitivity analysis. 
 
 
Timings of Depression- Is it soon or long after MI? 
The issue remains of whether it is the depression developing immediately after 
the MI or developing gradually over a period of months that is associated with a 
poor QoL. Some researchers have investigated this issue at length; Dickens C 
et al., (2006) assessed depression in their cohort within a week of admission, 
then at 6 and 12 months of the index admission. They strongly supported that it 
is the depression 6 months following MI having an impact on the QoL rather 
than the depression identified within a week or so of IHD, which may be a 
reflection of the mood in the period preceding MI. However a number of 
researchers assessed depression within days to weeks of the ischaemic heart 
disease (Sullivan, M D et al., 1997, Lane, D et al., 2000e & 2001b; Mayou, R A 
et al., 2000c; Beck, C A et al., 2001) but still found an association between 
depression and health related quality of life. This issue has been clarified to a 
significant extent by Thombs, D et al., (2008) when they found out that 
depression need to be ‘persistent rather than transient’ to have impact on the 
quality of life. So it looks like that the participants of those studies which failed to 
find any association of depression and health related quality might have 
experienced a transient spell of depression.  
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Cardiac Disease Diagnosis 
There is a possibility that different cardiac diagnoses could have been the factor 
accounting for the variations of results. Mayou, R A et al., (2000) studied 
patients  with MI and supported the association of depression and QoL while 
Beck et al., ( 2001) enrolled patients having MI but failed to find such an 
association. Rumsfeld, J S et al., (2001) and Thombs D et al., (2008) both 
recruited patients having acute coronary syndrome but still  found association of 
depression and QoL despite other methodological differences in their 
approaches. As the term ACS encompasses STEMI, non-STEMI and unstable 
angina, the studies recruiting participants with this diagnosis in fact have 
broadened their inclusion criteria to recruit a full range of IHD patients rather 
than having patients with MI only. Comparison of these studies with those 
having patients with MI only would be somewhat complex. Similarly, studies 
enrolling patients with coronary artery disease (after coronary angiography) 
have found the impact of depression on the QoL. This picture highlights that 
baseline cardiac diagnosis does not lead to any fixed pattern in the findings of 
the reviewed studies. 
 
 
Cardiac Disease - First or Subsequent MI 
It is important to know that whether it is a patient’s first or subsequent MI, as the 
history of previous MI can be a confounding factor in the association of 
depression and quality of life (Stewart LE et al., 1989; Brown N et al., 1998). 
Brink E et al., (2002) enrolled patients with first myocardial infarction but failed 
to find any significant association between depression and QoL whilst Dickens 
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C et al., (2006) also investigated patients with first MI but came up with a 
positive association of depression and QoL. The remaining studies (Lane, D et 
al., 2000 & 2001 ; Beck, C A et al., 2001 ; Mayou, R A et al., 2000 ; Brink, E et 
al., 2002;  Fauerbach, J A et al., 2005 and de Jonge P et al., 2006 have not 
clarified whether their participants were having  first or subsequent IHD, but it is 
more than likely that their cohort consisted of a mixture of the first and repeat 
spells of  ischaemic heart disease, possibly in varying proportions.  
 
 
Cardiac Disease Severity 
Cardiac disease severity has been an important variable in the statistical 
analysis. Five studies; Mayou, R A et al., (2000); Beck, C A et al., (2001); 
de Jonge PD et al., (2006); Dickens C et al., (2006) and Thombs D et al., (2008) 
controlled for disease severity and baseline health status in their analysis. They 
found a positive association between depression and QoL. Brink E et al., (2002) 
did not control for baseline health status and disease severity while looking at 
the association of health status and depression. 
 
However, there is the problem of whether the severity of disease can be 
adequately controlled (Mendes de Leon, 1999). The reason is that disease 
severity has various dimensions, and practically it is not possible to control for 
all of them. The studies  that tried to control  for disease severity, used various 
parameters such as the Peel Index and Killip class (Lane D et al., 2001),  
medical problems and procedures before the myocardial infarction (Mayou  RA 
et al., 2000), Killip class and left ventricular ejection fraction (de Jonge P et al., 
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2006) and Killip class (Thombs D et al., 2008).  Because individual measures of 
disease severity cannot provide a full picture  of disease severity, those studies 
that controlled for multiple  indicators are more likely to give a better picture of  
disease severity than those which only controlled for a few. 
 
 
Measures and Timings of QoL assessments  
A question may arise as to whether it is the diversity of QoL measures or the 
timings of its assessments that have led to inconclusive results. In the reviewed 
studies, some used generic (SF-36) while others used disease specific tools 
(SAQ). Similarly, others used indirect markers for QoL. 
 
Sullivan, M D et al., (1997) used  Activity Interference and Physical Functioning 
Scale for the quality of life whilst Lane, D et al., (2000 & 2001) used Dartmouth 
COOP Charts, an uncommonly used tool for assessing quality of life. Three 
studies (Mayou, R A et al., 2000, Fauerbach, J A et al., 2005 & Dickens C et al., 
2006 ) used SF-36 but came up with different findings. Similarly de Jonge P et 
al., (2006) used RAND-36, Thombs D et al., (2008) used SF-12 while Ruo, B et 
al., (2003) used a disease specific tool; the SAQ, leading to varying degrees of 
association between depression subsequent quality of life. Possibly using 
different tools for quality of life might have contributed to heterogeneity in the 
reviewed literature. 
 
SF-36 is a generic tool, which assess the broad-range functioning, health 
perception and symptoms. Such tools are generally used in different cohorts, 
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allowing the comparison of groups having different diseases. They have 
limitations as they cannot focus on the aspects of QoL that are disease specific. 
On the other hand, the SAQ is a commonly used disease specific tool in cardiac 
patients. Specific tools focus on problems associated with a specific disease 
like IHD and patient groups (old age). These tools are more responsive to any 
change in the QoL and more sensitive in discriminating the range of 
impairments because of their focus on the most relevant aspects of QoL. 
Nevertheless, using a disease specific QoL tool alone can overlook the impact 
of co-morbid medical conditions on the quality of life.  
 
The timings of the assessment of QoL have been also important. Some studies, 
Lane, D et al., (2000&2001), Beck, C A et al., (2001); Brink, E et al., (2002); de 
Jonge P et al., (2006) assessed the outcome measure (QoL) only at follow up, 
whereas  Sullivan, M D et al., (1997), Mayou, RA  et al., (2000), Fauerbach, J A 
et al., (2005) &Dickens C et al., (2006)  assessed QoL twice, at baseline and at 
follow up. Those who assessed QoL at follow up only, failed to adjust it in their 
multivariate analysis; leaving possibility of confounding effect.  
 
Despite quality of life being a soft outcome measure with inherent subjectivity, 
most of the reviewed studies have supported its association with depression 
following cardiac disease. Studies recruited patients with myocardial infarction, 
first myocardial infarction, acute coronary syndrome and those having coronary 
artery disease (without any history of ischaemic heart attack) and assessed 
depression over a wide period of time using different tools such as semi-
structured interview, standardised questionnaires and quality of life with generic 
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and disease specific tools; but still found more evidence to support the   
association of depression and health related quality of life. However this 
association becomes very complex due to medical, psychological and social 
profiles that are shared between depression, ischaemic cardiac disease and 
health related quality of life.  
 
As the current review mostly revolves around the White population, it is 
important that the quality of life of people of other ethnic origins living in the 
United Kingdom should be explored. Any migration of people into the United 
Kingdom may have been primarily to improve their quality of life and this would 
need to be taken into consideration in any future studies.  
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15 RATIONALE FOR THIS STUDY 
South Asians are the biggest ethnic minority group which accounts for 4% of the 
total UK population. They have higher rates of coronary heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989). Furthermore, their 
admittance to hospital with myocardial infarction is twice compared to their 
White counterparts (Wilkinson, P et al., 1996). Similarly, they are 40%-50% 
more likely to die prematurely from CHD than the general population (Balarajan, 
R.1996; BHF 2004).  
 
Limited research in this ethnic group highlights that depression is also common 
(22%-39%) among the South Asians living in the UK (Husain, N et al., 1997; 
Bhui, K et al., 2004; Commander JM et al., 2004; Scott W et al., 2004; Gator, R 
et al., 2009). Moreover, they have low levels of literacy and relatively high 
deprivation levels. This raises the possibility as to whether the excess of 
depression among them may be, at least in part, accounting for their higher 
cardiac morbidity. 
 
 
 The reviewed studies have highlighted that depression following CHD is 
common in the White population (16%-35%) despite the diversity of assessment 
tools; self report standardised questionnaire and diagnostic interviews. The 
results of these studies have been heterogeneous; some have supported the 
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association of depression and subsequent cardiac morbidity and mortality, while 
others failed to find such an association. 
  
Although lack of standardisation of depression measure, cardiac diagnosis, 
cardiac disease severity and outcome measure may have played their role in 
such inconsistent findings, equally it could be due to the recent advances in the 
management of coronary heart disease leading to improvement in the cardiac 
morbidity and mortality (Rumsfeld &Ho, 2005; BHF 2008). Hence, the main 
focus of treatment seems to be shifting from traditional medical outcomes to 
health related quality of life.   
 
The current literature review has also revealed that depression following CHD is 
associated with an adverse impact on the health related quality of life (Mayou 
RA et al., 2000c; Beck CA et al., 2001; Lane, D et al., 2001b; de Jonge P et al.,  
2006a) despite the fact that quality of life is a multidimensional soft outcome 
measure. Most of the researchers have concluded that it is the depression 
developing in the days or weeks after CHD (Mayou RA et al., 2000c; Beck CA 
et al., 2001; Lane, D et al., 2001b; de Jonge P et al., 2006a) which has an 
adverse impact on the quality of life and not the depression preceding the 
myocardial infarction (Dickens, C et al., 2006). Furthermore, it has been 
suggested that it is ‘persistent’ rather than ‘transient’ depression that is 
associated with a poor quality of life in patients with CHD (Thombs D et al 
2008b). Some researchers even went on to support the dose-response 
relationship between depression and HRQoL (Sullivan M D et al; 1997) 
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It is well known that CHD and  depression both can have an adverse impact  on 
health related quality of life and this impact has been reported to be additive 
when they occur concurrently (Glassman et al., 2003). Furthermore, ischaemic 
heart disease generally follows a chronic course; improvements in health 
related QoL would be an important goal from the patient’s point of view. 
 
Due to lack of research interest, there is hardly any significant piece of work 
available to date examining the prevalence of depression in South Asians 
following acute coronary syndrome, and then looking at the association of such 
depression with health related quality of life; hence this study is an attempt to 
explore the prevalence of depression and QoL of the UK South Asians after 
ischaemic heart disease. 
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16 METHODOLOGY 
16.1 AIMS 
Using a prospective cohort design, the following study examines the impact of 
depression on the health related quality of life of South Asians having acute 
coronary syndrome.  
 
16.2 HYPOTHESIS 
After controlling for the demographic and medical factors, South Asians with 
depression will be more likely to have poor health related quality of life 6 months 
after acute coronary syndrome than those who are not depressed. 
 
16.3 PROCEDURES 
16.3.1 SETTINGS 
This study was conducted at four hospitals in the North West of the UK. The 
hospitals were Burnley General Hospital, Burnley; Blackburn Royal Hospital, 
Blackburn; Rochdale Royal Infirmary, Rochdale and Fairfield General Hospital, 
Bury in Greater Manchester. Blackburn, Burnley, Bury and Rochdale all have a 
significant proportion of South Asians in the population, mainly of Pakistani or 
Indian origin. Most of these people speak Urdu in their daily communication. 
Urdu is the national language of Pakistan. 
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16.3.2 SUBJECTS 
 
All South Asian1 patients admitted to the coronary care units, medical admission 
units (MAU) or general medical wards of the above centres between April 2007 
and February 2009 were screened for their suitability for this study. 
 
16.4 POWER CALCULATION 
In a previous observational study (Dickens, C et al., 2006), in a predominantly 
Caucasian sample of people admitted to hospital following myocardial 
infarction, the prevalence of depression was around 24%. Subjects, who were 
depressed at the time of their index MI, had Physical Component Score (SF-36) 
of 34.9 (11.3) 6 months following MI compared to those who were not 
depressed; 40.8 (10.8). Assuming that the rate of depression will be at least the 
25%, a sample of 200 subjects would provide 83% power to detect difference of 
the same magnitude between depressed and non-depressed groups, at a level 
of significance of p = 0.05.  
 
Based on the previous experience of recruitment following myocardial infarction  
(Dickens C et al., 2004) it was anticipated that approximately 10% of  identified 
subjects will be  unsuitable or will refuse to consent and a further 15% -20% 
would fail to complete follow-up at 6 months. Therefore, a sample size of 280 
                                                           
1
 The term “South Asian” was used for people belonging to Pakistan, India & Bangladesh. Their 
ethnicity strictly required 3 (from 4) grand-parents to share the same ethnic group and was also 
self-defined using Census categories.  
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subjects was chosen with the intention of recruiting and collecting baseline data 
on 250 subjects and completing 6 months follow up assessments on more than 
200 subjects. 
 
Each morning, a researcher rang up each of the above centres to find out if 
there were any eligible patients. Patients were given up to two weeks to 
become medically fit. Appropriately translated consent forms, information 
sheets and questionnaires were used to prevent exclusion because of 
language. Those medically fit were handed over an information sheet and 
consent form by the researcher. They were given 24 hours to read the 
‘information sheet’ or to ask any questions relating to the study. Those giving 
written consent were asked to complete baseline questionnaires in their spare 
time in the hospital. Those requiring help in completing these questionnaires 
were given assistance by the researcher.  
 
16.5 INCLUSION CRITERIA 
Patients were included if they were; 
• Aged 18 or above  
•  South Asian in origin 
• Those having a diagnosis of acute coronary syndrome which 
encompasses unstable angina, ST segmented elevation myocardial 
infarction (STEMI) and non-ST segment elevation myocardial infarction 
(non-STEMI) (Grech ED et al., 2003). The diagnosis of ACS was based 
on the following; 
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a. Troponin level or CK-MB levels (based on the local laboratory 
assays)  
b. ECG ischaemic changes (in conformity with myocardial infarction) 
c. Confirmation with the local cardiologist  
 
16.6 EXCLUSION CRITERIA 
Patients were excluded if they met any of the following criteria; 
a. Any other life threatening medical condition likely to cause death within 6 
months  
b. Those who were cognitively impaired to be interviewed  
c. Acute coronary syndrome  as a result of angioplasty, angiography or any 
other surgical intervention  
d. Those who suffered from other major psychiatric disorders including 
schizophrenia, bipolar affective disorder, alcohol dependency or severe 
depression with suicidal risk.  
e. Those discharged from the hospital within 24 hours of their admission. 
 
 
 
ASSESSMENTS  
There were two main assessments in the study period. These were at baseline 
and at a follow up 6 months after the index acute coronary syndrome. 
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16.7 BASELINE ASSESSMENTS 
(A) PHASE ONE 
 
In the first phase of assessment following data were collected;  
• Demographic data 
• Psychosocial data (HADS) 
• Social support data (ENRICHD Social Support Instrument-ESSI) 
• Co-morbid conditions 
• Cardiac and non-cardiac medications 
• Health-related quality of life (SF-36) 
Details of these assessments are described fully in the following sections. 
 
16.7.1 DEMOGRAPHY 
The following demographic data were collected from the case notes and from 
the participant. 
• Name 
• Age of the participant  
• Gender of the participant  
• Marital status 
• Educational status   
• Employment status    
• History of nerves 
• History of nerves in the family 
• Duration of the cardiac illness 
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• Address  
 
PSYCHO-SOCIAL ASSESSMENTS 
 
16.7.2 HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Depression was measured using the self-report Hospital Anxiety & Depression 
Scale (Zigmond AS, & Snaith RP1983). The HADS has been proven a reliable 
and valid instrument for assessing anxiety and depression in medical patients 
(Herrmann C, et al., 1993). Its internal consistency is good, with Cronbach’s 
alpha ranging from 0.82 (depression subscale), 0.83 (anxiety subscale) and 
0.88 (total HADS) (Strik, JJMH et al., 2001). It consists of 7 questions for 
anxiety and 7 questions for depression. All questions are scored on a four-point 
scale ranging from 0-3. It has undergone several revisions since its original 
development and has been extensively used in a number of studies looking at 
the impact of depression on the prognosis of patients having myocardial 
infarction (Sydeman S J, 1999; Bush DE et al., 2001; Strik JJMH, 2003). 
 
 The HADS was chosen as it excludes bodily symptoms including insomnia, 
fatigue and pains that might arise as the result of physical illness; thus falsely 
inflating depressive scores in the study population. 
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16.7.3 SOCIAL SUPPORT ASSESSMENT 
 
Social support is generally defined as the existence or availability of individuals 
on whom one can rely; individuals who let one know that he or she is cared 
about, loved and valued (Sarason I. et al., 1983). Lack of social support has 
been shown to be a risk factor for depression (Brown, G & Harris 1978) and a 
predictor of poor outcome of MI (Jenkinson CM et al., 1993; Welin, C et al., 
2000; Dickens, C et al., 2004; Pedersen SS et al., 2004). As social support can 
confound the association between depression and the outcome measure (QoL), 
it was measured at baseline using the ENRICHD Social Support Instrument 
(ESSI) (Valiogo, J et al., 2004) which has been used in the ENRICHD clinical 
trial (ENRICHD 2001).  
 
ESSI is derived from questions on the Medical Outcomes Survey and earlier 
work examining the influences of social support (Williams RB et al., 1992;   
Gorkin L, et al., 1993). It is a 7-item self-report questionnaire that measures the 
four main attributes of social support: emotional, instrumental, informational and 
appraisal (ENRICHD 2001). Individual items are then summed up where a 
higher score indicates a high level of social support and vice versa. The ESSI 
has an established internal consistency and correlates positively with other 
social support instruments and negatively with measures of depression (Beck A. 
et al., 1981). Mostly ESSI questions explore the general feelings about being 
loved and valued rather than instrumental types of support. This approach 
supports the theory that social support is not a tally of actual supportive 
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"services" rendered, but rather an individual’s belief that others care about 
him/her and are available if and when needed (Langford CP, et al., 1997). 
 
16.7.4  HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
 
HRQoL has been defined as the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by him or her (Schipper, H 
1996). The subjective perception suggests that it is concerned with the illness 
experience rather than the disease itself.  
 
Short-Form 36 (SF-36) Health Survey was used to assess the quality of life in 
this study. A generic measure was deliberately chosen rather than a cardiac-
specific measure (SAQ) as patients having MI frequently experience co-morbid 
health problems. Hence, it was felt that a measure that was more sensitive to 
the impact of non-cardiac co-morbid conditions on the health related quality of 
life would be more appropriate. The SF-36 has been well validated in patients 
having coronary heart disease (Failde & Ramos, 2000; Morrin, L et al. 2000; 
Rumsfeld & Ho, 2005). Moreover, the influence of co-morbid medical conditions 
on the outcome measure of cardiac patients has been ignored in the previous 
research. 
 
 The SF-36 is a multi-purpose, self-administered tool which has proven useful in 
surveys of general populations, comparing the relative burden of diseases. It is 
a valid and reliable tool which is user friendly and requires only 5-10 minutes for 
its completion.  It has 36-items, which cover eight dimensions of health; mental 
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health, vitality, bodily pains, physical function, social function and role-physical, 
role-emotional and general health(McHorney C.A et al., 1993). Psychometrically 
based SF-36 has two summary scales; the Physical Component Scale (PCS) 
and the Mental Component Scale (MCS). The PCS consists of physical function 
(PF), role-physical (RP), bodily pains (BP) and general health (GH) (Ware, et 
al., 1994). We used PCS as a primary outcome measure in this study as MCS 
overlaps with items of HADS; hence it was excluded from the study. The PF, 
RP,  BP and GH have been shown to be the most valid for measuring physical 
health. Similarly MCS consists of 4 scales; mental health, role-emotional, social 
functioning and vitality. Physical Component Summary (PCS) and Mental 
Component Summary (MCS) scales of the SF-36 generally measure the 
physical and mental aspects of quality of life. Each summary scale ranges from 
0-100, with a higher score corresponding to a better quality of life and vice 
versa. They have been standardised to have a mean of 50 and a standard 
deviation of 10 for the US population. Although there is no documented 
difference in scores, which could be taken as clinically relevant to the patients 
having an AMI, the researchers classed a 3-5 point difference as clinically 
relevant.  
 
16.8 BASELINE MEDICAL DETAILS 
 
ACUTE CORONARY SYNDROME 
 
The diagnosis of acute coronary syndrome was recorded from the patient’s 
account, medical notes review and confirmation with the local cardiologists. The 
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severity of index ACS was determined from the hospital stay, and cardiac 
medications.  
 
CO-MORBID MEDICAL CONDITIONS 
 
Patients were asked whether they suffer from any co-morbid medical conditions 
including hypertension, diabetes-mellitus, arthritis, asthma, anaemia, thyroid 
disorder, neurological disorder and gastro-intestinal tract (GIT) disorder. Further 
details of their illnesses were verified from the case notes. 
 
MEDICATIONS 
 
All medications, including cardiac and non-cardiac medications, prescribed at 
time of the baseline assessment were recorded from the prescription charts.  
 
 
(B)PHASE TWO 
 
16.9 STRUCTURED CLINICAL INTERVIEW FOR DSM 1V (SCID) 
 
 As an Urdu version of HADS was used first time in South Asians with acute 
coronary syndrome living in the United Kingdom, it was felt appropriate to 
examine its validation. For this purpose, the SCID was used in the second 
phase of assessments. 
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In the first phase of assessments, all the participants completed HADS. An 
arbitrary cut off point on HADS (≥ 17) based on our previous research (Dickens 
C et al., 2004) in a similar population was used to divide the cohort into high 
and low scorers. In the second phase, all the high scorers and a randomly 
selected one in six (1:6) of the low scorers were administered semi-structured 
interview by the researcher; Structured Clinical Interview for DSM 1V (SCID).   
 
The data were weighted to account for the different sampling percentage of 
those scoring 17 or above or 16 and below on HADS. A Receiver Operating 
Characteristic (ROC) curve was then produced to find the most appropriate cut 
off point based on the combined HADS score. The ROC curve took into account 
every possible cut off point on the scale, determining sensitivity and specificity 
for each, and calculating false positive percentage (100-specificity) against the 
true positive percentage (sensitivity). An appropriate cut-off score was 
determined by keeping a balance between sensitivity and specificity. 
 
The false positive percentage was plotted on the “X” axis while the true positive 
percentage (sensitivity) was plotted on the “Y” axis. The area under curve 
(AUC) and its 95% confidence interval was calculated. 
  
The area under curve reflects the discriminating ability of the screening tool 
(HADS); the more closer it is to 1 better is the screening ability; or in other 
words it is the probability that a randomly selected case will achieve higher 
score on the HADS than a randomly selected non-case. 
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16.10 FOLLOW-UP ASSESSMENTS 
16.10.1  PSYCHO-SOCIAL ASSESSMENTS & HEALTH-RELATED 
QUALITY OF LIFE  
 
Follow-up assessment was performed at 6 months using postal questionnaires. 
The investigator rang up the participants in advance of posting the 
questionnaire as a reminder and to enhance the response rate. Participants 
completed the SF-36 and HADS as described above. Those who required help 
to complete the questionnaires were visited at home by the researcher, at a 
mutually agreed time. Some of the participants also required telephonic 
reminders to return the completed questionnaires. 
 
16.10.2 PLANNED ANALYSIS  
All un-weighted analyses were performed using Statistical Packages for the 
Social Sciences (SPSS version 16.0). Data were cleaned and screened by 
checking the frequencies of all variables to ensure that all entries were correct. 
Syntax files were prepared to calculate the physical summary scores of SF-36. 
Missing data were excluded from the Univariate analysis, but substitution of 
data was used in the hierarchical multiple regression analysis to maximise the 
inclusion of participants. All the test were considered significant at the p=0.05 
level. 
 
The baseline characteristics of the participants were described using means 
and standard deviation for continuous variables (such as age) and frequency 
(percentage) for categorical variables (such as depressed and non-depressed). 
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Pearson’s Chi Square test was used to look at the relationship of categorical 
variables. Pearson’s Product Moment Correlation was used to explore the 
relationship between pairs of continuous variables. Independent t test was 
applied to identify potential predictors of physical component scores (SF-36) at 
follow up. 
 
 Multiple regression analysis was used to measure the association of baseline 
variables with the health related quality of life. Baseline variables having a 
significant (p< 0.05) or near significant univariate associations with follow up 
PCS (SF-36), were entered as independent variables. In addition, any 
recognised risk factor for the development of coronary heart disease was 
entered into the regression analysis, irrespective of whether they were 
associated with PCS in the analyses. In regression models, independent 
variables were entered in blocks as follows; 
 
 Block 1; Socio-demographic factors 
 Block 2; Co-morbid medical conditions  
 Block 3; Psychological variables 
 
As a number of variables collected in this study were related to each other, co-
linearity diagnostics were performed. Variation Inflation Factor (VIF) and 
Tolerance were obtained for each variable. Cohen’s effect size was calculated. 
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16.11  ETHICAL IMPLICATIONS 
Prior to its commencement, the approval for the study was obtained from the 
Stockport Research and Ethics Committee. Approval was also sought from all 
the Research & Development departments of the District General Hospitals. 
Local collaborators were arranged in all hospitals. Medical teams were briefed 
about the study. 
 
All the potential participants were provided with written information about the 
study and were required to give their written consent prior to their participation. 
They were informed that they could withdraw from the study at any time and it 
would not have any impact on the clinical care. Those who could not read or did 
not want to read were provided with verbal information.  
 
The assessments were mostly by self report questionnaires or the interviews 
conducted by the researcher and as such there were no invasive procedures 
involved in this research. However, some participants were expected to get 
upset when recalling or talking about their social circumstances, which were 
dealt with by the researcher being an experienced psychiatrist.  
Their confidentiality was ensured at all stages of the project.  Data held on 
computer conformed to the Data Protection Act. 
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17 RESULTS 
17.1 DESCRIPTION OF PARTICIPANTS 
 
The medical admission and coronary care units of the Royal Blackburn 
Hospital, Blackburn; Burnley General Hospital, Burnley; Rochdale Royal 
Infirmary, Rochdale and Fairfield General Hospital, Bury were used as  
recruitment centres for this study. Of the 280 identified patients 20 (7.1%) were 
excluded; 4 were cognitively too impaired to be interviewed, 6 underwent 
surgical intervention and 10 developed acute coronary syndrome as a result of 
cardiac intervention. Of the remaining (260) eligible patients, 10 refused to 
participate while 250 (96%) gave informed consent, and completed baseline 
assessments. Figure A shows the flow of participants throughout the study. 
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Figure; A Participants recruited and assessed during the study 
 
 
Pat identified= 280 
 
Completed baseline 
assessment=250 
 
Number contacted for 
follow up = 237 
Completed follow up 
assessment =202 
 Excluded=20 
Declined=10 
Declined further 
participation=6 
 
Died before follow up =7 
Declined at follow up=20 
 
Unable to contact/moved out 
of area=15 
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Those who were excluded (20) were not significantly different from those who 
participated with regard to their age, gender, cardiac or non-cardiac co-
morbidity. Of the (250) who completed baseline assessment 6 more declined 
any further involvement; hence 244 participants were followed up. During follow 
up 7 participants died and the remaining 237 were sent follow-up 
questionnaires. A further 20 declined to complete follow up questionnaires, 
while 15 could not be contacted; either they had moved out of the area or had 
gone on long holidays back to their home country in South Asia. Thus, 202 
(81%) of the baseline participants completed follow up assessments. 
 
 
17.2 BASELINE ASSESSMENTS 
 
The participants’ demographic and current medical details are listed in table 13 
 
Two hundred and fifty (250) participants were enrolled for the study. The mean 
age of the sample was 53.71(SD 7.3). All the participants (100%) were married 
and the sample was predominantly male 179(72%).Nearly half of the 
participants 111 (44%) had 12 years or more of education, while 85 (34%) were 
un-employed. One fourth (25.2%) of the participants had family history of 
nerves while more than two thirds (78.8%) of the sample had a confirmed 
diagnosis of acute coronary syndrome. One third (38%) of the sample had 
history of heart attack. All the participants were assessed within 6 days 
(mean=2.5) of admission, and the mean duration of the cardiac illness was 4.12 
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(sd 1.53) years. Of the cohort 202 (81%) had non-cardiac co-morbid conditions; 
74 (30 %) had one, 85 (34%) had two, 32(13%) had three, 8 (3%) had four and   
3 (1.2%) had five non-cardiac illnesses. Of the cohort 43 (17%) had ≥ 3 non-
cardiac medical conditions. Amongst the common non-cardiac conditions 
were;CVD(47%),hypertension(39%),diabetes-mellitus(38%) and haematological 
disorders (28%). More than one-third of the cohort was on each of diuretics 
(38%), Calcium channel blockers (38%), and beta-blockers (36%), while 85% 
were on anti-platelet medications. Fifteen percent (n=37) of the participants 
were on anti-depressant medications. 
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Table 13 Participants demographic details (250) 
Variables   Frequency (Percentage) 
Gender 
        Male 
       Female 
 
179   (71.6%) 
71     (28.4%) 
       Age(yrs) 53.71 (7.13) 
Age range (yrs) 
        Max 
        Min 
34 
72 
38 
Marital status 
         Living with partner 
 
         Not living with partners  
 
203 (81%) 
47   (19%) 
Education  (≥ 12 yrs) 111 (44.4%) 
  Occupation 
        House wife 
        Unemployed  
        Employed 
        Retired  
 
54 (21.6%) 
85 (34%) 
63 (25.2% ) 
48(19.2 %) 
Family h/o nerves 63 (25.2%) 
History of nerves 54 (21.6%) 
Confirmation of ACS with cardiologists 198 (79.2%) 
Previous h/o heart attack 96   (38.4%) 
Assessment  day after admission  2.55 ( 0.956) 
Duration of cardiac illness (years) 4.12 ( 1.53) 
 Key; ACS; acute coronary syndrome 
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Table; 14 Participants current medical details (250) 
Variables  Frequency ( percentage) 
Beta blockers               89(35.6 %) 
Diuretics               95(38.0 %) 
A CE Inhibitors  57(22.8 %) 
A CE 11- Inhibitors 28(11.2 %) 
Calcium channel blockers                95(38.0 %) 
Nitrates ( anti-anginal)             101(40.4 %) 
Lipid Lowering drugs               104(41.6 %) 
Anti-platelet drugs                212(84.8 %) 
Anti-coagulants  33 (13.2 %) 
Anti-depressants 37 (14.8 %) 
 NCI (≥ 3) 43 (17.2%) 
Co-morbid Conditions 
Arthritis 57 (22.8%) 
Diabetes- mellitus 96 (38.4%) 
Hypertension 97 (38.8%) 
CVD (inc BP  )       118 (47.2 %) 
Respiratory disorders         37(14.8 %) 
Genito-Urinary disorders           32(12.8 %) 
Metabolic disorders (inc DM) 105 (42.0 %) 
Neurological disorders 56 (22.4 %) 
GIT disorders 37 (14.8 %) 
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Haematological disorders 69 (27.6 %) 
Other(non-cardiac) illnesses 53 (21.2 %) 
Key; NCI non-cardiac illness; CVD cardiovascular disorder 
 
Table 15 highlights the psychological status of the participants. One third (74) of 
the sample was depressed while a higher proportion of the females (38%) were 
depressed (HADS ≥17). The sample had a mean ESSI score of 2.7 (sd 0.6), 
mean HADS depression score of 5.5 (SD 3.8) and mean HADS anxiety score of 
5.4 (SD 4.1) at baseline. The combined HADS score of the cohort was 10.9 
(6.8) while the mean SF-36 physical component score was 44.5 (SD 8.1).  One 
fifth of the sample (n=48, 19%) was lost to follow up while 202 (81%) were 
followed up after 6 months.  
 
Table 15; Baseline psychological and health related questionnaires (250) 
Variables Mean(SD)  Frequency (percentage) 
  
 Physical component score (SF-36) 
 
44.54(8.08) 
HADS sub-scales 
      HADS   Anxiety score 
      HADS  Depression score 
      HADS   score (Total) 
 
 
 
5.40(4.07) 
5.52(3.76) 
10.92(6.78) 
Depression status 
        HADS   ≥ 17 
         HADS   < 17 
 
74   (29.6%) 
176 (70.4%) 
Gender & Depression status 
 Depressed male      (HADS ≥ 17) 
 
47   (26.3%) 
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Depressed female  (HADS ≥ 17) 27   (38.0%) 
ESSI score (total) 2.7( 0.6) 
 Follow up 
Lost to follow-up 
Completed follow-up 
 
48 (19.2%) 
202 (80.8%) 
 
 
17.2.1 DEFINING THE DEPRESSED AND NON-DEPRESSED PARTICIPANTS 
 
The following histograms (Figures B, C, D) highlight the distribution of HADS 
anxiety, HADS depression and total HADS scores of the sample, as assessed 
using the Hospital Anxiety and Depression Scale (HADS). The participants 
scored on the HADS depression scale from 0 to 15, on the HADS anxiety scale 
from 0 to 19 and on the combined HADS score from 0 to 26.  
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 Table 16,17 &18 highlight the comparison of the depressed and non-depressed 
participants.  
 
Table 16 highlights the comparison of the demographic and medical features of 
the depressed and non-depressed participants. Seventy-four (30%) participants 
were depressed (≥ 17 HADS) while 176 (70%) were not depressed at the 
baseline. A higher proportion of the female participants were depressed (36% 
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vs. 25%) compared to the males (64% vs. 75%) and it was not significant (χ2, 
3.38 p=0.09). House-wives were significantly more likely to be depressed 
(χ2=9.21, p=0.002) compared to others. There was significantly lower 
proportion of employed participants in the depressed than in the non-depressed 
group (χ2=3.41 p=0.034).The depressed group was significantly younger (51.0 
vs. 54.8) than the non-depressed group (p<0.005). The depressed participants 
were assessed significantly earlier in the hospital than the non-depressed 
participants (2.32 vs. 2.65 days; p=0.01) and they had longer history of duration 
of cardiac illness than the non-depressed participants (p < 0.05). Those who 
had education less than 12 years, were more likely to be depressed than those 
who were more educated for ≥ 12 years (χ2=7.55, p= 0.006). Similarly 
participants having a family history of nerves (n=25, 34%) were also more likely 
to be depressed compared to the non-depressed (p=0.04). However there was 
no significant difference between the depressed (n=16, 22 %) and non-
depressed group (n=38, 22%) with regard to history of nerves (p=0.9) or the use 
of anti-depressant medications (p= 0.49). Almost a similar proportion of the 
depressed and non-depressed participants had the confirmation of cardiac 
diagnosis with local cardiologist (76% vs. 81%, P= 0.39). There was no 
significant difference between the depressed and non-depressed participants in 
regard to the history of heart attack (40% vs. 37%; p=0.67 ). 
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Table 16; Demographic and medical history of depressed & non-depressed   
participants  
Baseline Variables Depressed (n= 74) 
  No (%) 
Non-depressed 
(n=176) No (%) 
Significance 
p= value 
Gender 
       Female 
       Male 
 
27 (36%) 
47 (64%) 
 
44   (25%) 
132 (75%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.04 ( 5.21) 54.83 ( 7.53) p= 0.001 
Assessment days-after 
admission 
2.32 (0.89) 2.65( 0.96) p = 0.01 
Duration of cardiac 
illness 
5.33 ( 1.59) 3.62(1.20) p < 0.001 
 Living with spouse 
            Yes 
            No 
 
58 (78.4%) 
16 (21.6%) 
 
145 (82.4%) 
3 1    (17.6%) 
 
p= 0.45 
 
House wife 
            Yes 
             Others          
 
25 (33.8%) 
49 (66.2%) 
 
29   (16.5%) 
147 (83.5%) 
 
χ2 = 9.21 
p= 0.002 
Employed 
              Yes 
              Others 
 
12 (16.2%) 
62(83.8%) 
 
51 (29%) 
125 (71%) 
 
χ2 =4.50, 
 p= 0.034 
Un-employed 
              Yes 
              Others  
 
22(29.7%) 
52(70.3%) 
 
63(35.8%) 
113(64.2%) 
 
 p= 0.35 
Retired 
             Yes 
             Others  
 
15 (20.3%) 
59 (79.7%) 
 
33 (19%) 
143 (81%) 
 
p=0.86 
Education   (> 12 yrs)           
          Yes 
           No 
 
23 (31.1%) 
51 (68.9%) 
 
88 (50%) 
88 (50%)  
 
χ2=7.55 
p = 0.006 
Family h/o nerves 
        Yes 
 
25 (33.8%) 
 
38   (21.6%) 
 
χ2= 4.10 
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        No 49 (66.2%) 138 (78.4%) p = 0.04 
History of nerves 
       Yes 
        No 
 
16 (22 %) 
58 (78%) 
 
38 (21.6%) 
138 (78.4%) 
 
p= 0.9 
Confirmation of the ACS         
          Yes 
           No 
56 (75.7%) 
18 (24.3%) 
 
142 (80.7%) 
 34   (19.3%) 
 
p= 0.39 
History of heart attack 
         Yes 
          No 
 
30 (40 %) 
44 (60 %) 
 
66 (37 %) 
110 (63 %) 
 
p= 0.67 
Anti-depressants         
Yes 
         No 
 
9 (12.2%) 
63 (87.8%) 
 
28 (15.9%) 
148 (84.1%) 
 
p=0.49 
 
 
Table 17 &18 compare the medical variables of the depressed and non-
depressed groups. There was no significant difference in the use of cardiac or 
non-cardiac medications between the depressed and non-depressed groups. 
Participants who were depressed at baseline were more likely to have a 
diagnosis of diabetes mellitus compared to those who were not depressed (51 
% vs. 33%; p=0.006). Similarly a higher proportion of the depressed participants 
had cardiovascular (57% vs. 43%, p=0.05) and respiratory disorders than those 
who were not depressed (23% vs. 11%; P< 0.05).  There was also a statistically 
significant difference between the depressed and non-depressed groups with 
regard to haematological disorders (58 % vs. 15%; p< 0.05) and “other” non-
cardiac illnesses (42% vs. 13%; p< 0.05). 
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Although a different proportion of the depressed (n=19,26%) and non-
depressed (n=38, 22%) suffered from arthritis, it was not significant (p= 0.51). A 
higher proportion of the depressed participants had ≥ 3 non-cardiac pathologies 
than the non-depressed participants, and this difference was statistically 
significant (χ2=23.74, p< 0.001). 
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Table 17 Baseline cardiac & non-cardiac medications  of the depressed and 
non-depressed participants  
Baseline Variables Depressed(n=74) 
 N (%) 
Non-depressed 
(n=176) N (%)  
Significance 
P value 
Beta blockers 
         Yes 
         No 
 
29 (39.2%) 
45 (60.8%) 
 
60   (34.1%) 
116 (65.9%) 
 
 
p= 0.44 
Diuretics 
         Yes 
          No 
 
30 (40.5%) 
44 (59.5%) 
 
65 (36.9%) 
111 (63.1%) 
 
p= 0.59 
ACE Inhibitor 
 Yes 
 No 
 
18 (24.3%) 
56 (75.7%) 
 
39 (22.2%) 
137 (77.8%) 
 
p= 0.71 
Calcium channel blockers 
 Yes 
            No 
 
24 (32.4%) 
50 (67.6%) 
 
71 (40.3%) 
105 (59.7%) 
 
χ2= 1.38 
p= 0.24 
Nitrates 
          Yes 
         No 
 
32 (43.2%) 
42 (56.8%) 
 
69 (39.2%) 
107 (60.8%) 
 
p= 0.55 
A-11 CE inhibitor 
        Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
18 (10.2%) 
158 (89.8%) 
 
 
p= 0.45 
Lipid Lowering drugs 
         Yes 
          No 
 
31 (41.9%) 
43 (58.1%) 
 
73 (41.5%) 
103 (58.5%) 
 
p= 0.9 
Anti-platelets 
         Yes 
          No 
 
60 (81.1%) 
14 (18.9%) 
 
152 (86.4%) 
24 (13.6%) 
 
p= 0.28 
Anti-coagulants 
          Yes 
          No 
 
10 (13.5%) 
64 (86.5%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.92 
Anti-depressants  
        Yes 
         No 
 
9 (12.5%) 
63 (87.5%) 
 
28 (16%) 
148 (84%) 
 
p= 0.56 
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Table 18; Co-morbidity of the depressed & non-depressed participants  
Variables Depressed(n= 74) 
 n (%) 
Non-depressed 
(n=176) or (%) 
Significance 
p= value 
Arthritis 
       Yes 
        No 
 
19 (25.7%) 
55 (74.3%) 
 
38 (21.6%) 
138 (78.4%) 
 
 
p = 0.51 
 Diabetes-mellitus 
        Yes 
        No 
 
38(51.4%) 
36(48.6%) 
 
58(32.9%) 
118(67.1%) 
 
p= 0.006 
χ2 = 7.45 
 
  Hypertension 
        Yes 
        No 
 
30 (40.5%) 
44 (59.5%) 
 
67 (38.1%) 
109 (61.9%) 
 
 
p= 0.777 
Cardiovascular disorders 
        Yes  
        No 
 
42 (56.8%) 
32 (43.2%) 
 
76 (43.2%) 
100 (56.8%) 
 
χ2 = 3.85 
p = 0.05 
Respiratory disorders 
       Yes 
        No 
 
17 (23.0%) 
57 (77.0%) 
 
20 (11.4%) 
156 (88.6%) 
 
χ2= 5.56 
p = 0.01 
Genito-Urinary disorders 
        Yes 
         No 
 
9 (12.2%) 
65 (87.8%) 
 
23 (13.1%) 
153 (86.9%) 
 
p= 0.81 
Metabolic disorders 
        Yes 
        No 
 
40 (54.1%) 
34 (45.9%) 
 
 (65) (36.93 %)  
 (111) (63.06%) 
 
χ2= 6.270 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
22 (29.7%) 
52 (70.3%) 
 
34 (19.3%) 
142 (80.7%) 
 
p = 0.07 
χ2= 3.24 
GI T disorders 
       Yes 
        No 
 
10 (13.5%) 
64 (86.5%) 
 
27 (15.3%) 
149 (84.7%) 
 
p = 0.84 
Haematological disorders 
       Yes 
 
43 (58.1%) 
 
26 (14.8%) 
 
χ2= 48.9 
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        No 31 (41.9%) 150 (85.2%) p < 0.05 
Others NCI 
       Yes 
       No 
 
31 (41.9%) 
43 (58.1%) 
 
22 (12.5%) 
154 (87.5%) 
 
χ2= 27 
p < 0.05 
    NCI(≥ 3) 
         Yes 
         No 
 
26(35%) 
48(65%) 
 
17 (10%) 
159(90%) 
 
χ2= 23.74 
p < 0.001 
Key; NCI non-cardiac illness 
 
Table 19 highlights comparison of psychological status, ESSI and PCS scores 
in the depressed and non-depressed groups. Participants who were depressed 
(≥17 HADS) had significantly lower PCS scores (40.46, SD 6.68) than the non-
depressed (46.28, SD 8.02) (p < 0.005). Similarly PCS sub-scales scores of the 
depressed group were lower than the non-depressed group; physical function 
64.61 vs. 74.42; role limitation (physical) 48.65 vs. 65.20; pain 58.26 vs. 64.39; 
health perception 33.01 vs. 52.00). HADS depression scores (9.08, SD 2.87) 
was higher in the depressed than the non-depressed (4.02, SD 3.02) group. 
Similarly HADS anxiety scores (10.1, SD 2.78) were higher in the depressed 
than the non-depressed (3.42 SD 2.65) group.  ESSI scores was lower for the 
depressed (mean 2.56) than the non-depressed (mean 2.77) group. The 
number of those who were lost to follow up was similar in the depressed (n= 15, 
20%) and the non-depressed (n= 33, 19%) groups. 
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Table 19 Comparison of psychological variables of the depressed and non-
depressed participants  
Baseline Variables Depressed ( n= 74) 
Mean (SD)  
Non-depressed 
(n=176) Mean 
(SD)  
Significance 
P value 
HADS  
  Anxiety score               
  Depression score    
Total (HADS) score 
 
10.10 (2.78) 
9.08   (2.87) 
19.17 ( 2.32) 
 
3.42(2.65) 
4.02(3.02) 
7.45(4.7)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                     2.56(0.58) 2.77(0.62) p= 0.01 
 PCS scores  40.46(6.68) 46.26(8.02) p < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61 (5.92) 
 
74.42 (7.61) 
 
p < 0.001 
Role limitation 
Physical Pain 
48.65 ( 50.32) 
58.26 ( 20.13) 
65.20 (47.65) 
64.39 (19.01) 
p= 0.01 
p < 0.001 
    
Health perception 33.01 ( 9.70) 52.00 (16.90) p < 0.001 
 
17.2.2 VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
In the first phase a total of 250 participants completed HADS. Based on our cut 
off point of 17 or more, 74 were classed as high scorers while 176 were classed 
as low scorers. In the second phase 103 participants were administered SCID; 
all 74 of the high scorers (≥ 17 HADS) and a randomly selected 29 from the low 
scorers (< 17 HADS). In all 56 of these (103) participants fulfilled the DSM VI 
criteria for depression.  
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Table 20 highlights the number of true/false positive and true/false negatives, 
sensitivity and specificity for each cut off point on the HADS scores. 
 
The area under curve (AUC) in our sample was 0.894 and the best cut-off point 
was ≥ 17; having a sensitivity of 82% and specificity of 89%. At this cut-off point 
HADS negative predictive value (NPV) was 93.1% while positive predictive 
value (PPV) was 73%. Therefore, the participants who scored ≥ 17 HADS, were 
classified as depressed and those who scored < 17 HADS, were classified as 
non-depressed in this thesis. 
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Figure, E; ROC curve HADS total score and SCID 
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Table 20; ROC curve statistics for Hospital Anxiety and Depression Scale   
HADS 
Cut-off  
Point 
Specificity 
% 
Sensitivity % True 
positive 
False 
positive 
True 
negatives 
False-
negative 
Participants 
2 
6 
8 
9 
10 
11 
12 
14 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
16.5 
19.8 
36.3 
49.5 
52.7 
62.6 
65.9 
75.8 
79.1 
89.0 
91.8 
95.6 
97.8 
98.4 
98.4 
98.4 
88.9 
98.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
90.9 
90.9 
81.8 
81.8 
81.8 
60.6 
39.4 
31.8 
19.7 
13.6 
7.6 
6.1 
3.3 
1.5 
56 
56 
56 
56 
56 
55 
55 
54 
54 
54 
40 
26 
21 
13 
9 
5 
4 
2 
1 
42 
41 
36 
32 
31 
28 
27 
24 
23 
20 
15 
8 
4 
3 
3 
3 
2 
2 
0 
5 
6 
11 
15 
16 
19 
20 
23 
24 
27 
32 
39 
43 
44 
44 
44 
45 
45 
47 
0 
0 
0 
0 
0 
1 
1 
2 
2 
2 
16 
30 
35 
33 
47 
51 
52 
54 
55 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
103 
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17.2.3 FACTORS ASSOCIATED WITH DEPRESSION (≥ HADS) 
 
The following table (21) shows the logistic regression to examine the baseline 
variables associated with depression status of the participants.  Females were 
2.7 times more likely to be depressed (≥ 17 HADS) than the males, but it was 
not statistically significant (p=0.09). Similarly as the age of the participants 
increased, the risk of depression (≥17HADS) was reduced significantly 
(p=0.005). Being a house-wife was associated with increased risk of depression 
(OR 2.73, p=0.136) compared to non-house wife but was not statistically 
significant. Those having high social support (high ESSI scores) were 
significantly less likely to be depressed (OR 0.33, CI; 0.16-0.72; p=0.005) than 
those having less social support. Those having haematological disorders were 
9.5 times more likely to be depressed than those without it (95% CI 3.57- 24.46; 
p<0.001). Similarly those having high PCS scores were at lower risk of 
depression than those with low PCS scores and it was statistically significant 
(OR 0.92, 95% CI; 0.86-0.98; p= 0.01). 
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Table 21; Logistic regression to examine the association of baseline variables 
and depression (≥ 17 HADS) 
Variables Odds 
Ratio 
95 % CI for Odds Ratio  
Significance Lower Upper 
Gender 2.728 0.829  8.973 p= 0.09 
Age  0.841 0.774 0.913 p= 0.005 
Assessment day 0.853 0.537 1.356 p=0.501 
Duration of illness 2.722 1.874 3.952 p=0.005 
House wife  2.739 0.729 10.297 p= 0.136 
Retired 1.249 0.373 4.182 p= 0.719 
Employed 0.846 0.225 3.177 p=0.804 
ESSI  Score 0.338 0.159 0.721 p= 0.005  
Education (≥ 12 yrs) 0.417 0.157 1.106 p= 0.079 
Living with spouse 0.605 0.176 2.083 p= 0.426 
Family h/o nerves 1.237 0.437 3.500 p= 0.689 
Diabetes-mellitus 1.181 0.456 3.054 p= 0.732 
CVD 1.374 0.549 3.441 p= 0.497 
Haematological 
disorders 
9.530 3.573 24.469 p= 0.005 
Neurological disorders 1.415 0.491 4.076 p= 0.521 
PCS baseline(SF-36) 0.925 0.866 0.986 p= 0.018 
Respiratory disorders 3.075 1.044 9.057 p=0.042 
 
Key; CI; confidence interval, CVD cardiovascular disorders 
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17.3 FOLLOW UP 
17.3.1 COMPARISON OF THOSE WHO WERE LOST TO FOLLOW UP AND 
THOSE WHO COMPLETED FOLLOW UP  
 
Participants who completed follow up (202) did not differ significantly from those 
who did not complete the follow up (48) assessment with regard to their age, 
gender, education or marital status. There was no significant difference in these 
groups with regard to the proportion of depressed participants or those being on 
anti-depressant medications. Those completing follow up were had significantly 
higher baseline PCS scores (45.76 vs. 39.44), higher ESSI scores (2.73 vs. 
2.61) and higher number of CVD (49% vs. 39%) than those who were lost to 
follow up.  
 
A higher proportion of the retired participants were lost to follow up than those 
who were followed up (46% vs. 13%; χ2=27.16, p< 0.001). A higher proportion 
those who were lost to follow up had previous history of heart attack (50% vs. 
36%) and haematological disorders (40% vs. 25%) compared to those who 
completed follow up.  
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17.3.2 DESCRIPTIVE STATISTICS OF THOSE WHO COMPLETED FOLLOW 
UP (202) 
 
The following analysis is based on data from the 202 (81%) who completed the 
6 months follow up. Tables (22 &23) show the demographic, medical and 
psychological characteristics of the participants who completed the 6 month 
follow up assessment. 
 
Table; 22 Demographic characteristics and medical details of participants who 
completed 6 months follow up (202) 
 
Variables  Frequency (%),Mean(SD) 
    Gender 
     Male 
    Female 
 
145 (72%) 
  57 (28%) 
  Age (years)  53.67 (7.0) 
  Age range (years) 
      Max 
      Min 
  34 
  72 
  38 
 
 Living with  spouse      
 
161 (79.7%) 
   Education (≥ 12 years)       115 (56.9%) 
Occupation 
         House Wife 
         Employed  
         Unemployed 
 
43 (21.28%)        
59 (29.2%) 
74 (36.6 %) 
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         Retired 26 (13%) 
Family history of  nerves 56 (28%) 
History of nerves 44 (21.8%) 
Confirmation of ACS 192 (95.0%) 
History of heart attack 72 (35.6%) 
Days baseline assessment conducted 2.58 ( 0.9) 
Duration of cardiac illness (years) 4.10 (1.5) 
Key; ACS, acute coronary syndrome 
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 Table; 23 Baseline psychological details of participants who completed 6 
months follow up (202) 
 
Baseline Variables Mean (SD) Frequency (%) 
HADS depression score 5.75   ( 3.47) 
HADS anxiety score 5.57   (3.88) 
Combined HADS score 11.34 (6.06) 
 Depressed  (HADS  ≥ 17) participants                                        59 (29.2%) 
 Non-depressed ( HADS < 17) participants                                 143 (70.8%) 
 Age of depressed (HADS ≥ 17)  participants                          50.9    (5.1) 
 Age of non-depressed( HADS < 17) participants                     54.7 (3.7) 
 Depressed   (HADS ≥ 17) Females                                                21 (36.8%) 
 Depressed  (HADS ≥ 17) Males                                   38    (26.6%) 
ESSI scores (total) 2.73 ( 0.5) 
SF-36 (PCS) 45.76 ( 8.0) 
PCS scores  of  the depressed participants 39.03 ( 6.4) 
PCS scores  of the non-depressed  participants 48.53 (6.9) 
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17.3.3 COMPARISON OF THE DEPRESSED (59) AND NON-DEPRESSED 
(143) PARTICIPANTS 
 
The following analysis is based on those (202) who completed 6 months follow 
up. The table numbers (24,25,26 &27) show the comparison of the depressed 
(HADS ≥ 17) and non-depressed (HADS < 17) participants at baseline. Females 
(χ2= 3.38, p=0.09), being a house wife (χ2=4.23, p=0.04), younger age 
(p=0.001), lesser education (χ2=15.04, p =0.001), lesser employment (χ2 = 
6.05, p=0.014), being retired (χ2= 8.76, p=0.003) and longer duration of cardiac 
illness (p<0.001) were associated with depression. Except gender these 
associations were statistically significant. Moreover diabetes-mellitus (χ2=6.21, 
p=0.013), respiratory disorders (χ2=6.79, p=0.009), haematological disorders 
(χ2=48.35, p< 0.005) and other (non-cardiac) illnesses (χ2=22.11,p<0.005) 
were strongly associated with depression. Similarly the depressed group scored 
lower than the non-depressed on a number of variables including; ESSI scores 
(2.57 vs. 2.79;p=0.01), PCS total scores (39.03 vs. 48.53; p < 0.001), PCS 
subscales; physical functioning (64.61 vs 74.42; p< 0.001), role limitations 
(48.65 vs. 65.20; p= 0.01), pain (58.26 vs. 64.39; p < 0.001) and general Health 
(33.01 vs. 52; p< 0.001); and these differences were statistically significant.  
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Table 24 Comparison of the demographic and medical variables of the 
depressed and non-depressed participants (202) 
Variables Depressed (n=59) n 
(%) 
Non-depressed (n=143) 
n (%) 
Significance 
P= value 
Gender 
       Female 
       Male 
 
21 (35.6%) 
38 (64.4%) 
 
 36  (25.2%) 
107 (74.8%) 
 
p= 0.09 
χ2= 3.38 
Age (years) 51.0 ( 5.2) 54.8 ( 7.5) p= 0.001 
Assessment -after 
admission (days) 
2.32 (0.8) 2.65( 0.9) p = 0.01 
Duration of cardiac 
illness 
5.3 ( 1.5) 3.6(1.2) p < 0.001 
Living with spouse 
           Yes 
            No 
 
47 (79.7%) 
12 (20.3%) 
 
114 (79.7 %) 
29    (20.3%) 
 
p= 0.992 
 
House wife 
           Yes 
           Others          
 
18 (30.5%) 
41 (69.5%) 
 
25   (17.5%) 
118 (82.5%) 
 
χ2= 4.23 
 p= 0.04 
Employed 
          Yes 
          Others 
 
10 (16.9%) 
49(83.1%) 
 
49 (34.3%) 
94 (65.7%) 
 
χ2 = 6.05  
p= 0.014 
Un-employed 
              Yes 
              Others  
 
17(28.8%) 
42(71.2%) 
 
57(39.9%) 
86(60.0%) 
 
 p= 0.355 
Retired 
             Yes 
             Others  
 
14 (23.7 %) 
45 (76.3 %) 
 
12 (8.4%) 
131 (91.6 %) 
 
χ2= 8.76  
p= 0.003 
Education(≥ 12 yr)  
           Yes 
           No 
 
13 (22.0%) 
46 (78.0%) 
 
74 (51.7%) 
69 (48.3%)  
 
χ2=15.04, 
 p = 0.001 
Family H/O nerves    
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        Yes 
        No 
17 (28.8%) 
42 (71.2%) 
30   (21.0%) 
113 (79.0%) 
χ2= 1.436 
p = 0.231 
History of nerves 
       Yes 
        No 
 
13 (22.0 %) 
46 (78.0%) 
 
31 (21.7%) 
112 (78.3%) 
 
p= 0.956 
H/o heart attack 
         Yes 
          No 
 
22 (37.3 %) 
37 (62.7 %) 
 
50 (35.0 %) 
93 (65.0 %) 
 
 
p= 0.754 
Anti-depressants 
         Yes 
         No 
 
6 (12.2%) 
53 (87.8%) 
 
24 (15.9%) 
119 (84.1%) 
 
p = 0.49 
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Table 25; Comparison of the medical variables (medications) of the depressed 
and non depressed participants  
Baseline 
Medications  
Depressed ( n=59) 
 n (%) 
Non-depressed (n=143) 
 n (%)  
Significance 
P value 
Beta blockers 
        Yes 
         No 
 
22 (37.3%) 
37 (62.7%) 
 
48   (33.6%) 
95 (66.4%) 
 
 
p= 0.61 
Diuretics 
         Yes 
          No 
 
25 (42.4%) 
34 (57.6%) 
 
52 (36.4%) 
91(63.6%) 
 
p= 0.42 
ACE inhibitor 
        Yes 
        No 
 
13 (22.0%) 
46 (78.0%) 
 
35 (24.5%) 
108 (75.5%) 
 
p= 0.71 
Calcium channel 
blockers 
         Yes 
          No 
 
 
20 (33.9%) 
39 (66.1%) 
 
 
65 (45.5%) 
78 (54.5%) 
 
 
χ2= 2.28 
p= 0.130 
Nitrates 
          Yes 
         No 
 
27 (45.8%) 
32(54.2%) 
 
57 (39.9%) 
86 (60.1%) 
 
p= 0.43 
ACE-11  inhibitor 
        Yes 
          No 
 
10 (16.9%) 
49 (83.1%) 
 
14 (9.8%) 
129 (90.2%) 
 
 
p= 0.15 
Lipid lowering drugs 
        Yes 
         No 
 
24 (40.7%) 
35 (59.3%) 
 
58 (40.6%) 
85 (59.4%) 
 
p= 0.98 
Anti-platelets 
         Yes 
          No 
 
49 (83.1%) 
10 (16.9%) 
 
124 (86.7%) 
19 (13.3%) 
 
p= 0.5 
Anti-coagulants    
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Table 26; Comparison of the medical co-morbidity of the depressed and non 
depressed participants  
          Yes 
          No 
7 (11.9%) 
52(88.1%) 
21 (14.7%) 
122 (85.3%) 
p= 0.59 
Anti-depressants  
        Yes 
        No 
 
6(10.2%) 
53(89.8%) 
 
24(16.8%) 
119(83.2%) 
 
χ2=1.44 
p= 0.22 
Variables Depressed (n= 59) 
 n (%) 
Non-Depressed 
(n=143) n (%) 
Significance 
P= value 
Arthritis 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
30(21.0%) 
113 (79.0%) 
 
 
Pp= 0.49 
 Diabetes-mellitus 
        Yes 
        No 
 
30(50.8%) 
29(49.2%) 
 
46(32.2%) 
97(67.8%) 
 
χ2 = 6.21 
 p= 0.013 
  Hypertension 
        Yes 
        No 
 
24 (40.7%) 
35 (59.3%) 
 
59 (41.3%) 
84 (58.7%) 
 
 
p= 0.939 
      CVD 
        Yes  
        No 
 
34 (57.6%) 
25 (42.4%) 
 
65 (45.5%) 
78 (54.5%) 
 
χ2 = 2.47 
 p = 0.11 
Respiratory disorders 
       Yes 
        No 
 
14 (23.7%) 
45 (76.4%) 
 
14 (9.4%) 
129 (90.2%) 
 
χ2= 6.79,  
p= 0.009 
Genito-Urinary disorders 
        Yes 
 
8 (13.6%) 
 
19 (13.3%) 
 
p= 0.95 
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Key; NCI, non-cardiac illness;CVD, cardiovascular disorders 
         No 51 (86.4%) 124 (86.7%) 
Metabolic disorders 
        Yes 
        No 
 
32 (54.2%) 
27 (45.8%) 
 
 51 (35.7%)  
92 (64.3%) 
 
χ2= 5.95 
p= 0.01 
Neurological disorders 
       Yes 
        No 
 
15 (25.4%) 
44 (74.6%) 
 
28 (19.6%) 
115 (80.4%) 
 
p= 0.35 
 
GI T disorders 
       Yes 
        No 
 
7 (11.9%) 
52 (88.1%) 
 
21 (14.7%) 
122 (85.3%) 
 
p= 0.59 
Haematological disorders 
       Yes 
        No 
 
34 (57.6%) 
25 (42.4%) 
 
16 (11.2%) 
127 (88.8%) 
 
χ2=48.35,  
p < 0.005 
NCI (≥3) 
         Yes 
         No 
 
21(35.6%) 
38(64.4%) 
 
15 (10.5%) 
128(89.5%) 
 
χ2= 23.74 
p < 0.001 
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Table  27; Comparison of the psychological variables of the depressed and non- 
depressed participants 
 
 
 
 
 
 
 
 
 
 
Variables Depressed ( n= 59) 
Mean (SD)  
Non-depressed 
(n=143) Mean (SD)  
Significance 
P value 
 
HADS Anxiety score  
HADS Depression score 
 HADS  total score 
 
10.00 (2.94) 
8.81   (2.96) 
18.81( 2.04) 
 
3.75(2.52) 
4.49(2.84) 
8.26(4.19)  
 
p < 0.001 
p < 0.001 
p < 0.001 
ESSI score                                   2.57(0.57) 2.79(0.58) p = 0.01 
 PCS score 39.03(6.44) 48.53(6.90) P < 0.001 
Sub-scales of PCS    
Physical functions 
 
64.61(5.92) 
 
74.42 (7.61) 
 
P < 0.001 
Role limitation (physical) 48.65( 50.32) 65.20 (47.65) P= 0.01 
 Pain 58.26 ( 20.13) 64.39 (19.01) P < 0.001 
Health perception 33.01 ( 9.70) 52.00 (16.90) P < 0.001 
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17.3.4  UNI-VARIATE ANALYSIS (202) 
This section examines the prospective relationships between baseline 
demographic, medical, social and psychological variables and the 6 months SF-
36 Physical Component Scores. The following tables (28 &29) show the 
association of baseline demographic, medical and psychological variables with 
outcome measure (PCS). 
 
Outcome PCS scores (SF-36) were significantly lower for those who were 
educated less than 12 years (t=2.93, p=0.004) and were retired (t=1.91,p= 
0.05).Those having respiratory disorders(32.17vs.35.13,p=0.01) haematological 
disorders (32.02 vs. 35.61 p=0.005), diabetes-mellitus (33.37 vs. 35.53 p= 
0.009) or “others” non-cardiac disorders (37.91 vs. 43.79 p= 0.005) were more 
likely to have poor quality of life (lower PCS scores) compared to those not 
having the respective disorders. Similarly baseline depression (HADS ≥ 17) was 
significantly associated with follow up PCS scores (28.63 vs. 37.23; t=13.42, 
p<0.005). However baseline social support (ESSI) was having weak correlation 
with follow up PCS (r=0.07, p=0.319).  Baseline PCS scores were strongly 
associated with follow up PCS (r =0.34, p< 0.005). 
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Table 28 Demographic and medical variables associated with the PCS.  
Baseline variable PCS Mean (Sd)  t- value   Significance (p) 
Gender  
      Female 
      Male 
 
34.34(5.61) 
34.87(5.74) 
 
0.585 
 
p= 0.559 
Living with partner 
      Yes 
      No 
 
34.74(5.76) 
34.64(5.49) 
 
 
0.1 
 
 
p=0.921 
Education(≥ 12 yr) 
     Yes 
     No 
 
36.05(5.05) 
33.71(5.96) 
 
 
2.93 
 
 
p= 0.004 
House wife 
    Yes 
    No 
 
33.57(5.89) 
35.03(5.62) 
 
1.588 
 
 
p= 0.136 
 
Unemployed 
    Yes 
    Others 
 
35.27(5.83) 
34.40(5.61) 
 
0.59 
 
p= 0.301 
Retired 
   Yes 
    Others  
 
32.74(4.93) 
35.01(5.75) 
 
1.91 
 
p= 0.05 
 Employed 
   Yes 
    Others 
 
35.75(5.46) 
34.30(5.75) 
 
2.15 
 
p= 0.100 
Family h/o nerves 
    Yes 
    No 
 
41.01(9.30) 
43.00(9.12) 
 
 
1.309 
 
 
p= 0.192 
History of nerves 
     Yes 
     No 
 
41.44(9.23) 
42.84(9.17) 
 
 
0.896 
 
 
p= 0.371 
H/O heart attack 
     Yes 
      No 
 
42.60(10.02) 
42.45(8.84) 
 
0.108 
 
p= 0.914 
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Table 29; Relationship between baseline medical, psychological variables and 
follow up PCS (SF 36) 
 
Baseline variable PCS Mean (sd)  t value  Significance (p 
value) 
Anti-depressants 
  Yes 
  No 
 
35.92(5.34) 
34.51(5.74) 
 
1.255 
 
p= 0.211 
Anti-platelets 
  Yes 
  No 
 
34.83(5.80) 
33.98(5.41) 
 
0.724 
 
p= 0.470 
ACE inhibitors 
  Yes 
  No 
 
34.87(5.73) 
34.66(5.73) 
 
0.218 
 
p= 0.828 
Beta blockers 
  Yes 
  No 
 
34.37 ( 5.59) 
34.97( 5.74) 
 
0.705 
 
p= 0.482 
Anti-cholesterol drugs 
   Yes 
   No 
 
35.03(5.55) 
34.51(5.80) 
 
0.630 
 
p= 0.529 
Diuretics 
   Yes 
   No 
 
34.54(5.55) 
34.83(5.80) 
 
0.348 
 
p= 0.728 
ACE-11- inhibitors 
   Yes 
   No 
 
33.20(6.13) 
34.92(5.62) 
 
1.39 
 
p= 0.165 
 Calcium channel blockers 
   Yes 
   No 
 
35.62(6.02) 
34.06(5.73) 
 
1.93 
 
p= 0.05 
Nitrates (anti-anginal ) 
   Yes 
   No 
 
35.07(5.90) 
34.47(5.55) 
 
0.738 
 
p= 0.461 
Diabetes- mellitus 
  Yes 
  No 
 
33.37(5.25) 
35.53(5.82) 
 
2.64 
 
p= 0.009 
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Respiratory disorders 
  Yes 
  No 
 
32.17(5.55) 
35.13(5.62) 
 
2.59 
 
p= 0.01 
Neurological disorders 
   Yes 
   No 
 
34.80(6.35) 
34.70(5.53) 
 
0.10 
 
p= 0.921 
Haematological disorders 
  Yes 
  No 
 
32.92(6.30) 
35.61(5.21) 
 
3.997 
 
P= 0.005 
Arthritis 
   Yes 
   No 
 
33.46(5.20) 
35.08(5.79 
 
1.69 
 
p= 0.09 
Genito-urinary disorders 
   Yes 
    No 
 
33.93(5.65) 
34.65(5.63) 
 
0.610 
 
p= 0.543 
Hypertension 
   Yes 
   No 
 
34.40(5.51) 
34.94(5.83) 
 
0.670 
 
p= 0.504 
CVD 
   Yes 
   No 
 
34.04(5.60) 
35.37(5.73) 
 
1.657 
 
P= 0.09 
GIT disorders 
   Yes 
    No 
 
35.72(6.12) 
34.56(5.62) 
 
1.004 
 
p= 0.316 
 Other(non-cardiac) illnesses 
   Yes 
    No  
 
37.91(10.50) 
43.79(8.40) 
 
3.84 
 
 
p < 0.005 
NCI(≥ 3) 
    Yes 
    No 
 
31.86(5.38) 
35.24(5.58) 
 
3.41 
 
p= 0.001 
HADS status 
≥ 17 HADS 
< 17 HADS 
 
28.63( 2.89) 
37.23( 4.55) 
 
 
13.42 
 
 
p < 0.005 
PCS(Baseline) r= 0.34  p < 0.005 
ESSI r= 0.07  p= 0.319 
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17.3.5  MULTIVARIATE ANALYSIS 
 
Hierarchical regression techniques were used to find demographic, medical and 
psychological variables, measured at baseline having independent association 
with the SF-36 physical component scores at 6 months.   
 
As a large number of variables were assessed at baseline, those having 
significant association (p=0.05) with outcome variable (PCS) were included in 
the analysis. Moreover any additional variables which may be clinically relevant 
or were found relevant in the previous research were also added.  
 
Mean substitution was used for independent variables with missing data where 
appropriate. Co-linearity diagnostics were conducted and showed that although 
some independent variables were associated, the degree of association was 
not great enough to threaten the reliability of the regression analysis. The 
average tolerance ranged from 0.58 to 0.85 and the variance inflation factors 
(VIF) were all < 2 (Field, 2005). 
 
17.3.6 PREDICTORS OF PCS AT 6 MONTH FOLLOW UP 
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The independent variables that were associated (p=0.05) with the primary 
outcome (SF 36 PCS) were entered in regression model one in separate blocks 
as followings; 
• Block 1 for demographic variables:  education ≥ 12 yrs and retirement  
• Block 2 for medical variables: ; respiratory disorders, diabetes mellitus, 
haematological disorders and other illnesses. 
• Block 3 for psychological variables: depression (HADS total ≥ 17)  
 
Table (30) shows the linear regression model (1) testing the main hypothesis. In 
block 1 education and being retired were entered, which explained 6 percent of 
the variance. In block 2 when diabetes-mellitus, respiratory, haematological and 
“other disorders” were entered, a further 11 percent of the variance was 
explained. In the final block the depression (HADS ≥17) explained an additional 
(29%) of the variance in PCS even when the effects of education, retirement, , 
diabetes-mellitus, respiratory disorders, haematological and “other” disorders 
were statistically controlled for. Cohen effect size for depression was in the high 
range (0.70). The model also highlights that being depressed is likely to reduce 
the physical component scores by 8.7 points, on average.  
 
In the Regression Model 2(table 31) baseline PCS which had significant 
correlation with follow up PCS was included along with other demographic and 
medical variables. Depression (HADS ≥ 17) still remained a significant predictor 
of physical component scores at 6 months follow up (B, - 9.043, 95% CI -10.84 
to - 7.24, p=0.001).  
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As age (Beck E et al., 2002) and history of depression (Rumsfeld JS et al., 
2003) are reported to be associated with quality of life, these variables were 
adjusted in our regression model 3(table 32). Depression still appeared to keep 
its independent impact (B; -8.980, 95% CI; -10.40 to - 7.09; p=0.001) on the 
quality of life (PCS).  
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Table 30 Regression Model 1; Demographic and medical predictors of PCS (SF-36) at 6 months 
 
Key; CI; 95 % confidence interval of B; B, un-standardised coefficient; VIF, variance of inflation 
Independent  Adjusted R² Changes in 
adjusted R² 
 P 
value 
Independent variables B  95% CI of B p value Tolerance VIF 
Final Model          
Block1 0.061 0.061 0.001 
 
 
 
Education( ≥ 12yrs) 0.238 -1.02 to  1.50 0.711 0.85 1.17 
Retired -1.39 -1.97 to 1.69 0.881 0.88 1.13 
Block 2 0.175 0.114 0.000       
 Diabetes-mellitus -0.671 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.030 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.017 -0.54 to 2.57 0.200 0.73 1.36 
Other illness 0.098 -1.40 to  1.59 0.898 0.88 1.13 
Block 3 0.468 0.293 0.000       
 HADS ≥ 17 -8.749 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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Table 31(Regression Model 2) Predictors of PCS at 6 months after adjustment of baseline PCS 
Key; T tolerance, VIF; variation inflation factor B; Unstandardised Coefficient; CI confidence interval;NCI, non-cardiac illnesses 
 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B p value T VIF 
Final Model          
Block1 0.136 0.136 0.000 
 
 
 
Education(≥ 12 yrs) 0.286 -9.83 to  1.55 0.657 0.844 1.184 
Retired -193 -2.03 to 1.64 0.836 0.878 1.140 
Baseline PCS -0.37 -1.23 to 0.50 0.404 0.693 1.444 
Block 2 0.200 0.064 0.001       
 Diabetes-mellitus -0.717 -1.94 to 0.51 0.253 0.936 1.068 
Respiratory disorder -1.071 -2.79 to  0.65 0.223 0.937 1.067 
Haematological disorder 0.999 -0.56 to 2.56 0.209 0.734 1.363 
Other (NCI)illnesses 0.067 -1.43 to  1.56 0.931 0.881 1.134 
Block 3 0.467 0.267 0.000       
 (HADS ≥ 17) -9.043 -10.84 to -7.24 0.000 0.498 2.010 
Constant  37.31  0.001   
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Table 32 (Regression Model 3) Predictors of PCS at 6 months after adjustment of age and history of depression 
 
Key; T; tolerance, CI; Confidence interval; VIF, variation inflation factor 
 
 
 
Independent  Adjusted R² Changes in 
adjusted R² 
Significance Independent variables B  95% CI of B P value T VIF 
Final Model          
Block1 0.075 0.075 0.001 
 
 
 
Education 0.063 -1.02 to  1.50 0. 0.85 1.17 
Retired -1.36 -1.97 to 1.69 0.881 0.88 1.13 
H/O depression 0.046 0.117 to 2.912 0.034 0.978 1.022 
Age 1.515 -0.131 to 0.039 0.287 0.917 1.090 
Block 2 0.164 0.089 0.000       
 Diabetes mellitus -0.646 -1.89 to 0.55 0.282 0.94 1.06 
Respiratory disorder -1.009 -2.75 to  0.69 0.239 0.94 1.06 
Haematological 
disorder 
1.054 -0.54 to 2.57 0.200 0.73 1.36 
Block 3 0.479 0.315 0.000       
 (HADS ≥ 17) -8.980 -10.40 to -7.09 0.001 0.58 1.71 
Constant  37.31  0.001   
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18 DISCUSSION 
 
United Kingdom is a multicultural society, and this study has been conducted in 
the South Asians accounting for (4%) of the UK population. Moreover, this study 
was conducted in the North-West of the country (Manchester & Lancashire) 
where South Asians constitute the 12% - 20% of the local population. 
 
South Asians have low levels of literacy, particularly the first generation which 
migrated to the UK for financial reasons. Moreover, migration and settlement in 
a different culture has its own inherent problems. According to one theory, 
migrants are the people who were unsettled in their own country and they have 
tended to see problems in the surroundings which at times leads to paranoia; a 
potential hurdle to successful integration into a new society. Moreover, these 
migrants have generally a lower financial profile which makes them even more 
vulnerable if a life event occurs. 
 
Due to lack of education, language and cultural barrier, these people developed 
their own communities in the thickly populated area of the cities where they had 
easy access to all culturally appropriate amenities. These people have 
maintained an active contact with their families in the South Asia, which is an 
important part of their acculturation.  Larger number of people per households 
lives in the South Asian communities. Either having an unskilled or a low grade 
job (Hemingway H et al., 2001) along with social isolation from rest of the 
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community can put them at high risk of depression. Similarly, cultural beliefs 
and stigmatisation is another dimension of their psychosocial risk for 
depression.  
 
The research has shown that depression is common in this ethnic group 
(Husain, N et al., 1997; Gater, R 2001, Bhui, K et al., 2004).  
 
South Asians have a higher prevalence of ischaemic heart disease than their 
Caucasian compatriots (McKeigue, P M et al., 1989) and their admittance to 
hospitals with myocardial infarction is higher compared to their White 
counterparts (Wilkinson, P et al., 1996). The explanations for the higher 
prevalence of ischaemic heart disease in this ethnic group remains unclear, 
though a number of risk factors including diabetes-mellitus, obesity, smoking, 
hypertension and sedentary life style are well reported. The excess of 
depression among them may be, at least in part, responsible for the higher 
rates of coronary heart disease. 
 
The importance of psychosocial risk factors in South Asians has not attracted 
much research interest, to date. Yet there is evidence that current depressive 
symptoms (Barefoot JC et al., 1996), a diagnosis of clinical depression (Pratt, 
LA et al., 1996; Ford DE et al., 1998) and history of major depression (Cohen, 
et al., 2001) can predict the development of coronary heart disease in otherwise 
healthy individuals. 
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Depression also predicts poor prognosis when it develops in people with 
established ischaemic heart disease. Depression following ischaemic heart 
disease is a recognised risk factor for impaired health related quality of life 
(Ladwig KH et al., 1994; Lesperance, F et al., 2000; Lane, D et al., 2000 & 
2001; Mayou R A et al., 2000; Dickens C et al., 2006; Thombs D et al., 2008). 
The evaluation of  QoL becomes even more important when both  depression 
and ischaemic heart disease  are known for their adverse impact  on the QoL 
and this impact becomes  additive when they occur concurrently (Glassman et 
al., 2003). Furthermore due to the chronic nature of the coronary heart disease, 
and reported improvements in the medical outcomes, the health related quality 
of life becomes even more important.  
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18.1 METHODOLOGICAL STRENGTHS 
This study has a number of strengths.  
This study has been conducted in the South Asians accounting for (4%) of the 
UK population. Burnley, Blackburn, Bury, and Rochdale where this study was 
conducted even constitute the higher proportion of this ethnic group. 
 
The principal researcher and research supervisor both belonged to the same 
ethnic group. They were multi-lingual and had full awareness of the culturally 
appropriate and sensitive approaches needed for conducting research in this 
ethnic group. 
 
Before the start of the study, the nursing and medical teams of the research 
centres were briefed about the study protocol and likely duration of recruitment 
phase. Local collaborators; generally a consultant cardiologist from each 
hospital were put in place.  
 
Patients were recruited from the four District General Hospitals located in 
Burnley, Blackburn, Rochdale and Bury covering a large geographical area; 
making it well representative of the target population. 
 
A power calculation was conducted prior to the start of study to determine the 
sample size so that statistically significant results could be obtained. 
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All the possible ethical issues were examined at length before commencing the 
study. 
Appropriately translated consent forms, patient information sheets and the 
questionnaires were used to prevent exclusion because of language in this 
ethnic group. 
 
All the consecutive admissions that were aged 18 or above,  were screened to 
rule out any selection bias. Potential participants were given up to two weeks to 
become medically fit and 24 hours to make a decision about their consent to 
participate in the study. 
 
Clear inclusion and exclusion criteria were used. Those who were excluded 
were similar in their age, gender, cardiac or non cardiac morbidity to those who 
were enrolled in the study.  
 
Unlike many other researchers who recruited patients only from the CCU of the 
hospitals, this study managed to screen even those who were admitted to the 
Medial Admission Units (MAU) and those who happened to be transferred 
directly from Accident & Emergency Department to the medical wards of the 
hospitals as an overspill.  
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All patients having acute coronary syndrome were included irrespective of 
whether they had a first or subsequent attack of ischaemic heart disease. We 
covered a broad range of ischaemic heart disease compared to many other 
studies that only studied myocardial infarction.  
 
For accuracy in most cases (> 95 %) cardiac diagnosis was confirmed with local 
cardiologists. 
 
Although at times due to the shift system and frequent use of the bank staff it 
was difficult to trace a South Asian patient over phone, the study was able to 
recruit a large sample size (250) from the four general hospitals. 
 
ENRICHD Social Support Instrument (ESSI) was used for the assessment of 
social support because it is an important risk factor for depression. It becomes 
even more important when it comes to a relatively isolated community such as 
South Asians with reported psychosocial adversity.  
 
The Hospital Anxiety and Depression Scale was chosen as a screening tool for 
depression as it has been used in a number of studies on similar population and 
it excludes bodily symptoms including insomnia, fatigue and pains that might 
arise as the result of physical illness; thus falsely inflating the depression 
scores. 
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As the HADS was used first time in British South Asians suffering from IHD, it 
was validated against Structured Clinical Interview for DSM 1V (SCID) to 
determine an appropriate cut-off point on the HADS.  
 
Short Form 36, a generic measure for the quality of life was used as it is more 
sensitive to the impact of co-morbid conditions which occur more commonly in 
this population. Moreover in the light of similarities between Mental Component 
Scale (SF-36) and the Hospital Anxiety and Depression Scale items, only the 
Physical Component Scale (PCS) was taken as a primary outcome measure in 
this study.   
 
Being a prospective study (April 2007- October 2009), it carries a higher weight 
in the hierarchy of research.   
At follow up participants were given up to two reminders (telephonic or letter) if 
they failed to return the completed questionnaires within two weeks. They were 
visited personally if they failed to respond within 6 weeks or they required help 
to complete the questionnaires. 
 
Finally, we performed robust statistical analysis. Univariate and multivariate 
linear regression analyses were performed to examine the independent impact 
of depression on the quality of life.  
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18.2  SUMMARY OF MAIN FINDINGS  
 
The hypothesis of this study was that after controlling for the demographic and 
medical factors, South Asians with depression will be more likely to have poor 
health related quality of life six months after acute coronary syndrome than 
those who were not depressed. 
 
A total of 280 South Asian patients with acute coronary syndrome were 
screened, 250 (89%) were enrolled for the study during their admission to the 
District General Hospitals.  
Those who were excluded (n=20) were similar in their age, gender, cardiac or 
non cardiac morbidity to those who participated.  
Of the cohort 48(19%) were lost to follow up while 202(81%) completed 6 
months follow up. There were no significant differences between the 
participants who completed and those who were lost to follow up with regard to 
depression, baseline quality of life and social support. 
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The prevalence of depression in this study was found to be 29%. A longer 
duration of illness (mean 5.3 vs. 3.6, p<0.001), younger age (mean 51 vs. 55, 
p=0.001), lack of education (χ2=7.55, p=0.006), family history of nerves (χ2 4.1, 
p=0.04) and being a house-wife (χ2=9.21,p=0.002) were associated with 
depression. No cardiac or non cardiac medications were associated with 
depression. 
  
Moreover, diabetes mellitus (χ2=7.45, p=0.006), respiratory disorders (χ2 5. 56, 
p=0.01),haematological disorders (χ2=48.9, p<0.05), and cardiovascular 
disorders (χ2=3.85, p=0.05) were associated with depression. 
 
 ESSI scores of the depressed participants were lower than the non-depressed 
(2.57 vs. 2.79,p=0.01) and same status was observed with regard to PCS 
scores (40.4 vs. 46.2) at baseline.  
 
Logistic regression analysis revealed that younger age, lesser education and 
lower social support (low ESSI scores) were associated with depression 
(p<0.05). Similarly longer duration of illness (OR 2.72, 95% CI 1.87-3.95, 
p<0.005), haematological disorders (OR 9.5 95% 3.57-24.46, p<0.005), and 
respiratory disorders (OR 3.0 95% CI 1.04-9.05, p=0.042) were associated with 
depression. It was also found that as the PCS scores increases, the risk of 
depression reduces (OR 0.92, 95% CI 0.86-0.98, p=0.018).  
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On univariate analysis lack of education(< 12 years), retirement, and respiratory 
disorders, diabetes-mellitus, haematological disorder, and ‘non-cardiac 
disorders’ appeared to be predictors of poor quality of life(p<0.05). Similarly 
baseline depression was a significant predictor of quality of life at 6 months 
follow up.  Of the medications, only calcium channel blockers were predictors of 
health related quality of life.  
 
Multivariate linear regression analysis revealed that depression (≥ 17 HADS) 
was an independent predictor of poor health related quality of life after 
controlling for demographic, medical and psychological variables (β= - 8.76, 
p=0.001). There was no identified role of any confounding factor in this 
association.  
 
Thus, my main hypothesis that depression after controlling for medical and 
demographic covariates will be associated with health related quality of life is 
supported and the null hypothesis can be rejected. 
 
In addition to our main findings we were also able to validate the HADS against 
SCID in our cohort. HADS ≥17 was identified as the best cut-off score for 
depression, with high sensitivity (82%) and specificity (89%).   
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 INTERPRETATION OF THE RESULTS 
 
18.2.1   A REPRESENTATIVE SAMPLE 
 
 In this study 88% of the eligible participants were enrolled while Lane, D et al., 
(2000) enrolled only 66% and Grace LS (2005) could enrol only 50% of the 
eligible patients with acute coronary syndrome. A high proportion (81%) of the 
participants was followed up in this study compared to Thombs D et al., (2008) 
where this figure was only 52%. Moreover, Thombs D et al., (2008b) recruited 
patients from two different hospitals; community and teaching. We know that 
teaching hospitals are more likely to get patients with severe medical conditions 
compared to the community hospitals; generally maintained by the local GPs 
suggesting non-homogenous sample. 
 
18.2.2 ASSESSMENT OF DEPRESSION 
 
In this study depression was assessed within the first week  of index admission   
like a number of researchers who recruited patients within first two weeks ( 
Mayou R A 2000c; Lane, D et al., 2000; Faurback, JA et al., 2005a) but then the 
question has been raised about the validity of this depression. It is claimed that 
fluctuating distress soon after the ischaemic heart disease may not necessarily 
be the true reflection of depression (Lloyd GG 1983). If so, such distress can be 
short-lived in a number of cases (Berkman LF 2003). We were able to address 
this problem by validating HADS against SCID. SCID was performed two weeks 
after the index ischaemic heart attack, ruling out the possibility of any acute 
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reaction. A cut-off point of 17 was identified as having best sensitivity and 
specificity in our results. Interestingly the same cut off point  was used by 
Dickens, C et al., (2004). However Thombs D et al., (2008) relied on Becks 
Depression Inventory for the assessment of depression which contains a 
number of somatic items such as insomnia, fatigue and pain. Perhaps this is the 
reason that Mendes de Leon (1999) has questioned whether it is actually the 
cardiac rather depressive  symptoms  being labelled  as depression. However it 
confirms that this study selected the right tool to measure depression in its 
cohort.  
 
18.2.3  PREVALENCE OF DEPRESSION  
 
My findings confirm that depression is common among South Asians following 
acute coronary syndrome, affecting 29% of the study participants. Based on our 
knowledge, this is the first study that has examined depression in South Asians 
after ACS, living in the United Kingdom. Our prevalence is not strikingly high 
when compared to other studies conducted in the UK; however it is markedly 
lower than the studies conducted in the Indian sub-continent. 
 
 
 
 
18.3  COMPARISON OF PREVALENCE OF DEPRESSION 
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The prevalence of depression in this study can be compared with existing 
studies in the UK and overseas. 
 
18.3.1 PREVALENCE OF DEPRESSION IN THE UK  
 
Our results are comparable with the studies conducted in the UK. Dickens, C et 
al., (2006) and Thombs, D et al., (2008) were very close to our methodology. 
Dickens,C et al.,(2006) recruited patients with first MI and assessed depression 
6 months after index MI using the same measure for depression (HADS) as we 
did. Their prevalence was considerably lower than our study (21% vs. 29%).  It 
could be possibly due to the fact that their cohort consisted of participants 
having first myocardial infarction while our sample was mixed; having both first 
and subsequent attacks of coronary heart disease. It is also possible that a 
number of  participants who were depressed  soon after myocardial infarction 
recovered 6 months later, leading to lower prevalence of depression in their 
cohort. 
 
Another explanation could be that the depression assessed 6 months after the 
myocardial infarction, might be due to an independent variable not relating to 
myocardial infarction as over the period of time circumstances of the 
participants might have changed.  They did not control for other life events 
happening during this period.  
 
Similarly Thombs, D et al., (2008) studied patients with acute coronary 
syndrome rather than just with myocardial infarction as happened in most of the 
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studies. Acute coronary syndrome consists of STEMI, non-STEMI and unstable 
angina covering a broad range of ischaemic heart disease. Moreover they 
assessed depression with Becks Depression Inventory within days of acute 
coronary syndrome; ensuring that it was the depression following acute 
coronary syndrome.  They found a prevalence of 29% which is closely matching 
with our depression rate. However there is a problem with their assessment of 
depression, they used Becks Depression Inventory which contains a number of 
somatic items which can inflate the depression scores. 
 
Furthermore, a literature review in this thesis has highlighted that those studies 
that used BDI as a measure for depression came up with a higher prevalence of 
depression than those studies that used HADS or semi-structured diagnostic 
tools (SCID &CIS). Moreover the prevalence rate based on the HADS and 
semi-structured interview was closely comparable in the reviewed studies which 
perhaps suggest that HADS is a more appropriate tool for the assessment of 
depression in patients with coronary heart disease.  
 
 Based on these findings depression does not appear to be strikingly higher in 
the South Asians than the Caucasians with coronary heart disease.  
 
 
18.3.2 PREVALENCE OF DEPRESSION IN PAKISTAN  
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Due to lack of research evidence in South Asians living in the UK, the studies 
conducted in Pakistan with coronary heart disease patients will be compared 
here.  
 
The prevalence of depression in patients with coronary heart disease in 
Pakistan is higher than those living in the UK.  Akhter M S et al., (2008) found a 
prevalence of 50% while Bokhari SS et al., (2002) came up with a prevalence of 
37% in their study. 
 
Akhter M S et al., (2008) looked at the prevalence of depression in patients 
having acute myocardial infarction. The HADS Urdu version was administered 
within 5-7 days of AMI, very much like our study. Overall 50% of the participants 
had symptoms of depression. The prevalence of depression in this survey is 
markedly higher than our study (50% vs. 29%); possibly it is the confirmation 
that depression is much more prevalent in people living in the Pakistan (Husain, 
N et al., 2004) being an underdeveloped country. The other possibility could be 
the small sample size in their study. Job related stress (p< 0.01) and lack of 
confiding relationship (p< 0.002) were significantly associated with depression. 
 
Bokhari SS et al., (2002) included patients both from the cardiology wards and 
outpatient clinic. Their prevalence of depression was higher than our study (37 
% vs. 29%). All those having a history of depression, were on anti-depressant 
medications (commenced by psychiatrist), or those whose first degree relative 
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had died in the last 6 months, were excluded. HADS Urdu version was used.  
Moreover financial pressure and low literacy were associated with depression. 
 
In summary depression following coronary heart disease is much more common 
in patients living in Pakistan. However prevalence of depression in South 
Asians living in the UK after acute coronary syndrome is comparable with the 
Caucasian population. 
 
18.4  DEPRESSION AND QUALITY OF LIFE 
 
Our primary hypothesis that depression following acute coronary syndrome will 
be associated with poor health related quality has been upheld. After controlling 
for demographic and medical variables depression was able to explain 29 % of 
the variance. My findings are comparable with the similar studies conducted in 
the cardiac patients. 
 
18.4.1  COMPARISON WITH STUDIES IN THE UK 
 
My findings can be compared with two studies (Dickens C et al., 2006; Thombs, 
D et al., 2008) that have been conducted in the Caucasian population. Both of 
them have found that depression following coronary heart disease is having an 
adverse impact on the QoL.  
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Some dimensions of depression and quality of life have similarities, which can 
cause problems in making a precise assessment of the QoL. Although our study 
has found a strong association of depression and poor QoL, there are a number 
of studies that have come up with varying results, partly due to the overlapping 
picture of depression and quality of life.  
 
When looking at the impact of depression on the quality of life, an issue arises 
regarding the way that depression is measured.  For example, the HADS has 
been used in our study and by a number of other researchers (Dickens C et al., 
2006). It has similarities with emotional aspects of quality of life such as Mental 
Component Scale (MCS). To address this issue, we excluded mental health 
related quality of life (MCS) from the primary outcome measure which was not 
considered by other researchers (Brink E et al., 2002). In their study Brink E et 
al., (2002) found an association of depression and mental health related quality 
of life (MCS), but not the association of depression and physical health related 
quality of life (PCS). One of the explanations for such an association could be 
that the apparently perceived quality of life (MCS) may in fact have been the 
reflection of concurrent depression. However there have been other studies that 
addressed this issue. Dickens C et al., (2006) are one of them who used HADS 
to determine depression but used physical health related quality of life (PCS) as 
an outcome measure. They were able to trace 87% of the survivors. Moreover 
the researchers assessed depression along with their outcome measure. They 
conducted a sensitivity analysis by removing the depressed participants from 
the analysis but they were still able to support that depression was associated 
with poor heath related quality of life but with a lesser magnitude. 
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 However there is one issue with Dickens C et al., (2006) who recruited patients 
having their first myocardial infarction rather than those having acute coronary 
syndrome. The research (Torres M & Moayedi S 2007) shows that acute 
coronary syndrome consists of three parts;STEMI (30%), non-STEMI (25%) and 
unstable angina(38%). These statistics indicate that unstable angina constitutes 
more than one third of the ischaemic heart disease spectrum.  Moreover, due to 
its unpredictable nature it is more likely to cause disease burden compared to 
angina pectoris or myocardial infarction. 
 
Thombs, D et al., (2008) recruited patients with acute coronary syndrome and 
assessed depression within days after ACS similar to our study but used a 
different depression tool; Becks Depression Inventory, which contains number 
of somatic items that can inflate the depression scores. It is important as 
cardiac patients tend to make physical complaints which can easily be 
misinterpreted as depressive symptoms. Their outcome measure; physical 
health related quality of life (SF-12) was comparable with our study. They found 
an association of depression and quality of life; however only 52% of their 
cohort could be followed up which is much lower than our study (81%).   
 
18.4.2  COMPARISON WITH STUDIES IN PAKISTAN 
 
 Only one study was identified that examined the association of depression and 
quality of life in patients with coronary artery disease.  
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Dogar I A et al., (2008) recruited patients from the Coronary Care Units of a 
District General Hospital. Participants completed HADS Urdu version and WHO 
QoL-BREF. BREF is a self reported tool developed by the WHO to determine 
quality of life across various cultures. It consists of 26 items which measure the 
four 4 main domains of quality of life; physical health, psychological health, 
social relationship and environment. Mean age of the sample was 52 years, 
comparable to our sample. Multivariate analysis revealed that depression was a 
predictor of poor quality of life across all the four domains. 
 
In summary depression following coronary heart disease is associated with poor 
heath related quality of life in South Asians and this finding is comparable with 
other studies conducted in the UK or in the underdeveloped world. 
 
18.5  HEALTH RELATED QUALITY OF LIFE  
Depression following coronary heart disease does have an impact on the quality 
of life. Quality of life is a soft outcome measure having various dimensions.   It 
is a concept, which encompasses the ways in which a patient is affected by an 
illness and its treatment (Wegner NK 1996). So basically it is the subjective 
perception of the person. Subjective view can vary from person to person 
depending on the available resources such as social support, financial position 
and psychological strengths including coping strategies. Psychological 
strengths depend on the level of education and previous exposure to the similar 
situation. Quality of life is concerned with the attributes of life, which are 
valuable to a patient such as sense of well-being, comfort, ability to maintain 
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reasonable level of physical, emotional and intellectual functions, and the ability 
to participate in various activities.  
 
Education level and psychosocial support are important determinants of quality 
of life. Previous studies in South Asians (Husain, N et al., 1997) have revealed 
a lack of social support in the Pakistani living in the UK. Similarly Gater, R et al., 
(2008) have reported that majority of Pakistani were unemployed, had low 
socio-economic status and no educational qualifications. Similar findings have 
been given by Hemingway H et al., (2001) in their Whitehall 11 Study. These 
studies seem to be supporting our study that has found low level of social 
support and low level of literacy in the depressed than the non-depressed 
group.   
 
 
18.5.1 EDUCATION AND QUALITY OF LIFE 
 
Education can have a direct impact on the heath outcome by making an 
individual more capable of processing information and thereafter becoming 
health conscious (Kenkel, 1991) or by improving the efficiency of treatment 
provisions. For instance, educated persons are likely to be prompt to seek help 
for clinical assessment and more diligent in adhering with treatment plans 
(Goldman and Lakdawalla, 2001; Goldman and Smith, 2002).  
 
Propper et al., (2004) have reported that educated persons are at significantly 
less risk of adverse mental health outcomes. Similarly, Kubzansky and Sparrow 
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(1999) found that those Americans having less than high school education were 
more likely (almost twice) to suffer from long-term stress than the individuals 
having at least college education even when age and lifestyle were adjusted. 
 
Dias CC et al., (2004) while exploring the impact of depression on the quality of 
life also found that those having a low literacy level  were at significantly higher 
risk of poor health related quality of life than those having a high literacy level 
(OR 3.9, p=0.02). 
 
Education can also influence the social circumstances through its impact on the 
labour market. Lack of education leads to unemployment or inadequately paid 
job with little satisfaction and subsequent poor housing having an impact on the 
well-being of individuals (Blanchflower and Oswald, 2004).  Similar views have 
been expressed by (Hemingway H et al., 2001) when they found that higher 
occupational grades were associated with greater job satisfaction than the low 
grade in their Whitehall 11 Study of civil servants in London.  
 
Patients’ beliefs system is also significantly affected by the level of education 
with subsequent impact on the recovery process. Many South Asians hold 
traditional beliefs about their physical health. The beliefs about the causation of 
the illness whether it is attributed to stress or poor life style will determine    the 
prospective course of the illness and its potential impact on the quality of life.  
 
Those believing that their illness is stress related are less likely to think about 
changing their life style in terms of smoking, body weight, exercise or dietary 
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habits; hence they are more likely to have further cardiac events with 
associated difficulties such as depression. Those having such beliefs are more 
likely to depart away from their work commitments and less likely to engage 
with the rehabilitation programme; hence getting trapped in a vicious cycle.   
 
Lack of education promotes the cultural or familial held beliefs that can be 
counter-productive in the recovery process of the disease; leaving behind a 
poor quality of life. The following account that was given by a participant during 
my visit to collect follow up questionnaires, gives a better reflection. 
 
MR AR is a 45 years old Taxi-driver who lives with his 36 years old wife in a 
mortgaged house in the crowded vicinity of the city centre. He has two girls 
aged 10 and 12 years. He attended primary school and then left his education. 
He is overweight, borderline diabetic and suffered from the first myocardial 
infarction in his life time. He has not been doing his business for the last 5 
months (since hospital discharge). First four months went well but since then   
disputes started emerging revolving around financial and marital life. He said 
that eating more fish, fruits and vegetables was becoming an unviable option. 
Furthermore he appeared to have firm belief that that any pressure of work or 
strenuous physical activity will lead to further heart attacks; hence he avoids 
most of the physical activities. 
 
 He also said that he was not having any sexual encounter with his wife as he 
believed that it could trigger further heart attacks. Such an attitude paved the 
way for marital strain, because his wife wanted to conceive with the hope of 
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having a boy son after two consecutive daughters. If a family cannot have a son 
then it is the wife who generally has to bear the brunt in Asian culture.  
Furthermore he used to play squash once a week prior to his illness but he was 
out of practice now. He admitted to be gaining some weight since his discharge.  
He claimed that his illness has taken away almost everything he loved. 
 
 
18.6  VALIDATION OF HOSPITAL ANXIETY AND DEPRESSION SCALE  
 
The HADS has been used widely and validated in a number of countries 
including Middle East, China Indian sub-continent including Pakistan as a 
screening tool for depression. It has been translated into many languages 
including Chinese, Spanish, Urdu, Punjabi, Iranian and Arabic. Moreover it has 
been used extensively in patients having coronary heart disease across the 
world (Dickens C et al., 2004; Brink et al 2005 ).  
 
To our knowledge this is the first study that has tried to conduct a formal 
validation of HADS in South Asians with coronary heart disease living in the 
United Kingdom. 
 
We recruited South Asians with coronary heart disease admitted to the four 
District General Hospitals in the North-West of the Manchester, located in 
Blackburn, Burnley, Rochdale and Bury. Due to the high population of South 
Asians in this part of the country, we think that our sample is well representative 
of the South Asians with coronary heart disease.  
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In the first phase 250 participants completed Urdu version of the HADS. In the 
2nd phase, 103 of them were administered SCID. Fifty-six participants qualified 
for depression. Sensitivity and specificity was calculated for each possible cut 
off point.  
 
Our results have shown that a cut off point of 17 was the most appropriate for 
this cohort because it was having the best sensitivity (82%) and specificity 
(87%). Based on this cut off score, the prevalence of depression in our cohort 
was 29%. The area under curve (ROC) was high (0.83) suggesting that HADS 
was an appropriate tool to detect depression in South Asians with acute 
coronary syndrome. 
 
 COMPARISON WITH OTHER STUDIES 
 
HADS has been validated in the developed and under developed world.  
 
18.6.1  VALIDATION OF HADS IN DEVELOPED COUNTRIES 
  
A-UNITED KINGDOM  
 
Dickens C et al., (2004) assessed depression with HADS in patients having 
myocardial infarction. For the validation of the HADS, they administered the 
Schedule for Clinical Assessment in Neuropsychiatry (SCAN), to their patients. 
SCAN is a semi-structured research interview which provides International 
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Classification of Diseases (ICD-10) diagnoses based on symptoms over the last 
four weeks. Interestingly Dickens C et al., (2004) found the same cut off point in 
their cohort of the Caucasian population. Their sensitivity (88%) and specificity 
(85%) was quite high and comparable with our findings, suggesting that HADS 
is an appropriate tool to assess depression in patients having ischaemic heart 
disease. 
 
18.6.2 VALIDATION OF HADS IN DEVELOPING COUNTRIES  
(A)  PAKISTAN 
HADS Urdu version has been well used in Pakistan. Rehman U R et al., (2009) 
validated the HADS Urdu version in Pakistanis admitted with first myocardial 
infarction. The correlation co-efficient between the HADS and Hamilton 
Depression Rating Scale was high (r=0.55, p<0.001) and statistically significant.  
 
Similarly Akhter M S et al., (2008) made an attempt to validate the HADS Urdu 
version in patients after acute myocardial infarction. HADS was administered 
within 5-7 days of AMI followed by a semi-structured interview by a psychiatrist 
for clinical assessment. The validity of the HADS depression scale was 0.70 
and HADS anxiety scale was 0.74.  
 
(B) UNITED ARAB EMIRATES 
Rufaie Al OEE et al., (1994) validated HADS in the Middle East in a community 
sample when they came up with two cut off scores on the HADS; 6/7  for  HADS 
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anxiety scale with a high sensitivity (78%) and specificity (80.7%); 3/4 for HADS 
depression scale with good sensitivity (81.5%) and specificity(85.5%). The cut 
off point on HADS depression scale was comparatively lower but it could be due 
to the specific Arab culture or other linguistic problems. Although high sensitivity 
and specificity was highlighted the participants were not having coronary heart 
disease.  
 
 (C) CHINA 
Lam LKC et al., (1995) validated a Cantonese version of HADS in Chinese 
aged over 60 to detect psychological problems. HADS was administered to 298 
patients by the interviewers prior to their consultation with doctor. Clinical 
Interview Schedule (CIS) was performed on a random sample of 100 patients 
by two psychiatrists. Receiver Operating Characteristic (ROC) analysis revealed 
an optimum cut off point of 6 for depression and 3 for anxiety. The sensitivity 
(80%) and specificity (90%) was quite high in their sample. Thirty-six percent 
(36%) of the participants scored above the cut off point.  The cut off score for 
depression and anxiety is lower than other studies. The HADS was seen to be 
effective screening tool for depression in this study.   
 
In conclusion the HADS seems to be a reliable tool to detect depression across 
a number of developed and under-developed countries. The optimal cut off 
score may vary from one population to another. HADS Urdu version has been 
  
314 
 
used in the cardiac and non-cardiac South Asians patients in the Indian 
subcontinent.  
 
Furthermore, we can claim with confidence that HADS is a valid tool for 
detecting depression in South Asians with coronary heart disease living in the 
United Kingdom. 
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18.7  IMPLICATIONS 
 
This study has been performed in the largest ethnic group in the United 
Kingdom. According to our knowledge this is the first study looking at the 
prevalence of depression and its impact on the quality of life of South Asians 
with acute coronary syndrome.  
 
A prevalence of 29% of the depression in our study is comparable with other 
studies conducted in Caucasian population (Dickens C et al., 2006; Thombs D 
et al., 2008). Previous reports of the depression being much higher in South 
Asians may not be necessarily applicable to South Asians with acute coronary 
syndrome.  
 
As liaison psychiatry is still developing in this country, service planners will 
require considering the ways of addressing this psychological morbidity in a 
culturally sensitive way. Knowledge of trans-cultural psychiatry and fair 
representation of the South Asians in the multidisciplinary teams can be a 
crucial step forward.  
 
It has been supported that depression adversely impacts the quality of life of 
South Asians. On the other hand, only 12% depressed patients were on anti-
depressant in our cohort. The research has found that treating depression can 
have a modest effect on the quality of life.   
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It is the first time that the HADS Urdu version has been validated in South 
Asians in the UK with acute coronary syndrome that will facilitate its use in the 
further research in the South Asians.   
 
Lack of education has been associated with depression and a predictor of poor 
quality of life. Availability of written information in simple language about the risk 
factors leading to CHD and depression can play a role in public health 
education.  The concept of stigma about mental health needs addressing as 
well. The importance of engaging with rehabilitation programmes needs to be 
widely disseminated and understood. 
 
 To get the message across the community, it would be prudent to organise 
meetings or workshops at the public platforms; Asian Community Centres, 
mosques, temples or Gurdawaras. The service planners may require 
considering culturally acceptable and sensitive psychosocial interventions. 
 
Medical teams working in the cardiology department may require improving 
their knowledge of trans-cultural psychiatry as well. 
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18.8  POSSIBLE LIMITATIONS 
 
The following may be considered as the potential limitations of my study. 
 
Although HADS and SCID Urdu version have been used in our study, these 
measures are based on Western culture. The expression of distress and its 
implications can vary from culture to culture.  
 
 This study conducted a two phased  screening;  in the second stage all the 
high scorers but a small number of low scorers (1:6) were selected  for  the 
SCID, which can be seen as a potential limitation. However in a non-funded 
study, it is an alternative approach to conduct such important research in 
cardiac patients rather than relying on a self-report questionnaire for 
depression.  
 
At times due to the full capacity of Coronary Care Unit, patients with acute 
coronary syndrome were directly transferred from the A&E to other medical 
wards, which might have led to some patients being missing. However keeping 
daily contact with the wards and visiting hospital two to three times a week 
minimised such events. Moreover the researcher made retrospective enquiries 
during all of his visits to the hospitals. 
 
As patients were recruited from four districts general hospitals, there were 
differing attitudes of the cardiologists towards the newly evolving term of “Acute 
coronary syndrome”, which led to some difficulties at times.  
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Those discharged within 24 hours were excluded from the study; possibly they 
were having less severe cardiac pathology with better quality of life. Their 
inclusion might have had an impact on our primary outcome. 
 
A high proportion of those who had previous history of heart attack, high social 
support (high ESSI) and better quality of life at baseline were also lost to follow 
up. 
 
It may be a bit difficult to compare the results of this study with many other 
studies that looked at the impact of depression following myocardial infarction 
rather than following acute coronary syndrome in the Caucasian population 
(Dickens, C et al., 2006).  
 
A big majority of our participants were Pakistani in origin, which may not allow 
generalisation of the study results to the whole South-Asian population as per 
our definition of the South Asians. 
 
Quality of life is a soft outcome measure which is very subjective in nature.  
Perception of people varies from time to time depending upon the level of 
support, education and reserve resources to cope with the illness.   
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18.9  PROSPECTIVE RESEARCH  
 
Further prospective studies examining the association of depression following 
acute coronary syndrome and health related quality of life among admitted 
South Asians would be required to replicate the findings of the current study. 
These studies should also extend the follow up period to 12 months to examine 
whether the depression still maintains its impact on the health related quality of 
life. 
 
Further prospective studies will also be addressing the question of cardiac 
disease severity more thoroughly by taking into account all necessary 
parameters.  
 
Moreover studies will be required to recruit both White and South Asians 
patients with acute coronary syndrome to compare this association. 
 
It still remains a debate as to whether it is the depression that develops for the 
first time following CHD that leads to poor QoL or whether the risk is higher in 
those who have experienced previous episodes of depression.  Additional 
research will be required to identify the patients who are at increased risk so 
that efforts to reduce the risk can be targeted at these patients. 
 
This study and others have shown that the association between depression and 
poor prognosis is not limited to patients whose mood was assessed shortly 
following an acute cardiac event. Other coronary heart disease patients, 
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including those assessed at the time of catheterisation, a few months following 
hospital admittance for acute coronary syndrome and patients with stable 
coronary heart disease have also been shown to have depressive symptoms 
that can impact upon poor prognosis. However, the question remains of 
whether there is an optimal time for identifying patients with depression?  
 
Furthermore intervention studies will be required to see whether treating 
depression in the IHD patients has any role in improving their quality of life. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
321 
 
 
 
19 REFERENCES 
 
• Ahern, D. K., Gorin L, Anderson GL, Tierney C, Hallstrom A, Ewart C, 
Copne RJ, Schrom E, et al. (1990-A) Cardiac Arrhythmia Pilot Study 
(CAPS) Investigators: Bio-behavioural variables and mortality or cardiac 
arrest in the Cardiac Arrhythmia Pilot Study (CAPS) Am J Cardiol; 66:59-
62 
• Akhter SM, Malik BS, Khan AM (2008). Psychosocial factors associated 
with symptoms of depression and anxiety following AMI. Pak J Med Scie. 
24(2) 192-197 
• American Psychiatric Association Committee on Nomenclature and 
Statistics. Diagnostic and Statistical Manual of Mental Disorders, 
Revised. 4th ed. Washington, DC: APA (1994) 
• Balarajan, R.(1996).Ethnicity and variations in morality from coronary 
heart disease. Hlth Trends; 28:45-51 
• Barefoot JC, Schroll M. Symptoms of depression, acute myocardial 
infarction and total mortality in a community sample. Circulation 1996; 
93:1976–80. 
• Barefoot, J. C., Helms, M. J., Mark, D. B., Blumenthal, J. A., Califf, R. M., 
Haney, T. L., et al. (1996). Depression and long-term mortality risk in 
patients with coronary artery disease. American Journal of Cardiology, 
78(6), 613-617. 
• Bayard-Burfeld L, Sundquist J, Johansson SE, (2001) Ethnicity, self 
reported psychiatric illness and intake of psychotropic drugs in five ethnic 
groups in Sweden. J Epidemiology Community Health. 55:657-664 
• Beck A. T., Ward CH, Mendelson M, et al. (1961). An inventory for 
measuring depression. Arch General Psychiatry ;4 : 561-571 
• Beck A. T., Steer RA., (1987). Beck depression inventory manual. San 
Antonio: Harcourt Brace Jovanovich. 
  
322 
 
• Beck, A. T., Steer RA, Garbin M (1981). Psychometric properties of the 
depression inventory. Twenty-five years of evaluation. Clinical 
Psychology Review; 8:1003-1009.  
• Beck, C. A., Joseph, L., Belisle, P., & Pilote, L. (2001). Predictors of 
quality of life 6 months and 1 year after acute myocardial infarction. 
American Heart Journal, 142(2), 271-279. 
• Berkman, L. F., Leo-Summers, L., & Horwitz, R. I. (1992). Emotional 
support and survival after myocardial infarction. A prospective, 
population-based study of the elderly. Annals of Internal Medicine, 
117(12), 1003-1009. 
• Bhui, K et al. (2004). Assessing the prevalence of depression in Punjabi 
and English primary care attenders: the role of culture, physical illness 
and somatic symptoms, Transcult Psychiatry, 41(3): 307-22.  
• Bhui, K., Bhugra, D., & Goldberg, D. (2000). Cross-cultural validity of the 
Amritsar Depression Inventory and the General Health Questionnaire 
amongst English and Punjabi primary care attenders. Social Psychiatry 
and 
• Bokhari SS, Samad AH, Hanif S et al (2002)., Prevalence of depression 
in patients with coronary heart disease in a tertiary care hospital in 
Pakistan. J Pak Med Assoc ; 52(9)  436-439) 
• Brink, E et al (2002). Health Experience of first time myocardial 
infarction: factors influencing women’s and men’s health related quality of 
life (QOL) after five months. Psychology, Health and Medicine, 7, 1:5 -16. 
• Brown, G.W. & Harris, T.(1978) Social Origins of Depression. London:  
• Brown, N., Melville, M., Gray, D., et al. (1999). Quality of life four years 
after acute myocardial infarction: Short form 36 scores compared with a 
normal population. Heart; 81:351-358 
• Bush, D.E., Zeigelstein, R.C., Tayback, M., et al. (2001). The American 
Journal of Cardiology; 88(15):337-341 
• Carney R, Blumenthal J, Cattelier,D et al (2003). Depression s a risk 
factor for mortality after AMI; Am J Cardiology 92: 1277-1281 
  
323 
 
• Carney, R. M., Rich, M. W., Freedland, K. E., et al. (1988). Major 
depressive disorder predicts cardiac events in patients with coronary 
artery disease. Psychosomatic Medicine, 50(6), 627-633. 
• Carney, R. M., Rich, M. W., Freedland, K. E., Saini, J., teVelde, A., 
Simeone, C., et al. (1988).  Major depressive disorder predicts cardiac 
events in patients with coronary artery disease. Psychosomatic Medicine, 
50(6), 627-633. 
• Christenfeld, N., J, S, Sloan, R., P, Carroll, D., & Greenland, S. (2004). 
Risk factors, confounding and the illusion of statistical control. 
Psychosomatic Medicine, 66, 868-875. 
• Cohen, J. (1988). Statistical power analysis for the behavioural sciences. 
Hillsdale, NJ, Erlbaum. 
• Commander, J.M., Odell, S.M., Surtees, P.G., Sashidharan, S.P. (2004). 
Care pathways for South Asian and white people with depressive and 
anxiety disorders in the community. Soc Psychiatry Psychiatr Epidemiol, 
39:259-264. 
• de Jonge, P., Spijkerman, T. A., Van den Brink, R. H., & Ormel, J. 
(2006a). Depression after myocardial infarction is a risk factor for 
declining health related quality of life and increased disability and cardiac 
complaints at 12 months. Heart, 92, 32-39. 
• Dean, C., Surtees, P.G. & Sashidharan, S.P. (1983). Comparison of 
research diagnostic systems in an Edinburgh community sample, British 
Journal of Psychiatry. 142:247-256. 
• Dias CC, Mateus P, Santos L et al (2005)  Acute coronary syndrome and 
predictors of quality of life. Rev Port Cardiol;24:819– 31. 
• Dickens, C. M., McGowan, L., Percival, C., Tomenson, B., Cotter, L., 
Heagarty, A., et al. (2006). Contribution of depression and anxiety to 
impaired health-related quality of life following first myocardial infarction. 
British Journal of Psychiatry, 189(4), 367-372. 
• Dickens, C. M., McGowan, L., Percival, C., Tomenson, B., Cotter, L., 
Heagarty, A., et al. (2007). Depression is a risk factor for mortality after 
myocardial infarction. Journal of the American College of Cardiology, 
49(18), 1834-1840. 
  
324 
 
• Dickens, C. M., McGowen, L., Percival, C., Douglas, J., Tomenson, B., 
Cotter, L., et al. (2004). Lack of a close confidant, but not depression, 
predicts further cardiac events after myocardial infarction. Heart, 90(5), 
518-522. 
• Dogar AI, Khawaja SI , Azeen WM et al ( 2008). Prevalence and risk 
factors for depression and anxiety in hospitalised cardiac patients in 
Pakistan. Psychiatry ( Edgmont) .5( 2) 38-41. 
• Failde, I. & Ramos, I. (2000) Validity and reliability of the SF^36 Health 
Survey Questionnaire in patients with coronary artery disease. Journal of 
Clinical Epidemiology, 53, 359-365. 
• Fauerbach, J. A., Bush, D. E., Thombs, B. D., McCann, U. D., Fogel, J., 
& Ziegelstein, R. C. (2005). Depression Following Acute Myocardial 
Infarction: A Prospective Relationship with Ongoing Health and Function. 
Psychosomatics, 46(4), 355-361  
• Field, A. (2000) Discovering statistics using SPSS for Windows. London: 
Sage Publications. 
• Frasure-Smith, N., Lesperance, F., & Talajic, M. (1995 a1). The impact of 
negative emotions on prognosis following myocardial infarction: is it more 
than depression? Health Psychology, 14(5), 388-398. 
• Frasure-Smith, N., Lesperance, F., & Talajic, M. (1995 a2). The impact of 
negative emotions on prognosis following myocardial infarction: is it more 
than depression? Health Psychology, 14(5), 388-398. 
• Frasure-Smith, N., Lesperance, F., & Talajic, M. (1993 b1). Depression 
following myocardial infarction: impact on 6 month survival. JAMA, 
270(15), 1819-1825. 
• Frasure-Smith, Lesperance, & Talajic. (1995 b2). Coronary Heart 
Disease / Myocardial Infarction: Depression and 18-month prognosis 
after myocardial infarction. Circulation, 91(4), 999-1005. 
• Frasure-Smith, Lesperance, & Talajic. (1995 b4). Coronary Heart 
Disease / Myocardial Infarction: Depression and 18-month prognosis 
after myocardial infarction. Circulation, 91(4), 999-1005. 
 
  
325 
 
• Frasure-Smith, N., Lesperance, F., Juneau, M., Talajic, M., & Bourassa, 
M. G. (1999). Gender, depression and one year prognosis after 
myocardial infarction. Psychosomatic Medicine, 61(1), 26-37. 
• Gater, R, Tomenson B, Percival C, et al., (2009) Persistent depressive 
disorder and social stress in people of Pakistani origin and white 
Europeans in the UK. Soc Psychiatry Psychiatrica Epidemiol. 44:198-207 
• Glassman, A., Shapiro, P., Ford, D., Culpepper, L., Finkel, M., Swenson, 
R., et al. (2003). Cardiovascular Health and Depression. Journal of 
Psychiatric Practice, 9(6), 409-421. 
• Goldberg, D. & Huxley, P. (1992). Common Mental Disorders: Bio-Social 
Model. Routledge: London. 
• Goldberg, D. P., Gater, R., Sartorius, N., Ustun, T. B., Piccinelli, M., 
Gureje, O., & Rutter, C.(1997). The validity of two versions of the GHQ in 
the WHO study of mental illness in general health care. Psychological 
Medicine, 27(1),191–197. 
• Gorkin, L., Schron EB, Brooks MM, et al. (1993). Psychosocial predictors 
of mortality in the Cardiac Arrhythmias Suppression Trial-1(CAST-1). 
.Am J Cardiol ;71: 263-267 
• Grace, S. L., Abbey, S. E., Kapral, M. K., Fang, J., Nolan, R. P., Stewart, 
D. E., et al. (2005). Effect of depression on five-year mortality after an 
acute coronary syndrome. American Journal of Cardiology, 96(9), 1179-
1185. 
• Hemingway, H., Whitty, C. J., Shipley, M, et al( 2001). Psychosocial risk 
factors for coronary disease in White, South Asian and Afro-Caribbean 
civil servants: the Whitehall II study. Ethn Dis;11:391-400 
• Husain, N; Gater,R, Tomeson B et al ( 2004). Social factors associated 
with chronic depression among a population based sample of women in 
rural Pakistan. Soc Psychiatr Epidemiol39: 618-624 
• Husain, N., Creed, F., & Tomenson, B. (1997). Adverse social 
circumstances and depression in people of Pakistani origin in the UK. 
British Journal of Psychiatry 
• Husain, N., Creed, F., Tomenson, B., (2000) Depression and social 
stress in Pakistan. Pschol Med 30:395-402. 
  
326 
 
• Jacobs, K. S., Bhugra D, Mann AH. (1991). Validation of the 12-item 
General Health Questionnaire among ethnic Indian women living in the 
United Kingdom. Psycol Med; 10:18-24  
• Jenkinson, C. M., Coulter, A., & Wright, L. (1993). Short form 36 (SF 36) 
health survey questionnaires: normative data for adults of working age. 
British Medical Journal, 306, 1437-1440. 
• Jenkinson, C. M., Madeley, R. J., Mitchell, J. R., & Turner, I. D. (1993). 
The influence of psychosocial factors on survival after myocardial 
infarction. Public Health, 107(5), 305-317. 
• Kaplan, R.M., (2003). The significance of quality of life in health care. 
Qual Life Res; 12(suppl 1):3-16 
• Kaufmann, W. M., Fitzgibbons JP, Sussman EJ, Reed JF III et al. (1999). 
Relation between MI, depression, hostility, and death.  American Heart 
Journal; 138 (3) :550-553 
• Ladwig KH, Kieser M, Konig J, Breithardt G, Borggefe M. (1991). 
Affective disorders and survival after acute myocardial infarction: results 
from the post-infarction late potential study. Eur Heart J; 12:959-964 
• Ladwig, K. H., Roll, G., Breithardt, G., Budde, T., Borggrefe, M., Ladwig, 
K. H., et al. (1994). Post-infarction depression and incomplete recovery 6 
months after acute myocardial infarction.[see comment]. Lancet, 343(88), 
20-23. 
• Lam CLK, Pan PC, Chan AWT et al (1995). Can the HADS be used on 
Chinese elderly in general practice? Family Practice  12 (2) 149-154 
• Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. (2000). Do 
depression and anxiety predict recurrent coronary events 12 months 
after myocardial infarction? Quarterly Journal of Medicine, 93, 739-744. 
• Lane, D., Carroll, D., Ring, C., Beevers, D. G., Lip, G. Y., Lane, D., et al. 
(2000). Effects of depression and anxiety on mortality and quality-of-life 4 
months after myocardial infarction. Journal of Psychosomatic Research, 
49(4), 229-238. 
• Lane, D., Carroll, D., Ring, C., Beevers, D. G., Lip, G. Y., Lane, D., et al. 
(2001). Mortality and quality of life 12 months after myocardial infarction: 
  
327 
 
effects of depression and anxiety. Psychosomatic Medicine, 63(2), 221-
230. 
• Langford, C. P, Bowsher J, Maloney JP et al (1997).Social Support: a 
conceptual analysis. J Adv Nurs; 25: 95-100 
• Lauzon, C., Beck, C. A., Huynh, T., Dion, D., Racine, N., Carignan, S., et 
al. (2003). Depression and prognosis following hospital admission 
because of acute myocardial infarction. Canadian Medical Association 
Journal, 168(5), 547-552. 
• Lesperance, F., Frasure-Smith, N., & Talajic, M. (1996 b3). Major 
Depression Before and After Myocardial Infarction: Its Nature and 
Consequences. Psychosomatic Medicine, 58(2), 99-110. 
• Lesperance, F., Frasure-Smith, N., Talajic, M., & Bourassa, M. G. (2002). 
Five-year risk of cardiac mortality in relation to initial severity and one-
year changes in depression symptoms after myocardial infarction. 
Circulation, 105(9), 1049-1053. 
• Lloyd GG, Cawley RH. (1983) Distress or illness? A study of the 
psychological 
• Mayou, R. A., Gill, D., Thompson, D. R., Day, A., Hicks, N., Volmink, J., 
et al. (2000). Depression and anxiety as predictors of outcome after 
myocardial infarction. Psychosomatic Medicine, 62(2), 212-219. 
• Mc Dowell, I , Newall C (1996) Measuring Health; In a guide to rating of 
the Scale  and Questionnaires, Second Edition ,New York,  Oxford  
University Press ; 380-492 
• McHorney, C., Ware, J., Rogers, W., Raczek, A., & Lu, R. (1992). The 
Validity and Relative Precision of MOS Short and Long Form Health 
Status Scales and Dartmouth COOP Charts: Results from the Medical 
Outcomes Study. Medical Care, 30(5 (Suppl.)), 253-265. 
• McKeigue, PM, Miller GJ, Marmot MG. (1989) Coronary heart disease in 
South Asians overseas, a review. J Clin Epimediol; 42: 597-609 
• Meltzer H, Gill B, Petticrew M, et al.(1995) The OPCS survey of 
Psychiatric Morbidity in Great Britain.  Report Number One.  The 
prevalence of psychiatric morbidity among adults aged 16-64 living in 
private households in Great Britain. HMSO: London 
  
328 
 
• Mendes de Leon, C. F. (1999). Depression and social support in 
recovery from myocardial infarction: Confounding and confusion. 
Psychosomatic Medicine, 61(6), 738-739. 
• Morrin,L, Black,S, & Reid R (2000). Impact of duration in a cardiac 
rehabilitation program on coronary risk profile ad health related quality of 
life outcomes. J Cardio-pulmonary Rehabilitation.;20: 115-121  
• Murray, C., & Lopez, A. (1997a). Alternative projections of mortality and 
disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 
349, 1498-1504. 
• Murray, C., & Lopez, A. (1997b). Global mortality, disability and the 
contribution of risk factors: Global Burden of Disease Study. Lancet, 349, 
1436-1442. 
• Musselman, D., L, Evans, D., L, & Nemeroff. (1998). the relationship of 
depression to cardiovascular disease. Archives of General Psychiatry, 
55, 580-592. 
• Nazroo, J, Fenton S, Karlsen S , et al (2002).Context, cause and 
meanings: qualitative insights. In : Sproston K , Nazroo J (eds) Ethnic 
minority psychiatric illness rates in the community ( EMPIRIC). National 
Centre for Social Research, London, pp 137-158 
• Odell , S , Surtees PG, Wainwright NW J et al (1997). Determinants of 
general practioner recognition of pschological problems in a multiethnic 
inner city health district. Br J Psych; 171: 537-541 
• OPCS (1992). 1991 Census Definitions Great Britain. HMSO: London 
• Parashar, S., Rumsfeld, J. S., Spertus, J. A., Reid, K. J., Wenger, N. K., 
Krumholz, H. M., et al. (2006). Time course of depression and outcome 
of myocardial infarction. Archives of Internal Medicine, 166(18), 2035-
2043. 
• Pilote, L., LauzonC, Huynh T et al. (2002). Quality life after AMI among 
patients treated at sites with and without on site availability of 
angiography. Arch Intern Med; 162:553-559 
• Pratt, et al; (1996).Depression, psychotic medication and the risk of MI: 
Prospective data from the Baltimore ECA follow up. Circulation 94:3123-
31 
  
329 
 
• Rahman, A., Iqbal, Z., Waheed, W., Hussain, N., (2003). Translation and 
cultural adaptation of health questionnaires. J Pak Med Assoc (JMPA) 
53:142-147. 
• Rehman UR, Ansari AM , Siddiqui A A et al ( 2009). Correlation of Urdu 
version of HADS and Hamilton Depression Rating Scale in quantifying 
depression  among post-MI patients 8( 02) 131-135  
• Ronalds, C., Creed FH., Webb S,. et al (1997). The outcome of anxiety 
and depressive disorder in primary care. BJ Psychiatry; 171:427-433 
• Rufaie OEF, Absood GH (1995). Retesting the validity of the Arabic 
version of the HADS in primary health centre. Soc Psychiatry Psychiatr 
Epidemiol; 30 ; 26-31 
• Rumsfeld, J. S et al (2003). History of depression, angina, and quality of 
life after acute coronary syndrome. Am Heart J March 2003; 493-499. 
• Rumsfeld, J.S., Magid DJ, Plomondon ME, O’Brien MM, Spertus JA, 
Every NR, Sales AE. (2001). Predictors of quality of life following acute 
coronary syndromes. Am J Cardiol. 88:781-4 
• Ruo, B., Rumsfeld JS, Hlatky MA, et al. (2003). Depressive symptoms 
and health related quality of life. The Heart and Soul Study. JAMA;290: 
215-221.  
• Sarason, I., Levine H, Basham R et al. (1983).Assessing social support. 
The Social support Questionnaire. J of Personality and Social 
Psychology.;44: 127-139.  
• Schipper, H., Clinch JJ, Olweny CLM (1996): Quality of life studies: 
definitions and conceptual issues. In Quality of Life and Pharmaco-
economics in Clinical Trials, Second Edition. Edited by Spilker B, 
Philadelphia: Lippincott-Raven; 11-23. 
• Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin 
R, Zucker HD.  (1989). Nature and course of depression following 
myocardial infarction. Arch Intern Med. 149:1785-1789. 
• Shiotani, I., Sato, H., Kinjo, K., Nakatani, D., Mizuno, H., Ohnishi, Y., et 
al. (2002). Depressive symptoms predict 12-month prognosis in elderly 
patients with acute myocardial infarction. Journal of Cardiovascular Risk, 
9(3), 153-160. 
  
330 
 
• Singleton, N., Bumpstead, R., O’Brien et al. (2001). Psychiatric morbidity 
among adults living in private households. The Stationary Office: London 
• Smith, P. & Prior, G. (1997). The fourth National Survey of Ethnic 
Minorities: Technical Report. Social and Community Planning Research: 
London. 
• Stewart, R. A., North, F. M., West, T. M., Sharples, K. J., Simes, R. J., 
Colquhoun, D. M., et al. (2003). Depression and cardiovascular morbidity 
and mortality: cause or consequence? European Heart Journal, 24(22), 
2027-2037. 
• Strik, J. J., Denollet, J., Lousberg, R., & Honig, A. (2003). Comparing 
symptoms of depression and anxiety as predictors of cardiac events and 
increased health care consumption after myocardial infarction. Journal of 
the American College of Cardiology, 42(10), 1801-1807. 
• Strik, J. J., Honig, A., & Maes, M. (2001). Depression and Myocardial 
Infarction: Relationship between Heart and Mind. Neuro-
psychopharmacol & Biological Psychiatry, 25, 879-892. 
• Strik, J. J., Lousberg, R., Cheriex, E. C., & Honig, A. (2004). One year 
cumulative incidence of depression following myocardial infarction and 
impact on cardiac outcome. Journal of Psychosomatic Research, 56, 59-
66.  
• Sullivan, M, D et al. (1997).  Functional Status in Coronary Artery 
Disease (CAD): A one-year prospective study of the role of Anxiety & 
Depression. The Am J of Medicine. 103: 348-56. 
• Thombs, B. D., Ziegelstein, R., Stewart, D. E., Abbey, S. E., Parakh, K., 
& Grace, S. L. (2008). Usefulness of Persistent Symptoms of Depression 
to Predict Physical Health Status 12 Months after an Acute Coronary 
Syndrome. American Journal of Cardiology, 101, 15-19. 
• Valiogo, J., Conrad, M; Poston SW et al(2004).Testing the performance 
of the ENRICHD Social Support Instrument in cardiac Patients. Health 
Qual Life Outcome; 2:24.  
• van der Wurrf FB, Beekman AT, Dijkshoorn et al (2004) Prevalence and 
risk factors for depression in elderly Turkish and Moroccan migrants in 
the Netherlands. J Affect Disord 83: 33-41 
  
331 
 
• van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G., Ormel, 
J., van Veldhuisen, D. J., et al. (2004). Prognostic association of 
depression following myocardial infarction with mortality and 
cardiovascular events: a meta-analysis. Psychosomatic Medicine, 66(6), 
814-822. 
• Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey 
(SF-36). I. Conceptual framework and item selection. Med Care (1992); 
30:473– 83. 
• Ware, J E , Kosinski M., Keller, S.(1994) SF-36 Physical and Mental 
Health Summary Scales: a user’s manual  (2nd edition) Boston ,MA: The 
Health Institute. 
• Weich S, Karlsen S, King M, Lloyd K, Stansfeld S, Tyrer P, (2004). 
Common mental disorders and ethnicity in England: the EPMIRIC study. 
Psychol Med 34:1543-1551 
• Welin, C., Lappas, G., & Wilhelmsen, L. (2000). Independent importance 
of psychosocial factors for prognosis after myocardial infarction. Journal 
of Internal Medicine, 247, 629-639. 
• Wenger NK (1999): Improvement of quality of quality of life in the 
framework of cardiac rehabilitation. In Clinical Cardiac Rehabilitation: A 
Cardiologist’s Guide, Second Edition. Edited by Pashkow FJ, Dafoe WA. 
Baltimore: Williams & Wilkins; 1999:43-51. 
• Wilkinson, P., Sayre J, Lajik, et al. (1996). Comparison of case fertility in 
South Asians and White patients after acute MI: Observational study. 
BMJ; 312: 1330-1333 
• Williams, R. B. , Barefoot JC , Califf RM (1992). Prognostic importance of 
social and economic resources among medically treated patients with 
angiographically documented CAD. JAMA;m267: 520-524 
• Wilson IB, Cleary PD (1995). Linking clinical variables with health-related 
quality of life: a conceptual model of patient outcomes. JAMA; 273:59– 
65. 
• Wilson, S., Delaney, B., Roalfe, A., Roberts, L., Redmain, V., Wearn, A., 
et al. (2000). Randomised controlled trials in primary care: case study. 
British Medical Journal, 321, 24-27. 
  
332 
 
• World Health Organisation (1947). Constitution of the World Health 
Organisation: Chronicle of the world health organisation, Geneva 
• Ziegelstein, R., Fauerbach, J., Stevens, S., Romanelli, J., Richter, D., & 
Bush, D. (2000). Patients with depression are less likely to follow 
recommendations to reduce cardiac risk during recovery from myocardial 
infarction. Archives of Internal Medicine, 160, 1818-1823. 
• Ziegelstein,R,C. (2001).Depression in patients recovering from a 
myocardial infarction. JAMA 286:1621-7 
• Zigmond, A., & Snaith, R.P (1983). The Hospital Anxiety and Depression 
Scale. Acta Psychiatr Scand, 61, 361 - 370. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
333 
 
 
 
 
 
  
 
 
 
 
 
20 APPENDICS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
334 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
335 
 
 
 
 
  
336 
 
 
  
337 
 
 
  
338 
 
 
  
339 
 
Demographic Data Sheet  
 
 
  
340 
 
 
 
 
 
  
341 
 
 
 
  
342 
 
 
 
  
343 
 
 
 
  
344 
 
 
 
  
345 
 
 
  
346 
 
 
  
347 
 
 
  
348 
 
 
 
  
349 
 
 
  
350 
 
 
  
351 
 
 
  
352 
 
 
 
 
  
353 
 
SCID 
 
CURRENT MAJOR 
DEPRESSIVE EPISODE 
MDE CRITERIA RATING 
Now I am going to ask you 
some more questions about 
your mood. 
 
 
 
 
 
A. Five ( or more) of the following 
symptoms have been present during the 
same two week period and represent  a 
change form previous functioning; at 
least one of the symptoms is either (1) 
depressed mood, or (2) loss of interest 
or pleasure. 
 
 
 
In the last month…. 
                 …. Has there 
been a period of time when 
you were feeling depressed 
or down most of the day 
nearly every day? (What 
was that like?) 
 
 If YES: How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)Depressed mood most of the day, nearly 
every day, as indicated either by subjective 
report (e.g. feels sad or empty) or observation 
made by others (e.g. appears tearful). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
DEPRESSED MOOD what’s your mood 
been like this past week? 
Have you been feeling down or depressed? 
Sad? Hopeless? 
In the last week how often have you felt (OWN 
EQUIVALENT)? 
Every day? All day? 
Have you been crying at all? 
How long have you been feeling this way? 
0 = Absent 
1 = These feeling states indicated only on 
questioning. 
2 = These feeling states spontaneously reported 
verbally 
3 = Communicates feeling states non verbally 
i.e. through facial express, posture, voice, and 
tendency to weep. 
4 = Patients reports VIRTUALLY ONLY 
these feeling states in his spontaneous verbal 
and nonverbal communication 
 
INSIGHT 
Rating based on observation. 
0 = Acknowledges being depressed and ill(or no 
longer depressed) 
1 = Acknowledges illness but attributes cause to 
bad food, climate, overwork virus etc. 
2 = Denies being ill at all. 
 
 
 
 
 
 
 
 
 
?     1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
0    1     2 
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…. What about losing interest 
or pleasure in things you 
usually enjoyed? 
 
IF YES: was it nearly 
everyday? How long did it last? 
(As long as two weeks?) 
 
 
 
 
 
 
(2) Markedly diminished interest or pleasure in 
all, or almost all, activities most of the day, 
nearly everyday (as indicated either by 
subjective account or observation made by 
others). 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
WORK AND ACTIVIES How have you been 
spending your time this week (when not at 
work)? 
How you felt interested in doing (those things) or 
do you feel you have yourself to do them? 
Have you stopped doing anything you used to? 
If yes, Why? Is there anything you look forward 
to? 
 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, 
weakness related to activities, work, or hobbies. 
2 = Loss of interest in activity, hobbies or work 
either directly reported by the patient or indirect 
in listlessness, and  vacillation (feels she has to 
push self to work or activities)* 
3 = Decrease in actual time in activities or 
decrease in productivity 
4 = stopped working because of present illness** 
 
Do not code if associated with limited time 
available to do so. 
Do not code if solely because of maternity leave 
or personal choice. 
 
NOTE:WHEN RATING THE FOLLOWING 
ITEMS, CODE “X” IF CLEARLY DUE T O 
A GENERAL MEDICAL CONDITION, OR 
TO MOOD INCONGRUENT DELUSIONS 
OR HALLUCINATIONS 
EXCLUDE FORM STUDY END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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FOR THE FOLLOWING 
QUESTIONS,FOCUS ON THE 
WORKS TWO WEEKS IN THE 
PAST MONTH (OR ELSE THE 
PAST TWO WEEKS IF 
EQUALLY DEPRESSED FOR 
ENTIRE MONTH) 
  
During This (Two week Period). 
  
.. did you lose or gain any weight? 
(How Much?) (Were you trying to 
lose weight?) 
 
IF NO: How was your appetite? 
(What about compared to your 
usual appetite?) (Did you have to 
force yourself to eat?) (Did you to 
force yourself to 
eat?)(Eat[less/more] than usual?) 
(Was that nearly everyday?) 
 
 
 
 
(3)Significant weight loss when not dieting or weight 
gain (e.g. a change of more than 5% of body weight in 
a month) or decrease or increase an appetite nearly 
every day. Note; in children, consider failure to make 
expected weight gains. 
Check if: 
_____ weight loss or decreased appetite 
_____ weight gain or increased appetite 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
LOSS OF APPETITE how has your appetite been 
past week? What about compared to your usual 
appetite? How you had to force yourself to eat? Have 
other people had to urge you to eat? 
0 = None 
1 = Loss of appetite, but eating without 
encouragement heavy feeling in abdomen 
2 = Difficulty eating without urging. Requests or 
requires laxatives or medication for bowels or 
medication for O I symptoms. 
 
HYPERPHAGIA 
Have you been eating more than usual or overeating? 
0 = Not present 
1 = Mild to moderate increase in hunger, increased 
eating 
2 = Hungry all the time, Uncontrolled eating 
 
LOSS OF WEIGHT Have you lost or gained any 
weight since this (depression) began? 
If yes How much? 
If not sure; do you think your clothes are any looser 
(or higher) on you?  
0 = No weight loss 
1 = probable weight loss associated with present 
illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed ( do not including in scoring) 
WEIGHT GAIN 
0 = No weight gain 
1 = probable weight gain associated with present 
illness 
2 = Definite (according to patient) weight gain. 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
0  1   2   3   4 
 
 
 
 
 
 
 
 
0  1   2 
 
 
 
 
 
 
0  1  2  3 
 
 
 
 
 
 
0  1   2 
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..How were you sleeping? 
(Trouble falling as sleep, 
waking frequently, trouble 
staying asleep, waking too 
early, OR sleeping too much? 
How many hours a night 
compared to usual? Was that 
nearly every night?) 
     
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Insomnia or hypersomnia nearly every day 
Check If: 
_______ insomnia 
_______ Hypersomnia 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
INSOMNIA EARLY Have you bee sleeping over the 
last week? Have you had only trouble falling asleep at 
the beginning of the night? Right after you go bed how 
much it has been taking you to fall asleep? How many 
nights this week have you trouble falling asleep? 
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep 
i.e. more than ½ hour** 
2 = complains of nightly difficulty falling asleep  
***not related to childcare responsibilities.  
 
INSOMNIA MIDDLE during the past week, have 
you been waking up middle of the night? 
If yes: Do you get out of bed? What do you do? (only 
to go to the bathroom) 
When you get back in bed are you restless or disturbs 
some nights? 
0 = No difficulty 
1 = Patient complains of being restless and disturbed 
during the night*** 
2 = Walking during the night, nay getting out of bed 
(except for purpose of voiding)*** 
***Not related to childcare responsibilities.  
 
INSOMNIA LATE what time you have been waking 
up in the morning for the last since this past week? 
If early; Is that with an alarm clock, or do you just 
wake up yourself? What time do you usually wake up 
(what is before you got depressed)? 
0 = No difficulty 
1 = Waking in early hours of the morning but goes 
back to sleep *** 
2 = Unable to fall asleep again if she gets out of 
bed*** 
*** Not required to childcare responsibilities 
 
HYPERSOMNIA  
0 = No difficulty  
1 = Frequently sleeps at least 1hour or more ( or 
spends 1 hour or more in bed) than when not 
depressed*** 
2 = Frequently sleeps 2 or more hours ( or spends 2 or 
more hours in bed) than when not desired *** 
***Not related to night time childcare responsibilities. 
 
 
 
 
 
 
 
 
? 1  2  3 
 
 
 
 
 
 
 
 
 
    0    1     2 
 
 
 
 
 
 
 
 
 
 
 
    0   1    2 
 
 
 
 
 
 
 
 
 
 
0     1      2 
 
 
 
 
 
0      1     2 
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…were you so fidgety or restless 
that you are unable to sit still? 
(Was it so bad that other people 
noticed it? What did they notice? 
Was that nearly everyday?) 
 
IF NO: What about the opposite 
talking or moving more slowly 
than is normal for you? (Was it so 
bad that other people noticed it? 
What did they notice? Was that 
nearly everyday?) 
  
 
 
(5)psychomotor agitation or retardation nearly 
everyday ( Observable by others not merely 
subjective feelings of restlessness or being slowed 
down) 
NOTE: CONSIDER BEHAVIOR DURING THE 
INTERVIEW 
Check if: 
_______psychomotor retardation 
_______psychomotor agitation 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
RETARDATION (slowness of thought and 
speech; impaired ability to concentrate, decreased 
motor activity) 
Rating based on observation during interview 
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = interview difficult 
4 = complete stupor  
 
AGITATION rating based on observation during 
interview or by que whether the person has 
engaged in any of the behaviors listed below 
0 = None 
1 = Fidgetiness 
2 = playing with hands, hair, etc 
3 = Moving about  can’t sit still 
4 = Hand wringing nail-biting, hair-pulling, biting 
of lips 
 
ANXIETY SOMATIC (physiological, 
Concomitants of anxiety such as ; 
Gastrointestinal= dry mouth, gas, indigestion , 
diarrhea,  cramps, belching, 
cardiovascular=palpitations, headaches, 
Respiratory= hyperventilation, sighing, urinary 
frequency; sweating) 
In this past week have you had any of these 
physical symptoms? (Read list above pausing after 
each symptom for reply) How much have these 
things been bothering you thus past week?(allow 
bad have they gotten? How much of the time, or 
how often, have you had them?) 
NOTE: Don’t rate if clearly due to medication 
(e.g, dry mouth and imipramine)  
0 = Absent 
1 = mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
 
 
 
 
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
0  1  2  3  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1  2  3  4 
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…What was your energy like? 
(Tired all the time? Nearly 
every day? ) 
 
 
 
 
 
 
(6)Fatigue or loss of energy nearly every day 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOMATIC SYMITOMS GENERAL 
How has your energy been this past week? 
Have you been tired all the time? 
This week have you had any heaviness in 
your limbs, back or head? 
 
0 = None 
1 = Heaviness in limbs, back or head, 
Backbones, headaches 
2 = any clear-out symptom rates 2 
 
 
 
HYPOCHONDRIASIS In the last week, 
how much have your thoughts been focused 
on your physical health or how your body is 
working (compared to your normal thinking)? 
Do you complain much about how feel 
physically? 
Have you found yourself asking for help with 
things you could really do yourself? 
If yes; Like what for example? How often has 
that happened? 
0 = Not present 
1 = self-absorption (bodily) 
2 = Preoccupation with health. 
3 = Frequent complains, requests for help etc 
4 = hypochondriacally illusions  
 
 
 
 
 
 
 
 
?  1   2   3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0      1     2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1   2   3   4 
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During this time……. 
 
….how did you feel about 
yourself? (Worthless?)(Nearly 
Every day?) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(7)feelings of worthlessness or excessive or 
inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or 
guilt about being sick) 
 
NOTE: CODE “1” OR “2” IF ONLY LOW 
SELF _ESTEEM 
 
Check if: 
_______worthlessness 
_______inappropriate guilt 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
FEELINGS OF GUILT how you have been 
especially critical of yourself this past week, 
feeling you have done things wrong, or  let others 
down? 
If yes: What have your thoughts been? 
Have you been feeling guilty about anything that 
you’ve done or not done? 
Have you thought that you’ve brought (this 
depression) on yourself in some way? 
Do you feel you are being punished by being sick? 
 
0 = Absent 
1 = Self reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or 
sinful deeds 
3 = Present illness is a punishment. Delusions of 
guilt 
4 = Hears accusatory or denunciatory voices and 
experiences throntoning visual hallucinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0   1   2   3   4 
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…did you have trouble thinking 
or concentrating? (What kinds of 
things did it interfere with?) 
(Nearly every day?) 
 
 
 
(8) diminished ability to think or concentrate, or 
indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
 
Check if:  
_______diminished ability to think 
_______ indecisiveness 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
 
 
 
 
ANXIETY PSYCHIC 
Have you been feeling especially tense or irritable 
this past week? 
Have you been worrying a lot about unimportant 
things, things you wouldn’t ordinarily worry 
about? 
If yes Like what, for example? 
 
0 = No difficulty 
1 = subjective tension and irritability 
2 = worrying about minor matters 
3 = Apprehensive attitude apparent in speech 
4 = Fears expressed without questioning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0  1   2    3    4 
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…were things so bad that you 
were thinking a lot about death 
or that you would be better off 
dead? What about thinking of 
hurting yourself? 
 
IF YES: Did you do anything to 
hurt yourself? 
 
 
 
 
 
 
 
 
 
 
 
(9) Recurrent thoughts of death (not just fear if 
dying), recurrent suicidal ideation without a 
specific plan or a suicide attempt or a specific 
plan for committing suicide 
NOTE: CODE “1” FOR 
SELF_MULTILATION W/O SUICIDAL 
INTENT 
 
Check if: 
______ thoughts of own death 
______ suicidal ideation 
______ Specific plan 
______ Suicide attempt 
 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
SUICIDE 
This past week, have you had any thoughts that 
life is not worth living, or that you’d be better off 
dead? What about having thoughts of killing 
yourself? 
 
0 = Absent  
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of 
possible death to self 
3 = Suicide ideas or gesture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
?    1    2    3 
 
 
 
 
 
 
 
 
 
0    1    2    3 
 IF ACTIVELY SUICIDAL, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW REFER. 
 
IF AT LEAST FIVE OF THE ABOVE SXS [A 
(1-9)] ARE RATED “3” AND AT LEAST ONE 
OF THE THESE IS ITEM (1) OR (2), GO TO 
NEXT SECTION 
 
IF AT LEAST TWO (BUT LESS THAN 5) OF 
THE ABOVE SXS ARE RATED “3” AND AT 
LEAST ONE OF THESE IS ITEM (1) OR (2), 
GO TO MINOR DEPRESSIVE DISORDER 
(PG 13). 
IF NONE OF THE ABOVE, USE CODE X 
AND EXCLUDE FROM STUDY, END 
INTERVIEW 
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IF UNCLEAR: Has (DEPRESSIVE 
EPISODE/ OWN WORDS) made it 
hard for you to do your work, take care 
of things at home, or get along with 
other people. 
 
 
 
B. The symptoms cause clinically 
significant distress or impairment in 
social, occupational, or other important 
area of functioning 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF 1, USE CODE X AND EXCLUDE 
FROM STUDY. END INTERVIEW 
 
 
 
 
 
 
?   1   2   3 
Just before this began, were you 
physically ill? 
 
IF YES: what did the doctor say? 
 
Just before this began, were you using 
any medications? 
 
IF YES: Any change in the amount you 
were using? 
 
Just before this began, were you 
drinking or using any street drugs? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. The symptoms are not due to the direct 
physiological effects of a substance (e.g., 
a drug of abuse, medication) or to a 
general medical condition 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE, 
USE CODE X OR X RESPECTIVELY 
AND EXCLUDE FROM THE STUDY, 
END INTERVIEW 
Etiological general medical conditions 
include: 
Degenerative neurological illnesses (e.g., 
Parkinson’s disease), cerebrovascular 
disease (e.g., stroke), metabolic conditions 
(e.g., vitamin B-12 deficiency), endocrine 
conditions (e.g., hyper- and 
hypothyroidism, hyper- and 
hypoadrenocorticism); viral or other 
infections (e.g., hepatitis, mononucleosis 
HIV), and certain cancers (e.g., carcinoma 
of the pancreas).  
Etiological substances include: 
Alcohol, amphetamines, cocaine, 
hallucinogens, inhalants, opioids, 
phencyclidine, sedatives, hypnotics, 
anxiolytics. Medications include 
antihypertensive, oral contraceptives, 
corticosteroids, anabolic steroids, 
anticancer agents, analgesics, 
anticholinergics, cardiac medications. 
IF NOT, CONTINUE BELOW 
 
 
 
 
 
 
?   1   2   3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. Not better accounted for by bereavement, 
i.e., after the loss of a loved one, the 
symptoms persist for longer than 2months or 
are characterized by marked functional 
impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic 
symptoms, or psychomotor retardation. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF SIMPLE BEREAVEMNET, USE CODE 
X AND EXCLUDE FROM STUDY.END 
INTERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSE MAJOR DEPRESSIVE 
EPISODE IF CRITERIA A,B,C AND D ARE 
RATED “3”  
 
IF NOT, CODE X AND EXCLUDE FROM 
STUDY. 
END INTERVIEW. 
 
 
 
  
 
IF MDE DIAGNOSED, GO TO NEXT 
SECTION. 
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CRITERIA FOR SERVERITY/PSYCHOTIC SPECIFIERS 
 
 
1   MILD: Few, if any, symptoms in excess of those required to make the 
diagnosis AND symptoms result in only minor impairment in occupational 
functioning or in usual social activities or relationships with others. 
IF YES, USE CODE X 
 
2   Moderate: Symptoms or functional impairment intermediate between “mild” 
and “severe”. 
IF YES, USE CODE X 
 
3   Severe Without Psychotic Features: Several symptoms in excess of those 
required to make the diagnosis AND symptoms markedly interfere with 
occupational functioning or with usual social activities or relationships with 
others. 
IF YES, USE CODE X 
 
4   Mood-congruent psychotic Features: Delusions or hallucinations whose 
content is entirely consistent with the typical depressive themes of personal 
inadequacy, guilt, disease, death, nihilism, or deserved punishment. 
IF YES, USE CODE X 
 
5   Mood-incongruent psychotic Features: Delusions or hallucinations whose 
content does not involve typical depressive themes of personal inadequacy, guilt, 
disease, death, nihilism, or deserved punishment. Included are such symptoms as 
persecutory delusions (not directly related to depressive themes), thought 
insertion, and delusions of control. 
IF YES, USE CODE X AND EXCLUDE FROM STUDY. END INTERVIEW 
REFER 
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MINOR DEPRESSIVE 
DISORDER 
MDD CRITERIA RATING 
REFER TO ITEMS A1-A9 ON 
PAGES 1 TO 9. 
 
 
 
 
 
 
 
 
IF UNCLEAR: HAS 
(DEPRESSIVE EPISODE/OWN 
WORDS) made it hard for you 
to do work, take care of things at 
home, or get along with other 
people? 
 
 
 
 
Just before this began, were you 
physically ill? 
IF YES: What did the doctor 
say? 
Just before this began, were you 
using any medications? 
IF YES: Ant change in the 
amount you were using? 
Just before the began, were you 
drinking or using any street 
drugs? 
 
 
 
 
 
 
 
A. A mood disturbance, defined as follows: 
(1) At least two (but less than 5) of the 
symptoms of major Depressive Episode 
during the same two-week period and 
represent a change from previous functioning; 
at least one of the symptoms is either (a) 
depressed mood or (b) loss of interest or 
pleasure. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
(2). The symptoms cause clinically significant 
distress or impairment in social, occupational, 
or other important areas of functioning. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
(3) The symptoms are not due to the direct 
physiological effects of a substance (e.g., a 
drug of abuse, medication or to a general 
medical condition. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF THERE IS ANY INDICATION THAT 
THE DEPRESSION MAY BE 
SECONDARY (I.E., A DIRECT 
PHYSIOLOGICAL CONSEQUENCE OF 
A GMC OR SUBSTANCE, USE CODE X 
OR X RESPECTIVELY AND EXCLUDE 
FROM THE STUDY. END INTERVIEW 
 
SEE PAGE 10 FOR MEDICAL 
CONDITIONS 
 
IF N OT, CONTINUE BELOW 
 
 
 
 
 
 
 
 
 
?   1  2  3 
 
 
 
 
 
 
 
?   1  2  3 
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Did this begin soon after 
someone close to you died? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4). Not better accounted for by Bereavement 
 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
 
 
 
 
B. There has never been a major Depressive 
episode and criteria are not met for dysthymic 
Disorder. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
C. Has never had a Manic Episode, Mixed 
Episode, or hypo-manic Episode and criteria 
are not met for Cyclothymic Disorder. Note: 
this exclusion does not apply if all of manic-
mixed-, or hypo-manic- like episodes are 
substance or treatment induced. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
D. The mood disturbance does not occur 
exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective 
Disorder, Delusional Disorder, or Psychotic 
Disorder NOS. 
? = Inadequate information 
1 = Absent or False 
2 = Sub threshold 
3 = Threshold or true 
 
IF CRITERIA A, B, C OR D ARE NOT 
MET, EXCLUDE FROM STUDY.END 
INTERVIEW. 
 
 
 
 
 
 
 
 
 
 
?   1   2   3 
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